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Abstract 
The sub-therapeutic use of antibiotics as growth promoters in animal diets has been of concern and 
even been banned in some countries due to the emergence of antibiotic resistant bacteria, associated 
with human and animal disease. Probiotics are increasingly popular as an alternative to antibiotic 
growth promoters.  
Bacillus amyloliquefaciens strain H57 (H57) is a spore forming aerobic bacterial strain that has 
been used as a probiotic with ruminants. This thesis examined H57 as a probiotic for broiler 
chickens; bird growth performance and feed efficiency along with its effects on the gastrointestinal 
microbiome and function were assessed.  
Three broiler growth experiments were undertaken using diets with and without H57. The first 
experiment used a sorghum based diet, the second a wheat based diet and the third used three diets; 
i) sorghum based, ii) wheat based and iii) a sorghum and wheat blend (chapter 3). The effect of 
H57 on the intestinal microbial profile was studied using 16S rRNA gene sequencing of genomic 
DNA extracted from digesta samples from the ileum and caecum (chapter 4). The impact on 
potential caecal microbial function was studied using a shotgun metagenomic sequencing approach 
(chapter 5). The dynamics of H57 within intestinal content was measured by quantitative PCR 
(chapter 6).  
Measurement of the population dynamics of H57 in the ileum and caecum by quantitative PCR 
indicated that there was no apparent multiplication of H57 cells in the gastrointestinal tract (GIT) 
and if spores did germinate, then vegetative growth was only sufficient to maintain numbers within 
the GIT.  
Birds fed a sorghum based diet supplemented with H57 had improved body weight and feed 
conversion in both experiments 1 and 3. The response of H57 in wheat based diets varied between 
experiments; there was a positive effect of H57 in experiment 3 but not in experiment 2. In contrast, 
no improvement in bird performance was observed with birds fed a sorghum/wheat blend, with 
H57, in experiment 3. Notably, H57 had a positive effect on live weight gain only when control 
birds were underperforming, which presumably was ameliorated by H57.  
H57 modified both the ileal and caecal microbial communities of the broilers. However, the effect 
of H57 on intestinal microbiota was not uniform across all experiments, diets (sorghum, wheat or 
mixed) or the age of the birds. There were significant differences in the intestinal microbial 
communities between different batches of chickens. Microbial community structure also varied 
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with the diet fed. Although there were several intestinal microbes with significantly different 
abundance between control and H57 birds, correlation analysis indicated that all of the microbes 
affected by H57 were not directly correlated to body weight gain, indicating that these microbes do 
not have a direct influence on growth. Moreover, this study showed that the caecal microbial 
functional potentiality of H57 treated and control birds, could differ even though the microbial 
population structure was similar. Therefore, it appears that the response to H57 was not mediated by 
changes in the microbial population per se but rather their functionality.  
Several microbial functions in the caeca were significantly affected by feeding H57, both with 
wheat and sorghum based diets, as indicated by significantly different relative abundance of 
functional genes between H57 treated and control groups. Abundance of genes responsible for 
fermentation and energy metabolism (e.g. citric acid cycle and pentose phosphate pathway) were 
increased in the caeca of birds fed wheat based diets with H57, while the abundance of genes 
relating to microbial virulence (e.g. regulation of virulence, capsular and extracellular 
polysaccharide, biosynthesis of lipopolysaccharides, resistance to antibiotics) were significantly 
reduced in H57 fed birds fed the sorghum based diet. Increased fermentation rate as indicated by 
higher abundance of fermentation related genes in H57 treated birds may indicate a higher 
microbial digestion of non-starch polysaccharides, which are regarded as common anti-nutritional 
factor in wheat. Positive responses to H57 was only observed when there was growth depression in 
control birds (chapter 3). This was accompanied by modulation of intestinal microbial profiles 
(chapter 4) and fewer microbial virulence factors (chapter 5) in H57 treated chickens; leading to 
the presumption that H57 may modulate the intestinal microbiome and/or its function to reduce 
microbial virulence factor(s) responsible for the depression of growth in chickens. This could 
provide additional energy, otherwise used to maintain immune function, for increased live weight 
gain. The differences in the effects of H57 with different batches of chicks and different diet 
composition may have been due to inherent differences in the resident intestinal microbial 
populations in birds from different hatcheries as well as different batches from the same hatchery.  
Thus, while B. amyloliquefaciens H57 appears to have significant potential for use as a probiotic in 
poultry production, its possible modes of action and production benefits remain to be fully 
elucidated. 
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Chapter 1 General introduction 
1.1 Background 
The world’s population is expected to reach more than 9 billion by 2050, imposing food security 
challenges particularly for developing countries. Moreover, economic growth has increased the 
demand for livestock products putting pressure on the livestock sector to produce more with limited 
resources. Nevertheless, the livestock sector is one of the fastest growing agricultural sectors 
contributing about 40 % of the global value of agricultural production (Bruinsma, 2003), supporting 
the livelihoods and food security of almost 1.3 billion people.  
Livestock provide a major source of disposable income for disadvantaged and marginal populations 
in developing countries and a major entry point to fight against rural poverty (Randolph et al., 2007, 
Smith et al., 2013). In addition to being a good source of income and nutrition, livestock provide 
draft power and manure for use as fuel and fertilizer. Also livestock enterprises can offer inflation-
proof animal assets for insurance and financing (Ehui et al., 1998, Sansoucy et al., 1995). Intensive 
production systems are playing an increasingly important role in the livestock sector worldwide. 
Poultry are the cheapest source of animal protein significantly contributing to supplying the 
growing demand for animal food products around the world. The global poultry industry is growing 
faster than other agricultural commodities making it the second largest source of meat after pork. 
Despite the benefits to many of increased livestock production, this has created two major public 
health issues. Firstly, sub-therapeutic use of antibiotics as growth promoters in animal feed has 
evoked widespread concern and their use banned in many countries, including the European Union 
(EU), due to the potential to develop antibiotic resistance in microbial populations associated with 
human and animal diseases. Secondly, some of the food borne zoonotic diseases like salmonellosis, 
campylobacteriosis and pathogenic Escherichia coli infection, among others are serious public 
health concerns around the world and can cause serious economic loss.  
Probiotics (or direct fed microbials) are becoming increasingly popular as one of the alternatives to 
Antibiotic Growth Promoters (AGP). The most important objectives for using probiotics in animal 
feed are to maintain and improve the performance (productivity and growth) of the animal and 
prevent and control enteric pathogens. In the context of the growing concern with the sub-
therapeutic use of AGP in animal feed and greater appreciation of the role of the microbial ecology 
of the gastrointestinal tract (GIT) in determining animal productivity, increasing numbers of 
probiotic products are being developed and used in animal nutrition.  
 2 
1.2 Research problem 
Sub-therapeutic use of antibiotics as growth promoters in animal feed has received widespread 
concern and even been banned from use in many countries. There is therefore a urgent need to fine 
feed additives to fill the void left by the reduction in the use of AGPs; probiotics have great 
potential in this regard. Two of the most important objectives for using probiotics in poultry feed 
are to promote productivity and control enteric pathogens.  
Recently, there have been many studies to evaluate the performance of probiotics to improve the 
growth rate in poultry/broilers and to control or prevent of enteric diseases like salmonellosis, 
campylobacteriosis, necrotic enteritis etc. Although probiotics have been found to be beneficial in 
poultry production, the results are highly variable and there is limited information about their mode 
of action and effects on gastrointestinal microbial ecology. There is limited knowledge about the 
function of microbes occurring in the GIT. Currently there is no single probiotic strain which is 
beneficial across different production systems and which addresses all of the issues raised above. 
Researchers from the University of Queensland (UQ) have isolated a novel strain of Bacillus 
amyloliquefaciens strain H57 (H57) from a lucerne plant at the UQ Gatton Campus. The strain has 
been shown to prevent mould development on hay.  The strain was used in the commercial product 
HayRite. and studies have demonstrated benefits to animal agriculture, in terms of improved 
nitrogen retention and therefore reduced feed protein wastage in ewes fed hay treated with H57 
(Brown and Dart, 2003). The bacterial strain was effective in enhancing the performance of sheep 
(Le et al., 2017).  
1.3 Objectives of the PhD 
There have been no studies using B. amyloliquefaciens strain H57 in nonruminant/monogastric 
animals. The current studies have been designed with the major objectives of assessing the effect of 
this bacterium in poultry and studying the effects of this probiotic on the function and profile of the 
gastrointestinal microbiota. It was also hoped that these studies would assist in the elucidation of 
the mode of action of this probiotic bacterium.  Specific objectives were; 
1. To evaluate the effects of B. amyloliquefaciens H57 on performance of poultry.  
2. To study the effects of B. amyloliquefaciens H57 on the intestinal microbial population of 
poultry. 
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3. To study the effects of B. amyloliquefaciens H57 on the gastrointestinal microbial function 
in poultry. 
To achieve these objectives, the candidate probiotic B. amyloliquefaciens H57 has been produced in 
the fermentation facility established on the Gatton Campus of the University of Queensland. The 
bacterial spore produced were mixed in poultry feed and fed to broilers and bird productivity 
measured.  Microbial profiling of the ileum and caecum of chicken was determined by 16s rRNA 
sequencing of the genomic DNA extracted from the intestinal contents. Metagenomic shotgun 
sequencing was used to study the microbial function in the caecum. 
1.4 Significance of the project 
Although the candidate probiotic B. amyloliquefaciens strain H57 has been found to be effective in 
ruminants, its efficacy has not been tested in monogastrics. Therefore, its efficacy has to be tested in 
a range of production scenarios, if this probiotic is to be developed further and is to be used in 
commercial poultry production. If the tested probiotic is found effective, it could be a candidate to 
replace antibiotic growth promoters in poultry feed which could reduce the public health hazard 
associated with the use of antibiotics as growth promoters in feed.  
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Chapter 2 Literature review† 
2.1 Probiotics: Definition and classification 
2.1.1 Definition 
The term ‘probiotics’ was first used by Lilly and Stillwell (1965) to designate unknown growth 
promoting substances produced by a ciliate protozoan which stimulated the growth of another 
ciliate. The term now covers a much broader group of organisms. Parker (1974) defined probiotics 
as “organisms and substances which contribute to intestinal microbial balance” thus including both 
living organisms and non-living substances. Fuller (1989) was critical of the inclusion of the word 
‘substances’ and redefined probiotics as “a live microbial feed supplement which beneficially 
affects the host animal by improving its intestinal microbial balance”.  
The joint Food and Agriculture Organization of the United Nations (FAO) and World Health 
Organization (WHO) working group defined probiotics as “live microorganisms which when 
administered in adequate amounts confer a health benefit on the host” (FAO and WHO, 2001). This 
definition is widely accepted and adopted by the International Scientific Association for Probiotics 
and Prebiotics (Hill et al., 2014). 
The FAO and WHO definition of probiotics as “live microorganisms that, when administered in 
adequate amounts, confer a health benefit on the host” is the most widely accepted.   
2.2 Microorganisms used in probiotics  
Many commercial products use multi-strain probiotics although the benefits of using more than one 
strain or species in a single product has not been clearly established (Zhao et al., 2013). 
Microorganisms that have been used as probiotics in animal feed are listed in Appendix 1 table S1. 
2.3 Mode of probiotic action 
Although probiotics are found beneficial to improve production and growth in poultry, their mode 
of action is not always clear (Ajuwon, 2015). Different probiotics exert their effects through 
different mechanisms not fully understood and presumed to be due to their action either in the 
                                                 
† An extensive literature review with wider scope covering impacts of probiotics in poultry, pig and 
ruminants; and safety and regulation of probiotics has been done during candidature of this PhD and 
published by Food and Agriculture Organization of the United Nations  (http://www.fao.org/3/a-
i5933e.pdf). Remaining sections of literature review is given in Appendix 1. 
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gastrointestinal lumen or the wall of the GIT. Although probiotics are being promoted as a 
substitute for AGP, the mechanism of action of these feed additives appears to be different (Fajardo 
et al., 2012).  
Probiotics help to prevent and control gastrointestinal pathogens and/or improve the performance 
and productivity of production animals through different mechanisms. Closely related strains may 
differ in their mode of action (Roselli et al., 2007, Fioramonti et al., 2003, Lodemann, 2010). There 
are increasing number of spore forming bacterial strains to be used as probiotics. A small 
proportion of ingested spores is believed to germinate in the intestine of animals (Casula and 
Cutting, 2002, Tam et al., 2006). However, it is not clear whether the germinated spores or the 
spores in its ingested form exert beneficial effects on the host. Major mechanisms of action 
proposed for probiotics are as follows. 
2.3.1 Modification of the microbial population of the GIT: promoting 
favourable GIT microflora 
Maintaining the gut health in animals, particularly in the context of AGP being gradually phased 
out, through the manipulation of diet is crucial to maintain/improve the performance of production 
animals (Choct, 2009). One of the major determinants of a healthy GIT is the composition of the 
microbial population. Probiotics can change the microbial population dynamics in the GIT 
eventually creating a more favourable microbial population due to a shift in the balance of 
beneficial and harmful microbes (Mountzouris et al., 2007, Mountzouris et al., 2009, An et al., 
2008). Healthy microbial populations in the GIT are often associated with enhanced animal 
performance, reflecting more efficient digestion and improved immunity (Hung et al., 2012, Niba et 
al., 2009). The reduction in pathogenic microorganisms in the GIT may be attributable to the 
production of antimicrobial substances such as bacteriocins (Shim et al., 2012) and adhesion of the 
probiotic microbes to the intestinal epithelium, thereby excluding pathogens competitively or by 
inducing immune system response. 
The most common modulation of the GIT microflora by probiotics (for example in chickens) is the 
increase in the populations of Lactobacillus and Bifidobacteria (Shim et al., 2012, Mountzouris et 
al., 2010, Mookiah et al., 2014, Abdelqader et al., 2013, Hung et al., 2012, Yang et al., 2012a, 
Zhang et al., 2011, Zhang et al., 2014a, Cao et al., 2013, Vahjen et al., 2002, Khaksar et al., 2012, 
Landy and Kavyani, 2013) while populations of coliforms particularly Escherichia coli (Shim et al., 
2012, Mountzouris et al., 2010, Mookiah et al., 2014, Abdelqader et al., 2013, Hung et al., 2012, 
Yang et al., 2012a, Samli et al., 2010, Zhang et al., 2014b, Cao et al., 2013, Khaksar et al., 2012, 
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Landy and Kavyani, 2013) and Clostridium spp. (Shim et al., 2012, Abdelqader et al., 2013, Yang 
et al., 2012a, Cao et al., 2013) decrease. This pattern of modification of the GIT microflora occurs 
with all the common types of bacteria used as probiotics, such as lactic acid bacteria (LAB) 
(Mountzouris et al., 2010, Mookiah et al., 2014, Cao et al., 2013), spore forming bacteria (Bacillus 
spp.) (Shim et al., 2012, Abdelqader et al., 2013) and clostridial bacteria (C. butyricum) (Yang et 
al., 2012b, Zhang et al., 2011), and with both Gram positive and Gram negative strains 
(Hashemzadeh et al., 2013). In contrast, dietary supplementation of broiler diet with a commercial 
probiotic containing S. cerevisiae did not affect total aerobic microbes, lactose faecal coliforms, 
Lactobacillus, and E. coli in the content of all intestinal sections (duodenum, jejunum, ileum and 
caeca) at day 21 (Abdel-Raheem et al., 2012). At day 42 only the population of Lactobacillus in the 
duodenum was increased significantly without change in the population of all other measured 
microbes (as mentioned above) in all intestinal sections. However, the probiotic induced body 
weight increase of 9%, feed intake by 3% and FCR by 6%.  
Lactobacilli and bifidobacteria produce proteins or polypeptide bacteriocins which reduce the 
growth of closely related bacterial species (Kawai et al., 2004, Yildirim and Johnson, 1998), which 
may reduce the number of harmful microorganisms in the GIT.  
Lactobacillus adheres to the ileal epithelial cells of chickens (Jin et al., 1996). This may 
competitively exclude pathogenic microorganisms from the GIT (Mookiah et al., 2014). In addition, 
these bacteria produce short chain fatty acids (SCFA) such as acetic and lactic acid which can 
inhibit harmful microbes in the GIT (Jin et al., 1996, Watkins et al., 1982, Mookiah et al., 2014).  
Probiotics may increase the population of beneficial microorganisms including lactobacilli and 
bifidobacteria, which then inhibit growth of harmful microorganisms by producing inhibiting 
substances (bacteriocins and/or organic acids) and by competitive exclusion. 
However, because only a small proportion of the microbial flora in the GIT can be cultured, modern 
DNA sequencing methods are required to delineate the effects of probiotics on the animals GIT 
microbiome. In a probiotic dose response study, Mountzouris et al. (2010) showed that 
improvement in the growth rate of chickens occurred without a significant change in the 
populations of microbes in the GIT assessed using culture based techniques. Inclusion of the multi-
strain commercial probiotic (PoultryStar ME) in poultry feed at 108 cfu/kg enhanced the growth rate 
of broiler chickens without an observable effect on caecal microflora composition. Increasing the 
concentration of the probiotic in feed to 109 cfu/kg, however, altered the caecal microbial 
populations reducing coliforms.  
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Two important points about the effects of probiotics in gastrointestinal microbial ecology are: i) 
There appear to be species specific effects of probiotics on GIT microflora and ii) Traditional 
culture-based techniques applied in most of the studies are not able to adequately reflect the actual 
GIT microbial population. As traditional culture-based techniques are extremely limited in their 
ability to decipher changes in microbial ecosystems, the application of modern molecular 
identification and sequencing techniques are required to provide insight into the effects of 
probiotics on the GIT microbiota. 
2.3.2 Increase in digestion and absorption of nutrients 
Improvements in productivity of animals due to probiotics can be associated with an increase in 
digestion and absorption of nutrients. The response in broiler chickens to dietary supplementation 
of L. bulgaricus varied with level of probiotic provided.  At the rate of 2x106 cfu/g there was no 
significant effect on digestibility of crude protein or fat, but at 6x106 cfu/g and 8x106 cfu/g there 
was a significant increase ranging from 7-11% for protein and 6.5 -13.4% for fat with 7.9-11.7% 
increase in weight gain (Apata, 2008). In another study, although supplementation of broiler diet 
with the commercial probiotic (AgiPro A100) increased digestibility of dry matter (DM) by 12.4% 
at day 42 (Li et al., 2008) weight gain, average daily gain, feed intake and FCR were not 
significantly affected. Similarly, probiotics increased the apparent ileal digestibility of essential 
amino acids with 5% improvement in body weight gain (Zhang and Kim, 2014) and improved the 
bioavailability of calcium in chicken (Chawla et al., 2013).  
Increased digestibility of nutrients in diet may be due to increased enzyme activity in the intestine 
due to probiotics. Lactobacillus probiotics altered the digestive enzyme activity in the GIT of 
poultry and pigs. Amylase activity in the small intestine of poultry increased by 42% in response to 
L. acidophilus supplied at the rate of 2x106 cfu/g of corn-soybean based diet (Jin et al., 2000). 
However, there was no change in proteolytic and lipolytic activity. This improvement in amylase 
activity was associated with a 4.6% increase in body weight gain and 5% improvement in feed use 
efficiency. Similarly, sucrose, lactase and amylase but not peptidase activity in the small intestine of 
pre-weaned pigs increased in response to a commercial probiotic (Probios) containing L. plantarum, 
L. acidophilus, L. casei and E. faecium (Collington et al., 1990). 
Spore forming bacteria, like Bacillus amyloliquefaciens, produce extracellular enzymes including α-
amylase, cellulase, proteases and metalloproteases (Gould et al., 1975, Lee et al., 2008, 
Gangadharan et al., 2008), which could increase nutrient digestion.  
 8 
Increased enzyme activity in the gastrointestinal tract of animals supplemented with probiotics 
could be due to either production of enzyme by the probiotic itself or induced change in the 
microbial population and thence enzyme production.  
Probiotics increased the height of intestinal villi and villus height: crypt ratio in poultry (see section 
7.1.5) (Afsharmanesh and Sadaghi, 2014, Jayaraman et al., 2013, Biloni et al., 2013), thus 
increasing the surface area for nutrient absorption. 
2.3.3 Production of antimicrobial substances 
Some probiotics produce antimicrobial substances which may inhibit growth of pathogenic 
microorganisms in the intestine. 
Many bacterial species including lactic acid bacteria (LAB) (Flynn et al., 2002, Nes et al., 1996, 
Klaenhammer, 1988), bifidobacteria (Cheikhyoussef et al., 2008) and bacillus (Hyronimus et al., 
1998, Le Marrec et al., 2000) can produce several types of thermostable bacteriocins (Cotter et al., 
2005) which have antimicrobial activity against a range of potential pathogens of animals including 
Bacillus, Staphylococcus, Enterococcus, Listeria, and Salmonella species (Rea et al., 2007, Flynn et 
al., 2002, Corr et al., 2007). Corr and colleagues (2007) demonstrated that the probiotic L. 
salivarius strain UCC118 produced a broad spectrum bacteriocin, Abp118, which protected mice 
against pathogenic Listeria monocytogenes. A mutant of the same probiotic unable to produce 
bacteriocins did not protect the mice confirming bacteriocins were the active agent.  
Bacteriocin produced by LAB (for example Nisin) inhibits the growth of pathogenic 
microorganisms by inhibiting cell wall synthesis with the formation of pores in the bacterial surface 
(Hassan et al., 2012, Wiedemann et al., 2001). To achieve this, the bacteriocin binds the cell wall 
precursor, lipid II, forming a complex which can form a pore in the bacterial cell membrane leading 
to the death of the bacterium (Bierbaum and Sahl, 2009, Wiedemann et al., 2001). 
Many probiotic bacteria, especially LAB producing SCFA, particularly lactic and acetic acids, can 
inhibit pathogenic bacteria (Commane et al., 2005, Fayol-Messaoudi et al., 2005). SCFA reduce the 
pH in microenvironments within the intestinal lumen and can then be taken up by GIT microbes in 
broiler chickens reducing their intracellular pH to a lethal level for some bacteria (Daskiran et al., 
2012).   
Probiotic bacteria produce other antimicrobial compounds which may inhibit harmful microbes in 
the GIT. Brashears et al. (1998) found that Lactobacillus lactis strains when inoculated in 
refrigerated raw chicken meat inoculated with E. coli 0157: H7 inhibits the growth of E. coli 0157: 
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H7 due to production of hydrogen peroxide. Does Lactobacillus produce hydrogen peroxide in the 
gastrointestinal environment? B. subtilis PB6, a bacterial strain isolated from the GIT of chickens 
produces a heat stable anticlostridial factor, which inhibited Clostridium perfringens, the causative 
agent of necrotic enteritis in poultry, in vitro as well as Clostridium difficile, Streptococcus 
pneumoniae, Campylobacter jejuni, and Campylobacter coli (Teo and Tan, 2005). Similarly, B. 
amyloliquefaciens a probiotic which improved performance of broiler chickens (Lei et al., 2015, 
Ahmed et al., 2014) produces several antimicrobial cyclic lipopeptide compounds (e.g. surfactin, 
fengycin, bacillomycin D, iturin A) (Sun et al., 2006, Ongena and Jacques, 2008, Chen et al., 2009, 
Arrebola et al., 2010) and polyketides (e.g. macrolactin, difficidin, bacillaene, chlorotetaine) (Chen 
et al., 2009, Rapp et al., 1988) which antagonise the growth of plant pathogens (Chen et al., 2009).  
2.3.4 Alteration in gene expression in pathogenic microorganisms 
Bacteria communicate cell to cell through the secretion of chemical signals called autoinducers, that 
affect the behaviour of bacteria (Miller and Bassler, 2001, Waters and Bassler, 2005). This process 
of bacterial communication, called quorum sensing, is also used for communication between 
bacteria and their host (Hughes and Sperandio, 2008).  
Probiotics may affect quorum sensing in pathogenic bacteria thus influencing their pathogenicity. 
Extracellular secretion of a chemical signal (autoinducer-2) by human enterohaemorrhagic E. coli 
serotype O157:H7 was substantially inhibited by fermentation products from L. acidophilus La-5, 
resulting in the suppression of virulence gene (LEE - locus of enterocyte effacement) expression in 
vitro. This disrupts quorum sensing and eventually prevents GIT colonization by E. coli serotype 
O157:H7 in the GIT (Medellin-Peña et al., 2007).   
2.3.5 Immunomodulation 
The gastrointestinal tract component of the immune system protecting the host from the different 
types of antigens in the lumen of the GIT is affected by probiotics. Both innate and adaptive 
immunity are affected by probiotics.  
2.3.5.1 Improvement in innate gut immunity through restitution of intestinal barrier 
function 
Epithelial cells in the gastrointestinal mucosa create a selectively permeable barrier between the 
intestinal lumen (which contains harmful substances such as foreign antigens, microorganisms, and 
toxic materials as well as beneficial nutrients) and the internal environment of the body (Blikslager 
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et al., 2007, Groschwitz and Hogan, 2009). This barrier is the first line of defence against the 
microbes in the GIT (Baumgart and Dignass, 2002, Peterson and Artis, 2014). It has a combined 
defence function; incorporating anatomical structures, immunological secretions consisting of 
mucus, immunoglobulins eg IgA, antimicrobial peptides, and the epithelial junction adhesion 
complex (Baumgart and Dignass, 2002, Ohland and MacNaughton, 2010). Disease conditions 
which cause immunological disturbances disrupt this barrier (Turner, 2009), inducing inflammation 
of the intestinal wall and intestinal disorders (Hooper et al., 2001, Sartor, 2006).  
Probiotic formulations prevent chronic inflammation of the GIT through stimulation of innate 
immunity in the gastrointestinal epithelium (Pagnini et al., 2010, Galdeano and Perdigon, 2006). 
For example, a high dose (50 × 109 cfu/day) of a probiotic formulation (VSL#3) containing four 
strains of lactobacilli (L. casei, L. plantarum, L. acidophilus, and L. delbrueckii subspecies 
bulgaricus); three strains of bifidobacteria (Bi. longum, Bi. breve, and Bi. infantis); and one strain 
of streptococcus (S. salivarius subspecies thermophilus) when fed to senescence-accelerated-prone 
mice for six weeks either completely prevented ileitis or significantly reduced the severity of 
inflammation (Pagnini et al., 2010). Although this probiotic formulation was found to prevent 
ileitis, it was ineffective in treating the inflammation when administered to older mice that had 
already developed ileitis (Pagnini et al., 2010).  
Experiments in animal models have shown that improvement in intestinal barrier function by 
probiotics is due to a reduction in the permeability of the intestinal epithelium. Translocation of 
intestinal microbes out of intestinal sites and into sites such as the liver, spleen and mesenteric 
lymph nodes decreased in mice with induced colitis and pre-treated with Lactobacillus probiotics 
(Mao et al., 1996, Pavan et al., 2003, Llopis et al., 2005). Translocation of enterotoxigenic E. coli to 
mesenteric lymph node was reduced in post weaning piglets with dietary supplementation of 
probiotic P. acidilactici compared to control group after enterotoxigenic E. coli challenge (Lessard 
et al., 2009). 
Generally, timing of probiotic treatment is very important in maintaining intestinal barrier function. 
Administration of probiotics before the infectious/pathogenic agent is introduced experimentally or 
the pathogens enter the GIT and multiply naturally is the most effective time for probiotic 
introduction (Lodemann, 2010).  
2.3.5.2 Stimulation or suppression of immune response 
The immune response in the host should be sometimes stimulated (for example infection and 
immunodeficiencies) while it should be supressed in some other cases (for example allergy and 
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autoimmune diseases) based on the clinical condition (Borchers et al., 2009). Diets containing 
probiotics could modulate the host immune response.  
The responses are complicated as they vary with the probiotic strain or species, with the dose level 
and may differ in their effect pre and post weaning, and whether the antigen is a bacterium such as 
Salmonella or a virus such as the human rotavirus.   
The pattern of immune response related blood plasma cells can vary between the ileum and jejunum 
lymph tissue.  Probiotics can affect the expression of the anti-inflammatory cytokine or cell 
signalling proteins and may do so differentially depending on the cytokine. Can probiotics “prime” 
the immune system in commercial operations to support response to animal and/or human bacterial 
and viral disease antigens and reduce their shedding in faeces?  These are very complicated 
responses and the variation between probiotic strains means that there is no general “story” about 
the way probiotics might affect the immune system.  
However the significant outcome is that probiotic microbes can modulate the immune system and 
response to pathogen antigens and a systems based approach is required to address the response to a 
probiotic in terms of host disease susceptibility, shedding of pathogens both human and/or porcine, 
growth and feed use efficiency, as a guide to what probiotic a producer may wish to use. It may 
depend on what is the dominant factor needing to be addressed in the production system.  With 
increasing community (and regulatory) pressure to reduce antibiotic use in commercial animal 
production, modulation of the immune system by probiotics is a major potential benefit to be 
factored into production systems.  
Several studies have demonstrated immunostimulatory effects of probiotics. Bai et al. (2013) 
demonstrated that a probiotic containing L. fermentum and S. cerevisiae stimulated the intestinal T-
cell immune system, indicated by increased production of CD3+, CD4+, and CD8+ T-lymphocytes 
in the GIT of broiler chickens. Expression of CD3+, IL-2 and IFN-γ genes was significantly greater 
in small intestine of neonatal chicks (day 3 and 7) fed with probiotics  L. jensenii TL2937 and L. 
gasseri TL2919 than control without probiotics (Sato et al., 2009).  Dalloul et al. (2003) found 
similar effects of probiotics on the intestinal immune system of broiler chickens treated with a 
commercial probiotic product (Primalac) containing L. acidophilus, L. casei, E. faecium and Bi. 
Bifidium and infected with coccidia oocysts, the response being an increased population of 
intestinal intraepithelial lymphocytes (IEL) cf. control birds not given the probiotic. An increase in 
expression of CD3+, CD4+, CD8+ and αβTCR (T Cell Receptor - a double chain glycoprotein on 
the surface of the T cell) was observed. Probiotic B. cereus var. toyoi also caused significant 
increase in the intraepithelial population of CD8+ T cells in intestine of piglets (Scharek et al., 
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2007). Similarly, administration of probiotic E. faecium to broiler chickens challenged with E. coli 
resulted in increased concentrations of cytokines (IL-4 and TNF- α) and IgA in the small intestinal 
mucosa (Cao et al., 2013). 
Probiotics also increase serum immunoglobulin levels. A multi-strain probiotic containing L. 
acidophilus, B. subtilis and C. butyricum increased serum levels of IgA and IgM in chickens (Zhang 
and Kim, 2014). Likewise, addition of the commercial product (Gallipro) containing B. subtilis to 
broiler chicken diets increased the antibody response to sheep red blood cells administration 
(Afsharmanesh and Sadaghi, 2014). Antibody titre against the common poultry diseases Newcastle 
Disease, Infectious Bronchitis and Infectious Bursal Disease was increased by the use of probiotic 
product Primalac (Landy and Kavyani, 2013).  
In the piglets, probiotic L. fermentum I5007 modulated immune function in piglets by enhancing T 
cell differentiation and upregulating ileum cytokine expression (Wang et al., 2009). Similarly, 
probiotic containing P. acidilactici and S. cerevisiae ssp. boulardii increased T cells in ileum and 
IgA secretion in post weaning piglets challenged with enterotoxigenic E. coli (Lessard et al., 2009). 
In contrast, some studies have shown immunosuppressive action of probiotics in the host. E. 
faecium NCIMB 10415 had an immunosuppressive effect delaying early immune response to 
antigens in post weaning piglets (Siepert et al., 2014). E. faecium NCIMB 10415 reduced 
proliferation of blood mononuclear cells in response to Salmonella serovar typhimurium DT104 
antigen during 1 to 3 days post-infection followed by a similar proliferative response with or 
without the probiotic 7 days post-infection (Siepert et al., 2014). Similarly, expression of intestinal 
immune-associated genes , especially during the post-weaning period, were reduced (Siepert et al., 
2014). In the post-weaning period, expression of IL-8, IL-10 and CD86 (cluster of differentiation 
86) genes in ileal Peyer’s patches was significantly reduced in probiotic treated piglets. In contrast, 
probiotic caused increased expression of IL-10 gene and CTLA4 (T cell inhibitory molecule) in 
Jejunal Peyer’s patches in post-weaning period. Blood serum inflammation related cytokines IL-6 
and IL-8 were not affected by the probiotic.  
In an earlier study, supplementation of piglets diet with the same probiotic strain (E. faecium 
NCIMB 10415) had no effect on the lymphocyte populations in the jejunal Peyer’s patches 
(Scharek et al., 2005). The serum level of immunoglobulin IgG was reduced in probiotic treated 
piglets during the post-weaning period (28-56 days) but was not affected in the pre-weaning period 
(Scharek et al., 2005).  
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In another study, oral administration of L. brevis ATCC 8287 at the high dose rate of 1010 cells per 
animal per day to weaned piglets reduced expression of IL-4, IL-6 and TGFβ1 genes in the ileum 
and increased expression of IL-4 and IL-6 gene in the jejunum, caecum and colon (Lähteinen et al., 
2014). However this change in cytokine gene expression in the intestine did not change the 
systemic humoral immune response. Levels of serum immunoglobulins IgA and IgG were the same 
in control and probiotic treated piglets.  
Drenching of L. acidophilus strain NCFM at low dose rate (up to 106 cfu/dose x 5 doses) 
significantly increased the population of the antiviral interferon IFN-γ producing T cells and 
reduced the regulatory T cells and production of TGF-β and IL-10 in intestinal lymphoid tissue of 
gnotobiotic piglets compared to untreated animals (Wen et al., 2012). In contrast, the same 
probiotic when administered at a high dose rate (up to 109 cfu/dose x 14 doses) increased regulatory 
T cells.  
Such dose dependent response could be one of the reasons for variable results in different studies 
and with different probiotics. The gastrointestinal microbial profile of the host also could influence 
the immune response of the host against specific probiotic (Borchers et al., 2009). 
2.3.6 Colonization resistance  
The GIT of neonatal animals and birds reared naturally are colonized with microorganisms, 
generally originating from the adult (mother). These microorganisms provide protection from 
enteric pathogens. Intensification of animal agriculture has reduced the opportunity for natural 
colonization of the GIT making animals more susceptible to intestinal pathogen challenge. 
Probiotics could mimic natural colonization in neonates or colonize adult animals preventing 
pathogenic organisms from colonizing the intestinal mucosa. 
Certain strains of Lactobacillus and Bifidobacterium possess hydrophobic surface layer proteins 
which help the bacteria to non-specifically adhere to the animal cell surface (Johnson- Henry et al., 
2007, Coconnier et al., 1992, Bernet et al., 1994, Hudault et al., 1997, Tuomola and Salminen, 
1998, Bibiloni et al., 2001). Such adhesion of probiotic bacteria to the intestinal epithelium covers 
the receptor binding sites preventing pathogenic microorganisms like E. coli O157:H7, Salmonella 
etc., from attaching to the epithelium (Johnson- Henry et al., 2007, Bernet et al., 1994, Hudault et 
al., 1997). 
There are several proposed modes of action of probiotics. Some of these mechanisms are associated 
with the inhibition of enteric pathogenic microorganisms while others are responsible for improved 
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animal performance. Different probiotics may have similar mode(s) of action while a specific strain 
could function through multiple mechanisms. For example, several probiotic strains have similar 
effects on the gastrointestinal microbial population. However, modes of action of specific probiotics 
are generally not understood. In most of the studies about effects of probiotics on performance the 
exact mode of action of probiotics is not fully understood. Because closely related probiotic 
microorganisms appear to have different modes of action, mechanisms need to be studied on a 
case-by-case basis. Effects of probiotics are the outcome of interaction between host and probiotic 
microorganism. Therefore, further studies on host-microbes interaction could elucidate the 
probiotic mode of action. The rapid advances in molecular methods and DNA sequencing used to 
study microbial ecology will greatly facilitate our understanding of the way probiotics work. 
2.4 Effects of probiotics in poultry  
Poultry are the cheapest source of animal protein contributing significantly to supplying the 
growing demand for animal food products around the world (Farrell, 2013). The consumption and 
trade in poultry products is increasing rapidly as the human population increases, making it the 
second largest source of meat after pork (FAO, 2014).  
Probiotics are being used in poultry production as an alternative to antibiotic growth promoters. 
Probiotics can improve broiler chicken growth rates (Afsharmanesh and Sadaghi, 2014, Zhang and 
Kim, 2014, Mookiah et al., 2014, Lei et al., 2015) and control or prevent enteric diseases, including; 
salmonellosis (Tellez et al., 2012, Haghighi et al., 2008, Biloni et al., 2013), necrotic enteritis 
(Jayaraman et al., 2013) and coccidiosis (Dalloul et al., 2003). However the outcomes from 
probiotic use are not consistent. 
2.4.1 Growth rate 
Probiotics have enhanced the growth rate in broilers better than AGP (avilamycin) (Zhang and Kim, 
2014) and other substitutes for AGP like phytochemicals (e.g. essential oils) (Khaksar et al., 2012). 
However, the general applicability of the probiotic approach as an alternate for AGP is not yet well 
established. 
Probiotics ranging from non-spore forming LAB to spore formers and yeast have been evaluated for 
their potential to improve growth rate in commercial poultry production (Afsharmanesh and 
Sadaghi, 2014, Bai et al., 2013, Shim et al., 2012). In many cases the improvement in growth rate in 
the probiotic treated birds was associated with increased feed intake (Abdel-Raheem et al., 2012, 
Landy and Kavyani, 2013, Lei et al., 2015) and improved feed use efficiency (Shim et al., 2012, 
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Mountzouris et al., 2010, Zhang and Kim, 2014) compared with untreated birds. Therefore, 
increased digestibility of feed resulting improved feed use efficiency could be one of mode of 
actions for improved growth rate (also see section 7.1.2 and 7.1.4). Also, the differences in 
performance between treated and untreated birds may be due to a change in microbial populations 
in the GIT resulting from increased production of SCFA and immuno-modulation (Zhao et al., 
2013). Increased growth rate has also been associated with increased villus height (also see section 
7.1.5) which increases absorption of nutrients from the intestine.  
In contrast, some probiotics did not improve growth in broilers (Hung et al., 2012, Fajardo et al., 
2012, Zhao et al., 2013) even with the same species of probiotic microbe while some probiotics 
were inferior to AGP in enhancing the growth rate (Abudabos et al., 2015). For example, Cao et al. 
(2013) found that E. faecium (HJEF005) at 109 cfu/kg of feed improved growth rate in male Cobb 
broilers challenged with E. coli, while Zhao et al. (2013) using a different strain (LAB 12 – 
CGMCC 4847), fed at the rate of 2x109 cfu/kg of feed to male Ross broilers, found no growth 
effect.  Use of different broiler breeds in these two studies or different probiotic strains could be the 
reason for contrasting results. Recent studies suggested that probiotics could be more effective 
when used with prebiotics (Mookiah et al., 2014). In contrast, Abudabos et al. (Abudabos et al., 
2015) reported that body weight gain in the broiler chickens fed the combination of prebiotics and 
probiotics was less than the birds fed either probiotics or prebiotics individually. “A prebiotic is a 
selectively fermented ingredient that allows specific changes, both in the composition and/or 
activity in the gastrointestinal microflora that confers benefits upon host wellbeing and health” 
(Gibson et al., 2004). 
Effects of probiotics on growth in poultry are detailed in Table 2-1. 
One of the interesting observations from probiotic feeding trials in poultry is that some promote 
growth in the starter (early) phase (Bai et al., 2013) while others affect the grower-finisher (later) 
phase (Abdel-Rahman et al., 2013, Chawla et al., 2013, Shim et al., 2012) (Table 2). Other studies 
found improved growth throughout the broiler production cycle (Rahman et al., 2013, Cao et al., 
2013, Landy and Kavyani, 2013, Mookiah et al., 2014) (Table 2). The underlying reason for this 
difference is not known but presumably relates to the dynamics of the gut microbiota. Whether 
different probiotics should be used in particular growth periods i.e. choosing the right probiotic for 
the right time, remains to be determined.  
Many strains of probiotic microbes improve the growth rate of poultry but results can be 
inconsistent
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Table 2-1: Probiotic effects on performance of poultry 
Microorganisms 
(species) 
Commercial 
products* 
Growth rate/Body weight 
gain 
Feed 
intake 
FCR Histomorphology 
References Prestarter-
starter 
phase 
Grower-
finisher 
phase 
Over 
all 
(lifeti
me) 
Prestar
ter-
starter 
phase 
Grower-
finisher 
phase 
Over 
all 
(lifetim
e) 
Villus 
height 
Villus 
height/crypt 
depth ratio 
B. subtilis GalliPro, PrimaLac NS - S (+) S (+) NS   S (+) S (+) 
(Afsharmanesh and 
Sadaghi, 2014) 
B. subtilis GalliPro S (+) S (+) S (+) S (+) S (-) S (-) S (-) S (+) - (Abudabos et al., 2015) 
B. subtilis Super-CyC  NS S (+) S (+) - NS   - - (Abdel-Rahman et al., 2013) 
E. faecium Anta Pro EF NS S (+) S (+) - NS   - - (Abdel-Rahman et al., 2013) 
L. fermentum 
S. cerevisiae 
JSA -101 
Gold 
S (+) NS - S (+) S (-) NS NS - - (Bai et al., 2013) 
L. salivarius  
P. parvulus  
FloraMax- 
B11  
NS - -  - - - S (+) NS 
(Biloni et al., 2013) 
L. acidophilus 
D2/CSL (CECT 
4529)  
- 
S (+) S (+) NS S (-) NS NS S (-) - - 
(De Cesare et al., 2017) 
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E. faecium    NS S (+)        (Chawla et al., 2013) 
B. coagulans   NS NS NS NS S (-) S (-) S (-) NS NS (Hung et al., 2012) 
B. coagulans   - - S(+) - - - S (-) - - (Zhou et al., 2010) 
B. licheniformis  
B. subtilis  
Enhancer 
NS S (+) S (+) S (+) S (-) S (-) S (-) - - 
(Abdel-Hafeez et al., 
2017) 
L. plantarum B1   NS S (+) S (+) NS NS S (-) NS NS NS (Peng et al., 2016) 
L. acidophilus, B. 
subtilis S. 
cerevisiae A. 
oryzae  
 
NS S (+) S (+) NS S (-) S (-) S (-) - - 
(Shim et al., 2012) 
L. reuteri  
E. faecium 
Bifidobacterium 
animalis 
Pediococcus 
acidilactici  
L. salivarius    
PoultryStar 
ME  
NS S (+) S (+) NS NS S (-) S (-) - - 
(Mountzouris et al., 2010) 
C. butyricum  NS S (+) S (+) S (+) NS NS NS - - (Zhao et al., 2013) 
E. faecium   NS NS NS NS NS NS NS - - (Zhao et al., 2013) 
L. acidophilus, B. 
subtilis DSM 
17299, and C. 
Probion  NS S (+) S (+) NS NS S (-) NS - - (Zhang and Kim, 2014) 
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butyricum.  
L. acidophilus 
L. bulgaricus L. 
plantarum  
S. faecium  
Bi. bifidus 
B. subtilis  
B. licheniformis B. 
megaterum  
B. mesentricus 
B. polymyxa  
S. bourlrdii  
Microguard 
 
S (+) S(+) S(+) - - - - - - 
(Rahman et al., 2013) 
E. faecium  S (+) S (+) S (+) - - - - S (+) S (+) (Cao et al., 2013) 
S. cerevisiae 
Bro-bio-fair  
- - S (+) S (+) - - S (-) S (+) S (+) 
(Abdel-Raheem et al., 
2012) 
L. plantarum L. 
delbrueckii ssp. 
bulgaricus  
L. acidophilus  
L. rhamnosus  
Bi. bifidum  
S. salivarius ssp. 
thermophilus  
E. faecium  
 A. oryzae  
C. pitolepesii  
Protexin  
NS NS NS NS NS NS NS - - 
(Daskiran et al., 2012) 
L. casei subsp. 
casei CECT 4043  
 S (-) - NS NS NS - NS - - (Fajardo et al., 2012) 
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L. lactis subsp. 
lactis CECT 539 
 
S (-) - NS S (-) NS - NS - - 
(Fajardo et al., 2012) 
L. acidophilus  
L. casei  
E. faecium  
Bi. bifidium 
Primalac 
S (+) S (+) S (+) S (+) S (-) S (-) S (-) - - 
(Landy and Kavyani, 
2013) 
11 Lactobacillus 
strains (L. reuteri 
C 1, C 10 and C 
16; L. gallinarum I 
16 and I 26; L. 
brevis I 12, I 23, I 
25, I 218 and I 
211, and L. 
salivarius I 24) 
 S (+) S (+) S (+) NS S (-) S (-) S (-) - - (Mookiah et al., 2014) 
B. 
amyloliquefaciens 
 NS S (+) S (+) S (+) S (-) S (-) S (-) S (+) S (+) (Lei et al., 2015) 
B. 
amyloliquefaciens 
 S (+) S (+) S (+) S (+) S (-) NS S (-) - - (Ahmed et al., 2014) 
S (+) = significantly increased, S (-) = significantly decreased, NS = non-significant, - = not studied, *Details (manufacturer, city and country) of commercial 
products are given in appendix 1. 
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2.4.2 Feed intake and feed efficiency 
As feed is the largest cost in poultry production, small improvements in feed use efficiency have a 
significant economic impact. The improvement in performance and productivity of poultry due to 
the use of probiotics in feed has been attributed to increased feed intake and improved feed 
efficiency (Shim et al., 2012) but this is not always the outcome. Probiotics can: 
o Increase feed intake without significant improvement in feed conversion ratio (FCR) 
(Afsharmanesh and Sadaghi, 2014) 
o Improve FCR without significant difference in feed intake (Mountzouris et al., 2010, 
Shim et al., 2012, Zhang and Kim, 2014, Zhang et al., 2012) and  
o Increase feed intake along with significant improvement in FCR (Landy and 
Kavyani, 2013).  
In contrast, Hung et al. (2012) found that dietary use of the probiotic B. coagulans reduced the 
average daily feed intake by 8% in the broiler grower-finisher phase (day 22-42) with reduction in 
FCR by 10%. Similarly, Amerah et al. (2013) administered the commercial probiotics (Enviva Pro 
202 GT, Danisco Animal Nutrition, Marlborough, UK) containing three strains of B. subtilis 
(strains (BS8, 15AP4 and 2084) during grower/finisher phase of a 42 days feeding trial and found a 
reduction in feed intake of 2% along with reduction in  FCR by 2.7%.. Similarly, Mookiah et al. 
(2014) found a reduction in feed intake of 5.6% during the starter phase (1-21 days) in birds treated 
with a multi strain probiotic containing 11 Lactobacillus strains (L. reuteri C1, C10 and C16; L. 
gallinarum I16 and I26; L. brevis I12, I23, I25, I218 and I211, and L. salivarius I24). However, 
FCR was improved in both starter (by 7.3%) and finisher phase (by 12%).  
The effect of probiotics on feed intake and feed use efficiency may be growth phase dependent. 
Some probiotics had no effect on feed intake and FCR during the starter phase while feed intake 
increased during grower-finisher phase or vice versa (Afsharmanesh and Sadaghi, 2014, Chawla et 
al., 2013, Giannenas et al., 2012, Mookiah et al., 2014).  
Many probiotics have positive effects on feed intake and feed use efficiency. However, as with other 
effects of probiotics, the impact on feed intake and feed use efficiency has not been consistent 
across studies or with different probiotics. 
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2.4.3 Carcass yield and quality 
Few studies have examined the effects of probiotics on carcass yield and quality in poultry. 
Marketable carcass yield or ready to cook quantity of carcass at day 42 was increased concurrently 
with increased growth rate and improved feed use efficiency with the use of the commercial 
probiotic Anta Pro EF containing E. faecium DSM 10663 NCIMB 10415 (in drinking water) and 
Super-CyC , a mix of the spore forming bacteria B. subtilis and a yeast S. cerevisiae KCTC 7193 (in 
feed) (Abdel-Rahman et al., 2013). Anta Pro EF (E. faecium) in drinking water at the rate of 2 g per 
100 birds per day increased of ready to cook carcass weight and overall body weight gain at day 42 
(Abdel-Rahman et al., 2013). In contrast, Afsharmanesh and Sadaghi (2014) did not find any 
difference in carcass yield, growth rate and feed use efficiency of birds at day 42 treated with a 
commercial probiotic (GalliPro) containing B. subtilis.  
Water holding capacity of poultry meat was increased (reduced drip loss) in birds fed with the 
probiotic B. coagulans (Zhou et al., 2010). The tenderness of the meat was also improved in 
probiotic treated birds in the same study using a local breed of meat type chicken in China.   In 
contrast, Zhang et al. (2005) using another probiotic (S. cerevisiae), found no improvement in 
tenderness in breast meat of commercial broilers. However, both the probiotics had positive effects 
on growth rate and FCR.  
Zhao et al. (2013) found differences in meat quality of Ross broiler chicks between two different 
probiotics. The intramuscular fat content in breast muscle was increased by 3.6% (1.99 vs 1.92 
mg/g) in birds treated with probiotic C. butyricum while there was no effect with the probiotic E. 
faecium.  
The effect of probiotics on the relationship between carcass quality and yield is unclear – is it due to 
an effect on muscle or due to improved growth performance per se. The inconsistencies in the 
response may be due to the differences in probiotic strains and/or the breed of birds used. 
The effects of probiotics on carcass quality and yield are inconclusive.  
2.4.4 Nutrient Digestibility 
The apparent ileal digestibility (AID) of essential amino acids was improved in birds fed a maize-
soybean based diet supplemented with a low dose (1 to 2 × 102 cfu/g) of a multi strain commercial 
probiotic (Probion) containing L. acidophilus, B. subtilis and C. butyricum (Zhang and Kim, 2014). 
All essential amino acids, except histidine and phenylalanine, had improved AID in treated birds as 
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compared to control birds, but there was no effect of probiotics on digestibility of DM, nitrogen and 
energy. However, Li et al. (2008), found an increase in the apparent digestibility of DM, energy, 
CP, Ca, P and amino acids in male broilers fed corn-soybean based diet supplemented with 
commercial probiotic (AgiPro A100) containing yeast and other microbes. Interestingly, 
digestibility of nutrients in grower-finisher phase was higher than in the starter phase. Apata (2008) 
also found that the probiotic L. bulgaricus could improve apparent ileal digestibility of DM and CP 
in broiler chicken fed maize-soybean based diet. Similarly, Chawla et al. (2013) found the probiotic 
E. faecium increased blood calcium levels in Vencobb broiler chicks indicating improved 
bioavailability. Different strains of probiotic microbes produce different enzymes and 
understanding the effects these might have on different feed ingredients would help understanding 
of the way probiotics might “work” for animal production. 
Probiotics can improve nutrient digestibility in poultry, but the interaction with different feedstuffs 
used in poultry diets is little understood at present.  
2.4.5 Intestinal Histomorphology 
The structure of the intestinal mucosa is an important determinant of intestinal function (digestive 
and absorptive) affecting growth performance of poultry. Generally, increases in villus height and 
villus height:crypt ratio increases the absorption of nutrients due to a larger surface area 
(Afsharmanesh and Sadaghi, 2014). 
Probiotics in poultry diets can affect the histology of the intestinal mucosa. The villus height and 
the villus:crypt ratio in the intestinal mucosa were increased by B. subtilis (Afsharmanesh and 
Sadaghi, 2014, Jayaraman et al., 2013), B. coagulans (Hung et al., 2012), the lactic acid producing 
bacteria L. salivarius, P. parvulus (Biloni et al., 2013) and E. faecium (Cao et al., 2013, Abdel-
Rahman et al., 2013). 
Villus height in probiotic (B. coagulans ATCC 7050) treated birds was greater than in birds treated 
with an AGP (zinc–bacitracin) when measured at 6 weeks age (Hung et al., 2012). Similarly, the 
probiotic B. subtilis PB6 reconstituted the normal structure of chicken intestinal villi distorted and 
damaged by necrotic enteritis caused by Cl. perfringens (Jayaraman et al., 2013). 
Some probiotics affect intestinal histomorphology favourably. 
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2.4.6 Control or prevention of enteric pathogens  
The public health risk from zoonotic pathogens of poultry like salmonella and campylobacter and 
antibiotic resistance is increasing with intensification of the poultry industry in developing countries 
and imprudent use of antibiotics in animal production systems (Singer et al., 2003, van den Bogaard 
and Stobberingh, 2000). In addition, other enteric diseases of poultry, like necrotic enteritis and 
coccidiosis, cause huge economic losses to the industry (Bera et al., 2010, Williams, 1999, Skinner 
et al., 2010). The change in the poultry production systems which result in delayed colonization of 
the gastrointestinal mucosa by healthy microflora may be one of the reasons for the increasing 
incidence of enteric pathogens (Crhanova et al., 2011). The virtually sterile environment 
immediately post-hatch, makes it possible for opportunistic pathogens to colonize the intestine 
(Flint and Garner, 2009). Probiotics may prevent or control such enteric pathogens.  
2.4.6.1 Salmonellosis 
Salmonellosis in poultry is a significant food safety issue as the pathogen causes a major food borne 
illness in humans. Successful use of undefined gastrointestinal culture for the prevention and 
control of Salmonella infection in chicken by Nurmi and Rantala (1973) led to many studies about 
use of gastrointestinal culture and probiotics to control salmonella in poultry (Lloyd et al., 1977, 
Snoeyenbos et al., 1979, Bolder et al., 1992). Competitive exclusion between pathogenic and non-
pathogenic ingested bacteria was believed to be the mechanism preventing infection in earlier 
studies.  
Probiotics are emerging as an alternative salmonella control method which also addresses  the 
increasing concern about antibiotic resistant strains of Salmonella (Tellez et al., 2012). Haghighi et 
al. (2008) demonstrated that probiotics could reduce the caecal colonization by Salmonella by 
several fold (1.2 to 3.0 log10) depending on probiotic dose. With a single application at dose rate of 
1×105 and 1×106 cfu of a commercial probiotic product containing L. acidophilus, Bi. bifidum, 
and S. faecalis, the larger dose rate caused a larger reduction in the caecal Salmonella population.  
The protection against Salmonella colonization appeared linked to a change in cytokine expression 
(IFN-γ and IL-12) in gut-associated lymphoid tissue. Some probiotics produce SCFA in the caeca in 
sufficient amounts to inhibit Salmonella enterica serovar Enteritidis (Argañaraz-Martínez et al., 
2013). By using an in vitro test, Argañaraz-Martínez et al. (2013) demonstrated that SCFA 
production in the caeca of chickens treated with Propionibacterium acidipropionici LET 105 was 
30% greater than in the control birds. This probiotic also competed with Salmonella for adhesion to 
the intestinal mucosa (Argañaraz-Martínez et al., 2013). Probiotics also reduced the spread of 
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Salmonella from infected to healthy birds. Transmission of Salmonella infection within the flock 
(horizontal transmission) was slower with a probiotic containing L. salivarius and Pediococcus  
parvulus (Biloni et al., 2013).  
2.4.6.2 Campylobacteriosis 
Campylobacteriosis is an important zoonotic disease of poultry caused by Ca. jejuni. In vitro 
experiments with probiotic bacterial strains (E. faecium, P. acidilactici, L. salivarius, and L. reuteri) 
isolated from the GIT of healthy chickens showed that they could inhibit growth of Ca. jejuni on 
agar plates (Ghareeb et al., 2012). The result was confirmed in vivo with broiler chickens. Inhibition 
of growth in vitro suggests production of growth inhibiting compound by probiotics. Combination 
of four bacterial strains Lactobacillus paracasei J.R, L. rhamnosus 15b, L. lactis Y, and L. lactis 
FOa prevented the invasion and colonisation of Ca. jejuni in the duodenum and cecum (Cean et al., 
2015). Similarly, the commercial probiotic Primalac (containing Lactobacillus, Bifidobacterium and 
Enterococcus) reduced the prevalence of Campylobacter infection in broiler chickens (Willis and 
Reid, 2008). Morishita et al. (1997) had earlier demonstrated that oral administration (via drinking 
water) of a commercial probiotic containing a mixture of L. acidophilus and S. faecium, to broiler 
chickens, during the first 3 days of life, reduced the shedding of Campylobacter by 70% in 
artificially infected birds and decreased the intestinal colonization by Campylobacter by 27%. 
2.4.6.3 Necrotic enteritis  
Necrotic enteritis (NE) caused by Cl. perfringens is an economically important disease in poultry 
due to the high prevalence of losses (Hermans and Morgan, 2007, McDevitt et al., 2006) causing 
significant economic loss to the industry worldwide (Van der Sluis, 2000, Timbermont et al., 2011).  
Probiotics are being studied as an alternative to antibiotics to prevent necrotic enteritis in poultry 
(Caly et al., 2015). Administration of B. subtilis (strain PB6) to broiler chickens artificially infected 
with Cl. perfringens reduced the severity of intestinal lesions and significantly reduced the number 
of pathogen cells in the GIT (Jayaraman et al., 2013, Abudabos et al., 2015). B. subtilis strain PB6 
produces a heat resistant and anticlostridial factor which could be used to control clostridial 
infections caused by Cl. perfringens and Cl. difficile (Teo and Tan, 2005). Negative effect of 
subclinical Cl. perfringens infection on lipid content and fatty acid composition in chicken 
meat was ameliorated by Lactobacillus johnsonii administration in diet (Wang et al., 2017).  
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2.4.6.4 Coccidiosis 
Coccidiosis is the most important protozoan parasitic disease of poultry due to its ubiquitous nature, 
high rate of resistance to anticoccidial drugs and severe economic consequences for infected flocks 
(Williams, 1999). The disease is caused by different species of Eimeria protozoa that colonize 
different sections of the GIT. Studies evaluating the effects of probiotics on coccidiosis gave 
inconclusive results (Lee et al., 2007, Dalloul et al., 2003). However, Giannenas et al. (2012) found 
a reduction in coccidiosis by using probiotics based on E. faecium, B. animalis, L. reuteri and B. 
subtilis, either singly or in combination.  
The probiotics were thought to maintain intestinal health in infected birds and significantly reduce 
the shedding of oocysts from infected birds thereby reducing the spread of disease (Giannenas et al., 
2012, Dalloul et al., 2003, Abu-Akkada and Awad, 2015). 
Probiotics could be a potential alternative to antibiotic feed additives to manage the enteric 
pathogen load in poultry, by reducing intestinal colonization and spread of common zoonotic and 
other enteric pathogens.  
2.4.7 Prevention of bacterial chondronecrosis with osteomyelitis 
Bacterial chondronecrosis with osteomyelitis (BCO) is a major cause of lameness in chicken 
predominantly caused by Staphylococcus aureus infection of the proximal epiphyseal plate of the 
femur, tibiotarsus and flexible thoracic vertebrae (McNamee and Smyth, 2000, Wideman Jr et al., 2013, 
Wideman Jr, 2015, Jiang et al., 2015, Mandal et al., 2016). BCO is suggested to be caused by translocation of 
pathogenic bacteria through impaired tight junction from the intestine to the predilection site via the 
systemic circulation (Wideman Jr and Prisby, 2013, Wideman Jr, 2016). The incidence of lameness 
caused by wire-flooring induced BCO was reduced by at least 50% in chickens fed the probiotics 
containing Enterococcus faecium, Bifidobacterium animalis, Pediococcus acidilactici, 
Lactobacillus reuteri, Enterococcus faecium and Bacillus subtilis (Wideman Jr, 2016, Wideman Jr 
et al., 2012, Wideman Jr et al., 2015). The suggested mechanism to reduce the BCO lameness in 
chickens by probiotics are inhibition of pathogenic microbes in the gut, enhanced integrity of gut 
wall to prevent the translocation of microbes and stimulation of immune system to eliminate the 
microbes translocated into systemic circulation (Wideman Jr, 2016).  
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2.4.8 Egg production and quality 
While probiotics can affect the production, feed use efficiency and quality of eggs in laying hens, 
these effects have been very inconsistent (Table 3). Studies showing increase in egg production 
with  supplementation of diets with probiotics (Gallazzi et al., 2009, Kurtoglu et al., 2004, Yörük et 
al., 2004, Xu et al., 2006), contrast with those showing no effect on egg production (Mikulski et al., 
2012, Salma et al., 2007, Asli et al., 2007, Capcarova et al., 2010, Dizaji and Pirmohammadi, 2009). 
Similarly, there are variable effects of probiotics on feed use efficiency in laying hens.  One of the 
most promising effects of probiotics on egg quality is the consistent reduction of cholesterol in egg 
yolk. Yolk cholesterol has been reduced by lactic acid bacteria (Haddadin et al., 1996, Panda et al., 
2003), Bacillus spores (Kurtoglu et al., 2004) and yeast (Yousefi and Karkoodi, 2007).  
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Table 2-2: Probiotic effects on egg production and quality 
Microorganisms 
Egg 
production 
FCR (feed 
weight/egg 
weight) 
Quality of egg 
References 
Weight Egg shell 
thickness 
Yolk 
cholesterol 
Albumin 
viscosity 
(Haugh unit) 
Specific 
gravity 
L. acidophilus D2/CSL S (+) S (-) NS NS - S (+) S (+) (Gallazzi et al., 2009) 
P. acidilactici NS S (-) S (+) - S (-)12% - S (+) (Mikulski et al., 2012) 
R. capsulatus NS NS - NS S (-)26% NS - (Salma et al., 2007) 
L.  plantarum,  
L. bulgaricus,   
L.  acidophilus,   
L. rhamnosus,   
B.  bifidum,   
S. hermophilus,   
E.  faecium,  
A. oryzae and  
C. pintolopessi 
NS - - NS NS NS - 
(Asli et al., 2007) 
S.  cerevisiae NS - - NS NS NS - (Asli et al., 2007) 
B. licheniformis and B. 
subtilis 
S (+) S (-) NS - S (-)38% - NS 
(Kurtoglu et al., 2004) 
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Lactobacillus spp., 
Bifidobacterium spp., 
Streptococcus spp., and   
Enterococcus spp. 
S (+) S (-) NS - - - - 
(Yörük et al., 2004) 
L. acidophilus,    
L. casei,    
Bi.  bifidum,  
A. oryzae, 
S. faceium and 
Torulopsis spp., 
S (+) NS NS S (+) S (-) - - 
(Panda et al., 2003) 
E. faecium   NS - NS - - - - (Capcarova et al., 2010) 
S. cerevisiae (strain 
NCYC sc  47) NS S (+) S (-) - - - - 
(Dizaji and Pirmohammadi, 
2009) 
B. subtilis (CH201) and 
B. lichenioformis 
(CH200) 
NS S (+) S (-) - - - - 
(Dizaji and Pirmohammadi, 
2009) 
L. acidophilus S (+) S (+) - NS S (-) - - (Haddadin et al., 1996) 
S. cerevisiae 
NS NS NS S (+) - - - 
(Hassanein and Soliman, 
2010) 
E. faecium NS S (-) NS NS NS S (-) - (Hayirli et al., 2005) 
B. subtilis and  
B. lichenioformis  NS NS NS NS S (-) NS - 
(Mahdavi et al., 2005) 
B. subtilis S (+) S (-) NS - - - - (Xu et al., 2006) 
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S. cerevisiae 
NS NS NS NS S (-) - - 
(Yousefi and Karkoodi, 
2007) 
L. plantarum, 
L. delbrueckii ssp. 
bulgaricus  
L. acidophilus  
L. rhamnosus  
Bi. bifidum  
S. salivarius ssp. 
thermophilus  
E. faecium  
A. oryzae  
C. pitolepesii 
NS S (-) 
NS 
 
- - - NS 
(Balevi et al., 2001) 
S (+) = significantly increased, S (-) = significantly decreased, NS = non-significant, - = not studied 
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2.5 Microbiology of chicken GIT 
The gastrointestinal tract of the chicken is an intricate ecosystem which harbors a complex and 
dynamic consortium of microorganisms, both in the lumen and on the mucosal surface, consisting 
of more than 640 species of bacteria, bacteriophage and other viruses together with large numbers 
of protozoa, fungi and methanogenic archaea, which are co-existing with mutual benefit to each 
other and to the host under the normal circumstances (Yeoman et al., 2012, Saengkerdsub et al., 
2007a, Saengkerdsub et al., 2007b, Apajalahti et al., 2004).  
Due to apparent effects of gastrointestinal microbial dynamics in animal production systems, on 
food safety and environment, significant effort has been made to understand the characteristics and 
function of the chicken gastrointestinal ecology for more than four decades. Earlier studies mostly 
relied on culture based techniques (Salanitro et al., 1974) and had seriously underrepresented the 
richness of this ecosystem due to methodological limitations. Traditional culture dependent 
techniques are unable to cultivate and study the majority of the microorganisms present in the GIT 
and thus unable to unravel the complexity of this ecosystem to understand the composition, 
diversity, role and interaction of its members. However, recent developments in culture independent 
techniques through the use of molecular biology tools and bioinformatics have enabled an in-depth 
study of this ecosystem with an increasing database and understanding (van der Hoeven-Hangoor et 
al., 2013, Thompson et al., 2008, Torok et al., 2009, Cressman et al., 2010, Pissavin et al., 2012, 
Ammor et al., 2008). Particularly, the use of the 16S rRNA gene as a phylogenetic marker to study 
the microbial diversity, and the development of high-throughput DNA sequencing technologies 
have enabled the generation of this knowledge at unprecedented speed. There is an increasing thrust 
to modify the gastrointestinal ecology for the benefit of the host, producer, consumer or the 
environment by using different types of feed additives. Probiotics are one such feed additive used to 
modify composition and function of intestinal microbes for improved health or production of the 
animal.  
However, It has been postulated that it is less important to know which bacterial species are present 
than to know the overall function of the microbiome (Danzeisen et al., 2011).  
Bacteria form the most diverse microbial population (Yeoman et al., 2012) and probably, 
functionally, are the most important sector of the GIT environment. However, there are more 
bacteriophages than bacteria in the GIT (Rodriguez-Valera et al., 2009). Moreover, there is 
considerable variation in the microbial community present in the lumen of different sections of the 
gastrointestinal tract and the corresponding mucosa (Gong et al., 2007, Apajalahti et al., 2004, 
Apajalahti et al., 2001, Saengkerdsub et al., 2007a) (Figure 2-1). The population and composition of 
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this ecosystem are contingent mainly on the host diet (Apajalahti et al., 2001) and to some extent on 
the systemic response and local secretions in the host and on the type of litter material used (Torok 
et al., 2009). Composition, physical state and nutrient concentration of the animal diet and presence 
of feed additives have significant effects on the intestinal microbial dynamics (Thompson et al., 
2008, Knarreborg et al., 2002b, Singh et al., 2013, Engberg et al., 2000, Engberg et al., 2004). This 
microbial dynamic has profound effects on health, performance and physiological state of the host 
animal due to host-microbe interaction influencing nutrient digestion, absorption and immunity 
(Round and Mazmanian, 2009, Nicholson et al., 2005). 
 
Figure 2-1: Major microbial taxa reported from different sections of the gastrointestinal tract of 
chicken. Picture reproduced from Yeoman et al. (2012). Data in the figure are taken from Ammor et 
al. (2008), Saengkerdsub et al. (2007a), Saengkerdsub et al. (2007b) and Gong et al. (2002). 
Most of the studies about the microbiome of the chicken GIT have been done in broiler chickens. 
Therefore, the majority of the available information represents the microbiome of younger chickens. 
Dominant bacteria in 7-day old chickens are in the family Clostridiaceae both in the ileum and the 
caecum (Shaufi et al., 2015, Corrigan et al., 2015) while that in 35-day old chickens are in the 
family Lactobacillaceae in the ileum and family Lachnospiraceae in the Caecum (Pourabedin et al., 
2015) (Figure 2-2). The richness and diversity of microbial populations is greater in older birds than 
those in younger chickens, and the microbial population in the caeca shifts from simple and 
transient to complex and stable with age (Danzeisen et al., 2011, Videnska et al., 2014). 
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Chicken crop is generally dominated by Lactobacillus sp. (Stanley et al., 2014, Rehman et al., 
2007a). Previous studies have revealed that Lactobacillales (phylum Firmicutes), predominantly 
Lactobacillus and Enterococcus, and various species under Clostridiaceae were the dominant 
bacteria from the crop to the ileum, representing more than one third of total sequence reads (Choi 
et al., 2014, Kohl, 2012, Pan and Yu, 2014, Waite and Taylor, 2014, Stanley et al., 2014). Bjerrum 
et al. (2006) isolated 92 strains of anaerobic bacteria from the ileum of organically grown broilers 
and identified them by 16S rRNA gene sequencing. The lactic acid producing bacteria 
Lactobacillus reuteri and Lactobacillus salivarius were the two dominant isolates among these. In 
contrast, anaerobic bacteria such as Alistipes, unclassified Ruminococcaceae and unclassified 
Lachnospiraceae were the most prevalent bacteria from the large intestine (Choi et al., 2014).  
 
Figure 2-2 Dominant microbiome (phylum and family) in the ileum and the caecum of the chickens at 
day 7 and day 35. Figure reproduced from Pourabedin and Zhao (2015). Data from Shaufi et al. 
(2015), Corrigan et al. (2015) and Pourabedin et al. (2015). 
The caeca contain the most abundant and the most diversified microbial community of the GIT 
(Gong et al., 2007), containing about 1010 – 1011 bacteria per gram fresh weight of caecal digesta 
(Yeoman et al., 2012). Qu et al. (Qu et al., 2008) reported comparable number of 16s rRNA  gene 
sequences resulted from pyrosequencing studies on the chicken caecum and the bovine rumen. 
Firmicutes are the most abundant taxa representing more than half of the bacterial population (Qu et 
al., 2008, Lu et al., 2003, Danzeisen et al., 2011) while 23-46% are Bacteroidetes and 1-16% are 
Proteobacteria (Yeoman et al., 2012). Archaea represent 0.8% of the caecal microflora (Qu et al., 
2008). However, recent studies showed that microbial profile of the chicken GIT can vary 
considerably (Stanley et al., 2013). 
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Recent microbial profiling studies using 16S rRNA gene sequences reported as many as 3500 
genotypes (Qu et al., 2008) and more than 2300 operational taxonomic units (OTU’s) at 95% DNA 
sequence similarity (Danzeisen et al., 2011). Due to this microbial diversity, high number of 
microbes and the longer digesta transit time in caeca, microbial fermentation is the most active in 
this region (Rehman et al., 2007b).  
Choi et al. (2014) and Lu et. al. (2003) found Clostridia to be the dominant bacteria in the chicken 
caecum. Metagenomic sequencing by Danzeisen et al. (2011) showed that OTUs classified as 
Roseburia, a butyrate producing organism from the Lachnospiraceae family, were the most 
abundant OTUs in the caeca representing about 19% of total sequence reads. A spore forming gram 
positive anaerobic bacterium, Sedimentibacter, was also present (Danzeisen et al., 2011). In 
contrast, Ruminococcus was earlier reported as the dominant bacteria in the caeca followed by 
Streptococcus, Bacteroides, Clostridium, Fusobacterium and Bifidobacterium (Apajalahti et al., 
2001).   
Limited gene-based microbial studies on the function and gene expression of the microbial 
community in the chicken GIT have been done so far, and those that have been were mainly on the 
caecal microbial community (Qu et al., 2008, Danzeisen et al., 2011). The metagenome of the 
chicken GIT contains about 200,000 genes (Qu et al., 2008). The most prevalent functional groups 
in the metagenome were related to carbohydrate utilization, protein metabolism, and amino acid 
synthesis (Danzeisen et al., 2011). Firmicutes were responsible for encoding more than 95% of the 
genetic information in the caeca while Archaea encoded only 1-2% of the genetic information (Qu 
et al., 2008, Danzeisen et al., 2011). 
In the first extensive culture based study of the microbial community of the chicken GIT, Salanitro 
et al. (Salanitro et al., 1974) isolated 325 strains of culturable bacteria from the caeca of 5-week old 
hens. These strains have been reported to cover more than 80% of culturable microbes in the caeca. 
Videnska et al. (2014) studied the microbial ecology of layer chickens over the production lifespan 
(0 to 60 weeks) using pyrosequencing of V3/V4 regions of 16S rRNA genes and examined the 
caecal microbiota in four different phases or time periods. Phase one was the first week post-hatch 
with Enterobacteriaceae as dominant bacterial family. During the second phase from week two to 
week four, Lachnospiraceae and Ruminococcaceae were the dominant bacterial families. In the 
third phase from eight to 24 weeks was characterised by increased Firmicutes and decreased 
Bacteroidetes populations. In the final or fourth phase (egg production phase) from 28 weeks was 
characterised by a constant ratio of Firmicutes to Bacteroidetes. 
 
 34 
 
2.6 Bacillus amyloliquefaciens  
2.6.1 General introduction and taxonomy 
B. amyloliquefaciens is a gram-positive endospore forming aerobic bacterium which was initially 
classified B. subtilis subsp. amyloliquefuciens (Tsuru, 1962) and approved as a separate species in 
1987 (Priest et al., 1987). It is phenotypically very similar to B. subtilis and an important species 
used in the fermentation industry due to its ability to produce various secondary metabolites (Table 
2-3). This bacterium produces extracellular enzymes, e.g. α-amylase, cellulase, proteases and 
metalloproteases (Gould et al., 1975, Lee et al., 2008, Gangadharan et al., 2008) which are believed 
to be beneficial in digestion in poultry (Gracia et al., 2003). Several potent antimicrobial 
compounds belonging to lipopeptide and polyketide groups (table 3) are presumed to be 
antipathogenic in plants and animals (Chen et al., 2009, Kadaikunnan et al., 2015). B. 
amyloliquefaciens also produces bacteriocins with bactericidal properties against different bacteria 
including foodborne Salmonella sp. Listeria monocytogenes  and Shigella sp (Kaewklom et al., 
2013).  
This bacterium is a common soil and phyllosphere organism and has also been used in agriculture 
as plant growth promoter and biocontrol agent against plant pathogens (Chen et al., 2009, 
Koumoutsi et al., 2004, Liu et al., 2010). The growth promoting effects are attributed to the 
secondary metabolites produced (Chen et al., 2007).  
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Table 2-3: Secondary metabolites produced by B. amyloliquefaciens 
Group Metabolite Major characteristics  
Lipopeptides Surfactin • Cyclic lipopeptide 
• Amphiphilic 
• Characteristic "horse saddle" conformation 
• Antibacterial, antiviral, antifungal, 
antiprotozoal,  anti-
mycoplasma and hemolytic 
• Non specific cytotoxicity 
• Can alter membrane integrity 
(Hue et al., 2001, Koumoutsi et al., 2004, Sun et al., 2006) 
fengycin • Antifungal 
• Inhibits phospholipase A2 
(Ongena and Jacques, 2008, Nishikiori et al., 1986, Sun et al., 2006) 
bacillomycin D • Antifungal 
• Hemolytic 
(Chen et al., 2009, Koumoutsi et al., 2004) 
iturin A • Antifungal 
• Hemolytic  
(Ongena and Jacques, 2008, Thimon et al., 1995, Arrebola et al., 2010) 
polyketides Macrolactin  (Schneider et al., 2007, Chen et al., 2009) 
Difficidin Antibacterial (Chen et al., 2006, Chen et al., 2009, Zimmerman et al., 1987)  
Bacillaene  (Chen et al., 2006, Chen et al., 2009) 
Chlorotetaine  (Rapp et al., 1988) 
iron-siderophore bacillibactin   
Enzymes α-amylase Hydrolysis of starch  (Gangadharan et al., 2008, Gracia et al., 2003) 
cellulase Improve the digestion of nutrients (Lee et al., 2008) 
proteases Improve the digestion of nutrients (Gould et al., 1975) 
Bacteriocin barnase Antibacterial (Ulyanova et al., 2011) 
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2.6.2 Bacillus amyloliquefaciens as probiotic in poultry 
B. amyloliquefaciens has been tested as a probiotic in poultry (Lei et al., 2014, Lei et al., 2015) and 
in fish (Das et al., 2013, Huang et al., 2015) to improve feed conversion efficiency and growth. 
Recently, a probiotic product containing three strains of B. amyloliquefaciens spores when fed to 
male broiler chickens on a corn-soya based diet resulted in increased body weight gain, increased 
feed intake and improved feed conversion ratio (FCR) (Lei et al., 2015). Similarly, the digestibility 
of the feed during starter phase has also been significantly improved as indicated by higher apparent 
total tract digestibility of CP, DM and Gross Energy (GE). The improvement in performance of the 
birds in this experiment was presumed to be attributed to changes in histomorphology of the 
gastrointestinal tract as demonstrated by increased villus height, reduced crypt depth and increased 
villus height to crypt depth ratio in the duodenum, jejunum, and ileum; improved nutrient utilization 
and modified caecal microflora population (decreased E. coli and increased Lactobacillus 
populations). Similar effects of B. amyloliquefaciens occurred with broiler performance with a 
significant impact on average body weight gain, feed intake and FCR (Ahmed et al., 2014). 
Moreover, concentrations of serum IgG and IgA in birds fed B. amyloliquefaciens were 
significantly increased. Lei et al. (Lei et al., 2014) found that B. amyloliquefaciens could replace 
antibiotic growth promoters in the second half of the broiler life cycle, improving productivity of 
the birds by enhancing nutrient digestibility.  
In a previous study, broilers fed a commercial probiotic (Ecobiol) containing B. amyloliquefaciens 
at the dose rate of 106 cfu/g of feed attained marketable weight 2.5 days earlier than the birds fed 
the control diet (Ortiz et al., 2013). Similarly the same commercial product improved the feed 
conversion ratio in broilers (Diaz, 2007).  
Modern intensive poultry production systems have often been criticized for their negative impact on 
the environment due to emission of ammonia (NH3) and hydrogen sulfide (H2S). Microbial urease 
produced by microorganisms in the gastrointestinal tract of poultry hydrolyze the uric acid 
produced in the liver and excreted into the gastrointestinal tract to produce ammonia (Karasawa et 
al., 1988). Similarly, there are several bacterial species and genera in the gastrointestinal tract of 
poultry which reduce sulfate to produce hydrogen sulfide (Barbour et al., 1985). Ahmed et. al 
(Ahmed et al., 2014) demonstrated that B. amyloliquefaciens can reduce the environmental impact 
of poultry production by significantly reducing the amount of ammonia (NH3) and hydrogen sulfide 
(H2S) emission from poultry manure. Better nutrient utilization and modification in gastrointestinal 
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microbial populations were postulated to be the causes for reduced noxious gas emission in this 
study (Ahmed et al., 2014).  
2.6.3 Safety of Bacillus amyloliquefaciens 
B. amyloliquefaciens has not been found associated with any infections or toxicity in humans or 
animals. European Food Safety Authority (EFSA) has given the B. amyloliquefaciens Qualified 
Presumption of Safety (QPS) status (European Food Safety Authority, 2008). EFSA has been using 
the QPS concept as a generic risk assessment tool to assess the safety of microorganisms intended 
for deliberate entry into the food chain. Identification of the B. amyloliquefaciens with QPS status 
means this microorganism either does not pose any safety risk or risk could be clearly defined and 
eliminated (European Food Safety Authority, 2007). Therefore, this microorganism if intended to 
enter the market in EU may not be subjected to detail pre-market safety assessment other than 
satisfying predetermined specific qualifications (European Food Safety Authority, 2007). This 
microorganism is not in the list of Generally Recognized As Safe (GRAS) category of the United 
States Food and Drug Administration (USFDA) (USFDA, 2013). However, bacterially-derived 
carbohydrase and protease enzyme preparations from a non-toxigenic and non-pathogenic strain of 
B. amyloliquefaciens are listed as GRAS (US Government Publishing Office, 2013). 
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2.7 Methods to study the gastrointestinal microbiome 
2.7.1 Microbial community study by genomic approaches 
Every microbial community has its specific structure, function and ecosystem (Weinstock, 2012). 
Discovery of culture independent genomic methods has made the study of these communities 
possible. The structure and functions of microorganisms in the past (before 1980s) were generally 
studied on the basis of phenotypic characteristics, growth on a range of media (if they were 
culturable), enzymatic activity, staining characteristics and metabolism of cultured microorganisms 
(Clarridge, 2004, Petti et al., 2005).  
The 16S rRNA gene, which encodes small subunit ribosomal RNA, is one of the most widely used 
molecular markers in the study of microbial community structure. There are some unique 
characteristics of this gene, which has made it an “ultimate molecular chronometer” (Woese, 1987). 
All bacterial species carry at least one copy of this gene and it has the same function in all 
microorganisms (Woese, 1987).  In addition, the 16S rRNA gene consists of highly conserved and 
variable nucleotide sequences (Olsen et al., 1986, Case et al., 2007). The conserved sequences 
remain stable across all microorganisms which make the comparison between distantly related 
microorganisms possible while the variable regions are unique to each group (species/strains) of 
microorganism which helps to assess the similarity between closely related organisms (Olsen et al., 
1986, Case et al., 2007). In addition, large mutations and horizontal gene transfer in the 16S rRNA 
gene which might disrupt gene function are very rare, as cells cannot survive without ribosomes. 
Universal primers, which hybridise to highly conserved sequences, bind to all 16S rRNA genes 
present in the DNA sample and amplify all of these genes during the PCR reaction. The amplified 
DNA can then be sequenced using next generation sequencing technologies. The DNA sequences 
are then either compared with the sequences present in web based database applications like 
Greengenes (DeSantis et al., 2006) and the ribosomal database project (Cole et al., 2005, Cole et al., 
2009) to create a table of taxa and their abundances or the sequences could be assembled into 
operational taxonomic units (OTUs) to form an OTU table and their abundances (Weinstock, 2012) 
(Figure 2-3).  The OTUs which have at least 97% DNA sequence similarity are generally regarded 
as a species (Weinstock, 2012).  
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Figure 2-3: Flow diagram to study and analyse the microbial community in an ecosystem. Reproduced 
from (Weinstock, 2012). 
2.7.2 Next generation sequencing: effective and efficient tools to study 
microbiomes 
The automated Sanger method was a classical chain termination DNA sequencing method based on 
the use of dideoxynucleotides (ddNTPs), and has been used for about 20 years to sequence DNA 
(Metzker, 2005). Limitations of Sanger’s technique led to the search for more convenient and 
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effective DNA sequencing technologies resulting in the discovery of next-generation sequencing 
technologies like Roche 454 sequencing and Illumina sequencing (Metzker, 2010) which led to the 
generation of enormous amounts of DNA sequence data at an unprecedented rate and low cost. 
Next generation DNA sequencing techniques have been successfully used to study the microbial 
population structure and function in poultry (Guttala et al., 2017). Traditional culture based 
methods combined with modern sequencing techniques could be used to develop new probiotics 
(Adhikari and Kwon, 2017). 
However, these high throughput next generation sequencing techniques give shorter read lengths 
compared to traditional sequencing methods resulting in difficulties with assembling these reads 
into longer sequences (Morozova and Marra, 2008). The major challenge with these techniques is 
the downstream data analysis to extract meaningful insights from the vast amount of data (Shendure 
and Ji, 2008). The current pace of improvement in genomic data analysis and storage lags behind 
the pace of generating genomic data. 
2.7.2.1 Illumina sequencing 
Illumina sequencing, which is one of the widely used sequencing by synthesis (SBS) technologies, 
is a next generation DNA sequencing technology based on reversible dye-terminators which 
identify the nucleotide bases in DNA during the synthesis process by utilizing a solid (flow cell) 
surface to immobilize sequencing templates (Quail et al., 2008). During the synthesis of DNA, the 
base specific fluorescently labelled reversible terminators mixed in the template are attached to each 
template (Bentley, 2006). The terminator flourophore emits fluorescence which is measured by 
imaging to identify the added nucleotide followed by removal of the fluorescent group to initiate the 
next round of the synthesis reactions (Mardis, 2008). The process repeats indefinitely generating a 
large quantity of sequencing data (Mardis, 2008). Figure 2-4 shows the major steps in the illumina 
sequencing workflow (Illumina Inc, 2010, Quail et al., 2008, Metzker, 2010, Meyer and Kircher, 
2010, Pareek, 2014). 
Preparation of DNA library 
a. Fragmentation: The genomic DNA library preparation begins with breaking of DNA to 
produce DNA fragments of 0-1200 base pairs. Although there are different methods to fragment 
DNA, fragmentation by controllably focused acoustic energy is claimed to be more advantageous 
than other methods (eg. Nubilization) due to reduced loss of sample fragments. If there is a need for 
very narrow fragment size distribution, the DNA fragments could be separated on an agarose gel 
followed by excision from the gel.  
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b. Adaptor fill-in and size selection: Bst polymerase, an enzyme with strand-displacement 
property, is used for a fill-in reaction to remove nicks. The reaction is then cleaned up using either 
solid-phase reversible immobilization (SPRI) or the MinElute PCR Purification Kit depending upon 
the desired size of DNA fragments to be retained. 
c. Indexing PCR and pooling: The template DNAs are amplified, quantified and pooled. 
 
Figure 2-4: Illumina sequencing work-flow. Reproduced from (Quail et al., 2008) 
Cluster Generation 
a. Immobilization of templates: The templates are immobilized on a flow cell surface which is 
designed to facilitate the enzyme penetration ensuring stability of DNA templates. 
b. Solid phase amplification:  The amplification is accomplished in solid support through a 
PCR containing amplification reagents with immobilized primers and the adaptors. A bridge 
structure is formed during amplification due to the hybridization of free end of single stranded 
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templates with the complementary adaptors in the surface of the flow cell. The PCR reactions create 
a cluster of single stranded DNA templates containing more than 1000 copies of DNA on the 
surface of the flow cell.  
c. Linearization, blocking and hybridization: Following the formation of DNA cluster, the 
double stranded DNAs in the cluster are converted into single stranded DNA through a process 
called linearization. This process is followed by the blocking of the 3’ ends and hybridization of a 
sequencing primer. 
Sequencing by synthesis 
For the actual sequencing process, four fluorescently labelled terminator nucleotides are added in 
the reaction. When the reaction proceeds, a single deoxynucleoside triphosphate (dNTP) is 
incorporated in the single stranded template followed by fluorescence imaging to identify the base. 
The labelled terminator nucleotide then ceases the reaction and the terminator group and the dye is 
enzymatically cleaved to initiate the next round of reaction (Figure 2-5). 
 
Figure 2-5: Sequencing by synthesis (SBS) reaction chemistry. Reproduced from (Pareek, 2014)  
2.7.3 Quantification of microbes in the intestine by real–time quantitative 
polymerase chain reaction (qPCR) 
Real-time quantitate polymerase chain reaction (qPCR) is a quick and robust molecular 
biotechnology tool which can quantify the copy number of genes simultaneously within the 
reaction. This technique is very sensitive and specific which makes this technique the most common 
gene quantification method. Quantitative real time PCR will be used in this study to quantify the 
population of the probiotic (B. amyloliquefaciens) in the content of the chicken GIT and faeces.  
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The rate of reaction during PCR is not linear as the copies of DNA increase in exponential order at 
the beginning and eventually will plateau and the reaction will halt once any of the reaction 
components are exhausted (figure 5). This is the main reason that quantification of DNA copies at 
the end of the reaction cannot give the correct measurement of DNA number. Therefore, the best 
point to measure the number of DNA copies is during the exponential phase of the DNA 
multiplication reaction. Real time qPCR measures the quantity of DNA in the real time while it 
multiplies and thus makes possible to quantify the DNA during the exponential phase.  
 
Figure 2-6: Amplification plot of qPCR. Baseline-subtracted fluorescence versus number of PCR 
cycles. Picture reproduced from www.bio-rad.com 
2.7.3.1 Fluorescence as a proxy to quantify DNA 
In qPCR, measurement of fluorescence emitted by the particular fluorescent dye attached to the 
specific nucleotide probe used is converted into the number of copies of DNA in the reaction. For 
quantification, a target specific oligonucleotide probe is labelled with a fluorescence dye (reporter 
dye) at the 5' end and a quencher dye at the 3' end. Normally, the probe itself does not emit any 
detectable fluorescence as the quencher molecule absorbs the fluorescence. In the beginning of the 
reaction all the three added oligonucleotides present in the reaction, forward primer, reverse primer 
and dual-labelled probe anneal to the target present in the sample. Taq polymerase in the reaction, 
which has 5' to 3' exonuclease activity, cleaves the target specific oligonucleotide probe separating 
reporter dye and quencher dye. While reaction proceeds, the fluorescence is increased with every 
cycle due to separation of reporter and quencher dyes. During the initial phase of the reaction, 
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fluorescence from the reporter dye cannot be detected, as this is not significantly detectable from 
the background fluorescence. With the accumulation of amplification products in the reaction, the 
amount of free reporter dye keeps on increasing. The cycle number at which the fluorescence in the 
reaction can be detected as significant from the background fluorescence is called threshold cycle 
value (Ct or Cq). The more the copies of the template DNA at the beginning of the reaction, the 
sooner the fluorescence is detected as significantly different and thus fewer cycles are required to 
reach the threshold point (Bustin et al., 2005). The quantity of DNA in the reaction is quantified by 
comparing the Ct values of unknown samples to that of a known standard in real time while the 
reaction proceeds.  
2.8 Conclusion 
Increasing intensification of poultry with consequent imprudent use of antibiotic growth promoters 
poses risks to human and animal health in terms of increasing antibiotic resistance in pathogenic 
microorganisms. Live microorganisms have been studied and used as probiotics for a long time, and 
as an alternative to antibiotic growth promoters in poultry production. Several probiotics have been 
found effective in improving performance and preventing disease and the spread of the enteric 
pathogens.  
With the advancement in knowledge in gastrointestinal microbial ecology and mode of action of 
probiotics, the number of probiotic products available for use in animal nutrition is increasing. 
However, the microorganisms used as probiotics and their efficacy are highly variable. The claims 
made by commercial probiotic producers are often difficult to substantiate due to variation in results 
and lack of understanding about clear mode of action. It is not possible to generalize the mechanism 
of action of probiotics. 
There are many promising effects of probiotics on poultry performance and health. However, the 
major limitation for the widespread and sustainable use of probiotics is the uncertainty in the 
reproducibility of effect, with a wide range of probiotic species. Although the use of probiotics 
could be a potentially viable solution to address the issue of increasing antibiotic resistance, it 
requires much further study on the effect, mechanism of action and safety of probiotics, to obtain 
consistent effects and a similar economic benefit to AGPs. Use of next generation DNA sequencing 
technology to study the effects of probiotics in the structure and function of the GIT microbiota 
could be a promising method to elucidate the mode of action. As the effects of probiotics in the host 
is the outcome of interaction between the host and the probiotic microorganism, further studies 
should be focussed on these interactions to elucidate the mode of action.   
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Chapter 3 Broiler growth and performance following feed 
supplementation with Bacillus amyloliquefaciens H57 
3.1 Introduction 
The current study has been conducted to assess the effects of oral administration of H57 via a mash 
feed on the growth performance of broiler chickens. Three feeding experiments were conducted 
using standard animal husbandry practices as approved by the Animal Ethics Committee of the 
University of Queensland, as required by the Animal Care and Protection Act (2001) and The 
Australian Code for the Care and Use of Animals for Scientific Purposes.  
3.2 Materials and Methods 
3.2.1 Culture of Bacillus amyloliquefaciens strain H57 
B. amyloliquefaciens strain H57 was cultivated by using a batch fermentation technique (Schofield, 
2017). B. amyloliquefaciens H57 from stock culture was first multiplied overnight on nutrient agar 
(about 15 ml in slanting position) in a McCartney bottle at 30°C. McCartney bottle cultures were 
resuspended with 500 μl of sterile water and the bacterial suspension was then inoculated into 250 
mL CELLSTAR® Filter Cap Cell Culture Flask (Greiner Bio-One GmbH, Kremsmünster, Austria). 
Tissue culture flask flats (with about 120 ml nutrient agar slope) and grown overnight at 30°C. 
These cultures were then resuspended with about 10 ml of sterile water and the bacterial suspension 
then inoculated into 500 mL nutrient broth in 1L Erlenmeyer flasks to prepare the starter culture. 
One litre of starter culture was inoculated into sterile fermenter medium (Schofield, 2017) prepared 
in a 20-litre stainless steel modified drum fermenter and incubated for 7 hours at 30°C.  The 
composition of fermenter broth for one drum was 50g Soytone, 20g Yeast Extract, 90g K2HPO4, 
30g KH2PO4, 5g MgSO4.7H2O, 10g CaCO3 (precipitated), 1g CaCl2, 1g Na2CO3, 1g FeCl2, 1g 
Na2SO4, 3g MnSO4, 01 g H3BO3, 9 L distilled water and 1 L sugar solution (50 g Glucose + 50g 
Sucrose). Two 20-litre drum fermenters were used to grow the bacteria aerated initially via a fine 
metal sparger and at the latter stages of the fermentation with pure oxygen.  Foaming in the drums 
during bacterial growth was reduced by adding 5 ml of 5% (w/v) sterile Antifoam 1920 (Dow 
Corning, Midland, MI, USA) as required.  
After growing bacteria in the drum fermenter for 7 hours, the bacterial suspension (media + 
bacteria) was transferred into a 100-litre fermenter vessel (Electrolux, Göteborg, Sweden) used for 
inducing sporulation by nutrient limitation. The fermenter had been filled with 66 L of tap water 
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mixed with c.50 ml of 5M NaOH to increase the pH to 10. Fermenter media (water) along with all 
of the attached silicon tubing and accessories were sterilised by heating at 125°C to 128°C for 30 
minutes with steam and pressurised with air passed through sterile 0.2 μm air filter (PALL, 
Cheltenham, VIC, Australia). The bacterial suspension was incubated in the fermenter vessel for 
about 47 hours with continuous aeration by bubbling sterilised air through a metal sparger (100μ 
pores) and stirring with a rotating paddle at the bottom of the vessel (Schofield, 2017). The pressure 
in the fermenter vessel was maintained at 10 kPa by adjusting the inflow and outflow of air into and 
out of the vessel. The whole process was controlled and monitored through a computerised 
fermenter control system (Real Time Engineering, Warriewood, NSW, Australia). Excessive 
foaming was controlled by adding about 10 ml aliquots of 5% (w/v) sterile Antifoam 1920 as 
required.  
The bacterial spores were harvested by using a Sharples G high-speed (15,000rpm) continuous flow 
barrel centrifuge AS26 (Sharples Separator Works, West Chester, PA, USA). Fermenter content 
was fed into the centrifuge adjusting the flow rate at 4 L/min until the centrifuge bowl was filled 
and then at about 0.7 L/min to allow retention of solid materials (bacterial cells and extracellular 
materials) as much as possible in the centrifuge bowl. After completion of centrifugation, the solid 
materials in the bowl was collected using a customized spatula (Schofield, 2017).  
Finally, the bacterial pellet containing spores and extracellular material, were mixed with an equal 
quantity (w/w) of feed grade sodium bentonite powder (Unimin Australia Limited, Miles, QLD, 
Australia) and three volumes of water per unit weight of harvested product (v/w) and mixed with a 
kitchen food mixer.  The resultant paste was lyophilized using Beta 1-8 LSC Laboratory freeze-
dryer (Martin Christ Gefriertrocknungsanlagen GmbH, Osterode am Harz, Germany) after freezing 
the material at -20°C overnight. The freeze-dried inoculum was ground into powder with a mortar 
and pestle and stored at room temperature.  
Concentration of H57 cells (cfu/g) in the inoculum was measured by serially diluting (10-fold) the 
H57 in bentonite freeze dried inoculum in sterile water and plating the diluted inoculum on nutrient 
agar plate. The initial dilution bottle containing 1 g of H57 inoculum and 99 ml of sterile water was 
shaken on a reciprocal shaker for 20 minutes to dislodge the cells before further dilution.  The 
suspension was then serially diluted to count total viable cells while the suspension was heated for 
20 minutes at 80°C to kill the vegetative cells and count the spores.  
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3.2.2 Experimental birds and husbandry practices 
All experiments were carried out with different batches of day old male Ross 308 broiler chicks 
obtained from local hatcheries (one hatchery for experiment 1 and 3 and another hatchery for 
experiment 2).  Birds were fed for 21 days in experiment 1 and 3 and for 35 days in experiment 2.  
Feed and water were supplied ad libitum through one feeder and one drinker in each replicate cage 
or pen. Birds were fed starter ration till day 14 and grower ration from day 15 to the end of the trial 
in experiment 1 and 3 and from day 15 to 28 in experiment 2. Finisher diet was fed from day 29 to 
35 in experiment 2. The experiments were carried out in environment control rooms with 
temperature gradually decreased from 32°C on day 1 to 22°C on day 21. Birds were in a 24 hours 
light regime. Strict hygienic management practices were followed to prevent cross contamination 
between control and treatment birds with handling of control birds first during feeding, weighing, 
sampling etc.  
In experiment 1, the groups of chicks were housed in cardboard floor pens of size 95cm x 95cm x 
65cm (LxWxH) (Figure 3-1) covered with wood shavings with a layer of newspapers with stocking 
density of 17 birds per square meter. The newspapers were changed weekly.  
 
Figure 3-1 Cardboard floor pens used as replicates for experiment 1 and 2 
In experiment 2, half of the chicks (both in control and treatment) were raised in cardboard pens as 
in experiment 1 and half were raised in cages of size 90cm, 70cm and 50cm (LxWxH) with 
stocking density of 9 birds per square metre in pens and 13 birds per square meter in cages.  
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In experiment 3, all of the birds were raised in cages of size 0.85 x 0.7 x 0.5 m (Figure 3-2) high 
with stocking density of 17 birds per square meter.   
 
Figure 3-2 Wire cages used for experiment 2 and 3 
3.2.3 Study design and dietary treatment 
In all experiments, day old male chicks were individually weighed and allocated to groups by 
random stratification so that each group had the same mean and range of bodyweights.  
In experiment 1, one hundred and eighty day old chicks were randomly allocated into 12 floor pens 
based on their body weight, resulting in 15 birds in each experimental unit. Cardboard floor pens 
were then randomly divided into two identical environmentally controlled rooms at the Queensland 
Animal Science Precinct (QASP), UQ Gatton, with 6 pens in each room. Birds were fed with 
sorghum and soybean based balanced rations formulated to supply all of the nutrient requirements 
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of the chicks for two stages of growth: starter and grower (Table 3-1). Chicks in one room received 
the control diet (E1D1 – starter and E1D1 – grower where E1D1stands for Experiment 1 Diet 1) 
while chicks in the other room received the same diet but mixed with 2×107 spores of B. 
amyloliquefaciens strain H57 (H57) per gram of feed (E1D1 – starter +H57 and E1D1 – grower 
+H57) both in the starter and grower diets. Starter diet was fed up to 14 days and grower diet was 
fed from 15 to 21 days. Thus, there were two experimental diets (with and without inoculum of B. 
amyloliquefaciens strain H57). One extra control pen was kept in the inoculation treatment room to 
test for cross contamination between control and treatment pens. This pen was not included for 
other performance measurement and analysis. Transfer of H57 from H57 treated groups to control 
chickens in the same room was tested by counting H57 in the GIT of control chickens kept in the 
H57 room by quantitative PCR as described in chapter 6. There was no cross contamination 
detected within the room (data not shown) but H57 was detected in the GIT of treated birds. 
Table 3-1 Composition of starter and grower diet (E1D1 – starter and E1D1 - grower) in experiment 1 
Ingredients  E1D1 - Starter (%) E1D1 – Grower (%) 
Sorghum  54.72 59.52 
Soybean Meal 32.9 27.8 
Canola meal  3.2 3 
Meat and Bone Meal 4.4 3.3 
Sun-soy oil 2.94  4.33 
Lysine.HCl 78  0.24 0.22 
DL Methionine 0.37 0.33 
L-Threonine  0.1 0.09 
Limestone fine 0.063 0.25 
MDCP Biophos  0.114 0.181 
Salt fine 0.23 0.24 
Sodium bicarbonate 0.2 0.16 
Vitamin & minerals premix2 0.5 0.5 
Choline chloride  0.05 0.06 
In experiment 2, 190 two-day-old male chicks were randomly divided into 12 cardboard pens and 
12 cages based on body weight as above, resulting in 8 birds per replicate. As we planned to 
conduct future experiments with cages, half of the birds were kept in cages to compare the effects 
of H57 in pens with that in cages. Six pens and six cages were kept in one temperature controlled 
room at QASP, while the remaining six pens and six cages were placed in adjacent room. This was 
                                                 
2 Vit A: 10000000IU; Vit D3: 2500000IU; Vit E: 30g; Vit K3: 2g; Vit B1: 1.5g; Vit B2: 8g; Vit B6: 
4g; Vit B12: 20mg; D-Calcium pantothenate: 15g; Folic acid: 2g; Nicotinic acid: 45g; Biotin: 
135mg; Co: 200mg; Cu:6g; Fe: 50g; I: 750mg; Mn: 75g; Mo: 1g; Se: 150mg; Zn:60g 
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a different and larger room to those used in Experiment 1.  Control and treatment rooms were 
identical and environmentally controlled. Birds in the control room were fed a wheat and soybean 
based control diet (E2D1 – starter, E2D1 – grower and E2D1 – finisher; Table 3-2) while birds in 
the treatment room were supplied with the same diet mixed with 2×107 spores of B. 
amyloliquefaciens strain H57 per gram of feed (E2D1 – starter + H57, E2D1 – grower + H57 and 
E2D1 – finisher + H57). Birds were fed the starter diet for 14 days, with the grower diet from 15 to 
28 days and the finisher diet from 29 to 35 days. Hence, treatments were similar to those in 
experiment 1 (diet with and without probiotic) but based on wheat and soybean in contrast to 
sorghum and soybean in experiment 1.  
Table 3-2: Composition of starter, grower and finisher diet in experiment 2 
Ingredients 
E2D1 (Starter-
diet) (%) 
E2D2 (Grower-diet) 
(%) 
E2D3 (Finisher-
diet) (%) 
Wheat fine 2 (phantom) 64.88 69.89 71.63 
Oil 2.6 3.6 3.93 
Soybean meal 48 28.7 22.9 19.18 
Limestone fine bags 1.27 1.4 1.33 
Ram dried fine no2 salt 0.2 0.17 0.2 
Sodium bicarb 0.27 0.2 0.13 
Choline chloride 70% 0.03 0.03 0.03 
Dl-methionine 58.1 0.31 0.26 0.21 
L-lysine 94.5 0.34 0.31 0.25 
L-threonine 73.7 0.13 0.12 0.09 
Biofos mdcp bags 0.9 0.75 0.65 
Rap broil start/grow pmx 0.2 0.2 0.2 
Rovabio maxima 10% pmx broil 
(phantom) 
0.05 0.05 0.05 
Bentonite (control)/H57 
inoculum in treatment group 
(concentration 1.67x1010  cfu/g) 
0.12 0.12 0.12 
Celite - - 2 
In Experiment 3, 432 day old male chicks were allocated into 36 cages based on body weight 
resulting in 12 chicks in each cage. The dietary treatments were; 1) Sorghum based control diet 
(E3D1), 2) Wheat based control diet (E3D2), 3) Sorghum + Wheat blended control diet (E3D3), 4) 
E3D1 + H57, 5) E3D2 + H57 and 6) E3D3 + H57.  Soybean was the major source of protein in all 
diets.  The H57 inoculum added to each inoculated treatment diet was 8.33 × 107 per gram for 
starter diets and 5.19 × 107 per gram for grower diets. These concentrations were designed to 
provide uptake by the birds of >109 cells of H57 per bird per day. The ingredients and composition 
of starter and grower diets are presented in Table 3-3. Experiment 3 was carried out in single room 
as cross contamination test from experiment 1 showed no cross contamination from H57 groups to 
control. Eighteen control cages were kept at one end of a large temperature controlled room (13.5m 
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× 3.9m) and 18 treatment cages were placed at the other end of the room to avoid the cross 
contamination among control and treatment cages. Three control diets were allocated randomly to 
the 18 control cages and 3 H57 inoculated diets were allocated randomly to the other 18 or 
treatment cages.  
No other enzymes, anticoccidials or antimicrobials were added to the diet because the aim was to 
examine the effect of H57 per se on bird performance. H57 may have properties similar to such 
additives and this might not have been demonstrated in their presence. 
Table 3-3: Composition of starter and grower diets in experiment 3  
Ingredient E3D1-
Starter 
(%) 
E3D1-
Grower 
(%) 
E3D2-
Starter 
(%) 
E3D2-
Grower 
(%) 
E3D3-
Starter 
(%) 
E3D3-
Grower 
(%) 
Wheat  0 0 52.83 58.30 25.96 28.98 
Sorghum  52.82 56.64 0 0 28.22 29.24 
SBM  34.65 30.17 36.45 27.38 32.49 27.88 
Canola Meal 3.00 3.00 1.00 3.00 3.00 3.00 
Meat and Bone Meal 50% Beef Aust 4.69 4.00 0.90 2.30 4.69 3.80 
Soy Oil 3.12 4.59 5.54 6.73 3.87 5.46 
Lysine.HCl 78 Aust 0.18 0.13 0.18 0.16 0.20 0.15 
DL Methionine 0.35 0.30 0.29 0.24 0.32 0.27 
L-Threonine 98% Aust 0.07 0.05 0.07 0.05 0.08 0.06 
Limestone Fine 0 0.10 0.70 0.45 0.05 0.15 
MDCP Biophos Aust 15/21 0.02 0 0.87 0.32 0  
Salt Fine 0.24 0.27 0.27 0.21 0.21 0.23 
Sodium Bicarb 0.17 0.11 0.22 0.24 0.22 0.17 
Generic Vitamin & Minerals Pmx 0.50 0.50 0.50 0.50 0.50 0.50 
Choline Chloride 60% Dry 0.05 0.06 0.05 0.04 0.05 0.05 
Bentonite (control)/H57 inoculum in 
treatment group (concentration 
6.1x1010  cfu/g) 
0.14 0.08 0.14 0.08 0.14 0.08 
3.2.3.1 Preparation of experimental diets  
The probiotic H57 was supplied as a freeze dried preparation in a bentonite carrier.  The required 
quantity of inoculum powder was mixed with approximately 2 kg of ground sorghum or ground 
wheat (based on diet) in a blender and then further diluted to a 10% mixture with the ground cereal.  
All of the ingredients of the diet were weighed and mixed in a feed mixer.  The inoculum mix, 
prepared as above, was added and the feed was mixed again.  Feed was mixed during the week 
before the start of each experiment and stored at room temperature till fed as a mash. 
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3.2.4 Performance data collection 
Weights of chicks were measured weekly using a flat top weighing balance.  Feed intake was also 
measured weekly.  Mortality was recorded with cage or pen number and weight of dead birds.    
Digesta samples from the ileum and caeca and tissue samples of duodenum, jejunum, ileum and 
caeca from one bird per replicate were collected at day 4, day 13 and day 21 for microbial and 
molecular/genomic studies.  The samples were immediately frozen in liquid nitrogen and 
transported in dry ice to store at -80°C.  Similarly, faecal samples were also collected at day 4, day 
13 and day 21. 
3.2.5 Statistical analysis 
Means of body weight, daily weight gain, daily feed intake and feed conversion ratio (FCR) in 
individual cages or pens were analysed by one-way ANOVA with a p-value of <0.05 denoting a 
significant difference. Data were adjusted for any mortalities. The normality of distribution and 
homogeneity of variances were confirmed before applying the statistical tests. Tukey-Kramer post 
hoc test was used for pairwise comparison of means.  
3.3 Results 
3.3.1 Production of B. amyloliquefaciens H57 inoculum 
Approximately 1013 spores of H57 (average of 6 batches) per 100l fermenter run batch were 
produced. The details of the quantity of H57 production from each batch of fermenter runs with 
quantity of wet pellet, dry H57-bentonite inoculum powder and concentration of H57 is presented 
elsewhere (Schofield, 2017). 
3.3.2 Bird Performance - Experiment 1 
The results for Experiment 1 are shown in Table 3-4. The average daily weight gain of the birds fed 
H57 was significantly greater than controls over the periods of day 0 to 14 (7.0%) and day 0 to 21 
(6.9%).  This resulted in significantly higher body weight of birds fed H57 at day 21 (896 g vs 845 
g) when compared to control birds. Interestingly, there were no differences in feed intake between 
treatments but dietary addition of H57 significantly improved FCR. 
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Table 3-4: Effects of Bacillus amyloliquefaciens strain H57 on performance of broiler chicken fed 
sorghum based diet (experiment 1) 
 
a, b Means within columns followed by different superscripts are significantly different at P < 0.05 
3.3.3 Bird Performance - Experiment 2 
The results for Experiment 2 are shown in Table 3-5. There was no significant difference in body 
weight between treatments during the study, with no significant difference in ADG between control 
and treated birds overall (day 0 to 35).  In this experiment, H57 treated birds ate significantly less 
feed (c. 4%, 95.8g/d vs 92g/d) compared to control birds during the 35 days of the trial. However, 
there was no effect of H57 on FCR.  
Table 3-5: Effects of Bacillus amyloliquefaciens strain H57 on performance of broiler chickens fed a 
wheat based diet (experiment 2) 
Variables# Days 
(post hatch) 
Dietary Treatment p-value 
E2D1 
 
E2D1+H57 
BW (g) Initial 44.1 44.1 0.915 
day 7 185.9 185.7 0.943 
day 14 482.2 480.9 0.868 
day 21 963.4 941.7 0.186 
day 28 1641.1 1592.6 0.070 
day 35 2335.6 2298.2 0.102 
ADG (g) day 0 to 7 20.3 20.2 0.952 
Variables# Days 
(post hatch) 
Dietary Treatment p-value 
E1D1 
(control) 
E1D1+H57 
BW (g per 
bird) 
Initial 38.1 38.1 0.570 
day 7 165.2 169.3 0.248 
day 14 448.3a 477.7b 0.05 
day 21 844.7a 895.9b 0.007 
Average 
daily 
weight gain 
(g) 
day 0 to 7 18.2 18.8 0.223 
day 8 to 14 40.5a 44.0b 0.007 
day 0 to 14 28.4a 30.4b 0.004 
day 15 to 21 56.2 59.4 0.075 
day 0 to 21 34.8a 37.2b 0.002 
Average 
daily feed 
intake (g) 
day 0 to 7 18.2 18.0 0.82 
day 8 to 14 55.0 53.3 0.541 
day 0 to 14 35.1 34.3 0.565 
day 15 to 21 85.0 86.8 0.305 
day 0 to 21 48.8 48.9 0.943 
Feed 
conversion 
ratio 
day 0 to 7 1.00 0.96 0.151 
day 8 to 14 1.36a 1.21b 0.024 
day 0 to 14 1.23a 1.13b 0.027 
day 15 to 21 1.51 1.46 0.163 
day 0 to 21 1.35a 1.27b 0.022 
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day 8 to 14 42.3 42.2 0.848 
day 0 to 14 31.3 31.2 0.870 
day 15 to 21 68.8a 65.8b 0.041 
day 22 to 28 94.6 92.6 0.513 
day 29 to 35 99.2a 89.4b 0.018 
day 0 to 35 64.8 61.8 0.058 
ADFI (g) day 0 to 7 21.2 20.9 0.574 
day 8 to 14 56.3 54.6 0.273 
day 0 to 14 38.8 37.7 0.301 
day 15 to 21 85.2a 79.2b 0.001 
day 22 to 28 142.9 141.3 0.524 
day 29 to 35 175.8a 167.5b 0.049 
day 0 to 35 95.8a 92.0b 0.019 
FCR day 0 to 7 1.05 1.03 0.486 
day 8 to 14 1.25 1.25 0.811 
day 0 to 14 1.24 1.21 0.331 
day 15 to 21 1.24 1.21 0.404 
day 22 to 28 1.52 1.56 0.487 
day 29 to 35 1.79 1.89 0.064 
day 0 to 35 1.49 1.50 0.592 
a, b Means within columns followed by different superscripts are significantly different at P < 0.05 (highlighted rows) 
3.3.4 Bird Performance - Experiment 3 
The results for Experiment 3 are shown in Table 3-6.  In this experiment, H57 had a significant 
effect on growth rate of broilers.  For the sorghum based diet, H57 improved the average daily 
weight gain from day 0 to 21 from 39.6 g/day (control) to 46.6 g/day (H57 birds) or some 18% 
(Figure 3-4a and Figure 3-3).  Average weight of birds fed the H57 treatment were 184 g at day 7, 
506 g at day 14 and 1027 g with corresponding values for control birds 152 g, 411 g and 922g, 
respectively. 
The growth rate of birds fed the wheat based diet supplemented with H57was also improved; with 
an overall difference of 8.4% (40.5 g/day/bird vs 43.9 g/day/bird) between control and treated birds 
from day 0 to 21 (Figure 3-4b and Figure 3-3). The average weight of H57 treated birds were 183 g 
at day 7, 483 g at day 14 and 994 g at day 14 with corresponding weights of control birds of 158 g, 
416 g and 930 g, respectively  
In contrast, there were no significant differences for growth rate and body weight between control 
and H57 treated birds fed the diet based on a mixture of sorghum and wheat (Figure 3-4c and Figure 
3-3).  Growth rate and body weight of birds on the combined sorghum and wheat based diets (both 
H57 and control) were similar to those of birds fed on sorghum or wheat based diets supplemented 
with H57. 
55 
Figure 3-3: Comparison of average daily gain among different treatments at different ages in 
experiment 3. Error bars show standard error of the mean. S = Sorghum based feed. W = Wheat 
based feed, SW = Sorghum and wheat blend feed, S+H57 = Sorghum based diet mixed with Bacillus 
amyloliquefaciens strain H57, W+H57 = Wheat based diet mixed with H57, SW+H57 = Sorghum and 
wheat blend diet mixed with H57. 
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Figure 3-4: Body weight of chicks fed different diet types at different ages in experiment 3. Error bars 
show standard error of mean. a) Body weight of chicks fed sorghum based diet, b) body weight of 
chicks fed wheat based diet, c) body weight of chicks fed sorghum and wheat blend diet. S = Sorghum 
based feed. W = Wheat based feed, SW = Sorghum and wheat blend feed, S+H57 = Sorghum based 
diet mixed with Bacillus amyloliquefaciens strain H57, W+H57 = Wheat based diet mixed with H57, 
SW+H57 = Sorghum and wheat blend diet mixed with H57. 
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Table 3-6: Effects of Bacillus amyloliquefaciens strain H57 on performance of broiler chicken fed different diets (experiment 3) 
Variables# Days 
(post hatch) 
Dietary Treatment Statistics 
E3D1 
(Sorghum) 
E3D2 
(Wheat) 
E3D3 
(Sorg+Wheat) 
E3D1+H57 E3D2+H57 E3D3+H57 F* (5, 30) p-value 
BW (g) Initial 44.9 ± 0.07 44.8 ± 0.15 44.8 ± 0.16 44.8 ± 0.09 45.2 ± 0.14 45.1 ± 0.17 1.659 > 0.175 
day 7 151.9a ± 2.10 157.6a ± 2.04 183.1b ± 2.42 184.0b ± 2.97 183.7b ± 1.77 181.0b ± 3.65 32.675 < 0.001  
day 14 411.1a ± 10.35 416.4a ± 5.82 506.2b ± 5.69 505.8b ± 5.61 482.5b ± 4.98 497.7b ± 8.63 38.857 < 0.001 
day 21 921.8a ± 16.30 929.7a ± 15.37 1039.2b ± 12.22 1026.9b ± 13.76 993.7b ± 16.32 1024.4b ± 14.59 12.051 < 0.001 
ADG (g) day 0 to 7 15.0a ± 0.22 16.0a ± 0.29 19.3b ± 0.34 19.6b ± 0.42 19.5b ± 0.17 19.2b ± 0.51 35.322 < 0.001 
day 8 to 14 36.5a ± 0.99 36.8a ± 0.69 46.1cd ± 0.70 46.6bc ± 0.22 43.2de ± 0.60 45.1 ± 0.76cd 43.342 < 0.001 
day 0 to 14 25.0a ± 0.60 25.4a ± 0.39 32.2b ± 0.20 32.2b ± 0.20 30.2c ± 0.33 30.6bc ± 0.71 53.381 < 0.001 
day 15 to 21 73.0 ± 1.70 73.3 ± 1.41 76.1 ± 1.28 74.4 ± 1.21 73.0 ± 1.88 75.2 ± 1.32 0.773 > 0.577 
day 0 to 21 39.6a ± 0.80 40.5a ± 0.63 45.6b ± 0.46 46.6b ± 0.70 43.9b ± 0.73 44.8b ± 0.59 18.525 < 0.001 
ADFI (g) day 0 to 7 17.7a ± 0.23 18.4a ± 0.22 19.9b ± 0.38 20.9b ± 0.24 20.8b ± 0.16 20.5b ± 0.22 29.659 < 0.001 
day 8 to 14 47.3a ± 1.35 49.6a ± 0.85 56.4b ± 0.54 57.1b ± 1.31 55.3b ± 0.56 56.9b ± 1.32 16.248 < 0.001 
day 0 to 14 31.4a ± 0.70 32.7a ± 0.46 36.7b ± 0.40 37.8b ± 0.41 36.6b ± 0.30 36.7b ± 0.44 31.302 < 0.001 
day 15 to 21 91.3ab ± 1.39 94.8bc ± 1.33 102.8de ± 1.83 101.5de ± 1.53 97.2bd ± 1.17 99.1cd ± 0.92 9.525  < 0.001 
day 0 to 21 48.9a ± 0.77 50.9a ± 0.65 56.0b ± 0.58 56.4b ± 0.50 54.0b ± 0.53 54.9b ± 0.53 24.822 < 0.001 
FCR day 0 to 7 1.18a ± 0.02 1.15a ± 0.01 1.04b ± 0.02 1.06b ± 0.02 1.07b ± 0.01 1.07b ± 0.02 10.065 < 0.001 
day 8 to 14 1.30ab ± 0.03 1.35ac ± 0.03 1.22bd ± 0.01 1.23bd ± 0.03 1.28ab ± 0.02 1.26ab ± 0.03 3.407 < 0.05 
day 0 to 14 1.26ab ± 0.02 1.28bc ± 0.02 1.16de ± 0.01 1.17de ± 0.02 1.21ad ± 0.02 1.20ad ± 0.02 6.832 < 0.001 
day 15 to 21 1.25a ± 0.03 1.29ab ± 0.02 1.35bc ± 0.01 1.34ac ± 0.02 1.33ac ± 0.03 1.34ac ± 0.02 3.286 < 0.05 
day 0 to 21 1.26 ± 0.02 1.29 ± 0.02 1.26 ± 0.01 1.26 ± 0.01 1.27 ± 0.02 1.27 ± 0.01 0.708 > 0.622 
#measurements are presented as group mean ± standard error of mean (SEM).  
a, b, c, d, e numbers in the same row with different superscript letters are significantly different at p<0.05 (i.e. numbers with at least one common superscript are not 
statistically different).  
*numbers in the brackets are degree of freedom between groups and degree of freedom among groups  
BW = body weight. ADG = average daily gain. ADFI = average daily feed intake. FCR = feed conversion ratio.  
E3D1 = experiment 3, diet 1 (diet based on sorghum). E3D2 = experiment 3, diet 2 (diet based on wheat). E3D3 = experiment 3, diet 3 (diet based on mixture of sorghum 
and wheat). 
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In experiment 3, feed intake was significantly increased when H57 was mixed with both the 
sorghum and wheat based diets (Table 3-6 and Figure 3-5).  In the sorghum based diet, average 
daily feed intake increased throughout the 21 days of the trial by 15.3% (from 48.9 g/day/control 
bird to 56.4 g/day/H57 bird). The increase in feed intake for wheat fed birds for the same period 
was 6.1% (from 50.9 g/day/control bird to 54 g/day/H57bird). In contrast there was no 
improvement in feed intake for birds fed the wheat and sorghum mix supplemented with H57. 
Feed use efficiency was improved by H57 from day 0 to 7 with a reduction in the FCR from 1.18 to 
1.06 (9.5%) in sorghum based diet and from 1.15 to 1.07 (7.0%) in wheat based diet (Table 3-6 and 
Figure 3-6). However, this effect did not last beyond day 7 and there was no significant difference 
overall from day 0 to 21 for both diets.  There was no effect of H57 on FCR for the sorghum and 
wheat blended diet.  
 
Figure 3-5: Comparison of average daily feed intake among different treatments at different ages in 
experiment 3. Error bars show standard error +/- of the mean. S = Sorghum based feed. W = Wheat 
based feed, SW = Sorghum and wheat blend feed, S+H57 = Sorghum based diet mixed with Bacillus 
amyloliquefaciens strain H57, W+H57 = Wheat based diet mixed with H57, SW+H57 = Sorghum and 
wheat blend diet mixed with H57. 
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Figure 3-6: Comparison of feed conversion ration (FCR) among different treatments at different ages 
in experiment 3. Error bars show standard error of mean. S = Sorghum based feed. W = Wheat based 
feed, SW = Sorghum and wheat blend feed, S+H57 = Sorghum based diet mixed with Bacillus 
amyloliquefaciens strain H57, W+H57 = Wheat based diet mixed with H57, SW+H57 = Sorghum and 
wheat blend diet mixed with H57. 
3.4 Discussion 
Sorghum is one of the major energy sources used in poultry diets in Australia. This grain, however, 
has major limitations when used as sole source of carbohydrate due to the presence of anti-
nutritional factors such as kafirin, phytate, and polyphenolic compounds (Bryden et al 2009). 
Therefore, the first experiment was undertaken with the feed based on this challenging ingredient as 
the energy source. After encouraging results in terms of body weight gain and food conversion ratio 
the trial was repeated with the diet based on wheat, another common carbohydrate source used in 
the poultry industry. The third experiment was then designed with three diet types, sorghum, wheat 
and a sorghum and wheat blend, in order to assess whether there was an interaction between the 
type of cereal grain in the diet and the response to the probiotic. Soybean was the main protein 
source in all of the diet types.  
The first experiment was conducted for 21 days as raising chicks for 21 days while conducting 
chicken growth experiments is common practice. This is because if a treatment has positive effects 
on growth, the effect should generally be obvious by 21 days. This study was the first phase of 
research assessing the effects of H57 as a probiotic in poultry and the experiment was conducted for 
21 days at the beginning to establish any effects. The second experiment was then conducted for 35 
days. Unexpectedly, the result of the second experiment didn’t match with the first. Therefore, the 
third experiment was also conducted for 21 days with more variables. Moreover, It has been 
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suggested that maturity of the chicken gastrointestinal tract microbiome occurs between15 and 22 
days of age (Ranjitkar et al., 2016) 
Although there were significant positive effects of H57 on broiler growth rate and feed conversion, 
the effects were not consistent. Birds fed sorghum based diets supplemented with H57 had 
improved body weight gain and feed conversion both in experiments 1 and 3. The response to 
wheat based diets varied between experiments, as there was a positive effect of H57 in experiment 3 
but not in experiment 2 when the wheat based diet was supplemented with H57. In contrast, no 
improvement in bird performance was observed when the sorghum and wheat blended diet was 
supplemented with H57 in experiment 3. In contrast to our result, Crisol-Martinez et al. (2017) 
reported that chicks with sorghum-based diet had better growth performance than chicks with 
sorghum and wheat mixed diet.  
The major objectives of this PhD thesis were to analyze the impacts of the probiotic Bacillus 
amyloliquefaciens H57 on performance and intestinal microbial population and microbial functions 
across a range of feed compositions. In all of the experiments (Ex. 1, 2 and 3) the only variable that 
is different between control and treatment diets is the H57 added to the treatment diet. In each 
experiment, both control and treatment diets were prepared using the same batch of the ingredients, 
prepared on the same day using the same method and equipment. Significance of differences in 
performance, abundance of particular microbes (OTUs) and abundance of genes responsible to 
encode particular functions were analyzed by comparing the data between control and treatment 
(H57) groups for each experiment. Diet for each experiment was prepared with different batches of 
ingredients. Analysis of diets to measure nutrient composition, anti-nutritional factors and soluble 
non-starch polysaccharides was not undertaken, as it would require an expansion of the 
experimental variables tested beyond the scope of this PhD. 
There do not appear to be any other studies of the effect of feeding B. amlyloliquefaciens on the 
performance of poultry fed sorghum and/or wheat based diets. Nevertheless, our results are in 
partial agreement with Ahmed et al. (2014) and Lei et al. (2015) who reported positive effects on 
body weight gain, feed intake and FCR of broiler chickens fed a corn and soybean based diet 
supplemented B. amyloliquefaciens. In earlier studies, broilers fed with a commercial probiotic 
product (Ecobiol) containing B. amyloliquefaciens had increased growth rate (Ortiz et al., 2013) and 
improved feed efficiency (Diaz, 2007). However, it is difficult to compare studies as different basal 
diets were fed and the amount of B.amyloliquefaciens added to the diet is not given. In the current 
study, the aim was for each bird to have an intake of 109 cells/day.  
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The mechanism of action of H57 that results in the improved growth rate of birds is not apparent at 
this point in time. However, there were some common features across all experiments, which may 
assist in determining the mode of action. As stated earlier, there was no difference in growth rate 
and feed conversion between birds fed diet with and without H57 in experiment 2 (wheat based 
diet) and in experiment 3 (sorghum and wheat mixed diet). However, birds (both control and H57) 
in these experiments had what would be estimated to be the optimum growth rate (Aviagen, 2014b). 
To illustrate this, expected average daily gain (performance objective) and actual daily gain are 
shown in Figure 3-8 and Figure 3-9c. In contrast, growth rate of the control group was lower than 
predicted in experiment 1 (Figure 3-7), experiment 3 with the sorghum based diet (Figure 3-9a) and 
experiment 3 with the wheat based diet (Figure 3-9b). Interestingly, the birds fed the diet with H57 
had significantly higher growth rates than those fed the Control diet in these experiments. 
Therefore, one possible mechanism of action of H57 could be overcoming a suppression in growth 
rate.  
Figure 3-7: Average daily gain (g/bird/day) of control and H57 birds at different age in experiment 1 
and comparison with performance objective (Aviagen, 2014b). *P<0.05 
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Figure 3-8: Average daily gain (g/bird/day) of control and H57 birds at different age in experiment 2 
and performance objective (Aviagen, 2014b). 
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b) 
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Figure 3-9: Average daily gain (g/bird/day) of control and H57 birds at different age in experiment 3 
and comparison with performance objective (Aviagen, 2014b) a) sorghum based diet b) wheat based 
diet c) sorghum and wheat mixed diet.  
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all of these studies, growth rate of control (non-treated) birds had been supressed (Figure 3-10) as 
compared to a performance objective, in agreement with our experiments with H57.  
 
Figure 3-10: Growth rate of chickens and standard breed specific performance objectives (Aviagen, 
2014b, Aviagen, 2014a) in control and Bacillus amyloliquefaciens treated (dietary administration) 
birds in past studies. ADG = average daily weight gain (g/bird/day). BA = Bacillus amyloliquefaciens. 
*p<0.05 
In the experiments reported in this thesis, results appear to be related to diet composition and 
possibly the source of the chicks used in the experiments. Chickens fed either sorghum or wheat 
based diets without B. amyloliquefaciens H57 grew the slowest in our studies (experiment 1 and 
experiment 3).  Sorghum contains anti-nutritional compounds such as kafirin as the major storage 
protein, phytate and/or tannin (Johns and Brewster, 1916; Bryden et al 2008). Steaming sorghum in 
pellet formation may induce an interaction between kafirin protein bodies and starch granules 
inhibiting the digestion of the starch. Kafirin and tannin seem to act together to reduce amino acid 
digestibility and total metabolisable energy of feed for poultry but it is not clear whether a similar 
interaction occurs with unheated mash feed.  The amino acids in kafirin are poorly digested and 
deficient in essential amino acids lysine and cysteine. Sorghum may also contain condensed tannins 
in significant amounts (Butler et al., 1984) which complex with proteins including enzymes and 
thereby reduces digestion and uptake of amino acids by poultry (Bryden et al 2009). Because of 
these interactions sorghum is often regarded as an inferior grain for poultry feeds.   
More than 80% of total phosphorus (P) in sorghum and more than 70% of total P in wheat (Selle et 
al., 2000) is present as phytate-bound P (phytate-P). Mono-gastric animals like poultry cannot 
efficiently use phytate-bound P in their diet (Woyengo and Nyachoti, 2013, Ravindran et al., 2000, 
Nelson, 1967). Moreover, phytates are able to complex protein thereby reducing the digestibility of 
nitrogen and essential amino acids by poultry (Ravindran et al., 2000, Selle et al., 2000, Woyengo 
and Nyachoti, 2013).  Surprisingly H57 does not appear to produce phytase even though other B. 
amyloliquefaciens strains do (Le et al., 2016).  
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The anti-nutritional compounds in sorghum and/or wheat, for example non-starch polysaccharides 
or NSPs present in wheat, may reduce broiler growth rates. However, further study is needed to 
confirm whether this is the case in our study and how H57 assists in improving the feed value of 
ingredients by overcoming these effects.  
Bacillus amyloliquefaciens produces a large range of extracellular metabolites eg. enzymes such as 
α-amylase, proteases, cellulase, xylanase etc. (Gracia et al., 2003, Lee et al., 2008, Gould et al., 
1975, Breccia et al., 1998), antimicrobial and antifungal  lipopeptides eg. surfactin, fengicin, 
bacillumycin D, iturin A (Koumoutsi et al., 2004, Ongena and Jacques, 2008, Chen et al., 2009, 
Arrebola et al., 2010), polyketides eg. macrolactin, difficidin, bacillaene, chlorotetain (Schneider et 
al., 2007, Chen et al., 2006, Rapp et al., 1988) and bacteriocin (Ulyanova et al., 2011). Strain H57 
has genes to encode many of these exogenous metabolites including several carbohydrate activated 
enzymes including glycoside hydrolases, lipopeptides (surfactin, iturin, bacillomycin D and 
fengycin) and antibiotic polyketides (macrolactin, difficidin and bacillaene) (Schofield et al., 2016). 
At this stage, it is unknown whether these compounds are of benefit in poultry nutrition.  
Bacillus amyloliquefaciens has also been used to improve the quality of non-conventional 
feedstuffs, by solid-state fermentation, for use as potential ingredients in poultry diets (Wizna et al., 
2009, Wizna et al., 2008). The solid-state fermentation by B. amyloliquefaciens increased crude 
protein and decreased crude fibre of non-conventional feedstuffs (tapioca by-products, sago pith 
and rumen content) (Wizna et al., 2008, Wizna et al., 2009). Recently, Chistyakov et. al (2015) used 
solid-state B. amyloliquefaciens fermented soybean with retained spores and vegetative cells of B. 
amyloliquefaciens to inoculate a poultry diet, increasing body weight by 7 to 8% and improving 
FCR by up to 9%.  
There appear to be a number of ways in which H57 could influence bird performance and one could 
well be the modification of the gastrointestinal microbiome. In recent times, there has been a surge 
in interest regarding the role of the gastrointestinal microbiota in shaping the health and energy 
balance of the host. Study of the effects of H57 on intestinal microbiota could provide further 
insights on the mode of action of this probiotic. 
  
 66 
Chapter 4 Microbial community structure in the 
gastrointestinal tract of broiler chickens fed Bacillus 
amyloliquefaciens H57  
4.1 Introduction 
The gastrointestinal tract (GIT) of the chicken is a complex microbial with dynamic consortium of 
microorganisms, both in the lumen and on the mucosal surface with commensal (or probably 
symbiotic) relationship among themselves and with the host (Yeoman et al., 2012, Saengkerdsub et 
al., 2007a, Saengkerdsub et al., 2007b, Apajalahti et al., 2004). Contribution of the gastrointestinal 
microbiota to animal health, overall wellbeing and productivity is well appreciated. The chicken 
gastrointestinal microbiome has been studied for more than four decades to understand its 
characteristics and function. The population and composition of this ecosystem are contingent 
mainly on the host diet (Apajalahti et al., 2001), and to a lesser extent on systemic immune 
response, GIT secretions and on the type of litter material used (Torok et al., 2009). However, 
composition of the ileal and caecal microbiome can significantly differ (Mohd Shaufi et al., 2015). 
Composition, physical state and nutrient concentration of the animal diet and presence of feed 
additives have significant effects on the intestinal microbial dynamics (Thompson et al., 2008, 
Knarreborg et al., 2002b, Singh et al., 2013, Engberg et al., 2000, Engberg et al., 2004) which in 
turn affect the bird health, performance and physiological state (Round and Mazmanian, 2009, 
Nicholson et al., 2005). Here, we extend these findings by characterising the effects of H57 on the 
ileal and caecal microbiota of broiler chickens using high-throughput culture independent DNA 
sequencing (Illumina). 
Probiotics can change the microbial population dynamics in the GIT (Mountzouris et al., 2007, 
Mountzouris et al., 2009, An et al., 2008).  Earlier studies on the effects of probiotics on the GIT 
microbial population of poultry using traditional microbial growth methods were unable to 
adequately unravel the complexity of gastrointestinal microbial ecosystem. However, recent 
developments in culture independent techniques through the use of molecular biology tools and 
bioinformatics have enabled an in-depth study with an increasing database and understanding (van 
der Hoeven-Hangoor et al., 2013, Thompson et al., 2008, Torok et al., 2009, Cressman et al., 2010, 
Pissavin et al., 2012, Ammor et al., 2008). This study used next generation sequencing of DNA to 
study the microbiome composition of the ileum, caeca and faeces of broiler chickens. This study 
addresses the question “can the gastrointestinal microbial ecology be modified to improve 
production efficiency in chicken using feed additives such as probiotics?”  
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The 16S rRNA gene is one of the most widely used molecular markers in the study of microbial 
community structure. All bacterial species carry at least one copy of this gene with highly 
conserved and variable nucleotide sequences, which make the comparison between distantly related 
microbes and assessment of similarity between closely related organisms (more details in chapter 2) 
(Olsen et al., 1986, Case et al., 2007). The 16S rRNA amplicon sequencing by using next 
generation DNA sequencing technique was used to study the effects of H57 on the microbial 
population of the ileum and caecum.  
4.2 Materials and methods 
4.2.1 Experimental design 
Details about experimental design have been presented in the previous chapter (chapter 3). Briefly, 
experiment 1 was undertaken with a sorghum based diet consisting of two treatments (basal diet ± 
H57) and 6 replicates per treatment. Experiment 2 was carried out with a wheat based diet with and 
without H57 consisting of 12 replicates per treatment (half in cages and half in floor pens). 
Similarly, experiment 3 consisted of three types of diet (wheat, sorghum and wheat and sorghum 
mix) with and without H57 each with 6 replicates. Detail composition of each diets is given in 
chapter 3.  
4.2.2 Sample collection 
Samples of intestinal content from the ileum and caeca were collected on day 21 from experiment 1, 
on day 35 from experiment 2 and on day 4, day 13 and day 21 from experiment 3. Samples were 
collected from 24 birds (two birds from each replicate) in experiment 1, 24 birds (two birds from 
50% of replicates selected randomly) in experiment 2 and 36 birds (one bird from each replicate) at 
each time point (day 4, day 13 and day 21) in experiment 3. Approximately 0.5 g of digesta from 
the ileum and caeca were collected into 1.5 ml Eppendorf tubes by squeezing the content directly 
into the tubes from the intestine to prevent contamination. Samples from the ileum were collected 
from the distal part of the ileum while samples from the caeca were collected after removing about 
2 cm from the proximal end. Faecal samples were also collected at day 13 from each cage from 
experiment 3. Pieces of paper were kept under each cage and about 0.5 g of faecal samples were 
collected and placed into 2 ml Eppendorf tubes. The samples were immediately frozen in liquid 
nitrogen, kept on dry ice during collection and transportation, and stored at -80°Ç. Details of 
samples collected for microbial profiling  are given in Table 4-1. 
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Table 4-1 Details of samples used for 16S rRNA gene amplicon sequencing 
Experiment 
No 
Diet type Age 
(day) 
Site and no. of samples 
Ileum Caecum Faeces 
1 Sorghum based 21 24 24 - 
2 Wheat based 35 24 24 - 
3 
Sorghum based 
4 
12 12 - 
Wheat based 12 12 - 
Sorghum+wheat mix 12 12  
Sorghum based 
13 
12 12 12 
Wheat based 12 12 12 
Sorghum+wheat mix 12 12 12 
Sorghum based 
21 
12 12  
Wheat based 12 12  
Sorghum+wheat mix 12 12  
4.2.3 DNA extraction 
DNA from digesta samples was extracted by a modified repeated bead beating plus column 
(RBB+C) method (Yu and Morrison, 2004) and the QIAamp Fast DNA Stool Mini Kit (QIAGEN, 
Velno, The Netherlands). Briefly, 0.2 g of digesta samples were weighed into sterile bead beating 
tubes containing 0.5 g of 0.1 mm zirconia beads (BioSpec Products Inc., Oklahoma, USA) and 
suspended in 1 ml of lysis buffer (2.9% NaCl, 0.6% Tris, 0.05M EDTA pH 8.0 and 4% SDS). The 
suspension was homogenized twice in a mini bead beater (BioSpec Products Inc, Oklahoma, USA) 
for 5 minutes each, then heated at 70°C for 5 minutes followed by centrifugation (Eppendorf 5424) 
at 20,000 g for 3 minutes to separate bacterial genomic DNA from the digesta.  The separated 
supernatant was then treated with 1 ml of InhibitEX buffer from the kit to neutralize any PCR 
inhibitors present in the digesta samples followed by centrifugation at 20,000 g for 6 minutes to 
separate DNA from any debris present in the samples and incubated at 37°C for one hour with 20 µl 
(40 mg/ml) of DNase free RNase for ileal samples or 30 µl (40 mg/ml) of DNase free RNase for 
caecal samples. The samples were then transferred into 15 ml Falcon tubes containing 25 µl of 
Proteinase K (QIAGEN, Velno, The Netherlands), added 600 µl of buffer AL, vortex mixed and 
heated at 70°C for 10 minutes. Absolute ethanol (1.3 ml) was added in the tube and all the liquid in 
the tube was spun down through a QIAamp spin column by adding 600 µl at a time.  DNA in the 
column was washed with 500 µl of AW1 (wash buffer 1) and AW2 (wash buffer 2) according to the 
manufacturer’s directions and finally eluted with either 100 µl (ileum) or 200 µl (caecum) of elution 
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buffer (10mM Tris-cl, pH 8.5). The extracted genomic DNA was stored at -20°C until further 
analysis. 
4.2.4 Preparation of 16S rRNA gene amplicon libraries and sequencing 
To prepare for the sequencing the concentration of DNA in the genomic DNA samples was 
measured using a Qubit 2.0 fluorometer (Thermo Fisher Scientific Inc, Victoria, Australia) and 
diluted with ultrapure distilled water to 5 ng/μl.  
Four samples (1 each from Control and H57 from both sites – ileum and caecum) were selected to 
be sequenced initially twice by using two sets of primers, 926F/1392R and 803F/1392R for the 
amplification (Table 4-2). The primer pair 926F/1392R are specific to the V6-V8 variable region of 
the 16S rRNA gene of bacteria and archaea and 18S rRNA gene of eukarya (Engelbrektson et al., 
2010). Similarly, the primer pair 803F/1392R targets the V8 region of the 16S rRNA gene of 
bacteria and archaea but not the eukaryotic 18S rRNA gene (Goodfellow and Stackebrandt, 1991). 
Both primer pairs gave similar results. Universal primer pair 926F and 1392R were subsequently 
chosen for the amplification of DNA to be sequenced. 
Table 4-2: Primers used for the amplification of DNAs to be sequenced 
Primers Sequence (5' - 3') 
803F ATTAGATACCCTGGTAGTC 
926F AAA CTY AAA KGA ATT GAC GG 
1392R ACG GGC GGT GTG TRC 
The 16S rRNA gene sequencing library was prepared by standard library preparation method for 
Illumina, following the manufacturer’s protocol (Illumina Inc., San Diego, CA, USA). Two rounds 
of PCR reactions were undertaken to prepare the sequencing library. In the first round, the V6 -V8 
hypervariable region of 16S rRNA gene was amplified (primer pair 926F/1392R (0.2 μM each)) 
and included a ‘tag’ sequence complementary to the Illumina sequence adapter, in 25 μl reactions 
with 1x KAPA HiFi HotStart ReadyMix (Kapa Biosystems Inc., Wilmington, MA, USA). The PCR 
reaction parameters comprised an initial denaturation at 95°C for 3 min followed by 25 cycles of 
95°C for 30 s for denaturation, 55°C for 30 s for annealing and 72°C for 30 s for elongation, with a 
final extension for 5 min at 72°C. In the second round, indexing PCR was carried out in 50 μl 
reactions with Illumina sequencing adapters and dual indexing barcodes using 5 μL of template 
DNA, 5 μL of each index primer and 25 μl of 2x KAPA HiFi HotStart ReadyMix. The PCR 
reaction parameters comprised an initial denaturation at 95°C for 3 min followed by eight cycles of 
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95°C for 30 s for denaturation, 55°C for 30 s for annealing and 72°C for 30 s for elongation, with a 
final extension for 5 min at 72°C. The resulting amplicon libraries were cleaned using Agencourt 
AMPure XP beads (Beckman Coulter Australia Pty Ltd, Lane Cove, NSW, Australia) following 
manufacturer’s standard protocols and sequenced using Illumina NextSeq platform (Illumina, San 
Diego, CA, USA).  
4.2.5 Quality control and sequence processing 
Quality of the sequences was checked with fastQC (Andrews, 2010). The primer sequences were 
removed by trimming the first 20 bases. Quality filtering was done by Sliding Window quality 
filtering approach of Trimmomatic software truncating 3′ end of sequences at the first residue with 
an average base quality below 15 (Bolger et al., 2014). All sequences were finally trimmed to 250 
bases and translated to fasta format while reads with less than 250 bases were rejected. The 
sequences were then clustered into operational taxonomic units (OTUs) at 97% DNA sequence 
similarity using Quantitative Insights Into Microbial Ecology (QIIME) software (Caporaso et al., 
2010). Any OTU having less than 0.05% abundance were not included in subsequent analysis. 
OTUs were then identified by using Basic Local Alignment Search Tool (BLAST) (Altschul et al., 
1990) against Greengenes database version May 2013 and an OTU table with relative abundance 
for each OTU was generated. OTU numbers were adjusted for 16S gene copy number variances 
using software CopyRighter (Angly et al., 2014).  
4.2.6 Statistical analysis 
Further data analysis was done using R programming language (R Core Team, 2016) in RStudio, an 
integrated development environment for R.  Significance of difference in microbial population 
between treatments (Control and H57) was tested by Permutational Multivariate Analysis of 
Variance (PERMANOVA) of operational taxonomic units (OTUs) using adonis() function of the 
vegan package (Oksanen et al., 2016). Ordination of the samples (individual chickens) was done by 
principal component analysis (PCA) of Hellinger transformed (Legendre and Gallagher, 2001) 
relative abundance of OTUs data using vegan package in R (Oksanen et al., 2016). Monotonic 
relationships between relative abundance of OTUs and body weight of individual sampled chickens 
was analysed by using Spearman’s correlation test with ggscatter() function of the package ggpubr 
after testing the normality of the distribution of the data with the shapiro.test() function. 
Comparison of relative abundance of individual taxons (OTU to phylum) was done by T-Test (two-
tailed two-sample unequal variance). 
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4.3 Results 
4.3.1 Effects on intestinal microbiota of chicken fed sorghum based diet 
(experiment 1) 
PERMANOVA of operational taxonomic units from Control and H57 treated birds indicated that 
H57 significantly modified the microbial community structure both in the ileum (P = 0.001) and 
caecum (P = 0.001) with significant change in the relative abundance of multiple bacterial taxa 
(Table 4-3, Table 4-4, Figure 4-1, Figure 4-2, and Figure 4-3). Microbiota diversity (Shannon 
index) was significantly reduced (P = 0.023) in the ileum by dietary H57 addition (Control 4.35 vs 
H57 group 3.92) while diversity was not affected in the caecum (rarefaction with sequencing depth 
of 25,000 reads per sample in both sites). Among three experiments, H57 had the most prominent 
effects on the intestinal microbial profile in experiment 1. Therefore, results about the effects of 
H57 on the microbial profile of ileum and caecum in experiment 1 have been presented in detail.  
Streptococcus and Lactobacillus were the dominant OTUs in the ileum both in Control and H57 
treated birds while Faecalibacterium were dominant in the Controls and Bacteroides were dominant 
in the H57 treatment group in the caecum. Relative abundance of the genera Streptococcus and 
Bacillus increased (P < 0.05) while that of genera Staphylococcus, SMB53 and Blautia and families 
Peptostreptococcaceae and Clostridiaceae were reduced  (p < 0.05) for the birds given H57. In the 
caecum, relative abundance of the genus Bacteroides and Bacillus increased while the relative 
abundance of the genera Staphylococcus, Lactococcus, Faecalibacterium, Coprobacillus and 
Adlercreutzia and family Clostridiaceae decreased. The most prominent change was an increase in 
the relative abundance of Bacteroides in the caecum from 0.0002% relative abundance in Control 
birds to 17.4% in the H57 treated birds; becoming the most dominant taxon in the caeca. Major 
OTUs (>1% relative abundance) with significantly different relative abundance between Control 
and H57 are shown in Table 4-3 and Table 4-4.  
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Figure 4-1 Ordination of samples (individual chickens) by Principle Component Analysis (PCA) of 
normalised relative abundance of OTUs from ileum (experiment 1).  
  
Figure 4-2 Ordination of samples (individual chickens) by Principle Component Analysis (PCA) of 
normalised relative abundance of OTUs from caecum (experiment 1).  
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Table 4-3 Average relative abundances of OTUs (with more than 1% relative abundance) significantly 
altered due to H57 in ileum of birds on sorghum based diets (experiment 1). k = kingdom, p = phylum, 
c = class, o = order, f = family, g = genus, s = species 
OTUs Average relative abundance Ileum Control Ileum H57 P-Value 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Streptococcaceae; 
g__Streptococcus; s__alactolyticus 
16.61 28.82 <0.001 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__ 
1.52 5.78 0.001 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__salivarius 
3.08 5.12 0.015 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__salivarius 
3.14 4.80 0.022 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Enterococcaceae; 
g__Enterococcus; s__ 
2.17 1.94 <0.001 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Streptococcaceae; 
g__Streptococcus; s__alactolyticus 
1.83 1.36 <0.001 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Turicibacterales; f__Turicibacteraceae; 
g__Turicibacter; s__ 
4.38 1.35 0.026 
k__Bacteria; p__Proteobacteria; 
c__Gammaproteobacteria; o__Enterobacteriales; 
f__Enterobacteriaceae; g__; s__ 
0.07 1.34 0.001 
k__Bacteria; p__Actinobacteria; c__Actinobacteria; 
o__Actinomycetales; f__Corynebacteriaceae; 
g__Corynebacterium; s__stationis 
1.67 1.23 0.011 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Streptococcaceae; 
g__Streptococcus; s__alactolyticus 
0.44 1.04 <0.001 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__; g__; s__ 0.45 1.03 <0.001 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__Clostridiaceae; g__SMB53; 
s__ 
1.23 0.81 0.002 
At higher taxonomic level, there was no difference in phylum between Control and H57 group and 
significantly higher abundance of bacilli and lower abundance of clostridia (class) in H57 group 
compared to Control in the ileum (Figure 4-5). Similarly, order Lactobacillales (Figure 4-7) and 
families Streptococcaceae and Bacillaceae were significantly higher in H57 group (Figure 4-9) 
while order Clostridials (Figure 4-7) and families Preptostreptococcaceae, Clostridiaceae, 
Turibacteriaceae and Staphylococcaceae were significantly lower in H57 group as compared to 
Control (Figure 4-9).  
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Figure 4-3 Heat map showing the relative abundance of bacterial taxa in ileum and caecum of control 
and H57 fed birds in experiment 1. Each column represents an individual bird and each row 
represents a bacterial taxon. *significant difference in ileum, **significant difference in caecum, 
***significant difference in both ileum and caecum at p < 0.05 . 
Table 4-4 Average relative abundances of OTUs (with more than 1% relative abundance) significantly 
altered due to H57 in caeca of birds on sorghum based diets (experiment 1) 
OTUs 
Average relative abundance 
Caecum 
Control 
Caecum 
H57 P-Value 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__Ruminococcaceae; 
g__Faecalibacterium; s__prausnitzii 
9.95 4.13 0.008 
k__Bacteria; p__Bacteroidetes; c__Bacteroidia; 
o__Bacteroidales; f__Bacteroidaceae; 
g__Bacteroides; s__ 
0.00 13.60 0.010 
k__Bacteria; p__Bacteroidetes; c__Bacteroidia; 
o__Bacteroidales; f__Bacteroidaceae; 
g__Bacteroides; s__fragilis 
0.00 1.18 0.033 
k__Bacteria; p__Bacteroidetes; c__Bacteroidia; 
o__Bacteroidales; f__Bacteroidaceae; 
g__Bacteroides; s__fragilis 
0.00 2.64 0.033 
In caecum, family Firmicutes and Actinobacteria were significantly reduced in H57 group while 
Bacteroidetes were significantly increased (Figure 4-4). Class Clostridia had significantly lower 
relative abundance in H57 group but Bacteroidia had significantly higher abundance as compared to 
75%   
 60%    
 45%   
 30%   
 
15%   
 0% 
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Control (Figure 4-6). Similarly, order Clostridials (Figure 4-8) and family Ruminococcaceae 
(Figure 4-10) has been reduced and order Bacteroidels (Figure 4-8) and family Bacteroideceae has 
been increased in H57 group as compared to Control group (Figure 4-10).  
 
Figure 4-4 Relative abundance of different phyla in caecum in experiment 1. * (P<0.05). Error bars 
are standard error of mean (SEM) 
 
* 
* 
* 
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Figure 4-5 Relative abundance of different classes in ileum in experiment 1. * (P<0.05). Error bars are 
standard error of mean (SEM) 
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Figure 4-6 Relative abundance of different classes in caecum in experiment 1. * (P<0.05). Error bars 
are standard error of mean (SEM) 
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Figure 4-7 Relative abundance of different orders in ileum in experiment 1. * (P<0.05). Error bars are 
standard error of mean (SEM) 
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Figure 4-8 Relative abundance of different orders in caecum in experiment 1. * (P<0.05). Error bars 
are standard error of mean (SEM) 
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Figure 4-9 Relative abundance of different families in ileum in experiment 1. * (P<0.05). Error bars 
are standard error of mean (SEM) 
 
Figure 4-10 Relative abundance of different families in caecum in experiment 1. * (P<0.05). 
Error bars are standard error of mean (SEM) 
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4.3.2 Effects of H57 on intestinal microbial profile of chicken fed a wheat based 
diet (experiment 2) 
When chickens were raised on a wheat based diet for 35 days, H57 had a significant effect on the 
microbial community profile of the caecum (Figure 4-11, P = 0.04, PERMANOVA) but not of the 
ileum (P = 0.37, PERMANOVA).  
In the ileum, none of the major OTUs except two minor OTUs (order Clostridiales and genus Bacillus) 
had significantly different average relative abundance between Control and H57 treated chickens.  
In the caecum, five OTUs had significantly different average relative abundance between Control 
and H57 groups. Two of these OTUs (families Rikenellaceae (0.005% in Control vs 3.8% in H57) 
and Lachnospiracea (2.1% in Control vs 0.9% in J57)) had relative abundance of greater than 1% at 
least in one treatment group (Control or H57). 
 
 
Figure 4-11 Principle Component Analysis (PCA) of normalized relative abundance of OTUs from 
caecal digesta samples at day 35 (experiment 2).    
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4.3.3 Intestinal microbiota of chickens raised in wire cages and floor pens (deep 
litter) were not different 
In the first experiment the birds were housed on the floor with a simulated deep litter.  As it was 
planned to conduct future experiments with cages in a temperature controlled room, we compared 
bird performance raised in the litter system with those in metal cages, both receiving the same diet, 
in this case a wheat based diet, with and without H57.  We analysed the ileal and caecal microbiota 
of birds receiving Control diet (without H57) both in pens and cages to examine the effect of 
preventing coprophagy in cages on intestinal microbiota.  
PERMANOVA of microbial community data indicated that there was no significant difference in 
microbial community structure both in the ileum (P > 0.05) and caecum (P > 0.05) associated with 
housing type.  
The dominant OTUs in the ileum were Lactobacillus and the dominant OTUs in caecum were 
Faecalibacterium both in the cages and deep litter pens. However, the relative abundance of two of 
the OTUs representing Lactobacillus were significantly lower (P < 0.05, 1st 0.7% in pens vs 0.1% in 
cages, 2nd 2.1% in pens vs 0.3% cages) in the ileum of the birds raised in cages than in the birds 
kept in deep litter pens. Relative abundance of one OTU representing Ruminococcus was 
significantly increased (P < 0.05, 0.1% in pens vs 0.6% in cages) in the caecum of birds in cages 
compared to those in the deep litter pens. Microbial diversity (Shannon index) was similar (P > 
0.05) in both housing systems (rarefaction with sequencing depth of 4000 reads per sample from 
both sites).  
4.3.4 Effects on intestinal microbiota of chickens fed sorghum, wheat and wheat 
plus sorghum blend diets (experiment 3) 
4.3.4.1 Sorghum based diet 
Analysis of normalized relative abundances of OTUs showed that overall microbial population 
structures of Control and H57 treated chickens fed a sorghum based diet were significantly different 
on day 4 in the caecum (Figure 4-12, P = 0.027) and on day 13 in the ileum (Figure 4-13, P = 
0.024). There were no significant differences in the overall structure of the microbial populations 
between Control and H57 in the ileum on day 4, caeca on day 13 and both the ileum and caeca on 
day 21. Dominant OTUs in the ileum were genus Enterococcus both in the Control and H57 on day 
4, genus Lactobacillus in Control and genus Candidatus Arthromitus in H57 on day 13 and 
Streptococcus alactolyticus in control and genus Lactobacillus in H57 on day 21. In the caecum 
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Order RF39 in Control and genus Ruminococcus on day 4, Faecalibacterium prausnitzii both in 
Control and H57 on day 13 and family Coriobacteriaceae in control and Faecalibacterium 
prausnitzii on day 21 were the dominant OTUs.  
 
Figure 4-12 Principal Component Analysis (PCA) of normalised relative abundance of OTUs at day 4 
from the caecum of chickens fed sorghum based diet. 
Relative abundance of several OTUs was significantly different both in the ileum and caecum of 
Control and H57 treated birds of all three age groups (Table 4-5 and Table 4-6). In the ileum, 
notable effect was increase of Lactobacillus in H57 group on day 21 (5% in Control vs 15.4% in 
H57). Major OTUs (average relative abundance >1%) altered due to H57 in caecum were genus 
Coprococcus (control = 2.3%, H57 = 7.2%), order Clostridiales (control = 2.8%, H57 = 0.5%), 
genus Ruminococcus (control = 2.5%, H57 = 0.6%) and genus Oscillospira (control = 1.4%, H57 = 
0.5%) on day 4. However, other OTUs with significantly different average relative abundance 
between Control and H57 were represented in less than 1% relative abundance.  
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Figure 4-13 Principal Component Analysis (PCA) of normalised relative abundance of OTUs at day 13 
from the ileum of chickens fed sorghum based diet.  
Table 4-5: Average relative abundances of OTUs significantly altered due to H57 in ileum of birds on 
sorghum based diets 
Age 
(days) OTU ID OTUs 
Average relative abundance P - 
Value Control H57 Difference  (%) 
13 
350242 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__ 
0.88 0.05 -0.83 0.01 
4385535 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Bacillales; f__Bacillaceae; 
g__Bacillus; s__ 
0.00 1.85 1.84 0.01 
21 4414257 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__ 
4.96 15.36 10.40 0.05 
 
Table 4-6: Average relative normalised abundances of OTUs significantly altered due to H57 in 
caecum of birds with sorghum based diets 
Age 
(days) OTU ID OTUs 
Average relative abundance P-
Value Control H57 Difference  (%) 
4 
132253 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__Lachnospiraceae; 
g__Coprococcus; s__ 
2.29 7.23 4.94 0.03 
169364 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__Lachnospiraceae; g__; 
s__ 
0.84 0.22 -0.62 0.05 
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2182669 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__; g__; s__ 2.78 0.48 -2.30 0.04 
3438642 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__Lachnospiraceae; 
g__Ruminococcus; s__ 
2.48 0.55 -1.93 0.05 
845900 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__Ruminococcaceae; 
g__Oscillospira; s__ 
1.38 0.51 -0.87 0.03 
13 151870 
k__Bacteria; p__Firmicutes; 
c__Erysipelotrichi; o__Erysipelotrichales; 
f__Erysipelotrichaceae; g__Coprobacillus; 
s__ 
0.28 0.93 0.65 0.01 
21 
4414257 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__ 
0.02 0.08 0.06 0.05 
157573 
k__Bacteria; p__Bacteroidetes; 
c__Bacteroidia; o__Bacteroidales; 
f__Rikenellaceae; g__; s__ 
0.12 0.63 0.51 0.05 
4.3.4.2 Wheat based diet 
For the chicks raised on the wheat based diet with and without H57, intestinal microbiota were only 
significantly different between Control and H57 birds in the caecum digesta samples collected on 
day 21 (P = 0.02, Figure 4-14). There were no significant differences in microbiota structure in 
either the ileum or caecum between Control and H57 fed birds on day 4 and day 13 and in the ileum 
on day 21. On day 4, dominant OTUs belonged to the genus Enterococcus in the ileum and the 
family Lachnospiraceae in the caecum both in Control and H57 groups. Streptococcus alactolyticus 
and genus Candidatus Arthromitus were the dominant OTUs in ileum of control and H57 birds 
respectively on day 13 while Faecalibacterium prausnitzii was the dominant in Control and the 
genus Sutterella in H57 birds in the caecum. Dominant OTUs belonged to the genus Lactobacillus 
in the ileum of both Control and H57 birds on day 21 while Faecalibacterium prausnitzii 
dominated the caecum of the Control and the genus Megamonas dominated H57 treated birds.  
Addition of H57 to the wheat based diet altered the population of microbes both in the ileum and 
caecum at day 4, day 13 and day 21 with significant differences in relative abundances of several 
OTUs cf. the Control birds (Table 4-7 and Table 4-8). However, most of these altered OTUs were 
represented in less than 1% of relative abundance. None of the major OTUs were different in ileum 
between control and H57 birds. Relative abundances of twenty OTUs were significantly different in 
caecum between Control and H57 groups on day 13. Out of twenty significantly altered OTUs in 
caecum, three OTUs were represented in more than 1% of the microbial population. Relative 
abundance of genus Lactobacillus (control = 0.2%, H57 = 1.2%) and genus Sutterella (control = 
5.5%, H57 = 14.2%) was significantly higher in H57 birds as compared to Control on day 13 while 
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population of genus Coprococcus was increased in H57 gorup as compared to control on day 21 
(control = 0.3%, H57 = 1.3%). 
 
 
 
Figure 4-14 Principal Component Analysis (PCA) of normalised relative abundance of OTUs at day 21 
from the caecum of chickens fed wheat based diet.  
Table 4-7: Average relative abundances of OTUs in the ileum of birds raised on a wheat based diet 
with H57 supplement which were significantly different to the abundances in Control birds 
Age 
(days) OTU ID OTUs 
Average relative abundance P-
Value Control H57 Difference  (%) 
4 
New.Reference
OTU537 
k__Bacteria; p__Firmicutes; 
c__Bacilli; o__Lactobacillales; 
f__Lactobacillaceae; 
g__Lactobacillus; s__ 
0.09 0.02 -0.07 0.03 
21 
4385535 k__Bacteria; p__Firmicutes; 
c__Bacilli; o__Bacillales; 
f__Bacillaceae; g__Bacillus; s__ 
0.02 0.19 0.17 0.02 
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Table 4-8: Average normalised relative abundances of OTUs in the caecum of birds raised on a wheat 
based diets that were significantly different between birds given H57 and Control birds.  
Age 
(days) 
OTU 
ID OTUs 
Average relative abundance P-
Value Control H57 Difference  (%) 
4 
539647 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__ 
0.05 0.21 0.15 0.04 
2182669 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__; g__; s__ 0.92 0.08 -0.85 0.03 
13 
1141398 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__salivarius 
0.14 0.87 0.73 0.02 
4362942 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Enterococcaceae; 
g__Enterococcus; s__ 
0.01 0.03 0.02 0.03 
350242 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__ 
0.00 0.02 0.02 0.04 
166911 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__ 
0.05 0.78 0.74 0.03 
137580 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__ 
0.00 0.07 0.06 0.04 
176615 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__ 
0.00 0.03 0.03 0.02 
292057 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__; g__; s__ 0.00 0.02 0.02 0.02 
4338733 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__reuteri 
0.06 0.60 0.54 0.04 
New.Re
ference
OTU74
2 
k__Bacteria; p__Proteobacteria; 
c__Gammaproteobacteria; 
o__Enterobacteriales; f__Enterobacteriaceae; 
g__; s__ 
0.00 0.01 0.01 0.01 
1021172 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__salivarius 
0.18 1.19 1.00 0.02 
4429986 
k__Bacteria; p__Proteobacteria; 
c__Betaproteobacteria; o__Burkholderiales; 
f__Alcaligenaceae; g__Sutterella; s__ 5.54 14.16 8.62 0.03 
New.Re
ference
OTU67
0 
k__Bacteria; p__Proteobacteria; 
c__Gammaproteobacteria; o__Chromatiales; 
f__; g__; s__ 0.00 0.02 0.02 0.03 
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211212 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__Lachnospiraceae; g__; 
s__ 
0.52 0.13 -0.39 0.02 
4433833 
k__Bacteria; p__Proteobacteria; 
c__Gammaproteobacteria; 
o__Enterobacteriales; f__Enterobacteriaceae; 
g__; s__ 
0.01 0.03 0.03 0.02 
333205 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__Ruminococcaceae; 
g__Ruminococcus; s__ 
0.22 0.08 -0.14 0.04 
21 
129401 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__Ruminococcaceae; 
g__Oscillospira; s__ 
0.19 0.62 0.43 0.03 
2182669 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__; g__; s__ 0.03 0.46 0.43 0.02 
3141342 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__Lachnospiraceae; 
g__Coprococcus; s__ 
0.34 1.31 0.98 0.04 
166637 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__Lachnospiraceae; 
g__Dorea; s__ 
0.16 0.39 0.23 0.02 
850218 
k__Bacteria; p__Firmicutes; c__Clostridia; 
o__Clostridiales; f__Veillonellaceae; 
g__Phascolarctobacterium; s__ 
0.65 0.06 -0.58 0.02 
4.3.4.3 Sorghum and wheat blend diet 
Supplementing a diet based on a blend of sorghum and wheat with H57 resulted in significant 
differences in the microbial populations in the caecum of Control vs H57 treated birds at day 13 (P 
= 0.006, Figure 4-15). Microbiota structure of all other age group and sites were similar between 
Control and H57. Genus Enterococcus in ileum on day 4, genus Lactobacillus in caecum on day 4, 
family Clostridiaceae in ileum on day 13 and Faecalibacterium prausnitzii in caecum on day 13 
dominated both in control and H57 birds. At day 21 Lactobacillus were the dominant OTUs in the 
ileum of both Control and H57 birds while Faecalibacterium prausnitzii in Control and the genus 
Bacteroides in H57 groups were the dominant OTUs respectively in caecum.  
Although there were some OTUs with significantly different relative abundance between Control 
and H57 none of the OTUs with more than 1% of relative abundance were significantly different 
between two groups (Table 4-9). In caecum, reduction of genus Ruminococcus on day 4 and 
reduction of Faecalibacterium prausnitzii on day 13 in H57 group as compared to Control were the major 
changes (Table 4-10). 
 89 
 
Figure 4-15 Principal Component Analysis (PCA) of normalised relative abundance of OTUs at day 13 
from the caecum of chickens fed the diet based on sorghum and wheat blend.  
Table 4-9: Average normalised relative abundances of OTUs significantly altered in the ileum of birds 
raised on a sorghum and wheat blend diet when supplemented with H57. 
Age 
(days) OTU ID OTUs 
Average relative abundance 
P-Value Control H57 Difference  (%) 
4 4385535 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Bacillales; f__Bacillaceae; 
g__Bacillus; s__ 
0.00 0.30 0.29 0.03 
13 
New.Referen
ceOTU410 
k__Bacteria; p__Firmicutes; 
c__Clostridia; o__Clostridiales; f__; 
g__; s__ 
0.00 0.01 0.01 0.02 
4385535 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Bacillales; f__Bacillaceae; 
g__Bacillus; s__ 
0.00 0.77 0.77 0.02 
21 
4385535 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Bacillales; f__Bacillaceae; 
g__Bacillus; s__ 
0.00 0.19 0.19 0.01 
4334055 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__; g__; s__ 0.18 0.02 -0.16 0.02 
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Table 4-10: Average normalised relative abundances of OTUs significantly altered in the caecum of 
birds raised on a sorghum and wheat blend diet when supplemented with H57. 
Age 
(days) OTU ID OTUs 
Average relative abundance P-
Value Control H57 Difference  (%) 
4 
157516 
k__Bacteria; p__Firmicutes; 
c__Clostridia; o__Clostridiales; 
f__Lachnospiraceae; g__Ruminococcus; 
s__ 
2.98 0.88 -2.10 0.03 
3082155 
k__Bacteria; p__Firmicutes; 
c__Clostridia; o__Clostridiales; 
f__Lachnospiraceae; g__Ruminococcus; 
s__ 
3.53 0.53 -3.00 0.03 
13 
574528 
k__Bacteria; p__Firmicutes; 
c__Clostridia; o__Clostridiales; 
f__Clostridiaceae; g__; s__ 
1.44 0.18 -1.26 0.02 
New.Referen
ceOTU903 
k__Bacteria; p__Firmicutes; 
c__Clostridia; o__Clostridiales; 
f__Clostridiaceae; g__; s__ 
0.12 0.00 -0.12 0.04 
137580 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__ 
0.03 0.01 -0.02 0.04 
157297 
k__Bacteria; p__Firmicutes; 
c__Clostridia; o__Clostridiales; 
f__Ruminococcaceae; 
g__Faecalibacterium; s__prausnitzii 
20.49 7.96 -12.54 0.01 
157224 
k__Bacteria; p__Firmicutes; 
c__Clostridia; o__Clostridiales; 
f__Ruminococcaceae; 
g__Faecalibacterium; s__prausnitzii 
29.02 15.67 -13.35 0.04 
21 4447432 
k__Bacteria; p__Firmicutes; c__Bacilli; 
o__Lactobacillales; f__Lactobacillaceae; 
g__Lactobacillus; s__ 
0.21 0.98 0.77 0.04 
4.3.5 Experiment 3; effect of H57 on faecal microbiota  
In Experiment 3, the microbial profile of faeces was determined in the sample collected at age day 
13.  Overall there was a significant difference (P = 0.019) in the microbial profile in faeces between 
Control and H57 treated birds in the group fed a wheat based diet but there was no difference in the 
group fed a sorghum based diet or a mix of wheat and sorghum (P>0.05).   
The dominant OTU in the wheat diet was Streptococcus alactolyticus in the Control and 
Lactobacillus in the H57 treatment while in the sorghum diet Streptococcus alactolyticus was 
dominant in both the Control and H57.  For the mixed diet Lactobacillus was the dominant OTU in 
the Control group and Streptococcus alactolyticus in the H57 group. Relative abundance of six 
OTUs was significantly different between Control and H57 in the wheat based diet (Table 4-11) 
while there were three OTUs with significantly different relative abundance in sorghum diet (Table 
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4-12) There was no difference in the relative abundance of OTUs between Control and H57 for the 
mixed diet except for a very minor OTU representing Bacteroides plebeius (0.0004% in control and 
nil in H57). 
Table 4-11 Experiment 3.  OTUs with significantly different relative abundance between Control and 
H57 in the faeces of chicks at day 13 fed a wheat based diet 
OTU_ID OTUs 
Average relative 
 
P-
value 
Control H57 
New.ReferenceOTU742  f__Enterobacteriaceae; g__; s__ 0.17 0.65 0.04 
4473883  g__Streptococcus; s__alactolyticus 30.79 2.72 0.01 
4447567 o__Lactobacillales; f__; g__; s__ 1.46 0.24 0.04 
New.ReferenceOTU286 o__Chromatiales; f__; g__; s__ 0.52 2.41 0.02 
4337090 g__Streptococcus; s__ 0.89 0.03 0.02 
New.ReferenceOTU156 g__Streptococcus; s__alactolyticus 0.57 0.04 0.02 
Table 4-12 Experiment 3.  OTUs with significantly different relative abundance between Control and 
H57 in the faeces of chicks at day 13 fed a sorghum based diet.   
OTU_ID OTUs 
Average relative 
abundance P-value 
Control H57 
16195 g__Candidatus Arthromitus; s__ 0.14 1.06 0.04 
4447567 o__Lactobacillales; f__; g__; s__ 1.34 0.34 0.04 
New.ReferenceOTU156 g__Streptococcus; 
s__alactolyticus 
0.42 0.05 0.03 
4.3.6 Correlation between body weight of the chickens and microbial profile in 
experiment 3 
There was significant correlation (positive or negative) between body weight and relative 
abundance of OTUs for some OTUs but not for all OTUs that are significantly different between 
Control and H57.  For sorghum based diet, there were 11 OTUs (day 4 caecum = 5, day 13 ileum = 
2, day 13 caecum = 1, day 21 ileum = 1, day 21 caecum = 2) significantly different between Control 
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and H57. Out of these 11 OTUs, 4 OTUs (day 13 ileum = 2, day 13 caecum = 1, day 21 ileum = 1) 
were significantly correlated (positive or negative; Table 4-13, Figure 4-16, Figure 4-17, Figure 
4-18, Figure 4-19, and Figure 4-20) with body weight. For the wheat based diet, there were 24 
OTUs (day 4 ileum  = 1, day 4 caecum = 2, day 13 caecum = 15, day 21 ileum = 1, day 21 caecum 
= 5) significantly different between Control and H57. Out of these 24 OTUs, 16 OTUs (day 4 ileum 
= 1, day 4 caecum = 1, day 13 caecum = 14) were significantly correlated (positive or negative; 
Table 4-13, Figure 4-21, Figure 4-22, Figure 4-23) with body weight. Notably, there was no 
correlation between body weight and relative abundance of OTUs when there was no significance 
difference of body weight between Control and H57 i.e. there was no correlation between any 
of OTUs and body weight in wheat and sorghum mix diet even if there were 13 OTUs (day 4 ileum 
= 1, day 4 caecum = 2, day 13 ileum = 2, day 13 caecum = 5, day 21 ileum = 2, day 21 caecum = 1) 
significantly different between Control and H57. Monotonic relationship between relative 
abundance of OTUs and body weight of chickens (showing correlation coefficient and P value) for 
OTUs which have relative abundance of >1% at least in a sample and significantly correlated with 
body weight are shown in Figure 4-16 to 4-23 and Table 4-13.  
 
 
Figure 4-16: Correlation between body weight and relative abundance of g_Lactobacillus (OTU ID 
539647) in ileum of birds with sorghum based diet at age day 13. 
 93 
Table 4-13 Correlation between body weight and relative abundance of OTUs, which were 
significantly different between control and H57 treated chickens. Positive corelation coefficients 
indicate positive correlation while negative correlation coefficients indicate negative correlation. 
Diet Age 
(day) 
Site              OTU Correlation 
coefficient 
P-
Value 
Sorghum 13 Ileum Lactobacillus (OTU ID 539647)      -0.62 0.033 
Sorghum 13 Ileum Lactobacillus (OTU ID 350242)      -0.71 0.01 
Sorghum 13 Ileum Bacillus (OTU ID 4385535)       0.77 0.0036 
Sorghum 13 Caecum Coprobacillus (OTU ID 151870) 0.78 0.0047 
Sorghum 21 Ileum Lactobacillus (OTU ID 4414257) 0.61 0.034 
Wheat 13 Caecum Lactobacillus (OTU ID 166911) 0.76 0.0059 
Wheat 13 Caecum Lactobacillus (OTU ID 4447432) 0.67 0.02 
Wheat 13 Caecum Ruminococcus gnavus (OTU ID 
68842) 
0.70 0.011 
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Figure 4-17: Correlation between body weight and relative abundance of g_Lactobacillus (OTU ID 
350242) in ileum of birds with sorghum based diet at age day 13. 
 
Figure 4-18: Correlation between body weight and relative abundance of g_Bacillus (OTU ID 
4385535) in ileum of birds with sorghum based diet at age day 13. 
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Figure 4-19: Correlation between body weight and relative abundance of g_Coprobacillus (OTU ID 
151870) in caecum of birds with sorghum based diet at age day 13. 
 
Figure 4-20: Correlation between body weight and relative abundance of g_Lactobacillus (OTU ID 
4414257) in ileum of birds with sorghum based diet at age day 21. 
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Figure 4-21: Correlation between body weight and relative abundance of g_Lactobacillus (OTU ID 
166911) in caecum of birds with wheat based diet at age day 13. 
 
Figure 4-22: Correlation between body weight and relative abundance of g_Lactobacillus (OTU ID 
4447432) in caecum of birds with wheat based diet at age day 13. 
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Figure 4-23: Correlation between body weight and relative abundance of g_Ruminococcus s_gnavus 
(OTU ID 68842) in caecum of birds with wheat based diet at age day 13. 
4.3.7 Correlation between body weight of the chickens and microbial diversity 
in experiment 3 
Although correlation between body weight of the individual birds and the phylogenetic diversity 
(PD) was not consistent with feed (sorghum, wheat and mix), site (ileum and caecum) and age of 
the birds (day 4, 13 and 21), however, in general it appears that diversity is negatively correlated with body weight (growth rate). The body weight was negatively correlated with 
microbial diversity at day 13 and 21 for sorghum based diet, at day 4 for wheat based diet and at 
day 13 for mixed diet (Table 4-14 and Figure 4-24). 
Table 4-14 Correlation between body weight and microbial diversity (phylogenetic diversity) between 
control and H57 treated chickens. Positive correlation coefficients indicate positive correlation while 
negative correlation coefficients indicate negative correlation. 
Diet Age (day) Site Correlation coefficient P-Value 
Sorghum 13 Caecum -0.87 0.0002 
Sorghum 21 Ileum -0.63 0.029 
Wheat 4 Caecum -0.71 0.01 
Mix 13 Caecum         -0.69 0.013 
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a) 
 
b)  
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c) 
 
d) 
 
Figure 4-24 Correlation between body weight and microbial diversity. a) sorghum, day 13, caecum b) 
soghum, day 21, ileum c) wheat, day 4, caecum and d) mix, day 13, caecum 
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4.4 Discussion 
4.4.1 Effects of H57 on the intestinal microbiota and correlation with body 
weight 
Bacillus amyloliquefaciens H57 modified both the ileal and caecal microbial community structure 
of the broiler chicken. However, the effect of H57 on intestinal microbiota was not uniform across 
all the experiments, diet (sorghum, wheat or mixed) and age of the birds. We have found significant 
batch-to-batch difference in the intestinal microbial community but it is difficult to make the 
inference about how this difference relates to overall microbial function in the gut. 
Although there were several microbes significantly different between Control and H57 groups, 
there was significant correlation (positive or negative) between body weight and relative abundance 
of OTUs for some OTUs but not for all OTUs which are significantly different between Control and 
H57. Therefore, some of the OTUs might have directly contributed to the differences in the body 
weight while other may not have directly influence on the body weight even if there were 
significantly different abundance between Control and H57.  
4.4.1.1 Lactobacillus could be an important member of the intestinal microbiota determining 
birds performance 
Lactobacillus spp. are the most consistently altered bacterial species in our study. By doing a 
comprehensive meta analysis of 92 different studies in humans, domestic food animals and 
experimental models; Million et al. (2012a) concluded that Lactobacillus acidophilus, 
Lactobacillus fermentum and Lactobacillus ingluviei were associated with weight gain in poultry 
while Lactobacillus plantarum and Lactobacillus gasseri were associated with weight loss in 
human and animals. In our study, relative abundance of OTUs representing Lactobacillus salivarius 
and Lactobacillus spp. were significantly higher in the ileum of H57 treated birds in experiment 1. 
By contrast, L. salivarius has been suggested to be associated with growth depression in broilers 
through their effect on bile salts in a previous study (Ranjitkar et al., 2015). However, effect of H57 
on Lactobacillus is variable in experiment 3. Relative abundance of Lactobacillus spp. is reduced 
on day 4 – ileum (both in sorghum and wheat based diet) and increased on day 13 – caecum (wheat) 
and day 21 – caecum (both in sorghum and wheat based diet). Similarly, relative abundance of L. 
salivarius and Lactobacillus reuteri was increased on day 13 caecum on wheat based diet. Million 
et al. (2012b) have also reported that increased concentration of Lactobacillus reuteri in the 
gastrointestinal microbiota is associated with weight gain. Lactobacillus spp. have been shown to 
have diverse genetic and functional characteristics with species specific metabolic functions 
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(Million et al., 2012a). This could be related to the variable results in our experiments. We have 
found both positive and negative correlation of OTUs representing Lactobacillus with body weight 
(Figure 4-17, Figure 4-20, Figure 4-21, Figure 4-22). 
4.4.1.2 Ratio of bacteroidetes and firmicutes  
Previous studies have revealed that population concentration of the bacterial phylum bacteroidetes 
and firmicutes are associated with body weight in human and mice. Several studies have found 
reduced concentration of bacteroidetes is associated with weight gain in human and mice (Ley et 
al., 2006, Turnbaugh et al., 2009, Armougom et al., 2009, Santacruz et al., 2009, Zuo et al., 2011, 
Ley et al., 2005). In contrast, some other studies have reported the opposite results as higher 
concentration of bacteroidetes (Collado et al., 2008, Schwiertz et al., 2010) and lower concentration 
of firmicutes (Schwiertz et al., 2010) associated with weight gain. Mai et al.  (2009) found no 
difference in bacteroidetes population between obese and lean individuals. In experiment 1, 
population of bacteroidetes were significantly increased while firmicutes and actinobacteria were 
reduced in caecum. Colonization of the intestine with Bacteroides thetaiotaomicron and 
Methanobrevibacter smithii has shown to increase energy extraction from the diet in mice (Samuel 
and Gordon, 2006). Similarly, Intestinal microbiota consortium of obese mice has been shown to be 
more efficient to harvest energy from the diet as compared to microbiota of lean mice (Turnbaugh 
et al., 2006). In contrast, firmicutes were significantly higher in day 4 (both in ileum and caecum) in 
experiment 3 with the sorghum based diet. In experiment 3 with the sorghum based diet at day 13, 
relative abundance of bacteroidetes were significantly higher and that of firmicutes were 
significantly lower in H57 treated group. For wheat based diet (experiment 3), there was no 
difference in bacteroidetes or firmicutes instead proteobacteria was significantly lower on day 13 
but reversed (significantly higher) on day 21 in caecum of H57 treated birds.  
4.4.1.3 Structure of inherent resident microbes may determine the effects of H57 
The variability in results poses difficulty in elucidating the possible mode of action of H57 as a 
probiotic. The effects of H57 on growth, feed intake and feed conversion varied with the 
experiment (chapter 3) as with the effect on the intestinal microbiota. It could therefore be 
reasonable to assume that there may be correlation between inherent resident microbiota in the 
intestine and how H57 affects this microbiome and ultimately the performance of the chickens. If 
the inherent resident microbiome in the chickens was different in different batches of chickens then 
this may influence the impact that H57 is able to exert on that microbiome. 
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Due to intensification of the poultry industry, chicks are hatched in a relatively sterile environment. 
Therefore, microbes colonizing the GI tract depend mainly on the initial external environment (both 
in hatchery and the rearing farm) that they are exposed to and the feed and water. To investigate 
whether this hypothesis is feasible, the microbial profile of the ileum and caecum of Control group 
birds of the same age (21 days) from experiment 1 and experiment 3, fed a similar diet (sorghum 
based diet) was ordinated by Detrended Correspondence Analysis (Figure 4-25 and Figure 4-26). 
The inherent resident microbial profiles between these two experiments, both in ileum and caecum, 
were significantly different (PERMANOVA, P = 0.001) and clustered separately as shown in 
Figure 4-25 and Figure 4-26. 
 
Figure 4-25: Detrended Correspondence Analysis (DCA): Comparison of microbial profile in the 
ileum of birds from experiment 1 and experiment 3 both fed sorghum based Control diets.  Between 
the two experiments the microbial profiles at genus level are significantly different (p=0.001). 
The significantly different microbial profiles at day 21 between the birds of two experiments both 
fed similar diets suggests that the colonization of the intestine in these two groups of birds started 
with two different sets of “seed microbes” at and shortly after hatching. Therefore, we presume that 
the batch of the chicks could be a determining factor on the initial structure of the gastrointestinal 
microbiota colonising the gastrointestinal tract.   
Most of the studies about the effects of probiotics on the productivity and health of domestic 
animals and poultry have drawn their conclusions based on single experiments and the effect of 
probiotics have been reported quite variable and inconsistent (FAO, 2016). This variability of the 
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effects of probiotics could be the reflection of underlying variability in the gastrointestinal 
microbial structure, as we’ve seen in our study. This apparent lack of consistency of the 
microbiome composition over time and changes with treatment has been found in other studies 
based on DNA sequencing (Stanley et al., 2016, Stanley et al., 2013).  
 
Figure 4-26: Detrended Correspondence Analysis (DCA): Comparison of microbial profile in the 
caecum of birds from experiment 1 and experiment 3 both fed sorghum based Control diets. Between 
the two experiments the microbial profiles at genus level are significantly different (p=0.001) 
As discussed previously (chapter 2), H57 had been effective in improving the growth rate when the 
chickens were underperforming but not in the chickens growing optimally. In this context, we 
presume that some species within the intestinal microbiota could be responsible for the depression 
of growth in chickens and H57 may modify the intestinal microbial profile in a way that limits these 
species and overcomes growth depression.  
As there was no consistent effect on H57 on the GIT microbes, it appeared here that H57 either 
assists one of several beneficial microbial strains to establish (flourish) in the gut or reduces the 
populations of one or several growth depressing strains. Alternatively, H57 could be altering the 
GIT microbiota at a functional level rather than at the taxonomic level. To support this assumption, 
the effect of H57 on the overall microbial profile was significant in experiment 1 but the overall 
effect was less prominent in experiment 3. In contrast, the effect of H57 on growth rate was more 
prominent in experiment 3 than in experiment 1. To investigate possible functional variability 
between microbiomes, a metagenomic analysis of samples from experiment 3 was undertaken 
(chapter 5).  
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Chapter 5 Metagenomic analysis of the caecal microbiome 
in response to Bacillus amyloliquefaciens H57 
5.1 Introduction 
As described in chapters 3 and 4, H57 improved the growth performance of broiler chickens and 
modified the gastrointestinal microbial populations. However, improvement in growth rate occurred 
both with and without significant effects on caecal microbial populations. Therefore, it appears that 
the phenotypic response to H57 is due to its effect on the underlying microbial functional activity 
rather than the microbial diversity (OTU) profile per se. This chapter analyses the effect of H57 on 
potential microbial functions in the caeca.  
While phylogenetic marker gene sequencing (chapter 4) indicates ‘which microbes are where and at 
what abundance’ (Muyzer et al., 1993, Lane et al., 1985), it does not provide detailed insight into a 
microbiome’s functional capabilities. To address this a metagenomic analysis of the GIT was 
undertaken, i.e. direct shotgun sequencing of fragmented genomic DNA extracted from 
environmental samples (Venter et al., 2004). This approach facilitates identification and 
enumeration of the protein coding genes encoded within the genomes of the populations present in 
each sample, allowing inferences to be made about the community’s metabolic capabilities 
(Riesenfeld et al., 2004).  
The biggest difference in body weight between Control and H57 treated birds was on day 14 in the 
experiment 3 (chapter 3). Therefore samples collected from the caeca of birds at day 13 were 
chosen for metagenomic analysis. In addition, the microbial populations were significantly different 
between sorghum and wheat based diets. Therefore, samples from both sorghum fed and wheat fed 
chickens were selected for further study. As there was no effect of H57 on the sorghum plus wheat 
mixed diet, no samples were chosen for shotgun sequencing from these birds. The microbial 
population per unit digesta weight and the diversity are the largest in the caeca when compared with 
other parts of the gastrointestinal tract in chickens (Bjerrum et al., 2006, Sergeant et al., 2014, 
Apajalahti et al., 2004). The caecum is the most important and primary site for microbial 
fermentation of undigested carbohydrate into short chain fatty acids (Józefiak et al., 2004).  
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5.2 Materials and methods 
5.2.1 Experimental design and samples 
Metagenomic shotgun sequencing was undertaken with a subset of samples from experiment 3 
(chapter 3). A total of 20 caecal digesta samples from day 13 were randomly selected for 
metagenomic shotgun sequencing; five samples each for Sorghum Control, Sorghum H57, Wheat 
Control and Wheat H57.  
Samples were collected and DNA was extracted as described in chapter 4.  
5.2.2 Preparation of metagenomic library and sequencing 
The concentration of genomic DNA was measured using a Qubit 2.0 fluorometer (Thermo Fisher 
Scientific Inc, Victoria, Australia) with a dsDNA Broad Range Assay kit (Thermo Fisher Scientific 
Inc, Victoria, Australia) and diluted with ultrapure distilled water to 5 ng µl-1. A paired-end indexed 
library was prepared by using the Illumina Nextera DNA Library Preparation Kit (Illumina, San 
Diego, CA, USA) as per the manufacturer’s instructions. Genomic DNA (10 µl) was fragmented 
and tagged with adaptor sequences using the transposome enzyme (Tagment DNA Enzyme). 
Tagmentation (fragmentation and tagging) of genomic DNA was achieved by mixing 25 µl of 
Tagment DNA Buffer and 5 µl of Tagment DNA Enzyme with genomic DNA (50 ng in total) and 
running in a thermal cycler at 55°C for 5 minutes.  
Tagmented DNA was purified by spinning down the tagmented DNA solution mixed with 180 µl 
Zymo DNA binding buffer (Zymo Research, Irvine, CA, USA) through a Zymo-Spin I-96 Plate 
(Zymo Research, Irvine, CA, USA). DNA in the Zymo-Spin Plate was washed with 300 µl of Zymo 
Wash) and eluted with 25 µl of Resuspension Buffer (Zymo Research, Irvine, CA, USA).  
Limited cycle PCR was then used to amplify the purified tagmented DNA and add index adaptors 
Index 1 (i7), Index 2 (i5), sequencing adaptor and common adaptors (P5 and P7) (Nextera XT Index 
Kit, Illumina, San Diego, CA, USA). After arranging Index 1 and Index 2 adaptors in TruSeq Index 
Plate Fixture (Illumina, San Diego, CA, USA), PCR reaction plate was prepared by mixing 5 µl 
each of i7 adaptor, i5 adaptor and PCR Primer Cocktail, 15 µl of Nextera PCR Master Mix 
(Illumina, San Diego, CA, USA) and 20 µl of purified tagmented DNA. DNA was amplified by 
PCR with reaction parameters of 72°C for 3 minutes, 98°C for 30 seconds, 5 cycles of 98°C for 10 
seconds, 63°C for 30 seconds and 72°C for 3 minutes and finally holding at 10°C. 
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Agencourt AMPure XP beads (Beckman Coulter Australia Pty Ltd, Lane Cove, NSW, Australia) 
were used to clean DNA amplified as above. AMPure XP beads (30 µl) were added to 50 µl of PCR 
products and incubated at room temperature for 5 minutes. The samples were kept in magnetic 
stand and the supernatant was discarded after it was clearly separated from the beads (~2 minutes). 
The beads with DNA were washed twice with 200 µl freshly prepared 80% ethanol without 
disturbing the beads. The samples were then removed from the magnetic stand after air-drying for 
15 minutes and the DNA was resuspended in 32.5 μl of Resuspension Buffer and placed again in 
magnetic stand for 2 minutes to clear the liquid. The clean supernatant (amplified and cleaned 
DNA) then underwent quality control analysis to check the size distribution of the DNA library by 
running 1 µl of 1:3 diluted (with ultrapure water) library on an Agilent Technology 2100 
Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA).  
Concentrations of DNA in DNA library templates were measured using a Qubit fluorometer 
(Thermo Fisher Scientific Inc, Victoria, Australia) and normalized to 2 nM using Tris-Cl 10 mM, 
pH 8.5 with 0.1% Tween 20. Normalized DNA samples were pooled, denatured and diluted to 1.8 
pM and sequenced using the Illumina NextSeq 500 sequencing platform (Illumina, San Diego, CA, 
USA).  
5.2.3 Sequence processing and analysis 
5.2.3.1 Gene centric analysis 
Shotgun sequence reads were aligned with protein reference database Kyoto Encyclopedia of Genes 
and Genomes (KEGG) (Kanehisa and Goto, 2000) using double index alignment of next-generation 
sequencing data (DIAMOND) program (Buchfink et al., 2015) to assign shotgun reads to a 
functional gene. The gene abundance table obtained from DIAMOND was annotated with KEGG 
Orthology (KO) annotations using Client-side REST access to KEGG  (KEGGREST) (Tenenbaum, 
2013) package in R (R Core Team, 2016).  
The resulting KO gene count matrix with each row representing KO identifier and each column 
representing samples, was then analysed with the DESeq2 package (Love et al., 2014) in R to find 
differentially abundant genes between treatments (Control and H57). The DESeq2 package is 
generally used to analyse differential expression of genes from RNA-seq data. We used the package 
to analyse differential abundances of genes between treatments. DESeqDataSet, the data object 
class for DESeq2 package, was prepared separately for sorghum and wheat based diets by using the 
function DESeqDataSetFromMatrix() with associated “design formula” testing the effect of 
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treatment (Control and H57). Control was made the first level in the treatment factor with function 
relevel() to ensure that the default log2 fold change would be calculated as H57 over the Control.  
Variance-stabilizing transformation (Lin et al., 2008) was applied to the DESeqDataSet prepared 
from KO count table to reduce the heteroskedasticity and its subsequent effect in the downstream 
data analysis. Association of the gene population with treatments (Control and H57) was tested by 
Permutational Multivariate Analysis of Variance (PERMANOVA) of variance-stabilized data using 
adonis() function of the vegan package (Oksanen et al., 2016). Ordination of the samples was done 
by principal component analysis (PCA) of this data using rda() function in vegan (Oksanen et al., 
2016).  
Finally, the differential abundance of genes was calculated by calling the function DESeq(), which 
calculated differential abundance of genes between treatments through estimation of size factors, 
estimation of dispersion and fitting a generalized linear model. This analysis enabled production of 
a table showing the effect of H57 on the effect size (log2 fold change) in the functional genes, 
standard error and p-values.  The result was visualised with “MA-plot”, which is a scatter plot with 
the mean of normalized counts of genes on the x-axis and log2 fold changes on the y-axis.  
Functional analysis of the microbial population against KEGG (Kanehisa, 2002) and the SEED 
(Overbeek et al., 2005) database at higher level broadly defined functional categories was 
undertaken in Rapid Annotations using Subsystems Technology of Metagenomics (MG-RAST) 
server (Meyer et al., 2008). Shotgun sequences were uploaded to MG-RAST server after merging 
pair ends and run in its sequence-processing pipeline for subsequent analysis. Shotgun sequences 
were compared with KEGG Orthology (KO) and SEED subsystem based approach (Overbeek et al., 
2005) and annotated to level 1, level 2 and level 3 functional categories using default parameters 
(maximum e-value = 5, minimum identity = 60%, minimum alignment length = 15, minimum 
abundance = 1). Significance of difference in overall functional capacity at particular level is tested 
with PERMANOVA using vegan package in R after Hellinger transformation (Legendre and 
Gallagher, 2001) of normalised abundance data while differences in relative abundance of particular 
functional category between treatments was tested with t-test.   
5.2.3.2 Taxonomic analysis  
Taxonomic profiles of the samples were analysed by using community profiling tool GraftM (Boyd 
et al., 2015) which identifies 16S rRNA genes in metagenomic sequences and creates community 
composition. The output from GraftM is normalised by rarefying in QIIME (Caporaso et al., 2010) 
and adjusted for 16S rRNA gene copy number variances using CopyRighter (Angly et al., 2014). 
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Downstream analysis was done in R as described in chapter 4 to analyse OTU data. The effect of 
H57 on microbial community composition was analysed by PERMANOVA using the package 
vegan (Oksanen et al., 2016). PCA was undertaken after Hellinger transformation (Legendre and 
Gallagher, 2001) of OTU relative abundance data. The relative abundances of the OTUs between 
treatments were also compared with a heatmap using the packages ggplot2 (Wickham, 2016) and 
RColorBrewer (Neuwirth, 2014). Indicator species (Dufrene and Legendre, 1997) were identified 
by using the function Indval() of the R package labdsv. The composition of microbial communities 
in different treatments was visualised using Krona (Ondov et al., 2011). 
5.3 Results 
5.3.1 Gene centric analysis 
5.3.1.1 Run statistics  
An average of 4.9 million sequences were obtained per sample (st. dev. ≈1.08 million) (Table 5-1). 
KEGG Orthology (KO) identifiers were assigned to 8,628 molecular level functions.  
Table 5-1 Number of base pairs and sequence reads per sample 
Sample ID bp count No. of reads Treatment Average reads per sample SD 
SA1672 1381122671 4978846 
Sorghum_Control 5,345,929 602,869 
SA1673 1741923983 6380251 
SA1674 1462595220 5339668 
SA1675 1343509175 4891447 
SA1676 1405727028 5139432 
SA1677 1542344800 5574657 
Sorghum_H57 6,071,193 1,117,517 
SA1679 1612437500 6095116 
SA1680 1465262776 5426908 
SA1681 2206585988 7991520 
SA1682 1445061318 5267763 
SA1695 1149773851 4367649 
Wheat_Control 4,108,906 653,424 
SA1696 1262686589 4818896 
SA1697 1161297440 4388486 
SA1698 1024948122 3858590 
SA1699 821343406 3110910 
SA1701 1185320663 4588689 
Wheat_H57 4,143,848 285,562 
SA1702 1030360374 3864356 
SA1703 1046709699 4030524 
SA1704 1124210788 4251978 
SA1705 1040037766 3983692 
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5.3.1.2 Influence of H57 on KO profiles in sorghum and wheat-fed chickens 
PERMANOVA indicated that there was significant difference in the molecular-level functions 
(KOs associated with microbial communities) between the Control and H57 treatments for sorghum 
(p < 0.01) and wheat (p < 0.05) diets. Therefore, H57 was associated with significant change in the 
molecular level functional capacity of the microbiome in both diets. PCA also showed the moderate 
segregation of Control and H57 treated birds both in sorghum (Figure 5-1) and wheat (Figure 5-2) 
based diets. 
 
Figure 5-1 Principal component analysis of variance-stabilizing transformed KO function matrix for 
sorghum based diet. 
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Figure 5-2 Principal component analysis of variance-stabilizing transformed KO function matrix for 
wheat based diet. 
The number of genes affected by H57 was greater in sorghum-fed birds than in wheat-fed birds. In 
addition, the effect size (log2 fold change) of H57 on the affected genes was larger in sorghum-fed 
birds than in wheat-fed birds. Genes with a log2 fold change value of at least ±5 between Control 
and H57 for sorghum-based diet are given in Table 5-2 and genes with a log2 fold change value of 
at least ±2 between Control and H57 for wheat based diet are presented in Table 5-3. The MA-plots 
showing gene wise dispersion over the mean of counts normalized by size factor are shown in 
Figure 5-3 (sorghum) and Figure 5-4 (wheat).  
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Figure 5-3 MA-plot (sorghum) shows the gene wise dispersion (log2 fold change) over the mean 
between Control and H57 in chickens fed sorghum based diet. Red = significantly different. Positive 
fold change is higher abundance of genes in H57 and negative fold change is higher abundance in 
Control birds. It is evident from the plot that there are several genes represented that are higher in 
Control than in H57 as demonstrated by more red dots on the negative axis sides.  
Table 5-2 Genes in caeca with significant differential abundance between Control and H57 birds fed 
sorghum based diet with log2 fold change value of at least 5. Positive fold change indicates higher 
abundance in H57 groups and negative fold change indicates higher abundance in Control group. Padj 
is Benjamini-Hochberg (BH) adjusted (Benjamini and Hochberg, 1995) p-value.  
ID log2FoldChange pvalue padj annotations 
K01277 -9.8 2.2E-24 3.8E-21 DPP3; dipeptidyl-peptidase III [EC:3.4.14.4] 
K08676 -9.5 1.2E-34 6.0E-31 tri; tricorn protease [EC:3.4.21.-] 
K07405 -9.0 4.7E-19 2.2E-16 E3.2.1.1A; alpha-amylase [EC:3.2.1.1] 
K13043 -8.9 4.9E-19 2.2E-16 argF; N-succinyl-L-ornithine transcarbamylase 
[EC:2.1.3.11] 
K12343 -8.5 1.7E-17 5.6E-15 SRD5A1; 3-oxo-5-alpha-steroid 4-dehydrogenase 1 
[EC:1.3.1.22] 
K00346 -8.5 2.1E-19 1.4E-16 nqrA; Na+-transporting NADH:ubiquinone 
oxidoreductase subunit A [EC:1.6.5.8] 
K00210 -8.4 2.6E-17 8.3E-15 E1.3.1.12; prephenate dehydrogenase [EC:1.3.1.12] 
K01173 -8.1 1.8E-18 7.1E-16 ENDOG; endonuclease G, mitochondrial 
K09789 -7.7 2.0E-13 4.4E-11 bioG; pimeloyl-[acyl-carrier protein] methyl ester 
esterase [EC:3.1.1.85] 
K09011 -7.5 3.4E-24 4.2E-21 cimA; D-citramalate synthase [EC:2.3.1.182] 
K02429 -7.4 3.4E-25 8.6E-22 fucP; MFS transporter, FHS family, L-fucose permease 
K01278 -7.3 2.2E-19 1.4E-16 DPP4, CD26; dipeptidyl-peptidase 4 [EC:3.4.14.5] 
K02014 -7.2 3.0E-19 1.7E-16 TC.FEV.OM; iron complex outermembrane recepter 
protein 
K03832 -7.2 6.9E-21 6.9E-18 tonB; periplasmic protein TonB 
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K03444 -7.0 4.0E-10 4.2E-08 MFS.SP; MFS transporter, SP family, sugar porter, 
other 
K14440 -6.8 8.7E-14 2.1E-11 SMARCAL1, HARP; SWI/SNF-related matrix-
associated actin-dependent regulator of chromatin 
subfamily A-like protein 1 [EC:3.6.4.12] 
K00349 -6.6 1.1E-13 2.4E-11 nqrD; Na+-transporting NADH:ubiquinone 
oxidoreductase subunit D [EC:1.6.5.8] 
K15789 -6.5 4.2E-10 4.3E-08 TDH; threonine 3-dehydrogenase [EC:1.1.1.103] 
K15727 -6.5 7.1E-12 1.0E-09 czcB; membrane fusion protein, cobalt-zinc-cadmium 
efflux system 
K10742 -6.1 3.7E-13 7.7E-11 DNA2; DNA replication ATP-dependent helicase 
Dna2 [EC:3.6.4.12] 
K01284 -6.1 3.6E-11 4.8E-09 dcp; peptidyl-dipeptidase Dcp [EC:3.4.15.5] 
K15255 -6.1 7.7E-12 1.1E-09 PIF1; ATP-dependent DNA helicase PIF1 
[EC:3.6.4.12] 
K17744 -6.1 5.1E-13 9.8E-11 GalDH; L-galactose dehydrogenase [EC:1.1.1.316] 
K03561 -6.0 5.9E-20 4.9E-17 exbB; biopolymer transport protein ExbB 
K07164 -6.0 2.8E-15 8.2E-13 K07164; uncharacterized protein 
K06142 -6.0 1.5E-18 6.3E-16 hlpA, ompH; outer membrane protein 
K18303 -6.0 6.2E-11 7.6E-09 mexK; multidrug efflux pump 
K10532 -6.0 6.4E-08 3.0E-06 HGSNAT; heparan-alpha-glucosaminide N-
acetyltransferase [EC:2.3.1.78] 
K16363 -5.9 5.3E-18 1.9E-15 lpxC-fabZ; UDP-3-O-[3-hydroxymyristoyl] N-
acetylglucosamine deacetylase / 3-hydroxyacyl-[acyl-
carrier-protein] dehydratase [EC:3.5.1.108 4.2.1.59] 
K16053 -5.9 3.1E-14 8.5E-12 mscM; miniconductance mechanosensitive channel 
K01078 -5.9 1.4E-07 6.1E-06 E3.1.3.2; acid phosphatase [EC:3.1.3.2] 
K09516 -5.7 2.5E-07 9.9E-06 RETSAT; all-trans-retinol 13,14-reductase 
[EC:1.3.99.23] 
K03113 -5.6 1.7E-12 2.8E-10 EIF1, SUI1; translation initiation factor 1 
K12340 -5.5 6.5E-14 1.6E-11 tolC; outer membrane protein 
K19049 -5.5 2.1E-10 2.3E-08 cslA; chondroitin AC lyase [EC:4.2.2.5] 
K11537 -5.4 1.2E-10 1.5E-08 xapB; MFS transporter, NHS family, xanthosine 
permease 
K00889 -5.3 4.5E-09 3.2E-07 PIP5K; 1-phosphatidylinositol-4-phosphate 5-kinase 
[EC:2.7.1.68] 
K16327 -5.3 7.0E-06 1.9E-04 K16327; putative LysE/RhtB family amino acid efflux 
pump 
K09650 -5.2 8.7E-06 2.3E-04 PARL, PSARL, PCP1; rhomboid-like protein 
[EC:3.4.21.105] 
K15726 -5.2 5.6E-10 5.5E-08 czcA; cobalt-zinc-cadmium resistance protein CzcA 
K08289 -5.1 2.5E-08 1.3E-06 purT; phosphoribosylglycinamide formyltransferase 2 
[EC:2.1.2.2] 
K18299 -5.0 1.9E-07 7.8E-06 mexF; multidrug efflux pump 
K08138 -5.0 8.5E-08 3.9E-06 xylE; MFS transporter, SP family, xylose:H+ 
symportor 
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Figure 5-4 MA-plot (wheat) shows the gene wise dispersion (log2 fold change) over the mean between 
Control and H57 in chickens fed wheat based diet. Red = significantly different. Positive fold change is 
higher in H57 and negative fold change in higher in Control birds. In contrast to sorghum based diet, 
several genes are representatively higher in H57 treated birds than in Control birds groups.  
Table 5-3 Genes in caeca with significant differential abundance between Control and H57 birds fed 
wheat based diet with log2 fold change (estimate of effect size) value of at least 2. Positive fold change 
(green colour cells) indicates higher in H57 groups and negative fold change (orange color cells) 
indicates higher in Control group. Padj is Benjamini-Hochberg (BH) adjusted (Benjamini and 
Hochberg, 1995) p-value.  
ID log2 fold 
change 
pvalue padj annotations 
K02344 2.6 0.000047 0.01 DPO3P, holD; DNA polymerase III subunit psi [EC:2.7.7.7] 
K00844 2.5 0.000087 0.01 HK; hexokinase [EC:2.7.1.1] 
K00389 2.4 0.000052 0.01 yidH; putative membrane protein 
K03543 2.3 0.000003 0.00 emrA; membrane fusion protein, multidrug efflux system 
K07798 2.3 0.000015 0.01 cusB, silB; membrane fusion protein, Cu(I)/Ag(I) efflux 
system 
K15829 2.2 0.000199 0.02 hycD; formate hydrogenlyase subunit 4 
K16091 2.2 0.000704 0.04 fecA; Fe(3+) dicitrate transport protein 
K11391 2.1 0.000558 0.03 rlmG; 23S rRNA (guanine1835-N2)-methyltransferase 
[EC:2.1.1.174] 
K04091 2.1 0.000260 0.03 ssuD; alkanesulfonate monooxygenase [EC:1.14.14.5] 
K10906 2.1 0.000093 0.01 recE; exodeoxyribonuclease VIII [EC:3.1.11.-] 
K06894 2.1 0.000005 0.00 K06894; uncharacterized protein 
K07008 2.1 0.000446 0.03 egtC; gamma-glutamyl hercynylcysteine S-oxide hydrolase 
[EC:3.5.1.118] 
K11735 2.0 0.000308 0.03 gabP; GABA permease 
K06144 2.0 0.001183 0.05 uspB; universal stress protein B 
K02336 2.0 0.000484 0.03 DPO2, polB; DNA polymerase II [EC:2.7.7.7] 
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K08137 2.0 0.000651 0.04 galP; MFS transporter, SP family, galactose:H+ symporter 
K00983 2.0 0.000415 0.03 E2.7.7.43, neuA, CMAS; N-acylneuraminate 
cytidylyltransferase [EC:2.7.7.43] 
K15723 2.0 0.000514 0.03 syd; SecY interacting protein Syd 
K13775 -2.1 0.001016 0.04 atuG; citronellol/citronellal dehydrogenase 
 
Genes were classified into six KO categories at broadest level (KO level 1) of functional 
classification (Table 5-4), into 42 categories at KO function level 2 (Table 5-5) and into 156 
categories at KO functional level 3 (details in appendix 3). These numbers represent the microbial 
functional diversity in the caeca of chickens at different level of classification. Although there was 
significant difference between Control and H57 in overall microbial functional capacity at 
molecular-functional level for both sorghum and wheat based diet as described above, there was no 
significant difference in potential function at KO level 1 (P = 0.16), level 2 (P = 0.95) and level 3 (P 
= 0.63) for sorghum-fed chickens. For wheat-fed chickens, functional capacity between Control and 
H57 was not different in KO level 1 (P = 0.46) whereas it was significantly different at KO level 2 
(P = 0.045) and level 3 (P = 0.049).  
Table 5-4 KO level 1 functional classification of the sequence reads with average relative abundance.  
KO Level 1 Percentage of reads (relative abundance) 
Sorghum Wheat 
Control H57 P-value Control H57 P-value 
Cellular Processes 3.48 2.99 0.11 3.28 2.67 0.04 
Environmental Information 
Processing 
11.66 14.53 0.10 14.66 14.87 0.82 
Genetic Information 
Processing 
25.23 26.11 0.74 24.44 24.81 0.87 
Metabolism 57.79 55.13 0.30 56.44 56.05 0.86 
Human Diseases 1.02 0.73 0.21 0.76 1.18 0.04 
Organismal Systems 0.81 0.51 0.11 0.43 0.41 0.83 
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Figure 5-5 Comparison of KEGG Orthology (KO) Level 1 functions between Control and H57 groups 
A) Sorghum based diet B) Wheat based diet. Error bars are standard error of mean (SEM). 
There were several individual functional pathways different at different levels of significance 
between Control and H57. At KO level 1, relative abundance (percentage of reads) of genes for 
cellular process was significantly lower (P = 0.04) in H57 groups for wheat based diet (Figure 5-5). 
There was no difference between Control and H57 groups at KO functional level 2 (Table 5-5, 
Figure 5-6 and Figure 5-7) both in the sorghum and wheat based diets. However, at KO functional 
level 3, a number of pathways had significantly different relative abundance between Control and 
H57 birds (Table 5-6). For sorghum-based diet, genes responsible for Tricarboxylic Acid Cycle 
(TCA cycle) (P = 0.03), Glutathione metabolism (P = 0.03), vitamin B6 metabolism (P = 0.01), 
pantothenate and CoA biosynthesis (P = 0.02), and protein processing in endoplasmic reticulum (P 
= 0.02) had significantly lower relative abundance in H57 treated groups while genes for carbon 
fixation pathways in prokaryotes (P = 0.03), and phosphotransferase system (P = 0.01) had 
significantly higher relative abundance in the H57 group when compared with birds on the Control 
diet (Figure 5-8). Similarly, for the wheat-based diet, genes for propanoate metabolism (P = 0.01) 
and thiamine metabolism (P = 0.03) had significantly lower relative abundance in the H57 group 
while genes responsible for the TCA cycle (P = 0.03), pentose phosphate pathway (P = 0.03), and 
riboflavin metabolism (P = 0.03) were represented at significantly lower in H57 treated birds when 
compared with the Control group (Figure 5-9).  
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Table 5-5 KO level 2 functional classification of the sequence reads with average relative abundance.  
KO level 2 
Percentage of reads 
Sorghum Wheat 
Control H57 P-value Control H57 P-value 
Cell communication 20.18 20.52 0.761 20.67 19.16 0.445 
Cell growth and death 16.54 17.25 0.210 16.12 16.78 0.544 
Cell motility 10.93 11.58 0.621 10.58 10.81 0.845 
Transport and 
catabolism 
9.10 12.25 0.096 12.07 12.40 0.658 
Membrane transport 6.41 6.64 0.744 6.23 5.77 0.610 
Signal transduction 5.63 5.96 0.339 5.95 5.49 0.175 
Signalling molecules 
and interaction 
4.37 2.75 0.054 3.29 3.33 0.816 
Folding, sorting and 
degradation 
4.17 4.45 0.652 4.22 4.05 0.832 
Replication and repair 3.72 3.45 0.330 3.40 3.64 0.342 
Transcription 3.45 3.11 0.402 3.68 3.65 0.610 
Translation 2.56 2.28 0.278 2.59 2.43 0.569 
Cancers 2.29 2.33 0.872 2.48 1.87 0.104 
Endocrine and metabolic 
diseases 
2.04 2.08 0.831 2.09 2.55 0.284 
Immune diseases 1.99 1.02 0.091 1.21 1.19 0.934 
Infectious diseases 1.97 1.32 0.253 1.73 2.13 0.177 
Neurodegenerative 
diseases 
1.11 0.78 0.072 1.12 0.69 0.069 
Substance dependence 0.88 0.29 0.107 0.42 0.41 0.942 
Amino acid metabolism 0.68 0.33 0.133 0.51 0.84 0.067 
Biosynthesis of other 
secondary metabolites 
0.55 0.51 0.755 0.37 0.38 0.880 
Carbohydrate 
metabolism 
0.41 0.27 0.276 0.53 0.65 0.503 
Energy metabolism 0.31 0.39 0.069 0.25 0.28 0.809 
Glycan biosynthesis and 
metabolism 
0.31 0.37 0.566 0.38 0.43 0.720 
Lipid metabolism 0.24 0 0.105 0.05 0.07 0.803 
Metabolism of cofactors 
and vitamins 
0.10 0.06 0.415 0.04 0.08 0.116 
Metabolism of other 
amino acids 
0.03 0 0.296    
Metabolism of 
terpenoids and 
polyketides 
0.02 0 0.235 0.01 0 0.301 
Xenobiotics 
biodegradation and 
metabolism 
0 0.01 0.253 0 0.02 0.232 
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Figure 5-6 Comparison of KEGG Orthology (KO) Level 2 functions between Control and H57 birds 
fed sorghum based diet. Error bars are SEM. 
 
Figure 5-7 Comparison of KEGG Orthology (KO) Level 2 functions between Control and H57 birds 
fed wheat based diet. Error bars are SEM. 
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Table 5-6 KO level 3 functional pathways with significantly different relative abundance (% of total 
reads) between Control and H57. Relative abundances are average of five replicate chickens.   
Sorghum Wheat 
KO level 3 pathway 
Percentage of reads KO level 3 pathway Percentage of reads 
Control H57 P-
value 
Control H57 P-value 
00020 Citrate cycle (TCA 
cycle) [PATH:ko00020] 1.08 0.51 0.03 
00020 Citrate cycle 
(TCA cycle) 
[PATH:ko00020] 
0.59 0.84 0.03 
00480 Glutathione 
metabolism 
[PATH:ko00480] 
0.22 0.07 0.03 
00030 Pentose 
phosphate pathway 
[PATH:ko00030] 
1.36 1.83 0.03 
00720 Carbon fixation 
pathways in prokaryotes 
[PATH:ko00720] 
0.37 0.43 0.04 
00640 Propanoate 
metabolism 
[PATH:ko00640] 
0.06 0.01 0.01 
00750 Vitamin B6 
metabolism 
[PATH:ko00750] 
0.25 0.03 0.01 
00730 Thiamine 
metabolism 
[PATH:ko00730] 
0.60 0.45 0.03 
00770 Pantothenate and 
CoA biosynthesis 
[PATH:ko00770] 
0.43 0.27 0.02 
00740 Riboflavin 
metabolism 
[PATH:ko00740] 
0.09 0.21 0.03 
02060 Phosphotransferase 
system (PTS) 
[PATH:ko02060] 
0.78 1.51 0.01 
  
04141 Protein processing 
in endoplasmic reticulum 
[PATH:ko04141] 
0.02 0.00 0.02 
Figure 5-8 Comparison of KEGG Orthology (KO) Level 3 functions which were significantly different 
between Control and H57 birds fed sorghum based diet. Error bars are SEM 
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Figure 5-9 Comparison of KEGG Orthology (KO) Level 3 functions which were significantly different 
between Control and H57 birds fed wheat based diet. Error bars are SEM. 
5.3.1.3 SEED Subsystem 
Annotation and classification of genomes according SEED subsystem classified genes into 28 
functional categories at subsystem level 1, into 154 categories at level 2 and into 953 categories at 
level 3 indicating the caecal microbial functional diversity. For wheat-fed birds, there was no 
significant difference for overall functional capacity between Control and H57 at level 1 (P = 0.10), 
level 2 (P = 0.57) and level 3 (P = 0.40). Although there was no difference at the broadest level of 
functional classification (subsystem level 1) between Control and H57 for sorghum-fed birds, the 
differences were significant at level 2 (P = 0.03) and level 3 (P = 0.03).  
At subsystem level 1, five subsystems were significantly different between the Control and H57 
group in the sorghum-based diet (Table 5-1). Relative abundance of genes classified as “cell 
division and cell cycle” (P = 0.003) and “stress response” (P = 0.04) were significantly higher in the 
birds fed H57 as compared to birds fed the Control diet while genes responsible for “cell wall and 
capsule” (P = 0.01) and “potassium metabolism” (P = 0.04) had significantly lower relative 
abundance in the H57 group than in Control birds (Figure 5-10 and Figure 5-11). However, there 
was no difference in subsystems level 1 in the samples collected from the birds fed wheat based diet 
(Table 5-7 and Figure 5-11). Seventeen different functional groups, as presented in Table 5-8 and 
Figure 5-12, had significantly different relative abundance between the Control and H57 groups for 
the sorghum-based diet. Only six functional groups at subsystem level 2 had significantly different 
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relative abundance between the Control and H57 groups for the wheat-based diet (Table 5-9). A 
large proportion (about one fifth) of the sequences were unclassified from the wheat based diet both 
in the Control and H57 groups.  
Table 5-7 SEED subsystem level 1 functional classification of the sequence reads with average relative 
abundance. Numbers in bold are significantly different between Control and H57. 
Subsystem level 1 
Relative abundance (percentage of the reads) 
Sorghum Wheat 
Control H57 P-value Control H57 P-value 
Amino Acids and Derivatives 8.88 8.75 0.89 9.68 9.61 0.93 
Carbohydrates 17.56 18.73 0.34 17.39 17.65 0.85 
Cell Division and Cell Cycle 1.39 2.14 0.00 1.85 1.83 0.94 
Cell Wall and Capsule 4.07 2.67 0.01 3.54 3.33 0.57 
Clustering-based subsystems 12.34 13.15 0.51 13.42 12.70 0.57 
Cofactors, Vitamins, Prosthetic 
Groups, Pigments 
3.78 2.98 0.05 3.32 3.27 0.91 
DNA Metabolism 6.93 7.81 0.14 7.05 6.43 0.31 
Dormancy and Sporulation 0.40 0.79 0.06 0.53 0.44 0.58 
Fatty Acids, Lipids, and Isoprenoids 1.47 1.48 0.92 1.76 1.94 0.47 
Iron acquisition and metabolism 1.12 0.80 0.09 0.86 0.50 0.19 
Membrane Transport 2.86 3.30 0.27 3.29 3.53 0.46 
Metabolism of Aromatic Compounds 0.31 0.44 0.23 0.32 0.44 0.18 
Miscellaneous 4.66 4.41 0.42 5.05 5.15 0.84 
Motility and Chemotaxis 0.15 0.14 0.90 0.10 0.14 0.21 
Nitrogen Metabolism 0.71 0.78 0.67 0.69 0.61 0.68 
Nucleosides and Nucleotides 3.50 3.80 0.28 3.99 4.20 0.69 
Phages, Prophages, Transposable 
elements, Plasmids 
4.54 3.20 0.10 3.11 3.06 0.95 
Phosphorus Metabolism 1.22 1.03 0.22 1.39 1.09 0.24 
Photosynthesis 0.03 0.00 0.12 0.00 0.01 0.49 
Potassium metabolism 0.39 0.14 0.04 0.40 0.34 0.66 
Protein Metabolism 9.98 10.04 0.95 9.76 10.61 0.33 
RNA Metabolism 5.14 5.18 0.92 5.10 5.54 0.32 
Regulation and Cell signalling 0.80 0.61 0.05 0.64 0.78 0.44 
Respiration 2.86 2.97 0.84 2.84 3.29 0.62 
Secondary Metabolism 0.03 0.09 0.14 0.09 0.10 0.86 
Stress Response 1.22 1.62 0.04 1.18 1.25 0.68 
Sulfur Metabolism 0.62 0.57 0.66 0.68 0.38 0.09 
Virulence, Disease and Defence 3.04 2.36 0.06 1.94 1.77 0.59 
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Figure 5-10 Functional analysis based on Subsystems level 1 classification in the caeca of birds fed 
sorghum based diet. Error bars are SEM. 
Table 5-8 Subsystems level 2 functions significantly different between H57 and Control birds fed 
sorghum based diet. 
  
Subsystem level 2 
Percentage of sequences   
P-value Control H57 
Capsular and extracellular polysacchrides 1.81 1.28 0.027 
Carbohydrates 0.05 0.13 0.014 
Clustering-based subsystems 0.39 0.57 0.011 
DNA uptake, competence 0.25 0.48 0.033 
Gram-Negative cell wall components 0.77 0.18 0.026 
Heat shock 0.42 0.64 0.014 
One-carbon Metabolism 1.10 0.60 0.028 
Probably GTP or GMP signaling related 0.19 0.05 0.006 
Putative GGDEF domain protein related to 
agglutinin secretion 
0.06 0.00 0.042 
Pyridoxine 0.32 0.24 0.007 
Pyruvate kinase associated cluster 0.01 0.11 0.019 
Regulation of virulence 0.22 0.07 0.047 
Resistance to antibiotics and toxic compounds 2.56 1.33 0.006 
Reverse electron transport 0.11 0.31 0.047 
Shiga toxin cluster 0.04 0.01 0.022 
Spore DNA protection 0.04 0.09 0.016 
TldD cluster 0.07 0.01 0.047 
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Figure 5-11 Functional analysis based on Subsystems level 1 classification in the caeca of birds fed 
wheat based diet. Error bars are SEM.  
Table 5-9 Subsystems level 2 functions significantly different between H57 and Control birds fed 
wheat based diet. 
Subsystems level 2 Percentage of sequences P-value 
Control H57 
Fermentation 1.661 2.144 0.03 
Gram-Positive cell wall components 0.140 0.355 0.02 
Hypothetical in Lysine biosynthetic cluster 0.170 0.046 0.02 
Periplasmic Stress 0.001 0.012 0.01 
Polysaccharides 0.710 0.431 0.03 
Protein secretion system, Type VII (Chaperone/Usher 
pathway, CU) 
0.003 0.016 0.03 
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Figure 5-12 Functional analysis based on Subsystems level 2 classification in the caeca of birds fed 
sorghum based diet. Only subsystems which are significantly different between Control and H57 birds 
are presented. Error bars are SEM. 
At subsystem level 3, sequences were classified into 953 functional groups. Out of these, 71 
functional groups (complete list in appendix 3) were significantly more abundant for the H57-
sorghum-based diet than in the Control birds. Similarly, 34 functional groups (complete list in 
appendix 3) had significantly different relative abundance between Control and H57 groups for the 
wheat-based diet. Only six functional groups were common between sorghum-fed birds and wheat-
fed birds which were significantly different between Control and H57 groups indicating diet 
independent effect of H57 on microbial function.  
5.3.1.4 Dominant microbial functions 
Metabolism was the most prevalent functional class, representing ~56% of genes (~58% in 
Sorghum Control, 55% in Sorghum H57, 56% in Wheat Control and 56% in Wheat H57) followed 
by genetic information processing, representing ~25% of genes (~25% in Sorghum Control, 26% in 
Sorghum H57, 24% in Wheat Control and 25% in Wheat H57) at the KO level 1. Environmental 
information processing was the third most abundant KO level 1 category in all treatments 
representing ~15% except in Sorghum Control with ~12% relative abundance.  
For the SEED subsystem based annotation, the top three functional gene categories in all treatment 
groups were genes related to carbohydrate utilisation (~18% in Sorghum Control, 19% in Sorghum 
H57, 17% in Wheat Control and 18% in Wheat H57), clustering-based subsystems (genes with 
evidence of functional coupling) (~12% in Sorghum Control, 13% in Sorghum H57, 13% in Wheat 
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Control and 13% in Wheat H57) and protein metabolism (~10% in Sorghum Control, 10% in 
Sorghum H57, 10% in Wheat Control and 11% in Wheat H57) (details in appendix 3). This 
conservation of microbial function also extended to dominant functional categories for more 
focussed classifications (KO levels 2 and 3 and SEED subsystems level 2) as revealed by similar 
relative abundance. (Figure 5.19 and Figure 5.20).  
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Figure 5-13 Composition of SEED subsystems level 1 functional categories in caeca of the chickens fed sorghum-based diet. Left: Control, Right: H57 
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Figure 5-14 Composition of SEED subsystems level 1 functional categories in caeca of the chickens fed wheat-based diet. Left: Control, Right: H57 
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5.3.2 Metagenome based microbial profiling 
5.3.2.1 H57 did not influence microbial community composition 
PERMANOVA of the relative abundances of OTUs indicated that there was no significant 
difference in microbial composition between Control and H57 in either the sorghum or the wheat 
based diets at day 13 (P > 0.05).  
5.3.2.2 Microbial community composition differed between diets 
However, there was significant effect of feed per se on microbiota as indicated by significantly 
different (P = 0.001) microbial populations between the chickens fed the sorghum-based diet and 
the wheat based diet (Figure 5-18). As there was no difference between Control and H57 group, 
indicator species analysis was done for sorghum-based diet and wheat-based diet including both 
Control and H57. Table 5-10 shows the indicator species which determines the characteristics of the 
site (Dufrene and Legendre, 1997) with relative abundance >0.1%. A heatmap comparing the 
relative abundance of OTUs with relative abundance >0.1% is shown in Figure 5-15. 
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Figure 5-15 Heat map showing OTUs with relative abundance >0.1% in at least one of four treatments 
(Sorghum Control, Sorghum H57, Wheat Control, Wheat H57). s = indicator species in sorghum-
based diet; w = indicator species in wheat-based diet. 
 
 
 129 
Table 5-10 Indicator species (or higher taxonomic classification in case species level classification in 
not known) in sorghum and wheat based diet with relative abundance >0.1%. f = family, o = order. 
Indicator Microbes in the Caeca 
OUT ID Sorghum OUT ID Wheat 
193 Faecalibacterium sp. 159 [Ruminococcus] sp. 
188 f_Ruminococcaceae 158 f_Lachnospiraceae 
130 o_Clostridiales 229 Sutterella sp. 
194 Oscillospira sp. 160 [Ruminococcus] sp. 
171 Dorea sp. 169 Coprococcus sp. 
51 Bacteroides sp. 28 Bifidobacterium sp. 
58 Bacteroides sp. 110 Lactobacillus sp. 
196 Ruminococcus sp. 171 Blautia sp. 
43 o_Bacteroidales 32 Bifidobacterium sp. 
295 o_RF39 161 [Ruminococcus] sp. 
165 Blautia sp. 35 Adlercreutzia sp. 
59 Bacteroides sp. 124 Streptococcus sp. 
213 f_Erysipelotrichaceae 220 Coprobacillus sp. 
218 cc_115 sp. 178 Roseburia sp. 
67 Parabacteroides sp. 258 f_Enterobacteriaceae 
73 f_Rikenellaceae 34 f_Coriobacteriaceae 
75 f_S24-7 56 Bacteroides sp. 
36 Collinsella sp. 116 Lactobacillus sp. 
69 Prevotella sp. 204 Megamonas sp. 
   216 [Eubacterium] sp. 
   111 Lactobacillus sp. 
   117 Lactobacillus sp. 
   10 Deinococcus sp. 
Fecalibacterium sp. (OTU ID 193) was the dominant OTU followed by Ruminococcus sp. (OTU ID 
159) in sorghum based-diet both in Control and H57 fed chickens. Although statistically not 
significant, the relative abundance of the dominant Fecalibacterium OTU increased from 16% in 
the Control group to 27% in the H57 group. Ruminococcus sp. (OTU ID 159) was the dominant 
OTU in the wheat-based diet fed chickens representing ~21% of the population both in the Control 
and H57 groups. Figure 5-16 and Figure 5-17 show the composition of microbial populations in the 
caeca of chickens fed sorghum-based and wheat-based diet respectively. Figure 5-18 compares the 
microbial composition in the chickens fed sorghum-based diet and wheat-based diet.  
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A)                                                                       B) 
Figure 5-16 Microbiota composition in caecum of the chickens fed sorghum based diet A) Control B) H57 
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A)        B) 
  
Figure 5-17 Microbiota composition in the caecum of the chickens fed wheat based diet A) Control B) H57 
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A)         B) 
Figure 5-18 Microbiota composition in the caecum of the chickens A) Sorghum-fed birds B) Wheat-fed birds 
 133 
5.4 Discussion 
5.4.1 Microbial functions differs between treatments but dominant functions at 
higher level of classification are conserved 
The inclusion of H57 in the diet appears to influence functional gene profiles in the caeca as 
indicated by significance differences in the abundance of molecular level functional genes. 
However, dominant microbial functions at broader level classification remained conserved between 
treatments. As presented above (section 5.3.1.4), dominant microbial functions (top 3 functional 
classifications) in the caeca were conserved across diet types (sorghum and wheat) and treatments 
(Control and H57) up to classification level 3 for annotation based on both KO and SEED 
subsystems. However, there were several molecular level functions and some other non-dominant 
higher-level classifications mainly related to fermentation and energy metabolism and microbial 
virulence factors with significantly different relative abundances between the Control and H57 
groups. This indicates that the phenotypic response produced by probiotic H57 could be due to an 
effect on minor genes affecting less dominant microbial functions. However, it is not known yet 
how these functions were actually expressed in the caeca as functional potential and their 
expression could differ (Franzosa et al., 2014).  To elucidate this would require a transcriptome 
and/or metabolome analysis to be undertaken. 
The dominant microbial functions in the caeca found in this study (~18% carbohydrates, ~13% 
clustering based subsystems, ~10% protein metabolism) were similar to previously reported 
functional group distributions in chicken caeca (Danzeisen et al., 2011). By contrast, carbohydrates 
(20%), cell wall and capsule (10%), amino acids and derivatives (9%), experimental subsystems 
(9%) were dominant subsystems level 1 functional categories as reported by (Qu et al., 2008).  
Several functional genes were significantly affected due to administration of H57 both with wheat 
and sorghum based diets. As the abundance of several genes was affected by H57, it is difficult to 
relate each function to the differences in growth rate and feed efficiency between the Control and 
H57 groups. Nevertheless, analysis of the differences between H57 and Control treatments at higher 
level of functional categories could give more insights into the possible mode of action of probiotic 
H57. We have discussed some important functions affected by H57, which could have direct or 
indirect impact on body weight gain in poultry.  
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5.4.2 Impact on bacterial fermentation and energy metabolism 
Functional analysis at subsystem level 2 indicated that the percentage of gene sequences responsible 
for fermentation was significantly higher (P <0.05) in H57 fed birds compared with birds fed the 
Control wheat-based diet. Wheat contains pentosans as one of the non-starch polysaccharides in 
significant amounts (Annison, 1991), which could increase the viscosity of digesta thereby slowing 
passage through the gastrointestinal tract (GIT) (Choct and Annison, 1990, Choct and Annison, 
1992b). Non-starch polysaccharides, particularly soluble non-structural polysaccharides present in 
cereal grains which are non-digestible by the endogenous enzymes of the chicken, can significantly 
increase the viscosity of digesta, even in small amounts (Annison and Choct, 1991), thereby 
affecting the nutrient uptake by the birds (Chesson, 2007) because the feed uptake of the birds is 
slowed by the slow passage through the GIT. This accompanied by reduced nitrogen retention 
(Choct and Annison, 1992b) and reduced digestibility of amino acids with endogenous amino acid 
loss (Angkanaporn et al., 1994) may reduce the performance of broiler chickens. Caeca are the most 
important site for the microbial fermentation of these polysaccharides in the diet of the chicken 
(Józefiak et al., 2004). Although, the quantitative contribution of caecal fermentation to total energy 
requirement of the chicken is only about 3–5% (Choct et al., 1992, JøRgensen et al., 1996, Jamroz 
et al., 2002), fermentative digestion of these polysaccharides may improve the performance of the 
birds partly by reducing the viscosity and partly by contributing to total energy in the form of 
SCFAs. Greater abundance of fermentation subsystem genes could lead to a higher rate of 
fermentation of non-starch polysaccharides with subsequent improvement in the performance of the 
birds. Schofield (2017) also found that H57 increased the fermentative breakdown of hemicellulose 
as indicated by increased expression of β-glucosidase, β-galactosidase, α- galactosidase and L-
arabinose isomerase in the rumen of sheep fed a palm kernel meal based diet resulting in improved 
weight gain. Measurement of the concentration of soluble non-starch polysaccharides (NSP) in the 
diet, intestinal viscosity, and concentration of short chain fatty acids (SCFA) in the intestine would 
give further insights. 
The effect of H57 on microbial energy metabolism of caecal microbes in the chickens fed wheat-
based diet was also demonstrated by significantly higher abundance of genes for citric acid cycle 
(or TCA cycle) and pentose phosphate pathway in the H57 groups. However, there was no 
difference in the abundance of fermentation subsystem genes in the experiment with sorghum-based 
diet. This could be due to the differences in the microbial composition between birds fed different 
diets (wheat vs sorghum).  
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5.4.3 H57 appears to act through inhibition of bacterial virulence related genes 
H57 appears to influence bacterial virulence factors in the gut as indicated by lower abundance of 
virulence related gene categories in H57 treated birds discussed in subsequent subsections. 
Microbial virulence factors can stimulate the immune system of the host (Barnes et al., 2002, 
Hanssen et al., 2004). Activation of immune system requires energy, which could otherwise be 
utilised for growth and production (Jiang et al., 2010). Measurement of variables that could indicate 
the stimulation of the immune system for example, level of expression of immunity related genes in 
the intestinal tissue and/or immunity related specific marker molecules in the blood would be 
helpful to understand this proposed mode of action of H57.  This is discussed in more detail in 
chapter 7 (section 7.2.1). 
5.4.3.1 Regulation of virulence 
Abundance of genes responsible for the subsystem “regulation of virulence” was significantly 
reduced (P<0.05) in the birds fed H57 when compared with that subsystem in Control birds in the 
experiment with sorghum based diet.  This could indicate the potential for inhibition of pathogenic 
microbes by H57 in the intestine or inhibition of virulence factors stimulating immune system of the 
host.   
Several genes, often located in special regions of bacterial DNA called pathogenicity islands are 
crucial for the bacteria to work as a pathogenic agent (Hacker et al., 1997).  Bacteria can modulate 
the expression of such genes to adapt in particular environments (Thomas and Wigneshweraraj, 
2014). Such genes are responsible for the production of virulence factors or pathogenicity 
determinants, which help the bacteria to successfully adapt in their environment or cause infection 
or disease with resulting damage to the host (Thomas and Wigneshweraraj, 2014). However, 
expression of such virulence by the bacteria is a complex process with an array of mechanisms and 
often depends on several factors (Thomas and Wigneshweraraj, 2014, Mekalanos, 1992). Such 
virulence factors of the microbes could activate the immunity system of the host (Medzhitov, 2007). 
Activation of immunity system in vertebrates is an energetically costly phenomenon significantly 
increasing amount of energy expenditure (Demas et al., 1997, Lochmiller and Deerenberg, 2000, 
Martin et al., 2003). Immunologically active chickens injected with sheep red blood cells (SRBC) 
had higher energy expenditure than Control chickens injected with phosphate buffered saline (PBS) 
as indicated by lower weight gain in spite of higher feed intake in SRBC challenged chickens 
(Henken and Brandsma, 1982). The energy cost of immune system activation could alternatively be 
used for growth and production in livestock (Colditz, 2002). Therefore, virulence factors in 
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intestinal microbes, which can trigger immune system activation, could affect nutrition partitioning 
with subsequent depression of the growth in the chickens.  
5.4.3.2 Capsular and extracellular polysaccharide 
Within the sorghum-based diet, genes annotated at functional subsystem level 2, pathways for 
“capsular and extracellular polysaccharide” were significantly reduced (P<0.05) in H57 treated 
birds compared to birds within the Control diet. Also the proportion of genes encoding the pathway 
for “gram-negative cell wall components” was significantly lower (P<0.05) in H57 group than in 
the birds with sorghum-based diet without H57. Capsular polysaccharides such as 
lipopolysaccharides in the cell wall of gram negative bacteria are other important virulence factors 
of prokaryotic cells (Moxon and Kroll, 1990, Sutherland, 1989). Although these compounds have 
proven virulence properties such as evasion of phagocytosis and activation of complement system 
(Moxon and Kroll, 1990), effects of capsular polysaccharides of intestinal microbes on the 
performance of chickens are yet to be established but stand as an intriguing possible explanation in 
part for the H57 response.  
5.4.3.3 Shiga-toxin 
Interestingly, a shiga toxin cluster annotated at subsystem level 2 was found in chickens in the 
experiment with the sorghum-based diet. The percentage of genes representing shiga toxin cluster 
were significantly lower (P<0.05) in H57 treated birds when compared with birds fed the Control 
diet. Shiga toxin, which is a cytotoxic protein, is a major virulence factor of shiga-toxin producing 
E. coli (STEC) (Law, 2000). Although ruminants are a major reservoir of these pathogens, chickens 
are considered less important (Beutin et al., 1993, Chapman et al., 1997, Smith et al., 1991). 
However, some studies have reported the contamination of poultry meat with STEC O157:H57 
(Doyle and Schoeni, 1987, Zhao et al., 2001). E. coli O157:H57 is able to colonise the chicken 
caeca in experimental infection with enterohaemorrhagic E. coli (Zhao et al., 1996, Beery et al., 
1985).  
5.4.3.4 Antibiotic resistance 
One of the important virulence factors of the intestinal microbes is the resistance to the 
antimicrobials. Proportion of genes for the subsystem “resistance to antibiotics and toxic 
compounds” were significantly lower (P<0.01) in H57 group than in the Control group in this 
experiment. 
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5.4.4 H57 did not reduce the abundance of genes related to bile salt hydrolase 
(BSH) activity in the caeca 
Probiotics are being considered as an alternative to antibiotic growth promoters in animal diet. 
Growth promoting effects of antibiotic growth promoters were linked to the reduced effects of bile 
salt hydrolase in the GIT of chickens (Feighner and Dashkevicz, 1987). There was no effect of H57 
on the relative abundance of BSH enzyme (choloylglycine hydrolase) encoding genes for sorghum-
based diet in experiment 3. Unexpectedly, relative abundance of choloylglycine hydrolase encoding 
genes were significantly higher (P = 0.029) in birds fed the H57 supplemented wheat based diet 
than for the birds fed the Control diet. However, most of the bile salts in the intestine are directly 
recycled through uptake into the enterohepatic circulation from the small intestine (Small et al., 
1972). Therefore, BSH activity has more relevance in the small intestine than in the large intestine 
and caecum. 
5.4.5 Effects of H57 on microbial function was different between the chickens 
fed wheat-based diet and sorghum-based diet  
Importantly the effects of H57 on the microbiome are different in wheat based and sorghum based 
diets. This is probably due to the differences in resident microbes in chickens receiving the two 
types of diets. As in previous chapters, different groups of microbes were affected by H57 in the 
three experiments and with different feed types, with different metabolic functions appearing to be 
affected in the chickens fed different feed types.  This reinforces the two major presumptions made 
in previous chapters that the effects of H57 depends on the structure of resident gastrointestinal 
microbes and H57 may effect one of several microbes in the intestine i.e. H57 either supresses or 
stimulates growth of one of several microbes or their metabolic pathways resulting in better 
performance of birds as an outcome. Also, the hypothesis made in chapter 3 that H57 may 
overcome the depression of growth in chickens is further supported here from the genomic data in 
this chapter showing that microbial virulence factors and regulation of virulence were less abundant 
in H57 treated chickens when compared with that in Control birds fed sorghum-based diet.   
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Chapter 6 Quantifying Bacillus amyloliquefaciens H57 in 
the ileum and caecum of chickens  
6.1 Introduction 
Most Bacillus amyloliquefaciens H57 (H57) cells fed to chickens are in spore form. These spores 
are metabolically inactive and are assumed to act as a probiotic following germination in the 
gastrointestinal tract (GIT). Nonetheless, evidence demonstrating that ingested H57 spores 
germinate and multiply in the chicken GIT is limited. In this chapter, we addressed this knowledge 
gap using real time PCR to quantify H57 in chicken ileum and caecum.   
Real-time quantitative PCR (qPCR) is a rapid and robust molecular biotechnological tool, 
commonly used to quantify the number of copies of a target gene (e.g. a phylogenetic marker or 
functional gene) in a sample. Quantification of H57 cells in the intestine by real time qPCR may be 
useful in determining the fate of ingested H57 spores, to assess whether spores have germinated and 
multiplied in the GIT.  
The poly-c-glutamic acid synthase (pgsB) gene is responsible for microbial production of 
polyglutamic acid (PGA) predominantly by Bacillus species (Shih and Van, 2001). This gene has 
been used as a phylogenetic marker to quantify B. amyloliquefaciens by qPCR (Yong et al., 2013) 
using primers and probe specific to B. amyloliquefaciens. This chapter outlines the optimisation of 
the qPCR reaction to detect and quantify B. amyloliquefaciens H57 in broiler GIT contents.  
6.2 Materials and Methods 
6.2.1 Samples and experimental design 
Samples for this study were collected from broiler feeding experiments 1 and 2 as described in 
chapter 3. Briefly, experiment 1 consisted of two treatments (a sorghum based basal diet ± H57) 
with six replicates per treatment while experiment 2 comprised two treatments (a wheat based basal 
diet ± H57) with twelve replicates (six in pens and six in cages) per treatment. Ileal and caecal 
digesta samples were taken from two birds at day 14 and at day 21 from each of the six replicates in 
experiment 1 and two birds at 35 days of age from six of the 12 randomly selected replicates in 
experiment 2. Birds were fed starter diet until day 14, then grower diet until Day 28 (until the end of 
the experiment in experiment 1) and finisher diet till Day 35. The starter and grower diets in 
experiment 1 were inoculated with 2x107 H57 cells per g of feed while the quantity of H57 in 
experiment 2 was approximately 6x107 H57 cells per gram of feed in the starter diet and 
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approximately 107 H57 cells per gram of feed in the grower and finisher diets. Thus, the quantities 
of H57 added in the feed for the samples selected in this study were 2x107 per gram in experiment 1 
and 107 per gram in experiment 2. Details of digesta sample collection method have been described 
in chapter 4.  
6.2.2 DNA extraction 
Genomic DNA was extracted from the digesta samples using the modified repeated bead beating 
plus column (RBB+C) method (Kawai et al., 2004) using QIAamp Fast DNA Stool Mini Kit as 
described earlier in Chapter 4. DNA concentration and purity were measured with Multi-Sample 
Micro-Volume UV-Vis Spectrophotometer NanoDrop 8000 (Thermo Scientific, Wilmington, USA) 
at an optical density of 260 and 280 nm. The extracted DNA was stored at -20°C until further 
analysis.  
6.2.3 Preparation of H57 standards 
A tenfold serial dilution series of B. amyloliquefaciens H57 was prepared from a fresh culture of 
known numbers of H57. For this, a stock culture of B. amyloliquefaciens H57 on nutrient agar 
(0.5% w/v Peptone, 0.5% w/v NaCl, 0.3% w/v Yeast extract, 1% w/v Glucose, 1.4% w/v Agar) 
slopes was subcultured on a nutrient agar plate to isolate single bacterial colonies so that 
descendants of a single cell could be used to prepare the standards. The plate was incubated 
overnight at 30ºC and a single well isolated colony was picked off with a sterile loop and inoculated 
into 5 ml of sterile nutrient broth in a Hungate tube and incubated again overnight at 30ºC with 
shaking in an orbital shaker (Ratek OM11, Ratek Instruments Pty Ltd, Boronia, VIC, Australia) at 
160 rpm. Next day, the broth with bacterial growth was poured into 100 ml sterile nutrient broth in 
a 250 ml Schott bottle and incubated overnight at 30ºC with shaking at 160 rpm.  
The concentration of bacterial cells in the resultant culture was determined using a Petroff-Hausser 
chamber (Hausser Scientific Company, Horsham, Australia) following manufacturer’s instructions. 
A 50 µl aliquot of the overnight H57 culture was diluted 1:20 with dilution solution (450 µl of 1x 
Phosphate Buffer Saline + 500 µl of 100% ethanol) and mixed by vortexing. An aliquot of 100 µl of 
the diluted cell suspension was placed on a clean and dry Petroff-Hausser chamber’s covering the 
counting grid and covered by a coverslip. The chamber was placed on a light microscope (Olympus 
BH-2, Olympus Corporation, Japan) stage cells allowed the cells to settle for 10 min following 
which the bacterial cells were counted. The average of three counts was used to calculate the 
number of cells per ml.  
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Two 10-fold serial dilutions (one for ileal and the other for caecal contents) of H57 in TE buffer 
containing H57 cells from 5x109 to 5x103 cells per ml were prepared. To account for the presence 
of any PCR inhibitors in the digesta, 0.2 g of ileal or caecal content (for their respective standard 
series) from control birds was added to each tube of the dilution series. This ensured the similar 
reaction environment for standards and unknown samples making them comparable (Ouwerkerk et 
al., 2002). The dilution series in the Eppedorf tubes were stored at -80ºC prior to DNA extraction. 
DNA was extracted from 1 ml aliquots of each tube using modified repeated bead beating plus 
column (RBB+C) method (Kawai et al., 2004) using QIAamp Fast DNA Stool Mini Kit and eluted 
in 200 µl final volume as described in chapter 4. 
6.2.4 qPCR Primers and probes 
Many Bacillus species including B. amyloliquefaciens produce poly-γ-glutamate (Luo et al., 2016, 
Shih and Van, 2001). Recently, a primer pair and probe specifically targeting the poly-γ-glutamic 
acid synthesis gene (pgsB) of B. amyloliquefaciens has been designed (Yong et al., 2013). Details 
of the primers and probe used in this thesis are listed in Table 6-1.  
Table 6-1: Primers and probe targeting the pgsB gene of B. amyloliquefaciens (Yong et al., 2013). 
Primers Sequence (5' -> 3') Molecular 
wt. 
GC% Melting 
temperature 
(ºC) 
pgsB726-f TGGCGCCATGAGAATCCT 5500 55.55 66.9 
pgsB791-r GCAAAGCCGTTTACGAAATGA 6463 42.86 65.8 
pgsB-
probe 
1FAM-
CCGCTGCTCAGCACGAAGGAG
C-TAMRA2 
78910 µm 68.18 76.3 
1 FAM (6-carboxy-fluorescein), 2TAMRA (6-carboxy-tetramethylrhodamine) 
6.2.5 Optimising the annealing temperature by thermal gradient PCR 
The temperature at which oligonucleotide primers anneal to a DNA template (i.e. annealing 
temperature) is an important parameter affecting the specificity of a PCR reaction. The original 
study which developed the primers and probe set was based on DNA samples extracted from pure 
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broth culture and solid-state fermentation product of B. amyloliquefaciens (Yong et al., 2013). In 
contrast, our samples contained DNA from a multitude of gastrointestinal microbes together with 
possible PCR inhibitors present in the broiler gut. In addition, PCR master mix and PCR machine 
used in our study was different from those used by Yong et. al (2013). Therefore, we tested 
modifications from the published method with a thermal gradient PCR to obtain optimal PCR 
amplification conditions.  
 
PCR reaction mix (25 µl) was prepared in triplicate by mixing 10 µl of 1xRealMasterMix Probe (5 
PRIME, Gaithersburg, MD, USA), 1.25 µl of 5 µM forward and reverse primers, 5 µl of template 
DNA sample and ultrapure water to make the final volume 25 µl. Thermal gradient PCR was 
carried out in Bio-rad C1000 thermal cycler (Bio-Rad, Singapore) under the following reaction 
parameters. 
• 95ºC for 30 s (for initial denaturation and activation of FastStart Taq DNA polymerase) 
• 34 cycles of  
o 95ºC for 5 s  
o Gradient 55/70ºC (70ºC, 69.2ºC, 67.5ºC, 64.5ºC, 60.9ºC, 58.0ºC, 56.0ºC, 55.0ºC) for 
30 s 
• Hold at 4ºC 
Amplified DNA was visualised by agarose gel electrophoresis. One per cent (w/v) agarose solution 
was prepared in 1X TBE  (Tris-Borate-EDTA) buffer with 10µl/100ml of fluorescent nucleic acid 
gel stain (GelRedTM 10000x, Biotium, Hayward, CA, USA). The solution was smoothly poured into 
an electrophoresis tank with combs fitted in a tray and left for 30 minutes to set. The gel was placed 
in an electrophoresis tank with 1X TBE buffer and the combs were carefully removed to make 
wells to load the samples. The first well of each row was loaded with 5 µl of 1 kb ladder (Bioline 
Aust. Pty. Ltd., Alexandria NSW, Australia) diluted into 1:4 with 5X loading buffer. The PCR 
products were then loaded into the wells by mixing 5µl of the products with 3 µl of 5X loading 
buffer. The electrophoresis was run at 95 volts and 400 mA for 45 minutes and visualised by using 
Gel Doc™ XR+ System (Bio-Rad Laboratories, Philadelphia, USA) on completion.  
6.2.6 Optimisation of primers and probe concentration 
Combinations of six concentrations of primers (100 nM, 150 nM, 200 nM, 250nM, 300 nM, and 
900 nM) and four concentrations of probe (50 nM, 100 nM, 150 nM, 200 nM) were tested by 
preparing 24 different reaction mixes. These 24 different reactions were run in triplicate in Rotor-
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Gene 6000 (Corbett Research, Australia) and analysed with Roter_Gene Q software version 
2.3.1.49 to find the lowest threshold cycle, the cycle number at which the fluorescence in the 
reaction can be detected from the background. The concentration of primers and probe that results 
lowest threshold cycle, would be the optimum concentration of primers and probe.  
6.2.6.1 qPCR of the ileum and caecum digesta samples gDNA 
The qPCR reaction was carried out in 25 µl volumes in 0.1 ml thin walled strip tubes (QIAGEN, 
Velno, The Netherlands). Each sample was amplified in duplicate in a Rotor-Gene 6000 (Corbett 
Research, Australia) with two non-template control reactions in each run. The PCR reaction 
consisted 10 µl of 1X RealMasterMix Probe (5 PRIME, Gaithersburg, MD, USA), primers and 
probe (optimised concentration as in section 6.2.6), 5 µl of sample gDNA diluted 1:10 in ultrapure 
nuclease free water and ultrapure water to make total volume 25 µl. The amplification parameters 
were 95°C for 30 s (denaturation), 40 cycles of 95°C for 5 s (denaturation) and 60.9°C (optimised 
as in section 6.2.5 above) for 34 s (annealing and extension). Respective H57 standard series from 
109 cells/ml to 104 cells/ml prepared as in section 6.2.3 were amplified with the samples in each 
run. The quantitation report was prepared by analysing the threshold cycle value (CT) with Rotor-
Gene Q software version 2.3.1.49. 
6.3 Results 
6.3.1 Optimization of annealing temperature 
The annealing temperatures 56ºC , 58ºC and 60.9ºC resulted in good yields of the PCR product of 
correct size as indicated by clear bands in agarose gel electrophoresis (Figure 6-1). As higher 
annealing temperatures have greater specificity (Wu et al., 1991) and typically annealing temperature 
is about 3 to 5ºC below the melting temperature of primers (i.e. the temperature at which the bonds 
between the oligonucleotide primer and the template are denatured), 60.9ºC was chosen for further 
qPCR reactions based on gradient PCR result and calculated melting temperature of the primers.  
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Figure 6-1 Optimization of annealing temperature by thermal gradient PCR. L = ladder 
6.3.2 Optimization of primers and probe concentration 
Among 24 different combinations of primer and probe concentrations tested, 250 nM of primers 
and 150 nM of probe resulted in the lowest threshold cycle (Ct) (data not shown). Therefore, 250 
nM of primers and 150 nM probe was used as the optimum combination for qPCR reactions.  
6.3.3 Optimization of background signal and Ct values 
Standards prepared with ileum or caecal digesta were used to offset the effect of any inhibitory 
factors present in GIT. In addition, "Dynamic Tube" normalisation, which is regarded as the most 
precise method for the normalisation of qPCR data, was used to optimise the background signal and 
the Ct values (Mallona et al., 2011). This method uses the second derivative of the sample to assign 
the baseline for each sample and the background fluorescence is averaged from the first cycle to 
this baseline for each reaction separately (Mallona et al., 2011).    
6.3.4 Standard curves and reaction efficiency 
Standard curves in each qPCR run were generated by using H57 standards consisting of tenfold 
serial dilutions of DNA representing H57 cells from 5×109 cells/ml down to 5×103 cells/ml. The 
linearity of the relationship between concentration of H57 and Ct values was tested by plotting the 
values. There was good linearity between concentration and Ct from 5×109 cells/ml to 5×104. 
Therefore, this range of H57 cell concentrations were  subsequently used. 
         L         70       69.2     67.5     64.5    60.9      58        56        55         L     
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6.3.5 qPCR with samples from ileum of H57(+) birds 
The H57 tenfold serial dilution series for ileum gave a good linear correlation (R2 = 0.998) and a 
high amplification efficiency (E = 100%) (Figure 6-2).  
a) 
 
b) 
 
Figure 6-2: a) Amplification curves for samples from ileum of H57+ birds. Blue = standard series. Red 
= Non-template control. Other colours = samples. b) Standard curve (regression line) generated with 
B. amyloliquefaciens H57 standards series (5×109 – 5×104) with ileum content. CT = Threshold Cycle. 
R and R^2: Correlation coefficients. M: Slope of the standard curve. B: Intercept with the ordinate. 
Efficiency: Reaction efficiency. 
6.3.6 qPCR of samples from caeca of H57(+) birds 
Results from caecal samples gave good linearity (R2 = 0.99) and amplification efficiency (97%) 
(Figure 6-3).  
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a) 
 
b) 
 
Figure 6-3: a) Amplification curves for qPCR run with samples from caeca of H57+ birds. Blue = 
standard series. Red = Non-template control. Other colours = samples b) Standard curve (regression 
line) generated with B. amyloliquefaciens H57 standards series (5×109 – 5×104) with caecal content. CT 
= Threshold Cycle. R and R^2: Correlation coefficients. M: Slope of the standard curve. B: Intercept 
with the ordinate. Efficiency: Reaction efficiency. 
6.3.7 qPCR run with samples from ileum and caecum of control birds 
As the samples from both ileum and caecum of the birds fed the diet without H57 were amplified in 
a single qPCR run, H57 standard series from 5×109 to 5×103 cells/ml prepared in TE (Tris-EDTA) 
buffer was used for qPCR. The standard curve was well correlated (R2 = 0.962) with a high 
amplification efficiency (E = 97%) (Figure 6-4). 
B. amyloliquefaciens is generally not present in the GIT of the chickens. Therefore, amplification of 
target sequence was not expected in control samples. Although there were some non-zero values for 
the quantity of B. amyloliquefaciens H57 in both the ileum and caecum samples of control birds in 
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both experiments, these values were below the detection limit of the assay (data not shown) i.e. 
below the concentration in which CT values and concentration had linear relationship (<5×103 
cells/ml). Some late cycle amplification in a few of the control birds (Figure 6-4a) were assumed to 
be due to non-specific amplification of the target sequence.  
6.3.8 Enumeration of H57 in the GIT of chicken 
The average number of B. amyloliquefaciens H57 cells in the ileum of H57 (+) birds in experiment 
1 - week 2 (day 14) was 1.1×107 cells/g while in week 3 (day 21) it was 1.05×107 cells/g of digesta 
(Table 6-2). There was no significant difference (P > 0.05) in the numbers of H57 in the ileum 
between week 2 and week 3. The average quantity of H57 in the ileum at day 35 in experiment 2 is 
3.75×106 cells per gram of digesta (Table 6-3).  
The average number of B. amyloliquefaciens H57 in the caecum of H57(+) birds in experiment 1 - 
week 2 (day 14) and week 3 (day 21) were 2.17×106 cells/g and 1.4×106 cells/g of digesta 
respectively (Table 6-2). The difference in the numbers of H57 between week 2 and week 3 was not 
significant (P > 0.05). However, the differences in the population of H57 between ileum and 
caecum were statistically significant (P <0.05). The average quantity of H57 in the caeca at day 35 
in experiment 2 was 1.27×105 cells per gram of digesta (Table 6-3). 
a) 
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b) 
 
Figure 6-4: a) Amplification curves for qPCR run with samples from ileum and caecum of control 
birds. Blue = standard series. Red = Non-template control. Other colours = samples b) Standard curve 
(regression line) generated with B. amyloliquefaciens H57 standards series (5×109 – 5×103) in TE 
buffer. CT = Threshold Cycle. R and R^2: Correlation coefficients. M: Slope of the standard curve. B: 
Intercept with the ordinate. Efficiency: Reaction efficiency. 
Table 6-2: Population density of B. amyloliquefaciens H57 in the ileum and caecum of H57+ chickens 
on day 14 and day 21 in experiment 1. Numbers are the average of two birds per replicate. 
Replicate
s 
Day Ileum (per 
gram of 
digesta) 
Caecum (per 
gram of digesta) 
Quantity added in 
feed (per gram) 
1 14 1.21 ×107 2.25 ×106 2×107 
21 1.07 ×107 4.57 ×106 2×107 
2 14 1.05 ×107 7.61 ×105 2×107 
21 6.64 ×106 1.82 ×106 2×107 
3 14 1.17 ×107 9.92 ×105 2×107 
21 1.09 ×107 1.94 ×106 2×107 
4 14 6.75 ×106 1.03 ×106 2×107 
21 1.16 ×107 1.17 ×106 2×107 
5 14 1.18 ×107 7.09 ×105 2×107 
21 1.55 ×107 8.42 ×105 2×107 
6 14 1.04 ×107 5.03 ×105 2×107 
21 1.03 ×107 2.70 ×106 2×107 
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Table 6-3: Population density of B. amyloliquefaciens H57in the ileum and caecum of H57+ chickens at 
day 35 in experiment 2. Numbers are average of two birds per replicate. 
Replicates Day Ileum (per gram of 
digesta) 
Caecum (per 
gram of 
digesta) 
Quantity added 
in feed (per 
gram) 
1 35 3.74×106 2.31 ×105 107 
2 35 2.75 ×106 1.22 ×105 107 
3 35 4.29 ×106 1.58 ×105 107 
4 35 3.72 ×106 2.66 ×104 107 
5 35 4.58 ×106 1.38 ×105 107 
6 35 3.42 ×106 8.62 ×104 107 
6.4 Discussion 
The numbers of H57 detected, as indicated by copy number of pgsB gene in digesta, were 
consistently lower than the number added into the feed. Therefore, we can presume that H57 has 
not multiplied noticeably in the intestine, and any cell division is about equivalent to or less than 
cell death. Also, lower numbers of H57 in the digesta tends to indicate the death of a small 
proportion of cells in the intestine, although higher moisture level in digesta than in feed may have 
been a factor.  
Significant effects of feeding H57 on production performance and intestinal microbiota populations 
and function might be suggestive of spores germinating in the intestine, as the spores would need to 
germinate to be metabolically active. Sequencing of the H57 genome indicated that this bacterium 
has the genetic potential to grow in anaerobic conditions (Schofield et al., 2016). Due to the 
relatively short (a few hours) transit and retention time of digesta in the chicken GIT (Shires et al., 
1987), probiotic spores would need to germinate soon after ingestion to produce a marked 
metabolic impact (Jadamus et al., 2001). Even though Bacillus can survive for long periods as a 
spore, these can be triggered to germinate within a short period of time (within a few minutes to 24 
hours) by different factors among which nutrients such as amino acids, sugars or nucleosides have 
been implicated (Moir, 2006, Setlow, 2003). Chicken diets are generally dense in nutrients, which 
could trigger germination of bacterial spores present in feed.  
Previous studies have demonstrated that Bacillus spore can germinate in the GIT of chicken. 
Cartman et al.  (2008) used Bacillus subtilis vegetative cell specific reverse transcriptase (RT)-PCR 
targeting a unique rrnO-lacZ fusion gene and demonstrated that B. subtilis spores germinated in the 
intestine of chickens. In this study, the number of vegetative cells was greater than spores in all 
sections of the GIT after 20 hours following oral administration of Bacillus subtilis spores to 
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chickens. However, Bacillus spores were unable to colonize the gastrointestinal tract of chickens as 
the number of Bacillus cells in different sections of the GIT decreased with time after a single large 
oral dose (109 spores) was administered to day old, specific pathogen-free chickens (Cartman et al., 
2008). In another study, Jadamus et al. (2001) showed that about 90% of the ingested spores of 
Bacillus cereus var. toyoi in feed germinated within 30 minutes in the crop while 99% of spores 
germinated by the time they reached the proventriculus.  
Probiotic bacteria need to survive the acidic environment of the gastric stomach to reach the lower 
GIT. Germination of most of the orally administered spores before they reached the stomach, and 
detection of the vegetative cells in the lower GIT, as discussed above indicates a tolerance of 
Bacillus vegetative cells to acid conditions in the proventriculus.  
However, some of bacterial cells may lose viability during germination or during transit from the 
small intestine to the caeca. In our experiments the population of H57 in the caeca is less than the 
population in the ileum based on number of cells per gram wet digesta. Jadamus et al. (2001) also 
found a similar result, that the total CFU of orally administered Bacillus cereus var. toyoi was less 
in caeca than in the ileum. Only finely ground, low molecular weight and non-viscous particles in 
the small intestine enter the caeca (Svihus et al., 2013). Therefore, some H57 cells could be directly 
shed to the faeces without going to the caeca resulting in lower numbers of H57 cells in the caeca. 
Some Bacillus probiotics cannot only germinate, but can also “re-sporulate” when the vegetative 
form is fed to the birds. Oral administration of vegetative cells of Bacillus cereus var. toyoi led to 
the in vivo sporulation of Bacillus cells in the chicken intestine resulting in the detection of the 
spore form in all sections of the GIT two hours after ingestion (Jadamus et al., 2001). Harsh 
environmental conditions and/or the anaerobic conditions of the GIT might have triggered 
vegetative cells to sporulate. An immunological study by Tam et al.  (2006) demonstrated that B. 
subitilis spores can germinate and “re-sporulate” in the intestine of mice.  
These findings indicate that H57 spores may germinate in the intestine, but undergo minimal cell 
division and multiplication. The newly germinated cells may also re-sporulate due to the harsh 
environmental conditions that prevail in the intestine. A proportion of cells might have lost their 
viability in this process leading to the decreased quantity in the caeca as compared to ileum.  
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Chapter 7 General discussion and implications of the 
research  
Administration of a novel Bacillus amyloliquefaciens strain H57 (H57) through feed improved the 
growth rate and feed use efficiency in broiler chickens, but the results varied between experiments 
and diets. This study indicated that H57 did not noticeably multiply in the intestine of the chickens 
but modulated the intestinal microbial profile and their function. These aspects of the research are 
further discussed below along with the possible mode of action(s) of H57 and potential future 
research directions.   
7.1 General considerations  
7.1.1 Variability of results  
While possible modes of action of the probiotic H57 discussed below provide a direction for further 
studies, the most confounding aspect of the results of this study is the inconsistency of results 
between experiments and the interaction of H57 with diets. There was a significant effect of H57 
both on intestinal microbiota (both in ileum and caeca) and growth rate in experiment 1. In 
Experiment 2, the microbiota was significantly affected by H57 (but less prominently than in 
experiment 1) with a shift in relative abundance of some OTUs in the caeca but there was no effect 
on growth rate. Conversely, growth rate was significantly increased by H57 in experiment 3 with a 
less prominent effect on the microbial profile than in experiment 1 (details in chapter 4).  
While there was a significant correlation (positive or negative) between body weight and relative 
abundance of some OTUs affected by H57 in experiment 3, other OTUs affected by H57 had no 
correlation with body weight. Therefore, some of the OTUs might have directly contributed to the 
differences in the body weight while others may not have had a direct influence on body weight 
gain even though they were significantly affected by H57. Even though there were no differences in 
microbial profiles in the caeca in experiment 3 at day 13, microbial functional capacity as indicated 
by differential abundance of functional genes was significantly different between Control and H57 
birds. However, by day 13 there was a significant increase in body weight with H57. Therefore, it 
appears that in some situations the response to H57 was mediated not by the microbial population 
per se but their functional potential to achieve a phenotypic response. Changes in the metagenomic 
profile but not in microbial community profile in experiment 3 indicated that the differences in 
genetic potential can be attributed to variation in microbial community differences below genus or 
species level, for example, different strains of same species having different levels of virulence due 
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to the presence or absence of pathogenicity islands (Salama et al., 2000, Medini et al., 2005). These 
observations indicated that the effect of H57 on growth are not necessarily associated with an effect 
on the microbial profile but rather on which microbes or microbial functions in particular were 
affected. These particular microbes or functions, which when altered can have a positive effect on 
the growth rate of the host, could encompass a range of microbes or functions which may differ 
between different experiments and diets. Two different batches of chicks with similar diets 
(sorghum based diets) developed different microbial populations at day 21 (chapter 4). This may 
be due to differences in the “seed microbes” initially colonizing the gut, which resulted in different 
resident microbes by day 21. Therefore, the difference in response to H57, positive in Experiment 1 
and none in Experiment 2 may be due to variability in the resident microbes in the gut resulting 
from the different batch of chicks and the different source/batches of feed ingredients between 
experiments.  
In experiment 3, birds fed sorghum and wheat mixed diet had higher growth rate than the birds fed 
the feed based on only sorghum or wheat. In contrast to our result, a recent study showed that birds 
with a sorghum based diet grew better than birds fed sorghum and wheat mixed diet (Crisol-
Martínez et al., 2017). In this study, the difference in birds’ performance between diets was 
associated with the microbial profile in the caeca. This result further reinforces our hypothesis that a 
bird’s performance and/or the effects of probiotics and feed depends on the resident microbes in the 
gut prior to the introduction of probiotic bacteria.  
However a recent study has reported that microbial population structure in the caeca of chickens is 
highly variable, varying from batch to batch even for the same breed of chicks, from the same 
hatchery and raised on the same diet (Stanley et al., 2013). The authors have suggested that this 
variation is due to “the lack of colonisation of the chicks by maternally derived bacteria”. The 
modern poultry industry hatches chicks in an environment with minimal contamination by 
microbes. Therefore, the development of resident microbial populations in the gut may depend on 
the microbes they are exposed to during the initial days of life, from the room and microbes in the 
feed. This could be a major reason for variability of results in the experiments reported in this 
thesis. Effects of probiotics in animal agriculture are highly variable (chapter 2) (FAO, 2016). 
These inconsistencies in results may be partly due to variation in the innate intestinal microbial 
profile. Furthermore, the GIT of the chicken also consists of protozoa, fungi, bacteriophages and 
other viruses together with bacteria (Yeoman et al., 2012, Saengkerdsub et al., 2007a, Saengkerdsub 
et al., 2007b, Apajalahti et al., 2004). Although this study focussed in bacterial population, which is 
believed to be the primary microbial population in the GIT, it could be further insightful to study 
the effects of H57 on microbes other than bacteria in future studies.  
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7.1.2 Germination and growth of B. amyloliquefaciens H57 spores in the avian 
GIT 
The extent of spore germination and multiplication of B. amyloliquefaciens in the presumed 
anaerobic gastrointestinal tract (GIT) of chickens remains unresolved. Although B. 
amyloliquefaciens is regarded as an aerobe, genome sequencing showed that H57 has the capacity 
to grow in a low PO2 using nitrate as an electron acceptor (Schofield et al., 2016). The number of 
H57 cells present in the digesta sample of birds was determined by a real time quantitative PCR 
(qPCR) method (chapter 6). This method unfortunately cannot distinguish between spore and 
vegetative or dead (recent) cell DNA. However the qPCR analysis showed that there was no major 
multiplication of vegetative cells in the GIT and if spores had germinated then the vegetative 
growth was just sufficient to maintain the inoculum population size. In the H57 inoculum, cells 
constitute less than 20% of the material spun down from the production fermentation from 
calculations based on the wet weight of material spun down from the fermenter, freeze dry weight 
of inoculum, cell number and dry weight (chapter 3). Thus the response to H57 could be mediated 
by the bacterium per se in some form or from products of growth in culture, such as extracellular 
materials, e.g. enzymes such as amylase and protease; lipopeptides such as surfactin, fengycin, 
iturin; polyketides; and signalling molecules affecting hormone production (Schofield et al., 2016), 
resulting in the modification of GIT microbiome and enabling a better utilisation of the nutrients 
present in feed.  
7.2 Possible modes of action 
7.2.1 Microbial virulence factor and possible role of immune system activation 
for growth depression 
It appeared from this study that H57 helped the underperforming chickens to overcome slower 
growth rate. One of the notable insights from three feeding experiments as discussed in chapter 3 is 
that H57 has an effect only when the growth rate was below the performance objectives, and this 
was interpreted as a growth depression in the chickens, which H57 ameliorated.  
Microbial virulence factors can trigger the immune system of the host to mount a response mediated 
through pattern-recognition receptors (Medzhitov, 2007). For example, lipopolysaccharides (LPS) 
(virulence factors in the cell walls of gram negative bacteria) can trigger an acute phase immune 
response in the host. This results in the activation of toll-like receptors and stimulation of 
macrophages to secrete pro-inflammatory cytokines like tumour necrosis factor (TNFα), interleukin 
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(IL)-6 and IL-1β and acute phase proteins in serum, for example, amyloid A (Werling et al., 1996). 
Even though immune responses may not always protect the host (Medzhitov, 2007), they could be 
detrimental for growth or production performance of the host due to the high energy cost associated 
with stimulation of the immune system (Wolowczuk et al., 2008). 
As demonstrated in chapter 5, the immune system of slower growing control chickens could be 
more active indicating stress as evidenced by higher relative abundance of genes in caecal bacteria 
encoding bacterial virulence factors; including biosynthesis of LPS (for example UDP-N-
acetylglucosamine acyltransferase) and genes involved in the regulation of virulence; in control 
birds compared to the H57 treated birds. The presence of LPS in the gut could lead to translocation 
of this virulence factor into the portal system (Jacob et al., 1977), which even in minute amounts, 
could trigger an immune response (Bjorneboe et al., 1972, Van Leeuwen et al., 1994). Activation of 
the immune system by LPS, particularly an acute phase response, can significantly affect protein 
metabolism (Barnes et al., 2002), bone homeostasis and body composition in broiler chickens 
(Mireles et al., 2005). Several acute phase proteins are formed during immune challenge utilizing 
free amino acids in the blood (Barnes et al., 2002), which could otherwise be used for growth and 
production. Jiang and colleagues (Jiang et al., 2010) have shown that acute phase immune response 
artificially induced by LPS in chickens diverts a large proportion of feed energy from tissue 
accretion, resulting in depression of growth. Chickens need about 112 kcal/kg0.75 of metabolisable 
energy (ME) per day for maintenance, about 10 kcal of ME/g for protein deposition and about 17 
kcal of ME/g for fat deposition at 23°C with a quadratic effect of temperature on maintenance 
requirements (Sakomura et al., 2005). Therefore, interactions with the bird’s immune system can 
affect energy partitioning with each 100 kcal of ME diverted towards immune system activation 
reducing body weight gain the equivalent to about 10 g of protein or about 6 g of fat. Moreover, 
immune system stimulation has also been found to reduce survival of birds (Hanssen et al., 2004). 
By contrast, translocation of LPS across the gut wall has been linked to weight gain in mice (Cani et 
al., 2007) and human beings (Creely et al., 2007). Further study is needed to explain this 
discrepancy between chickens and mammals.  
A multi-strain probiotic containing Enterococcus faecium, Lactobacillus reuteri, L. salivarius and 
Pediococcus acidilactici partially alleviated the growth depression due to LPS induced immune 
response in broiler chickens (Jiang et al., 2010). Positive responses to H57 only occurred when 
there was depression of growth (chapter 3), modulation of intestinal microbial profile by H57 
(chapter 4) and evidence for a larger amount of virulence factors in control chickens when 
compared with H57 fed chickens (chapter 5). This led to the presumption that H57 modulates the 
intestinal microbial structure or function to reduce microbial virulence factor(s) responsible for 
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depression of growth in chickens. However, the extent to which these virulence factors activate the 
immune response and thereby affect growth needs further study. Any effect on immune system 
activation in the host could be assessed by investigating the differences in immunity-related gene 
expression in the intestinal tissue of the host or level of immune system activation-related marker 
molecules in blood. Although there are strong indications that one of the probable mode of actions 
of H57 is by reducing microbial virulence factors in the gut thereby reducing the expenditure of 
energy on the immune system, variation of results between experiments and between diets also 
indicates that this is unlikely to be the sole mechanism.  
LPS are structural components in outer membranes of the gram-negative bacteria. There was a 
higher abundance of LPS synthesis enzymes in the caeca of control chickens even without 
significant differences between microbial profiles of Control and H57 treatment groups in 
experiment 3 (chapter 5). In contrast to this link between LPS and growth rate in experiment 3, 
there was a substantial increase in the gram-negative Bacteroides population in the H57 group, as 
determined by 16S rRNA gene sequencing, when compared with the Controls in experiment 1 
(Chapter 4). However, no metagenomic analysis was undertaken to assess the level of LPS 
synthesis genes in the caeca of birds in experiment 1. There was a positive response to H57 in both 
of the experiments. This indicates that there might be other modes of action of H57, in addition to 
the potential reduction in immune stimulating microbial virulence factors by H57.  
The relative abundance of genes responsible for antibiotic resistance, Shiga-toxin clusters and other 
important virulence factors found in microbes, were also significantly reduced in the H57 group 
(chapter 5). The emergence of antibiotic resistant pathogens has been identified as a major public 
health threat in recent times (World Health Organization, 2014, Roca et al., 2015, Ventola, 2015). 
Therefore, this effect of H57 could represent an important benefit relating to public health and 
warrants closer investigation in future studies. Shiga-toxin producing E. coli (STEC), are important 
zoonotic pathogens causing diseases like haemorrhagic colitis and haemolitic uremic syndrome 
(HUS) which can result in acute kidney failure in children (Karmali et al., 2010, Gyles, 2007). As 
reducing the contamination of animal products, particularly meat, with STEC has been a major 
emphasis in the public health sector, the effect of H57 to reduce Shiga-toxin cluster genes is 
interesting to pursue in future studies.  
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7.2.2 Short chain fatty acids – important metabolites in the GIT affecting 
energy homeostasis 
The suppression of growth of chickens also appeared to be associated with diet, as growth was 
depressed either with wheat or sorghum based diets but not with a mixed (wheat + sorghum) diet in 
experiment 3 (chapter 3). Also, growth depression and the effect of H57 varied with the 
experiment or batch/source of chicks as indicated by a significant difference in weight gain in 
experiment 1 and 3 but not in experiment 2. Intestinal microbial profiles were significantly different 
between the experiments. These differences may be the result of different ‘seed microbes’ 
colonising the GIT from the hatchery or rearing environment (feed, water, litter etc.) during the 
initial days of the chickens’ life. Thus, the growth depression or the effect of H57 may be 
associated, at least in part, with the composition of the resident microbes in the gut.  
The association of intestinal microbes with the suppression of growth in chickens has been 
established from past studies comparing growth of germ free birds with birds in a normal 
production environment (Forbes and Park, 1959, Forbes et al., 1959, Coates et al., 1963). Therefore, 
the apparent inconsistency in the effects of H57 reported in this thesis could be associated with 
different initial resident microbes in the gastrointestinal tract of chickens. Due to the apparent 
association between intestinal microbiota with growth rate and the beneficial effects of H57, 
modification of microbial function in the GIT by H57 is likely to have a subsequent effect on the 
energy homeostasis of the chickens. Based on past studies in mice and humans with host-microbes 
interactions, two of the most important metabolites in the intestine affecting energy homeostasis of 
the host are short chain fatty acids (SCFAs) (Byrne et al., 2015) and bile salts (Krogdahl, 1985, 
Maldonado-Valderrama et al., 2011). 
Chickens cannot digest digestive-enzyme-resistant non-starch polysaccharides, and these 
carbohydrates are not digested in the small intestine, reaching the caeca undigested (Józefiak et al., 
2004). The resident microbes in the caeca digest these carbohydrates through fermentation 
producing SCFA, mainly acetate, propionate and butyrate. However, the type and proportion of 
SCFA produced depends upon the diet, intestinal microbiota diversity and intestinal transit time 
(Brinkworth et al., 2009, Wisker et al., 1988, Peng et al., 2013, Murphy et al., 2010).  
SCFAs play an important role in appetite regulation and energy homeostasis in mice (Byrne et al., 
2015), thereby affecting body weight gain and adiposity (Ridaura et al., 2013, Liou et al., 2013). In 
general, in the mouse and human models, SCFAs reduce energy intake and increase energy 
expenditure through several interconnected mechanisms involving liver, adipose tissue, pancreas, 
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intestinal wall, skeletal tissue and nervous system (Figure 7-1) thereby reducing bodyweight (Byrne 
et al., 2015). Several studies, mainly on a mammalian (mouse) model, have shown how microbial 
SCFAs may regulate body weight in the host. Ridaura et al. (Ridaura et al., 2013) transplanted 
faecal microbiota of twin mice differing in body weight (obese vs lean) to germ free mice and 
showed that microbiota transplanted mice had similar body weight phenotype and microbiota to that 
of the donor. The amount of caecal propionate and butyrate was significantly lower in obese mice in 
comparison with their lean counterparts. Higher SCFA concentrations in lean mice were believed to 
inhibit fat accumulation. Similarly, Liou et al. (2013), showed that a faecal transplant from mice 
which had undergone bariatric (gastric bypass) surgery to germ free mice, increased the ratio of 
propionate to acetate, and this correlated with weight loss. It has been suggested that higher 
propionate levels inhibit the conversion of acetate into lipid in the liver and adipose tissue while 
reduced acetate production reduced lipogenesis (Hong et al., 2005, Wolever et al., 1991).  
 
Figure 7-1 Mechanism of action of short chain fatty acids (SCFAS) to regulate appetite and energy 
homeostasis in the mice and human models. FCs, fermentable carbohydrates; FFA, free fatty acids; 
FFA2, free fatty acid receptor 2; FFA3, free fatty acid receptor 3; GLP-1, glucagon like peptide-1; 
IGN, intestinal gluconeogenesis; PYY, peptide YY; SCFAs, short chain fatty acids; TG, triglyceride.  
Diagram reproduced from Byrne et al.  (2015). 
No studies were uncovered about the role of SCFAs on feed intake and energy homeostasis in 
chickens. However, the relative abundance of genes encoding for fermentation was higher in H57 
birds compared to control birds with a wheat based diet in experiment 3 (chapter 5). Therefore, 
fermentation of non-starch polysaccharides resulting in the production of SCFAs may have 
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different outcomes in chickens from that in mammalian (murine) model. Increased fermentation 
rate, as indicated by higher abundance of fermentation related genes in H57 treated birds, may be 
the indicator of higher microbial digestion of the non-starch polysaccharides which are regarded as 
a common anti-nutritional factor present in wheat resulting growth depression (Choct and Annison, 
1990, Angkanaporn et al., 1994, Choct and Annison, 1992a, Choct and Annison, 1992b). The role 
of caecal microbes in digesting wheat pentosans was demonstrated by Choct et al. (Choct et al., 
1992) using cecectomized broiler chickens. The faecal pentosan digestibility coefficient in 
cecectomized chickens was found to be significantly lower compared to that in normal chickens. 
Analysis of the transcripts from the genes related to fermentation expressed in the intestine, along 
with measurement of the quantity and composition of SCFAs production in the intestine, would 
help to further understand the role of fermentation and SCFAs in chicken metabolism.  
7.2.3 Depression of growth by gut associated bile salt hydrolase activity 
Bile acids (cholic acid and chenodeoxycholic acid) are important metabolites in the gut which can 
also act as hormones affecting energy homeostasis (Watanabe et al., 2006, Watanabe et al., 2012). 
Bile acids are mostly conjugated to glycine or taurine and exist in their anion form at physiological 
pH (as sodium salts, i.e. bile salts). While the role of bile salts in poultry has had little attention, 
studies in mammals showed that bile salts affect lipid, cholesterol and glucose metabolism (Thomas 
et al., 2008, Joyce and Gahan, 2016). Most of the bile salts in the intestine are directly recycled 
through uptake into the enterohepatic circulation (Small et al., 1972). Intestinal microbes and the 
host together determine the size of the bile salts pool (Ridlon et al., 2014). Bacterial bile salt 
hydrolase (BSH) activity removes glycine or taurine from conjugated bile acids forming their 
deconjugated counterparts (Figure 7-2), which are subsequently less efficiently recycled, affecting 
lipid and cholesterol metabolism and energy homeostasis (Joyce et al., 2014b, Joyce et al., 2014a).  
Although the effect of BSH activity in poultry has not been studied extensively, intestinal microbes 
like E. faecium and C. perfringens with higher BSH activity have been shown to depress growth 
rates in chickens (Knarreborg et al., 2002a, Stutz and Lawton, 1984, Houghton et al., 1981). 
Deconjugated bile acids increased the metabolic rate in brown fat tissue resulting in weight loss in 
mice fed a high fat diet (Watanabe et al., 2006). When there is inefficient recycling of the bile salts 
leading to a reduced uptake of deconjugated bile salt uptake cf conjugated salts, this creates a 
relative energy deficit, which might have to be overcome by increased metabolism of brown fat 
leading to weight loss. It has been suggested that antibiotic growth promoters improve the growth 
rate of poultry by lowering BSH activity in the GI tract (Guban et al., 2006, Feighner and 
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Dashkevicz, 1988). In the context of antibiotic growth promoters being gradually phased out from 
animal diets, non-antibiotic BSH inhibitors could be promising growth promoters (Lin et al., 2014).  
 
 
Figure 7-2 Metabolism of bile acids in the intestine. Picture copied from Joyce et al.  (Joyce et al., 
2014a). G = Glycine, T = Taurine, BAs = Bile Acids, CA = cholic acid, CDCA = chenodeoxycholic acid, 
TCA = taurocholic acid, GCDCA = glycochenodeoxycholic acid, DCA = deoxycholic acid, LCA = 
lithocholic acid. Conjugated bile salts are reabsorbed directly from the gut while the deconjugated 
salts are likely to be excreted. 
It is postulated that modification of intestinal microbes by H57 might reduce the BSH activity in the 
intestine subsequently overcoming the depression of growth of the birds by reducing the uptake of 
deconjugated bile salts and thereby their effect on metabolic rate. While BSH is commonly 
produced by gut-associated bacteria (Jones et al., 2008), isozymes from different bacteria can have 
different activity due to differences in substrate specificity, potency and susceptibility to inhibitors. 
Moreover, microbially altered bile acids themselves can have direct or indirect effects on intestinal 
microbiota (Wahlström et al., 2016) amplifying the net effect. There was no effect of H57 on the 
relative abundance of BSH enzyme (choloylglycine hydrolase) encoding genes for the sorghum 
based diet in experiment 3. Unexpectedly, the relative abundance of BSH encoding genes was 
significantly higher in the H57 group when compared with the Control group fed a wheat based diet 
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in experiment 3. However, BSH activity could be of more significance in the small intestine than in 
the caecum. The abundance and expression of the BSH gene in experiments 1 and 2 and BSH 
expression in experiment 3 were not examined. Further studies are needed to determine if H57 has 
an effect on BSH activity in the chicken GIT particularly in the small intestine. Measurement of bile 
salts in digesta and serum samples together with transcriptome analysis to see the expression level 
of BSH gene in Control and H57 fed birds would be insightful complemented by a metabolomic 
study.   
7.2.4 Feed intake and regulation of appetite in poultry 
Increased growth rate in the H57 fed birds, particularly in experiment 3, was concurrent with a 
significant increase in feed intake compared to Control birds. Supressed appetite could be one of the 
factors causing lower growth rates in Control birds. However, higher feed intake might not be the 
sole cause of better performance of H57 groups as feed use efficiency was also improved by 
inclusion of H57 as a probiotic.  
Feed intake in chickens is regulated through short-term (meal to meal intake) regulation by satiety 
signals between digestive system (intestinal tract, liver and pancreas) and the satiety centre in the 
brainstem and long term balance of energy storage by signalling between adipose tissue, liver and 
hypothalamus (Richards, 2003, Richards and Proszkowiec-Weglarz, 2007). Presence of feed and 
nutrients in the intestine releases cholecystokinin and bombesin, which inhibit feed intake by 
stimulating the satiety centre in the brainstem (Denbow, 1994, Kuenzel, 1994, Jensen, 2001). 
Ghrelin, a potent peptide responsible for appetite stimulation in mammals (Wren et al., 2000), also 
suppresses feed intake in chickens (Furuse et al., 2001, Saito et al., 2002). Long term energy 
balance in the body is maintained by regulation of feed intake and energy expenditure, mainly 
through the levels of leptin and insulin together with several other peptides (Richards and 
Proszkowiec-Weglarz, 2007, Richards, 2003). Leptin and its receptor play crucial roles for energy 
homeostasis and feed intake affecting body weight and accumulation of adipose tissue (Barb et al., 
1998, Friedman and Halaas, 1998). Leptin inhibits feed intake (Barb et al., 1998). However, the 
presence of a leptin gene in chickens has been controversial for years with some recent evidence 
supporting the presence of a leptin gene in chickens (Seroussi et al., 2015, Farkašová et al., 2016). 
Further study is warranted on the relationship between feed intake and appetite regulation and the 
probiotic mode of action of H57. For this, measurement of hormone levels, other metabolites in 
blood and expression of appetite related genes following H57 administration would be the starting 
point.  
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7.3 Commercial potential for H57 
There are strong indications that H57 can affect different microbiomes (chapter 4) and/or a range 
of microbial functions (chapter 5) in the broiler GIT. This is very important in the context of 
dynamic intestinal microbial populations whose constitution changes with age, diet, health 
condition etc. Positive responses to H57 with different sources of chicks, different gut microbial 
populations and different feed ingredients (wheat and sorghum) are positive outcomes for any 
future commercial developments. 
A higher dose rate of H57 was used in experiment 3 than in experiments 1 and 2 to obtain a range 
of dose rates, at which H57 may show positive effects. This range could be used in the next phase 
of studies as a yardstick around which to establish dose related responses, and optimum dose rate. It 
would also help establish commercial fermentation population requirements leading to media 
optimisation and a fermentation method to produce the required spore to vegetative cell ratio which 
engenders the optimum growth responses in poultry. This will determine in part the prospects for 
commercial use of this bacterial strain as a probiotic. 
Growth media constitutes about one third of the total cost of bacterial fermentation (Rodrigues et 
al., 2006). In these studies mostly pure chemicals were used in the growth medium, but other 
agricultural and industrial by-products could be tested in future studies to reduce the cost. Examples 
of such products include whey (Timmer and Kromkamp, 1994, Øyaas et al., 1996), molasses 
(Montelongo et al., 1993, Göksungur and Güvenç, 1997) starch (Xiaodong et al., 1997) and legume 
flour (Altaf et al., 2006). As well, bentonite was used as a carrier in the experiments reported in this 
thesis but H57 has been previously used as HayRite in a whey carrier. Methods and costs of drying 
the microbial cell paste concentrated following fermentation (by centrifugation, freeze drying or 
some other method) also remain to be determined. This process is where the mix of spore and 
vegetative cells required is going to be very important as some methods of drying require heat 
which may be detrimental to vegetative cell survival. 
Results described in this thesis indicate that H57 has potential commercial prospects. Several lines 
of research are required to elucidate the mode of action leading to optimisation of conditions under 
which a growth response in poultry can be expected. Fermentation protocols to reproduce the 
response at a commercially acceptable cost need to be developed. The intellectual property around 
some of the results in this thesis has been protected by patent applications under examination in 
Australia, USA, Europe, and South East Asia.  
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Appendix 1. Supplementary material for chapter 2 
Probiotics in animal nutrition: production, impacts and 
regulation‡‡ 
Yadav S Bajagai, Athol V Klieve, Peter J Dart, Wayne L Bryden 
1 Introduction 
Please see Introduction (section 2.1) in chapter 2. 
2 Probiotics: Definition and Classification 
2.1 Definition 
Please see Introduction (section 2.1) in chapter 2. 
2.2 Classification 
There is an array of microorganisms used as probiotics which can be classified as follows. 
1. Bacterial vs Non-bacterial probiotics: With the exception of certain yeast and fungal
probiotics most of the microorganisms used are bacteria. Examples: Bacterial probiotics –
several species of Lactobacillus (Mookiah et al., 2014), Bifidobacterium (Pedroso et al.,
2013, Khaksar et al., 2012), Bacillus (Abdelqader et al., 2013), and Enterococcus
(Mountzouris et al., 2010); Non-bacterial (yeast or fungal) probiotics - Aspergillus oryzae
(Daskiran et al., 2012, Shim et al., 2012), Candida pintolopesii (Daskiran et al., 2012),
Saccharomyces bourlardii, (Rahman et al., 2013), and Saccharomyces cerevisiae (Bai et al.,
2013).
2. Spore forming vs Non-spore forming probiotics: Although non spore forming
Lactobacillus and Bifidobacterium strains predominated initially, spore forming bacteria are
now used e.g. Bacillus subtilis (Alexopoulos et al., 2004a) and Bacillus amyloliquefaciens
(Ahmed et al., 2014).
‡‡  This literature review with wider scope covering impacts of probiotics in poultry, pig and 
ruminants; and safety and regulation of probiotics has been done during candidature of this PhD and 
published by Food and Agriculture Organization of the United Nations (Ed. Harinder P S Makkar)  
(http://www.fao.org/3/a-i5933e.pdf). Remaining sections of this publication is presented in Chapter 
2.
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3. Multi-species (or strain) probiotics vs Single-species (or strain) probiotics: The 
microbial composition of probiotic products ranges from a single strain to 
multistrain/species compositions (Table S1). Examples of multi-species probiotics are 
PoultryStar ME (contains Enterococcus faecium, Lactobacillus reuteri,  L. salivarius, and 
Pediococcus acidilactici) (Giannenas et al., 2012), PrimaLac (contains Lactobacillus spp, E. 
faecium, and Bifidobacterium thermophilum)  (Pedroso et al., 2013), and Microguard 
(contains different species of Lactobacillus, Bacillus, Streptococcus, Bifidobacterium and 
Saccharomyces (Rahman et al., 2013). Single-species probiotics include Bro-bio-fair 
(Saccharomyces servisia) (Abdel-Raheem et al., 2012) and Anta Pro EF (E. faecium) 
(Abdel-Rahman et al., 2013) . 
4. Allochthonous probiotics vs Autochthonous probiotics: The microorganisms used as 
probiotics which are normally not present in the GIT of animals are referred to as 
allochthonous (eg yeasts), while the microorganisms normally present as indigenous 
inhabitants of the GIT are referred to as autochthonous probiotics (eg. Lactobacillus and 
Bifidobacterium).  
3 Microorganisms used in probiotics  
Many commercial products use multi-strain probiotics although the benefits of using more than one 
strain or species in a single product has not been clearly established (Zhao et al., 2013). 
Microorganisms that have been used as probiotics in animal feed are listed in Table S1.  
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Table S4: Microorganisms used as probiotics in animal diet 
Genus Species Strains Commercial products containing the species References 
Aspergillus  oryzae   (Daskiran et al., 2012, Shim et al., 
2012) 
niger   (Seo et al., 2010) 
Bacillus   amyloliquefaciens CECT 5940 Ecobiol (Norel Animal Nutrition, Madrid, Spain) (Ortiz et al., 2013) 
toyonensis BCT-7112 Toyocerin (Rubinum S.A., Barcelona, Spain) (Taras et al., 2005, Kantas et al., 
2015) 
coagulans ATCC 7050, 
ZJU0616 
- (Adami and Cavazzoni, 1999, Hung 
et al., 2012) 
licheniformis DSM 5749  Microguard, (PeterLab Holdings, Negeri Sembilan, 
Malaysia),  LSP 122 (Alpharma, Vega Baja, Puerto Rico), 
BioPlus 2B (Chr Hansen, Hørsholm, Denmark), Probios  
(Chr Hansen, Hørsholm, Denmark), BioPlus YC (Evonik 
Industries, Essen, Germany), Enhancer (Performance Plus, 
Chicago, IL, USA) 
(Alexopoulos et al., 2004a, Rahman 
et al., 2013, Abdel-Hafeez et al., 
2017) 
megaterium - Microguard, (PeterLab Holdings, Negeri Sembilan, 
Malaysia) 
(Rahman et al., 2013) 
mesentricus - Microguard, (PeterLab Holdings, Negeri Sembilan, 
Malaysia) 
(Rahman et al., 2013) 
polymyxa - Microguard, (PeterLab Holdings, Negeri Sembilan, 
Malaysia) 
(Rahman et al., 2013) 
subtilis 588, CA #20, 
DSM 17299, 
PB6, ATCC-
PTA 6737, 
DSM 5750 
GalliPro (Evonik Industries, Essen, Germany), Microguard, 
(PeterLab Holdings, Negeri Sembilan, Malaysia), Super-
CyC (Choong Ang Biotech Co. Ltd., Gyeonggy, South 
Korea), CloSTATTM (Kemin Industries Inc., Des Moines, 
USA), MicroSource “S” (Agtech Products Inc., Waukesha, 
USA), BioPlus 2B (Chr Hansen, Hørsholm, Denmark), 
Probios  (Chr Hansen, Hørsholm, Denmark), BioPlus YC 
(Evonik Industries, Essen, Germany), Enviva Pro 
(DANISCO Animal Nutrition, Wiltshire, UK), Probion 
(Alexopoulos et al., 2004a, Rahman 
et al., 2013, Afsharmanesh and 
Sadaghi, 2014, Davis et al., 2008, 
Abudabos et al., 2015, Abdel-
Hafeez et al., 2017) 
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Genus Species Strains Commercial products containing the species References 
(Woogene B&G Co. Ltd., Seoul, South Korea ), Enhancer 
(Performance Plus, Chicago, IL, USA)  
Brevibacillus  laterosporus - - (Hashemzadeh et al., 2013) 
Bifidobacterium  animalis 503, DSM 
16284 
PoultryStar ME (BIOMIN GmbH, Getzersdorf, Austria), 
Probios  (Chr Hansen, Hørsholm, Denmark) 
(Giannenas et al., 2012, 
Mountzouris et al., 2010, Wideman 
Jr et al., 2012) 
bifidium  PrimaLac (Star Labs, Inc., Clarksdale, USA), Protexin 
(International Animal Health Products, Huntingwood, 
Australia) 
(Landy and Kavyani, 2013, 
Haghighi et al., 2008, Daskiran et 
al., 2012) 
bifidus  Microguard (PeterLab Holdings, Negeri Sembilan, 
Malaysia) 
(Rahman et al., 2013) 
thermophilus  PrimaLac (Star Labs, Inc., Clarksdale, USA) (Pedroso et al., 2013, Khaksar et 
al., 2012) 
longum   (Seo et al., 2010) 
pseudolongum   (Seo et al., 2010) 
lactis   (Seo et al., 2010) 
Candida pintolepesii   Protexin (Probiotics International Ltd., Lopen Head, 
Somerset, UK) 
(Daskiran et al., 2012) 
Clostridium butyricum  Probion (Woogene B&G Co. Ltd., Seoul, South Korea ) (Zhao et al., 2013, Zhang et al., 
2012, Zhang et al., 2014) 
Escherichia coli Nissle 1917  (Hashemzadeh et al., 2013) 
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Genus Species Strains Commercial products containing the species References 
Enterococcus faecium 589, NCIMB 
11181, E1708, 
DSM 10663, 
NCIMB 10415, 
DSM 16211, 
DSM 3530, 
HJEF005 
All-Lac (Alltech Inc., Nicholasville, USA), PoultryStar ME 
(BIOMIN GmbH, Getzersdorf, Austria), PrimaLac (Star 
Labs, Inc., Clarksdale, USA), Protexin (International 
Animal Health Products, Huntingwood, Australia), Pro-
Soluble (Probiotics International (Protexin) Ltd., Somerset, 
UK), Anta Pro EF (Dr. Eckel GmbH, Niederzissen, 
Germany), Biomin IMBO (BIOMIN GmbH, Getzersdorf, 
Austria), Probios (Chr Hansen, Hørsholm, Denmark) 
UltraCruz (Santa Cruz Animal Health, Paso Robles, USA) 
(Pedroso et al., 2013, Chawla et al., 
2013, Zhao et al., 2013, Wideman 
Jr et al., 2012, Landy and Kavyani, 
2013, Giannenas et al., 2012, 
Abdel-Rahman et al., 2013, 
Mountzouris et al., 2010, Cao et al., 
2013, Khaksar et al., 2012) 
faecalis   (Seo et al., 2010) 
Lactobacillus  thermophilus  All-Lac (Alltech Inc., Nicholasville, USA) (Pedroso et al., 2013) 
acidophilus  Probios  (Chr Hansen, Hørsholm, Denmark), Microguard 
(PeterLab Holdings, Negeri Sembilan, Malaysia), Protexin 
(International Animal Health Products, Huntingwood 
Australia), UltraCruz (Santa Cruz Animal Health, Paso 
Robles, USA), PrimaLac, Avian PAC Soluble, Probion 
(Woogene B&G Co. Ltd., Seoul, South Korea ) 
(Haghighi et al., 2008, Zhang et al., 
2014, Rahman et al., 2013, 
Daskiran et al., 2012, Khaksar et 
al., 2012, Shim et al., 2012, 
Morishita et al., 1997) 
brevis I 12, I 211, I 
218, I 23, I 25 
 (Mookiah et al., 2014) 
bulgaricus  Microguard, (PeterLab Holdings, Negeri Sembilan, 
Malaysia), Protexin (International Animal Health Products, 
Huntingwood, Australia) 
(Rahman et al., 2013, Daskiran et 
al., 2012) 
casei CECT 4043 PrimaLac (Star Labs, Inc., Clarksdale, USA), , Probios, 
UltraCruz (Santa Cruz Animal Health, Paso Robles, USA) 
(Khaksar et al., 2012, Landy and 
Kavyani, 2013, Fajardo et al., 2012) 
delbrueckii 
subspecies 
bulgaricus 
 Protexin (International Animal Health Products, 
Huntingwood, Australia) 
(Daskiran et al., 2012) 
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Genus Species Strains Commercial products containing the species References 
farciminis  Enviva MPI (DANISCO Animal Nutrition, Wiltshire, UK)  
fermentum JS JSA-101 Gold (Well-being LS Co. Ltd., Gangwon, Korea) (Bai et al., 2013) 
gallinarum I 16, I 26, LCB 
12 
 (Mookiah et al., 2014, Ohya et al., 
2000) 
jensenii   (Sato et al., 2009) 
paracasei   (Bomba et al., 2002) 
plantarum  Microguard (PeterLab Holdings, Negeri Sembilan, 
Malaysia), Protexin (International Animal Health Products, 
Huntingwood, Australia), UltraCruz (Santa Cruz Animal 
Health, Paso Robles, USA), Probios (Chr Hansen, 
Hørsholm, Denmark) 
(Rahman et al., 2013, Daskiran et 
al., 2012, Peng et al., 2016) 
reuteri 514, C 1, C10, 
C16, DSM 
16350, DSM 
16350 
PoultryStar ME (BIOMIN GmbH, Getzersdorf, Austria) (Giannenas et al., 2012, Mookiah et 
al., 2014, Mountzouris et al., 2010, 
Wideman Jr et al., 2012) 
rhamnosus   Protexin (International Animal Health Products, 
Huntingwood, Australia), Enviva MPI (DANISCO Animal 
Nutrition, Wiltshire, UK) 
(Daskiran et al., 2012, 
Hashemzadeh et al., 2013) 
lactis  Probios (Chr Hansen, Hørsholm, Denmark)  
salivarius DSM 16351, I 
24 
FloraMax-B11 (Pacific Vet Group, Fayetteville , USA), 
PoultryStar ME (BIOMIN GmbH, Getzersdorf, Austria) 
(Biloni et al., 2013, Mookiah et al., 
2014, Mountzouris et al., 2010) 
sobrius    (Konstantinov et al., 2008) 
Lactococcus lactis  CECT 539  (Fajardo et al., 2012) 
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Genus Species Strains Commercial products containing the species References 
Megasphaera  elsdenii   (Seo et al., 2010) 
Pediococcus acidilactici DSM 16210 All-Lac (Alltech Inc., Nicholasville, USA), PoultryStar ME 
(BIOMIN GmbH, Getzersdorf, Austria) 
(Pedroso et al., 2013, Mountzouris 
et al., 2010, Wideman Jr et al., 
2012) 
parvulus  FloraMax-B11 (Pacific Vet Group, Fayetteville,  USA) (Biloni et al., 2013) 
Prevotella  bryantii   (Seo et al., 2010) 
Propionibacterium  
 
shermanii   (Seo et al., 2010) 
freudenreichii   (Seo et al., 2010) 
acidipropionici   (Seo et al., 2010) 
jensenii   (Seo et al., 2010) 
Saccharomyces  bourlrdii  Microguard, (PeterLab Holdings, Negeri Sembilan, 
Malaysia) 
(Rahman et al., 2013) 
cerevisiae KCTC No.7193 JSA-101 Gold, Super-CyC (Choong Ang Biotech Co. Ltd., 
Gyeonggi, South Korea) 
(Bai et al., 2013, Shim et al., 2012, 
Abdel-Rahman et al., 2013) 
servisia  Bro-biofair (Vitality Co., Egypt) (Abdel-Raheem et al., 2012) 
Streptococcus  faecalis   (Haghighi et al., 2008) 
faecium  Microguard (PeterLab Holdings, Negeri Sembilan, 
Malaysia), Avian PAC Soluble (Loveland Industries Inc., 
Colorado, USA) 
(Rahman et al., 2013, Morishita et 
al., 1997) 
gallolyticus  TDGB 406  (Kumar et al., 2014) 
salivarius ssp. 
thermophilus  
 Protexin (International Animal Health Products, 
Huntingwood, Australia) 
(Daskiran et al., 2012) 
bovis   (Seo et al., 2010) 
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4 Manufacture of probiotics 
4.1 Selection of microbial strains 
In addition to being non-pathogenic to animals, microorganisms used as probiotics are selected on 
the basis of their survival in the gastrointestinal environment and ability to withstand low pH and 
high concentrations of bile acids. In addition, the chosen strain should tolerate the manufacturing, 
transportation, storage and application processes, maintaining its viability and desirable 
characteristics (Collins et al., 1998). The capacity of potential probiotic microorganisms to 
withstand the gastrointestinal environment can be tested in vitro by challenging with low pH (Hood 
and Zoitola, 1988, Collado and Sanz, 2006). The capacity to tolerate an acidic environment and bile 
varies between strains (Mishra and Prasad, 2005). Another desirable characteristic is the ability to 
adhere to the intestinal epithelium, enabling the probiotic strain(s) to colonize the intestine (Guarner 
and Schaafsma, 1998). In addition, ability to grow rapidly on inexpensive media is a requisite 
(Collins et al., 1998) for economically viable production.  
Spore forming bacteria, particularly from the genus Bacillus, are increasingly being used as 
probiotics. Bacillus spores are resistant to physical and environmental factors, such as heat, 
desiccation and UV radiation (Setlow, 2006, Mason and Setlow, 1986, Nicholson et al., 2000, 
Cutting, 2011) enabling them to maintain their viability during feed pelleting, storage and handling. 
Bacillus lavolacticus DSM 6475, and two species (total four strains) of Sporolactobacillus (Sp. 
Inulinus and  Sp. laevus) were resistant to pH 3 and B. racemilacticus and B. coagulans were 
tolerant of bile (Hyronimus et al., 2000).  
4.2 Fermentation 
Fermentation techniques are used either to produce microbial cells in large quantity or to produce 
extracellular microbial products (e.g. food-grade lactic acid), enzymes, amino acids, vitamins and 
other pharmaceutical compounds.  
Animal studies have used probiotics cultured in the laboratory (Zhou et al., 2010, Shim et al., 
2012), or commercially available probiotics. Upscaling from the laboratory to a commercial product 
is not a trivial process and quality control is paramount for a beneficial product outcome.  
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4.2.1 Growth media 
Microorganism specific growth media, either synthetic or dairy based, are generally used to grow 
probiotics in an economically viable way (Muller et al., 2009). Approximately 30% of the total cost 
of fermentation is media cost (Rodrigues et al., 2006). Dairy based media have been preferred for 
production of human probiotics, with the use of dairy based foods such as yoghurt as the carrier. 
Some countries have legal requirements preventing the use of synthetic media for the production of 
human probiotics (Muller et al., 2009), but there are no such restrictions for fermentation media for 
the production of probiotics for animal use.  
Use of pure chemical substrates as carbon sources (Javanainen and Linko, 1995, Xiaodong et al., 
1997) for fermentation generally results in high quality products. However, agricultural and other 
industrial by-products are preferred substrates for fermentation because of reduced cost 
(Hofvendahl and Hahn–Hägerdal, 2000). For example, whey (Timmer and Kromkamp, 1994, 
Øyaas et al., 1996), molasses (Montelongo et al., 1993, Göksungur and Güvenç, 1997) and starch 
(Xiaodong et al., 1997) are popular substrates for industrial fermentation. Similarly, yeast extract 
and peptone are popular nitrogen sources in fermentation media (Chiarini et al., 1992). Yeast 
extract can be replaced with cheaper agricultural products (e.g. lentil flour) as nitrogen sources 
(Altaf et al., 2006). Feed grade vegetable proteins and food grade carbohydrates have also been 
used for production of commercial probiotics (European Food Safety Authority, 2008). However, 
media information is not available for most commercial probiotics. 
The ideal growth medium that maximises microbial growth can be very complex and expensive 
(Muller et al., 2009). Different probiotic strains generally require different media.  
4.2.2 Growth conditions 
Temperature and pH affect fermentation growth rates, which are species and strain dependent. 
Optimum temperatures for Lactobacillus strains varies between 25oC and 45oC (Hofvendahl and 
Hahn–Hägerdal, 2000). Similarly, optimal pH for the growth of probiotics also varies with 
microbial species and strain. In some cases, pH is set at the beginning of fermentation and allowed 
to drift (often decreasing due to the production of acids) while fermentation proceeds while in other 
cases pH is kept fairly constant by adding buffer (Hofvendahl and Hahn–Hägerdal, 2000, Muller et 
al., 2009).  
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4.2.3 Fermentation methods 
Probiotics can be produced by either batch or continuous fermentation. In the batch fermentation, 
all of the substrates (sterilized) and the inoculum are mixed together in the fermenter at the 
beginning and kept at the optimum temperature for the growth of the probiotic. In fed-batch 
fermentation limiting nutrients can be added during the fermentation. The reduction of pH in the 
fermentation medium, to the level where it inhibits the rate of microbial growth, is one of the 
challenges with batch fermentation and is generally managed by adding a base or a buffer to the 
medium to maintain pH (Muller et al., 2009). After completion of the fermentation process, which 
is generally determined by measuring the concentration of probiotic in the fermenter, cells are 
recovered by centrifugation or filtration (Champagne et al., 2007). Obtaining a high cellular 
concentration while maintaining low viscosity is an important objective in optimizing the batch 
fermentation process, as high viscosity hinders the recovery of cells from the growth medium 
(Champagne et al., 2007). For spore-forming bacteria, vegetative cells are induced to sporulate, 
generally by limiting nutrient availability, before harvesting. Adjustment of pH is another method 
of triggering sporulation.  
With continuous fermentation, fresh growth medium is continuously added to the culture while 
bacterial cells and any inhibitory substances produced during fermentation are continuously 
removed so that continuous production of the probiotic can be maintained (Lamboley et al., 1997, 
Muller et al., 2009). Genetic drifts from mutation(s) or contamination with other bacteria occurring 
during the fermentation process are issues with continuous fermentation. Batch fermentation has 
been preferred because it is less costly than continuous fermentation (Muller et al., 2009).  
Doleyres et al. (2004) developed a two-stage fermentation system as used in yoghurt production in 
a laboratory trial where the inoculum strain(s) was immobilised as a pure culture in 
carrageenan/locust bean gel beads which then released bacteria at a controlled rate into the linked, 
continuous fermentation reactor to produce probiotics containing the required ratio of Lactococcus 
lactis subsp. lactis biovar. diacetylactis MD and B. longum ATCC 15707 cells but this ratio could 
not be maintained.  
4.3 Drying 
After fermentation the bacterial and yeast cells are usually dried for ease of transport and storage 
rather than needing the specialized facilities for storage and transport of liquid inoculants or frozen 
cells. Probiotic microorganisms are generally dried by freeze drying or spray drying (Muller et al., 
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2009), but vacuum drying and fluidized bed drying are also used. Maintaining cell viability during 
drying is critical for successful probiotic production (Meng et al., 2008). 
4.3.1 Freeze drying 
A two-step process of freezing and drying is used. The bacteria are first frozen by using liquid 
nitrogen or dry ice or refrigerated at -200 and then dried under high vacuum to reduce the moisture 
level to 4% or below (Ananta et al., 2004). During freezing, the process should be fast enough to 
prevent the formation of ice crystals inside the cell (Mazur, 1976). Although this is the best method 
to dry bacteria, in terms of maintaining viability, the high cost associated with the process often 
hinders its application (Chávez and Ledeboer, 2007).  
Similarly, yeast cultures have also been preserved and stored by freeze drying (Kawamura et al., 
1995). A modification of the standard freeze drying method involving evaporative cooling can 
preserve yeast cells for 30 years (Bond, 2007). In this method, a centrifugal head connected with a 
freeze dryer is used to initially dry the yeast culture mixed with lyoprotectant followed by 
secondary drying under vacuum using phosphorus pentoxide as a desiccant. Dehydration of yeast 
cells with successive reduction in pressure is a feasible alternative to freeze-drying (Rakotozafy et 
al., 2000). 
4.3.2 Spray drying 
Fine droplets of probiotic culture, atomized by spraying through a heated nozzle, are sprayed into 
the drying chamber against hot air (Knorr, 1998, Masters, 1972). The microorganisms (bacteria or 
yeast) are dried during the process and collected at the bottom of the chamber (Masters, 1972). The 
exposure to the high temperature during drying can kill a significant proportion of the vegetative 
cells, a major limitation (Elizondo and Labuza, 1974). However, the technique is popular because 
of the low cost of drying for the bulk production of probiotics. It is more suitable for drying spores 
as the probiotic product.  
Probiotic microorganisms are generally produced by a fermentation process with species and 
strain specific temperature and pH and mostly dried by a freeze-drying or spray drying process. 
Growth in inexpensive media is important for commercial production. Probiotics for animal 
nutrition need to maintain their viability during manufacturing, storage and handling and quality 
control is needed to ensure this. Probiotics are selected to presumably withstand the 
gastrointestinal environment and adhere to the intestinal epithelium. 
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5 Mode of probiotic action 
Please see section 2.3 in chapter 2. 
6 Probiotic application in different livestock production 
systems 
6.1 Probiotics in poultry nutrition 
Please see section 2.4 in chapter 2. 
6.2 Probiotics in pig nutrition 
Although banned in some countries including the EU, sub-therapeutic use of antibiotics in feed to 
prevent diarrhoea and improve performance is still common in the swine industry. Therefore, the 
substitution of probiotics to address the issue of antibiotic resistance is critical in pig production and 
reduction in the use of antibiotics in feed. For monogastrics, this substitution has been more 
extensively studied in poultry than in pigs.  
As with other livestock, it is difficult to make generalisations because of the variation in the 
microorganisms used, doses, duration of treatment and husbandry practices (Kenny et al., 2011).  
6.2.1 Growth rate and feed use efficiency 
Several probiotics have been used to enhance the performance of pigs (Table S2). In a large scale 
experiment in a high performing commercial setting, the commercial probiotic product BioPlus 2B 
containing B. subtilis and B. licheniformis was a viable substitute for AGPs (neomycin, 
oxytetracycline, tylosine etc.) without a decrease in weaned pig performance; and with no increase 
in production costs (Kritas and Morrison, 2005). BioPlus 2B also improved weight gain by up to 
8% and feed use efficiency by up to 10% in grower and finisher pigs in a dose dependent manner 
(Alexopoulos et al., 2004b). For doses of 0.64, 1.28 and 1.92 × 106 cfu/g of feed, the daily gain 
increased with dose rate. Guo et al. (2006) also found B. subtilis MA139 effective in significantly 
improving FCR. Kyriakis et al. (1999) reported that average daily gain in post weaning piglets was 
increased by 99% over a period of 28 days when the piglets diet was supplemented with spores of 
B. licheniformis at the rate of 107  spores per gram of feed. Feed use efficiency was improved by 
24%. In a recent study, the commercial probiotic product Toyocerin containing Bacillus toyonensis 
given to post-weaning piglets at the rate of 1.24x106 cfu per gram of feed improved average daily 
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gain by 5% over the 42 day experimental period (Kantas et al., 2015). Average daily feed intake 
was increased by 1.7% and feed use efficiency was improved by 4.7% over the same period.  In 
contrast, another commercial probiotic product MicroSource “S,” (Agtech Products Inc.) containing 
B. licheniformis and B. subtilis did not improve growth rate or feed intake (Davis et al., 2008) when 
fed at the very high dose rate of 1.47 × 108 cfu/g feed but did significantly improve feed use 
efficiency by 3%.  
Supplementation of weaned pigs with 2 × 109 cfu/kg feed with S. cerevisiae sub. boulardii CNCM 
I-1079 for 6 weeks followed by 1 × 109cfu/kg feed of P. acidilactici CNCM MA 18/5 M for 
3weeks significantly improved the FCR without affecting intestinal structure (villus height, crypt 
depth, the goblet cell number and the thickness of the mucus layer) (Le Bon et al., 2010). In 
contrast, Van Heugten et al. (2003) did not observe any positive responses in growth or nutrient 
digestibility when S. cerevisiae SC47 was added to a pig diet at a rate of 1.6 × 107 cfu/g of feed.  
Table S5: Probiotic effects on performance of pigs 
 
Microorganisms 
Growth rate 
(ADG) 
 
FCR 
Feed 
intake 
Age group 
 
Reference 
B.  subtilis  and C.  
butyricum  
S (+) S (-) NS Growing-
finishing pigs 
(Meng et al., 2010) 
L. acidophilus,  
S.  cerevisae and 
B.  subtilis   
S (+) NS NS Growing pigs (Chen et al., 2005) 
L. plantarum 
ATCC 4336,  
L. fermentum 
 DSM   20016   
and   E.   faecium   
ATCC   19434   
S (+) NS - Weaned 
piglets 
(Veizaj-Delia et al., 2010) 
E. faecium EK13 NS - - Newborn   
piglets 
(Strompfova et al., 2006) 
Bi.  longum  
(AH1206) 
NS NS - Neonatal 
piglets 
(Herfel et al., 2013) 
B. licheniformis S (+) S (-) - Weaned 
piglets 
(Kyriakis et al., 1999) 
B. subtilis and B. 
licheniformis 
S (+) S (-) NS Growing pigs (Kritas et al., 2000) 
B. subtilis and B. S (+) S (-) NS Grower (Alexopoulos et al., 2004b) 
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licheniformis finisher pigs  
B. subtilis MA139 NS S (-) NS Weaned 
piglets 
(Guo et al., 2006) 
Bacillus 
toyonensis 
S (+) S (-) S (+) Weaning 
piglets 
(Kantas et al., 2015) 
B. licheniformis 
and B. subtilis 
NS S (-) NS Growing-
finishing pigs 
(Davis et al., 2008) 
S. cerevisiae sub. 
boulardii CNCM 
I-1079 
- S (-) - Weaned 
piglets 
(Le Bon et al., 2010) 
S (+) = significantly increased, S (-) = significantly decreased, NS = non-significant, - = not studied, ADG 
= average daily gain, FCR = feed conversion ratio 
Similarly, probiotic L. sobrius DSM 16698 was effective in improving average daily gain by 74%  
with 6% increase in feed intake in piglets infected with enterotoxigenic E. coli and also fed the 
probiotic at the high rate of 1010 cfu/animal/day (Konstantinov et al., 2008). In another experiment, 
final body weight was not improved when L. amylovorus and E. faecium were fed at the rate of 
3x108 cfu/animal/day (Ross et al., 2010). However feed intake was significantly reduced with 
improvement in feed use efficiency by 15% to 42% during different periods of the experiment. 
Likewise, application of E. faecium to primiparous sows at 5 × 108 cfu/kg feed, increased feed 
intake and improved reproductive performance (Böhmer et al., 2006). 
Use of different strains and doses of microorganisms and differences in husbandry practices 
(nutrition, housing etc.), and age of pigs and feed type may explain contrasting results with the 
same species of probiotic microorganisms.   
Probiotics can enhance the growth of pig but with less consistent results than for poultry.  
6.2.2 Health 
Adding the commercial probiotic containing B. licheniformis and B. subtilis spores (BioPlus 2B) to 
the diet of weaned, grower and finisher pigs at the rate of 0.64 – 1.28  × 106 cfu/g feed significantly 
reduced morbidity and mortality (Alexopoulos et al., 2004b). The same combination of probiotics 
when fed to pregnant sows from two weeks prior to expected farrowing date and during lactation 
improved the performance of the litter with reduced piglet diarrhoea, reduced pre-weaning mortality 
and increased body weight at weaning (Alexopoulos et al., 2004a). Decreased weight loss in sows 
during lactation and production of milk with higher fat and protein content were suggested reasons 
for the improved health and performance of the piglets.  
 218 
Probiotics inhibits the adhesion of enteric pathogens in intestinal mucosa. Bi. lactis Bb12 and L. 
rhamnosus LGG individually or in combination inhibited adhesion of pathogens (Salmonella, 
Clostridium, and E. coli) to the intestinal mucosa collected from young healthy pigs in an in vitro 
experiment (Collado et al., 2007). Adhesion of pathogens was measured by using radioactively 
labelled microorganisms and measuring radioactivity before and after adhesion to the intestinal 
mucosa. However, Szabo et al. (2009) found that E. faecium NCIMB 10415 treatment did not 
improve the clinical signs in pigs experimentally infected with S. enterica serovar typhimurium 
DT104.  
Post weaning diarrhoea, caused mainly by enterotoxigenic E. coli, is one of the major health 
problems in swine worldwide causing substantial economic losses due to mortality, reduced growth 
rate and associated veterinary costs (Fairbrother et al., 2005). Probiotics reduced the incidence and 
severity of post weaning diarrhoea in pigs. Supplementation of weaned piglet diets with B. 
licheniformis spores at the rate of 106 and 107 cfu/g of feed significantly reduced post weaning 
diarrhoea and associated mortality (Kyriakis et al., 1999). Performance of piglets fed the higher 
dose (107 cfu/g) of probiotics was better than those fed the lower dose. In another study, the 
incidence of post-weaning diarrhoea decreased following the addition of B. toyonensis to the diet of 
pregnant sows from 90 days before farrowing to 28 days postpartum and in the diet of piglets from 
days 15 to 56 (Taras et al., 2005). Kantas et al. (2015) also demonstrated the beneficial effects of B. 
toyonensis (commercialised as Toyocerin) to reduce the enteric pathogen load and diarrhoea in post 
weaning piglets. 
Probiotics reduced intestinal colonization by pathogenic E. coli and prevented or reduced the 
severity of the intestinal infection. The level of enterotoxigenic E. coli in the ileum of 
experimentally infected piglets after weaning was significantly lowered by treating with L. sobrius. 
(Konstantinov et al., 2008). L. paracasei mixed with maltodextrin also reduced intestinal 
colonization by E. coli in piglets raised in an apparently sterile environment (Bomba et al., 2002). 
Similarly, translocation of pathogenic E. coli to mesenteric lymph nodes was reduced in pigs treated 
with P. acidilactici and S. cerevisiae ssp. boulardii and then challenged with pathogenic E. coli 
(Lessard et al., 2009). Positive effects on intestinal barrier function may be the possible mode of 
action for these probiotic effects.  
Le Bon et al. (2010) found a dramatic reduction in the level of E. coli after four weeks of treatment 
with S. boulardii and P. acidilactici in weaned piglets. Similarly, E. faecium added to pig diets 
controlled post weaning diarrhoea and mortality due to E. coli infection (Underdahl et al., 1982, 
Taras et al., 2006, Zeyner and Boldt, 2006). 
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Probiotics can be effective in reducing post weaning diarrhoea in piglets and morbidity and 
mortality in pigs.  
6.2.3 GIT microbial population 
A single large dose (5x109 or 5x1010) of L. plantarum (DSMZ 8862 and 8866) given to piglets one 
week before weaning or at weaning resulted in a significant change in the microbial population of 
the small and large intestines (Pieper et al., 2009). However, the observations were only made at 2 
weeks post treatment and did not explore the long-term effects of the single administration. In 
another study, the probiotic L. paracasei mixed with fructo-oligosaccharides increased populations 
of Lactobacillus spp., Bifidobacterium spp., total anaerobes and total aerobes and decreased 
Clostridium and Enterobacterium in faeces of weanling pigs (Bomba et al., 2002). Similarly, S. 
cerevisiae and P. acidilactici produced a temporary (about two weeks) reduction in the population 
of E. coli and other coliforms in pig faeces after application of probiotics for four weeks at 2×109 
cfu/kg feed (Le Bon et al., 2010). However in other trials, inclusion of a yeast probiotic (S. 
cerevisiae) did not change the populations of E. coli, Streptococcus, Lactobacillus and total 
culturable yeast in the GIT, as it did in some earlier feeding trials (Mathew et al., 1998, Li et al., 
2006). Nevertheless, pigs fed the probiotics performed better in terms of body weight gain and feed 
use efficiency in these experiments. Enhancement in performance in probiotic fed animals is 
apparently not necessarily associated with a change in the gastrointestinal microbial population that 
can be cultured. However, sequencing of the GIT microbial DNA indicates that the microbiome 
diversity is dominated by microbial species that have not yet been cultured.  
In pigs probiotics increased lactic acid bacteria and decreased Clostridium, E. coli and 
Enterobacterium spp. in the GIT. 
6.3 Probiotics in ruminant nutrition 
The rumen has a complex microbial ecology where polysaccharides and protein ingested by the 
host are degraded by rumen microorganisms resulting in the synthesis of SCFA and microbial 
protein which are used by the host as energy and protein sources. There is increasing international 
interest in manipulating the rumen ecosystem to increase the efficiency of the ruminal fermentation 
processes to improve animal productivity and reduce unwanted by-products like methane.  
Yeast (S. cerevisiae) is a commonly used probiotic in ruminants (Chaucheyras-Durand et al., 2008) 
affecting mainly the microbial population dynamics in the rumen  and the breakdown of nutrients. 
Lactic acid producing bacteria are another important group of probiotics.  
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Apart from the use of probiotics in formulated animal feed, beneficial bacteria used as silage 
inoculants may also have a probiotic effects in the rumen (Weinberg et al., 2004). However, this 
response depends on the survival of the silage inoculant in the silage as the pH drops. 
6.3.1 Milk yield 
Probiotics can improve the milk yield in dairy animals. Milk yield was increased by 2.3 litre per 
cow per day following dietary supplementation with 5×109 cfu of E. faecium and 2×109 yeast 
cells (S. cerevisiae) per cow per day (Nocek and Kautz, 2006). Weiss et al. (2008) found that dairy 
cattle fed the probiotic Propionibacterium strain P169 had the same milk production as control 
animals but with decreased feed consumption, resulting in 4.4% increase in energy efficiency. 
Dietary supplementation with a combination of L. acidophilus NP51 and P. freudenreichii NP24 (4 
× 109 cfu/animal/day) resulted in a 7.6% increase in average daily milk yield in Holstein cows 
(Boyd et al., 2011). Average milk yield per day increased by c.14% compared to non-treated, 
lactating Saanen dairy goats receiving S. cerevisiae at the rate of 4 × 109 cfu/day/animal (Stella et 
al., 2007). 
Desnoyers et al. (2009) undertook a quantitative meta-analysis of 110 papers, 157 experiments and 
376 treatments, studying the effects of yeast probiotics (containing at least one strain of S. 
cerevisiae) in ruminants (cattle, goats, sheep, and buffaloes) on feed intake, milk production and 
rumen fermentation. Supplementation with live yeast probiotics increased milk yield by about 1.2 
g/kg body weight. Dry matter intake by the animals was increased by 0.44 g/kg of body weight. 
Overall the effect on milk yield was significant, but the results were highly variable and the 
economic benefits were not analyzed. There was no effect on milk protein content. A similar meta-
analysis by Poppy et al. (2012) concluded that commercial probiotics containing S. cerevisiae 
increased milk yield by 1.18 kg/d, fat-corrected milk by 1.61 kg/d and energy-corrected milk by 
1.65 kg/d. Similarly, dietary supplementation of S. cerevisiae increased milk fat yield by 0.06 kg/d 
and milk protein yield by 0.03 kg/d. Dry matter intake was increased by 0.62 kg/d during early 
lactation and 0.78 kg/d during late lactation. Increased feed intake together with improved microbial 
digestion (also see section 7.3.3) of feed could be the possible mode of action for improved animal 
performance.   
In contrast, Krishnamoorthy and Krishnappa (1996) did not find any differences in dry matter 
intake, body weight gain, milk yield and milk composition when yeast was added in the diet based 
on finger millet (Eleusine coracana) straw of lactating crossbred cattle.  
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6.3.2 Growth 
Probiotics can increase the weight gain of ruminants. For example, a probiotic containing a mixture 
of microorganisms (L. reuteri DDL 19, L. alimentarius DDL 48, E. faecium DDE 39 and Bi. 
bifidium DDBA) isolated from a healthy goat, when fed to goats for eight weeks, commencing at 75 
days of age, resulted in improvement in average body weight by 9% (Apás et al., 2010). Similar 
improved growth rate was obtained with a yeast-based commercial probiotic containing S. 
cerevisiae given to growing dairy heifers (Ghazanfar et al., 2015). B. amyloliquefaciens strain H57 
when fed to pregnant White Dorper ewes on a palm kernel based diet, increased DM intake and live 
weight gain during pregnancy followed by better performance of the lambs during early lactation 
(Le et al., 2014, McNeill et al., 2016). The same strain of B. amyloliquefaciens when fed to dairy 
calves at the rate of 3.16 x 108 cfu per kg dietary DM from week 4 to 12 improved growth rate by 
39% (551 vs 767 g/d), increased feed use efficiency by 14% (2.5 vs 2.9 kg milk + starter DM/kg 
weight gain) (Le et al., 2016). Likewise, a novel bacterial strain isolated in Australia, P. jensenii 
702, significantly enhanced weight gain in Holstein calves by 25% during pre-weaning period and 
by 50% during the weaning period (Adams et al., 2008).  
Frizzo et al. (2011), based on meta-analysis of 21 publications between 1985 and 2010, concluded 
that lactic acid probiotic bacteria in comparisons with and without L. acidophilus; L. plantarum; L. 
salivarius; E. faecium; L. casei/paracasei; Bifidobacterium spp., increased body weight gain 
(standardized mean difference = 0.22822,  95% confidence interval = 0.1006 to 0.4638) and 
improved feed use efficiency (standardized mean difference = −0.8141, 95% CI = −1.2222 to 
−0.4059) in young calves compared to control groups when probiotics were added to milk replacer 
but were ineffective when added to whole milk. In contrast, some studies have reported no effect on 
calf growth when the diet was supplemented with L. acidophilus (Cruywagen et al., 1996, Abu-
Tarboush et al., 1996), mixture of L. acidophilus and Streptococcus faecium (Higginbotham and 
Bath, 1993), mixture of L. acidophilus and L. plantarum (Abu-Tarboush et al., 1996), B. subtilis  
(Galina et al., 2009), mixture of L. acidohilus, L. lactis, and B. subtilis (Galina et al., 2009).   
Quality control of the probiotics strain production and subsequent shelf viability is a critical 
component of trials assessing the affect they have when fed and often in nutrition trials this is 
inadequately dealt with and could be a reason for the variability in animal response between trials. 
6.3.3 Nutrient digestibility 
The improvement in performance by ruminants is often associated (at least partially) with 
improvement in nutrient digestibility. A combination of L. acidophilus NP51 and P. freudenreichii 
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NP24 improved the digestibility of crude protein, neutral detergent fiber and acid detergent fiber in 
lactating Holstein cows resulting in increased milk production per day by 7.6% without increase in 
dry matter intake (DMI) (Boyd et al., 2011) suggested to be due to a change in the rumen microbial 
ecosystem.. Similarly, supplementation of dairy cows with Probios TC containing 2 strains of 
Enterococcus faecium at the rate of 5x109 cfu per day as well as 2x109 viable yeast cells per day 
from 21 days prior to expected calving date through 10 week postpartum, increased milk production 
by 2.3 kg per cow per day, with no difference in 3.5% fat corrected milk.   The E. faecium strains 
were thought to act by producing lactic acid which supported a rumen microbial population which 
increased ruminal digestion of roughages in the corn silage and haylage diet as well as increasing 
DMI  (Nocek and Kautz, 2006). In contrast, Hristov et al. (2010) did not find any improvement in 
digestibility of corn silage based diet from supplementation with a yeast (S. cerevisiae) probiotic in 
Holstein cows. Although the yeast supplementation increased ruminal microbial protein synthesis, 
there was no difference in dry matter intake, milk yield and milk composition.  
Based on a meta-analysis of papers published on the effects of yeast probiotics in all ruminant 
species reared for milk or meat, Desnoyers et al. (2009) found much variability in response with an 
overall average increase in DM intake by 0.44 g/kg body weight and total tract organic matter 
digestibility by 0.8%, effects too small to warrant probiotic addition. However particular strains, 
increasing levels of inoculum addition, and feed compositions with a larger proportion of 
concentrates have produced a better response than this average. Improvement in microbial digestion 
of feed may be either due to production of enzymes by probiotics or alterations in rumen microbial 
ecology.  
Probiotics improve productivity; increase milk yield, induce better nutrient digestion and enhance 
growth rate in ruminants.  
6.3.4 Health 
Apart from their use in improving the performance of ruminant animals, probiotics have been 
effective in improving animal health. Apas et al. (2010) demonstrated that a probiotic containing L. 
reuteri DDL 19, L. alimentarius DDL 48, E. faecium DDE 39 and Bi. bifidum DDBA (at the ratio 
of 1:1:1:1), isolated from the faeces of healthy goats, when fed to weaned goats (dose rate of 2x109 
cfu/animal/day) reduced the number of pathogenic bacteria (Salmonella and Shigella) in faeces.  
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6.3.4.1 Rumen acidosis 
The pH of the rumen may drop below the optimum range, following consumption of a diet with a 
high proportion of non-structural carbohydrates (starch) and/or decreased proportion of fibre 
(Duffield et al., 2004); short chain fatty acid (SCFA) accumulate and unbalance the buffering 
capacity of the rumen (Plaizier et al., 2008). The condition is referred to as sub-acute ruminal 
acidosis (SARA) when the pH decreases below 5.6 and remains between 5.2 and 5.6 for at least 3 
hours per day (Gozho et al., 2005). This condition is economically very important as milk 
production by the suffering animal is reduced due to loss of appetite, diarrhoea, dehydration, 
debilitation, impaired rumen motility and impaired fibre digestibility (Duffield et al., 2004, Plaizier 
et al., 2008). Lactic acidosis is the more severe form of ruminal acidosis where the pH drops below 
5.2 due to accumulation of lactate (Owens et al., 1998). 
Probiotics are effective in preventing or treating ruminal acidosis. Application of 
Propionibacterium P63, L. plantarum strain 115 and L. rhamnosus strain 32 to the rumen directly 
via a rumen cannula at the rate of 1 × 1011 cfu/animal/day, a very high dose, was effective in 
stabilizing rumen pH and preventing acidosis artificially induced by three days of concentrate 
challenge (wheat, corn or beet pulp) in sheep (Lettat et al., 2012). It was hypothesized that stability 
in ruminal pH was achieved by the probiotics modulating rumen microbes so that their capacity to 
hydrolyse cellulose was increased and lactic-acid producing bacteria were inhibited. Similarly, the 
lactate utilising bacteria, Megasphaera elsdenii (Prabhu et al., 2012) was effective in preventing 
lactic acid accumulation during in vitro fermentation (Kung and Hession, 1995). Klieve et al. 
(2003) demonstrated that the probiotic M. elsdenii strain YE34 could be established in the rumen of 
cattle fed high grain diets, inducing the establishment of lactic acid-utilizing bacteria some 7-10 
days earlier than in non-inoculated cattle. Interestingly, ruminants fed high grain diet (barley) have 
Ruminococcus bromii as a dominant bacterial population in the rumen and this bacterium has been 
suggested as a potential probiotic to enhance the efficiency of starch utilization in grain fed cattle 
(Klieve et al., 2007). Similarly, yeast S. cerevisiae decreased the lactic acid concentration in the 
rumen of lactating Holstein cows (Marden et al., 2008), which may prevent ruminal acidosis 
(Thrune et al., 2009). In contrast, Hristov et al (2010) found no effect of  S.  cerevisiae culture, 
containing  metabolites of yeast fermentation, on ruminal fermentation.  
Even though probiotics were found effective to prevent rumen acidosis, it has been difficult to 
establish stable populations of potential probiotics in the rumen. Chiquette et al. (2007) tried to 
establish Ruminococcus flavefaciens NJ by adding the bacterium with the probiotic yeast S. 
cerevisiae hoping it would stabilize ruminal conditions to favour the establishment of the inoculated 
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bacteria. Similarly, Ruminococcus bromii YE282 was inoculated with Megasphaera elsdenii YE34 
as an alternative starch utilizing bacterium in steers (Klieve et al., 2012). There was no effect on 
acidosis and only M. elsdenii YE34  established in the rumen environment. However, Jones and 
Megaritty (Jones and Megarrity, 1986) successfully introduced and established an exogenous 
microbe Synergesties jonesii (Allison et al., 1992) in the rumen of goat and subsequently cattle 
(Pratchett et al., 1991, Jones et al., 2009) which at the time was believed to prevent toxicity due to 
the amino acid mimosine when leaves of the leguminous shrub Leucaena are used as fodder.  But 
another mechanism may be a buildup of tolerance to mimosine and its toxic breakdown product 
3,4-dihydroxypyridine  and its detoxification in the liver (Halliday et al., 2013). 
 
6.3.4.2 Reduced shedding of E. coli O157:H57 
E. coli O157:H57, the Shiga-toxin producing E. coli, is an important zoonotic pathogen causing 
haemorrhagic diarrhoea and haemolitic uremic syndrome (HUS) which can result in acute kidney 
failure in children (Karmali et al., 2010). Contamination of animal products (meat, milk, egg) from 
infected animals with this pathogen is a serious public health issue. Wisener et al. (2014) undertook 
a meta-analysis of the effect of probiotics in reducing the shedding of E. coli O157:H57 in beef 
cattle and found both the long (> 90 days) and short (< 90 days) term applications were effective. 
The combination of L. acidophilus and P. freudenreichii was the most effective probiotic treatment 
while a dose rate of 109 cfu/animal/day was more effective than lower dose rates. Earlier studies had 
also found that a combination of L. acidophilus and P. freudenreichii significantly reduced faecal 
shedding of O157 in cattle (Sargeant et al., 2007). 
Similarly, Ohya et al. (2000) developed a probiotic containing S. bovis LCB6 and L. gallinarum 
LCB 12, isolated from adult cattle, that was effective in eliminating the shedding of O157. They 
postulated that a significantly increased concentration of SCFA, particularly acetic acid, in the GIT 
could be the reason for the inhibition of O157.  
6.3.4.3 Calf scours 
Stress in young calves frequently leads to scours or diarrhoea and weight loss. The stressors are 
often animal husbandry practices including weaning, vaccination, dehorning, castration, tagging etc. 
or high temperature. In addition, the rumen and its microbial population are not fully-developed and 
functional in the early days of life.  
Probiotics can reduce such problems in young calves, but results were variable. The effect of the 
probiotic L. acidophilus in reducing the incidence of diarrhoea in young dairy calves was reported 
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as early as 1977 (Bechman et al., 1977). Other studies using LAB probiotics, also obtained a 
reduced incidence of diarrhoea in calves (Abe et al., 1995, Abu-Tarboush et al., 1996, Jatkauskas 
and Vrotniakiene, 2010). Similarly, the incidence of diarrhoea per calf, the duration of each event of 
diarrhoea and total number of days of diarrhoea in dairy calves from week 4 to 12 raised in sub-
tropical summer was significantly reduced by dietary supplementation of B. amyloliquefaciens 
strain H57 (Le et al., 2016). In contrast, Cruywagen et al. (1996) did not find a reduced incidence of 
diarrhoea, when young dairy calves were fed L. acidophilus with milk replacer at the rate  of 108 
cells per animal per day. However, the probiotic did prevent weight loss in the treated calves, while 
the control calves lost weight. Riddell et al. (2010) also found no effect on the incidence and 
duration of diarrhoea in young calves from feeding with milk replacer the commercial probiotic 
(Bioplus 2B) containing B. licheniformis (DSM 5749) and B. subtilis (DSM 5750). Stress in 
animals causing dysbiosis or microbial imbalance in the GIT may be needed for the probiotic to 
benefit calf health.  
Probiotics can reduce diseases of ruminants particularly those related to the disturbance of rumen 
pH (e.g. acidosis), calf scours and pathogenic E. coli. Probiotics are believed to stabilize ruminal 
pH by modulating rumen microbes. Lactate utilizing bacteria (e.g. Megasphaera elsdenii) could 
potentially be used to prevent the accumulation of lactic acid in the rumen. However, the 
establishment of such microorganisms in the rumen is difficult. Similarly, probiotics are effective in 
reducing the incidence of calf scours by preventing ruminal dysbiosis. Probiotics are also effective 
in reducing the faecal shedding of the shiga-toxin producing E. coli O157:H57. However, these 
responses to use of probiotics are highly variable and reflect differences in microorganisms 
(species, strains) used as probiotics and differences in animal husbandry practices (nutrition, 
housing etc.). 
6.3.5 Rumen fermentation 
The meta-analysis of the application of yeast probiotics (containing at least one strain of S. 
cerevisiae) in ruminants by Desnoyers et al. (2009) demonstrated that live yeast significantly 
increased rumen concentrations of SCFA and increased rumen pH, but the results were highly 
variable. Although yeast supplementation moderately decreased rumen lactic acid concentration, 
there was no effect on the acetate to propionate ratio. However, the effect of yeast supplementation 
on rumen fermentation varied with the proportion of concentrate in the diet. In general, “The 
positive effect of yeast supplementation on rumen pH increased with the percentage of concentrate 
in the diet and with the Dry Matter Intake (DMI) level” (Desnoyers et al., 2009). Similarly, yeast 
probiotics increased the concentration of SCFA with increased CP concentration and DMI 
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(Desnoyers et al., 2009). The higher the proportion of concentrate and neutral detergent fibre in the 
diet, the better the digestibility of organic matter resulting from the live yeast supplementation 
(Desnoyers et al., 2009).  
It has been postulated that yeast based probiotics in ruminants increase the number of cellulolytic 
bacteria which affects the microbial fermentation resulting in higher cellulose degradation and 
increased microbial protein production (Dawson et al., 1990, Newbold, 1996, Chaucheyras-Durand 
et al., 2008). 
Using quantitative real-time PCR, Ding et al. (2014) demonstrated that S. cerevisiae increased the 
total number of rumen bacteria in crossbred steers fed alfalfa mixed with concentrates, but the 
number of rumen fungi and protozoa did not change. The percentage of Selenomonas ruminantium, 
a lactate utilizing bacterium, increased while the percentage of Ruminobacter amylophilus, a starch-
degrading bacterium, decreased.  
Saccharomyces cerevisiae based probiotics affect rumen fermentation resulting in an increased 
concentration of SCFA and increase in rumen pH with moderate reduction in rumen lactic acid 
concentration. These probiotics generally increase the population of cellulolytic bacteria which 
may result higher cellulose degradation. Generally, the greater the proportion of concentrates in 
the diet, the more beneficial the administration of yeast to ruminants. With the intensification of the 
animal production system, use of concentrate has increased. In this context, probiotics may 
increasingly become a component in intensive ruminant production systems.  
6.3.6 Probiotics with roughage based diet 
Most ruminant animal production occurs on low quality roughage and the improvement of 
digestibility with the use of probiotics is of much interest, even though at present it is only animals 
fed high quality diets where probiotics could be readily applied.  
Yeast probiotics can increase the population of cellulolytic bacteria in the rumen(Dawson et al., 
1990, Harrison et al., 1988) which may result in an increased rate of fibre digestion and increased 
microbial protein turnover, hopefully  improving animal performance(Newbold, 1996). However, 
increase in cellulolytic bacteria may not always result in increased fibre digestion as their activity 
depends on rumen pH (Russell and Wilson, 1996). Dawson et al. (1990) found an increase in the 
population of cellulolytic bacteria in the rumen of Jersey steers, when a high roughage based diet 
was supplemented with either S. cerevisiae or a combination of S. cerevisiae, L. acidophilus, and E. 
faecium.  
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The effects of yeast on rumen fermentation in animals with roughage-based feed are variable. 
Dietary inclusion of S. cerevisiae and/or Armillaria heimii (white rot fungi) in sheep increased the 
dry matter intake, metabolisable energy intake and digestibility of neutral detergent fibre(Mpofu 
and Ndlovu, 1994). Potentially digestible neutral detergent fibre, crude protein and dry matter of 
alfalfa hay, cornstalk and coffee hull fed to fistulated Holstein steers was increased with the 
supplementation of S. cerevisiae (Roa et al., 1997). In contrast, addition of yeast to cattle fed a high 
fibre (barley straw based) diet (Moloney and Drennan, 1994) or high grain diet (Mir and Mir, 1994) 
did not affect the digestibility of dry matter and neutral detergent fibre and decreased the 
digestibility of crude protein. Supplementing a sugar cane tops based diet for sheep with yeast did 
not improve rumen fermentation and digestibility although rumen pH decreased (Arcos-Garcı́a et 
al., 2000).  
Although probiotics especially Saccharomyces cerevisiae can improve digestibility of low quality 
roughage by ruminants, the results are inconsistent. Further study with a wider selection of well 
characterised probiotic microorganisms (including bacteria) and animal feed constituents, 
including non-conventional feed resources like agricultural by-products, is needed to assess the 
benefits. 
7 Safety of probiotics and potential public health risks  
The safety of probiotics is discussed in general terms and is not specific to those used in animal 
feed. The possibility of probiotics used in animal feed entering the human food chain cannot be 
ruled out. However, there is very little information available about the risk of human food 
“contamination” with probiotics used in animals.  
The microbial genera and species used as probiotics in animal feed are generally considered safe. 
The most serious risk posed by probiotic microbes in feed are i) transfer of antibiotic resistance due 
to the presence of transmissible antibiotic resistance genes/determinants in some probiotic bacteria 
and ii) infections from the probiotic microorganisms and presence of enterotoxins and emetic toxins 
in probiotic bacteria.  
Most publications relating to probiotics deal with their efficacy rather than safety. Most of the 
information about the safety of probiotics is based on Lactobacillus and Bifidobacterium 
(Shanahan, 2012, Hempel et al., 2011). Therefore more research is required in relation to the safety 
of probiotics.  
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Shanahan (2012) highlights the limitations of claims made about the safety of probiotics in general 
and especially the safety of any particular probiotic. According to Shanahan (2012): 
1. Safety assessment and information on a particular probiotic strain cannot be generalized to 
similar probiotics (even with a different strain of the same species), as each probiotic 
requires safety and risk assessment on a case-by-case basis.  
2. The adverse effects and the severity of the effects of a probiotic could be context specific 
and depend on the susceptibility (immunity) and physiological state of the host (animals or 
human). Therefore, probiotic strains deemed to be safe in certain conditions may not be safe 
in other conditions. For example, the prematurely born and immunologically compromised 
host could be at greater risk than the host born at term. 
3. No probiotic can be regarded as 100% safe or with zero risk as is the case with drugs.  
4. Public awareness about the risk from probiotics is limited and there is a need for proper risk 
benefit analysis and communication of this to the user/consumer of the probiotics.  
5. The contamination of probiotics with unwanted microbes or substances is an important 
safety and quality issue as with the safety and quality of probiotics microorganisms per se. 
Sometimes, hazards associated with contaminants may be a more important issue than the 
specific quality of the probiotics.  
In 2010, the Agency for Healthcare Research and Quality under the U.S. Department of Health and 
Human Services conducted a systematic study of published data and information on the safety of 
probiotics. The study concluded that “there is a lack of assessment and systematic reporting of 
adverse events in probiotic intervention studies, and interventions are poorly documented” (Hempel 
et al., 2011). Although there are many publications on the safety of probiotics, the evidence 
available is not enough to address all the safety issues and precludes a declaration of probiotics as 
universally safe or unsafe (Hempel et al., 2011).  
Although microorganisms used as probiotics in animal feed are generally safe some of the bacterial 
species and/or strains pose risks mainly by transmission of antibiotic resistance to pathogenic 
microbes or production of enterotoxins (Anadón et al., 2006).  
7.1 Risk associated with probiotics 
Although microorganisms used as probiotics in animal feed are relatively safe, precaution should be 
taken to protect animals, humans and the environment from potentially unsafe microorganisms. 
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Theoretically, risks associated with the use of probiotics in animal feed are as follows (Marteau, 
2001, Doron and Snydman, 2015, FAO and WHO, 2002): 
1. Infection (gastrointestinal or systemic) of the animal fed the probiotic 
2. Infection (gastrointestinal or systemic) of the consumers of animal products produced by 
animals fed probiotics 
3. Transfer of antibiotic resistance from probiotics to other pathogenic microorganisms 
4. Release of infectious microorganisms or noxious compounds to the environment from the 
animal production system 
5. Infection (gastrointestinal or systemic) of the handlers of animal or animal feed 
6. Skin and/or eye and/or mucus membrane sensitisation in the handlers of probiotics 
7. Detrimental metabolic or toxic effects in the host due to the production of toxins by the 
microorganisms contained in probiotics  
8. Hyper-stimulation of the immune system in susceptible hosts 
 
7.1.1 Assessment of risk 
The microorganisms considered for use as probiotics in animal diets should be assessed against the 
above-mentioned risks. The microorganism under consideration need to be identified to strain level 
(Figure S1). The particular strain of microorganism should not have been associated with any 
infection in humans or animals. Similarly, the putative probiotic should not harbour transferable 
antibiotic resistance genes. Microorganisms which either produce toxins or cause hyper-stimulation 
of the immune system in the host are generally not suitable for probiotics.  
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Figure S1: Major questions to be addressed when assessing the safety of microorganisms being 
considered for use as probiotics in animal feed 
 
7.1.1.1 Qualified Presumption of Safety (QPS): European approach for the assessment of the 
safety of probiotics 
In 2002, a group of scientists, consisting of members of the former Scientific Committees on 
Animal Nutrition, Food and Plants of the European Commission, developed the concept of QPS to 
address a need for a tool which selectively prioritizes the assessment of risk of the use of a 
particular microorganism in food and feed (European Food Safety Authority, 2007). EFSA has been 
using this concept since 2007 as a generic risk assessment tool to assess the safety of a 
microorganism intended to deliberately enter the food chain. According to this concept, if 
microorganisms of certain predetermined taxonomic groups either do not pose any safety risk or 
risk can be clearly defined and eliminated, the group can be designated as a group with QPS status. 
Any particular microorganism intended to be introduced into the food chain, which can be 
unequivocally identified and have QPS status, may not be the subject of a detailed pre-market 
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safety assessment other than satisfying predetermined specific qualifications (European Food Safety 
Authority, 2007). Thus, resources (time and money) could be prioritized to those microorganisms, 
which do not fulfil the above mentioned qualifications and have an uncertain risk status, thus 
avoiding the need to investigate microorganisms with proven safety. Microorganisms, not listed as 
having QPS status, would undergo a detailed pre-market safety assessment. QPS status is only 
given to microorganisms but not to any product containing such microorganism (European Food 
Safety Authority, 2007). QPS status is maintained up to the species level.  
Safety assessment of a particular microorganism or a taxonomic group to decide QPS status is 
usually done on the basis of four pillars of QPS assessment (European Food Safety Authority, 
2007) as outlined in Figure S2. EFSA has listed more than 100 species of microorganisms under 
QPS status; which are broadly categorized into i) Gram-positive non-sporulating bacteria, ii) 
Bacillus species and iii) yeasts. 
 
Figure S2: Assessment of a microorganism or a taxonomic unit to assign QPS status  
 
Probiotic use is not without risk. Probiotics could be responsible for a range of hazards in animal 
health, human health and the environment ranging from mild reactions to serious life threatening 
infections. Moreover, information about safety of one particular microorganism should not be 
applied to other closely related microorganisms. Present levels of information are not sufficient to 
declare any group of probiotics 100% safe. Therefore, risk assessment on a case by case basis is 
recommended.  
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7.2 Safety of microbial genera commonly used as probiotics 
7.2.1 Lactobacillus and Bifidobacterium 
Lactobacillus and Bifidobacterium are probably the safest microorganisms used as probiotics 
because i) these microorganisms have been safely used traditionally in various fermented food 
(Shortt, 1999); ii) these microorganisms are naturally present in the GIT and other sites in humans 
(Human Microbiome Project Consortium, 2012, Huse et al., 2012) and animals (Yeoman and 
White, 2014, Yeoman et al., 2012) in large quantities; and iii) infections associated with these 
microorganisms are extremely rare (Gasser, 1994, Saxelin et al., 1996). L. acidophilus and L. 
bulgaricus have been categorized as “Generally Regarded as Safe” by US Food and Drug 
Administration (FDA) (USFDA, 2013). Nevertheless, LAB have been reported to cross the 
intestinal mucosal barrier resulting in bacteraemia and inflammation of the heart muscle 
(endocarditis) in susceptible people with compromised immunity (Soleman et al., 2003, Cannon et 
al., 2005, De Groote et al., 2005, LeDoux et al., 2006). However, the chance of this happening is 
extremely rare and reported to be less than 1 per 106 (Sanders et al., 2010). These rare incidences of 
lactobacillaemia can be very serious or even fatal (Saxelin et al., 1996, Husni et al., 1997).  
In a small number of cases, incidences of endocarditis and other internal infections characterized by 
internal inflammatory lesions (e.g. liver abscess) were reported to be associated with the 
consumption of large quantities of dairy products containing L. rhamnosus GG as a probiotic 
(Cannon et al., 2005, Rautio et al., 1999). However, the nature of risk from the probiotics used in 
animal diets and those from human food could be entirely different.  
It is often difficult to define the clinical significance of the occurrence of Lactobacillus in clinical 
specimens as mostly the infection is opportunistic due to compromised immunity of the host 
(European Food Safety Authority, 2007). Therefore, safety assessment tools may not be able to 
exclude these types of opportunistic infections (European Food Safety Authority, 2007). There are 
35 species of Lactobacillus included in the Qualified Presumption of Safety (QPS) list of the 
European Food Safety Authority (EFSA) (EFSA BIOHAZ Panel, 2013).  L. plantarum KKP/593/p 
and L. rhamnosus KKP 825 were the latest addition to be authorised as safe to use as feed additive 
for chickens (EFSA FEEDAP Panel, 2016). 
In the context of Lactobacillus taxonomy being updated with advances in knowledge from 
molecular biology, some of the previous claims about Lactobacillus and its aetiology in clinical 
disease may have been wrongly reported due to misidentification of the causative agent as 
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Lactobacillus (Salminen et al., 2002, Bernardeau et al., 2008).  
Like Lactobacillus, Bifidobacterium are also another safe choice as probiotic bacteria. They are 
very rarely associated with infections in healthy hosts. Bifidobacterium adolescentis, Bi. animalis 
Bi. bifidum, Bifidobacterium breve and Bi. longum have been given Qualified Presumption of 
Safety (QPS) status by the European Food Safety Authority (EFSA) (EFSA BIOHAZ Panel, 2013). 
However, incidences of bifidobacteria being found associated with infections have been reported in 
immunocompromised hosts (Jenke et al., 2011, Barberis et al., 2012, Ohishi et al., 2010).  
Lactobacillus and Bifidobacterium species are generally considered the safest choice as probiotics. 
Nevertheless, some very rare cases of infections (e.g. endocarditis, lactobacillaemia) have been 
reported in immunocompromised people. 
7.2.2 Bacillus 
Spore forming bacteria, particularly different species from the genus Bacillus, are becoming 
increasingly popular as probiotics for use in animal feed, due to their robustness in withstanding 
high temperatures making them easier to handle during manufacture, storage, and transportation of 
feed. The European Commission has identified 13 Bacillus species and given QPS status including 
B. subtilis, B. amyloliquefaciens, B. licheniformis, B. coagulans and B. megaterium which are used 
in probiotics for animal feed (EFSA BIOHAZ Panel, 2013). These Bacillus species were identified 
as safe mainly due to an absence of enterotoxins and emetic toxins (EFSA BIOHAZ Panel, 2013).  
The use of spore forming bacteria as probiotics is not risk-free as some Bacillus species (e.g. B. 
anthracis, B. cereus, B. thuringiensis etc.) are pathogenic in humans and animals (Little and Ivins, 
1999, Kotiranta et al., 2000, Hernandez et al., 1998, Damgaard et al., 1997, Raymond et al., 2010). 
Although there is detailed information about the pathogenicity of B. anthracis and B. cereus, there 
is no evidence for pathogenic effects for other endospore forming bacteria.  
B. cereus produces the emetic toxin cereulide and enterotoxins haemolysin BL (Hbl) and non-
haemolytic enterotoxin (Nhe) and cytotoxin K (CytK), which cause serious illness in humans 
(Schoeni and Lee Wong, 2005, Granum and Lund, 1997). From et al. (2005) screened 333 strains 
from different species of Bacillus to investigate the production of enterotoxins and emetic toxins. 
Eight Bacillus strains belonging to B. subtilis, Bacillus mojavensis, Bacillus pumilus, and Bacillus 
fusiformis were found to produce cytoxic and emetic toxins. In addition, some Bacillus species such 
as B. cereus has been reported to cause mastitis in cattle (Parkinson et al., 1999) and B. 
licheniformis was associated with abortion in cattle (Agerholm et al., 1997). 
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Some Bacillus species used as probiotics (e.g. Bacillus subtilis) produce cytotoxic and emetic 
toxins.  Therefore, detailed safety studies are recommended for these microbial strains before use 
as probiotics.  
7.2.3 Enterococcus 
In spite of several examples of beneficial effects of Enterococcus probiotics in animals and humans 
and a long history of safe use, these bacteria have been associated with several infections in humans 
and the presence of transferable antibiotic resistance determinants (Franz et al., 2011, Franz et al., 
2003, Franz et al., 1999). Enterococcus species, particularly E. faecalis and E. faecium, are 
associated with community and hospital acquired infections and were amongst the most prevalent 
causes of hospital acquired infections in the 1990s (Spera and Farber, 1992). Several virulence 
factors from Enterococcccus have been identified and are associated with either colonisation, 
invasion or production of pathological lesions (Franz et al., 2011). These bacteria are also 
opportunistically associated with urinary tract infection, endocarditis and enterococcal bacteraemia 
in humans (Morrison et al., 1997).  
There are many commercial probiotic products available on the market, which contain 
Enterococcus bacteria (Abdel-Rahman et al., 2013, Mountzouris et al., 2010, Wideman Jr et al., 
2012, Landy and Kavyani, 2013, Khaksar et al., 2012). Due to the widespread prevalence of 
enterococcal infections and proven virulence of the bacteria, the EU has not given this genus QPS 
status, thus requiring safety assessment on a case by case basis (EFSA BIOHAZ Panel, 2013).  
Enterococcus bacteria are associated with community and hospital acquired infections and 
therefore stringent safety evaluations are required before use as probiotics.  
7.3 Antibiotic resistance associated with probiotics 
The emergence of multi-drug resistant pathogens is now one of the greatest threats to public health 
around the world (Sengupta et al., 2013). Although the initial emergence of antibiotic resistance is 
believed to be the outcome of evolution, imprudent use of antibiotics is believed to be the major 
cause of widespread antibiotic resistance (Laxminarayan et al., 2013, Davies and Davies, 2010). 
Antibiotic resistance genes are generally present in plasmids, transposons and integrons of bacteria 
and can transfer from one bacterium to another (intra- or inter-species) by mechanisms of horizontal 
gene transfer (Alekshun and Levy, 2007, van Reenen and Dicks, 2011, Santagati et al., 2012, Blair 
et al., 2015). Transposons are the most important mobile element in the bacterial cell and 
responsible for inter-species transfer of antibiotic resistance genes (Wozniak and Waldor, 2010). 
 235 
The nature of antibiotic resistance determinants is more important than antibiotic resistance per se 
because all of the determinants of antibiotic resistance may not be transferrable (Davies and Davies, 
2010).  
Although resistance to antifungal drug in pathogenic fungi is becoming a problem of increasing 
importance (Pfaller and Diekema, 2004, Morschhäuser, 2010), the mechanism of transfer of 
resistance determinants in fungi is different from antibiotic resistance in bacteria (Anderson, 2005). 
In fungi, horizontal transfer of drug-resistance gene (and other genes) does not take place easily 
particularly among divergent taxa (Anderson, 2005).  Therefore, there is no evidence about the risk 
of transfer of antifungal resistance from yeast probiotics.  
The GIT of animals contains a complex microbial ecosystem with diverse and large numbers of 
microorganisms. Proximity of bacteria to each other in complex microbial ecosystem like intestine 
can favour the transfer of genetic material including antibiotic resistance gene from non-pathogenic 
to pathogenic microorganisms (Aarts and Margolles, 2015). The possibility of the transfer of 
antibiotic resistance genes to potential enteric pathogens in the GIT cannot be excluded (Aarts and 
Margolles, 2015). Therefore, if a bacterium intended to be used as an animal probiotic is harbouring 
transferable antibiotic resistance genes this could be a medium for transfer of antibiotic resistance to 
the environment and humans (González-Zorn and Escudero, 2012).  
7.3.1 Antibiotic resistance in Lactobacillus 
Although Lactobacillus are considered one of the safest bacteria used as probiotics, many species of 
these bacteria harbour one or more antibiotic resistance genes (Mathur and Singh, 2005, Ammor et 
al., 2007, Gueimonde et al., 2013). The possibility of horizontal transfer of these antibiotic 
resistance genes and their association with mobile elements (plasmids, transposons and integrons) 
has not been extensively studied. Nevertheless, some of the food borne species of Lactobacillus 
have antibiotic resistance genes which are capable of being transferred horizontally to pathogenic 
bacteria and are associated with mobile elements (Table S3) (Tannock et al., 1994). Some 
Lactobacillus species have acquired antibiotic resistance genes from other Gram positive bacteria 
(Shrago et al., 1986, Tannock, 1987).  
The Lactobacillus species reported to harbour transferable antibiotic resistance genes, are 
components of some commercial probiotics (Mookiah et al., 2014, Bai et al., 2013, Daskiran et al., 
2012, Biloni et al., 2013, Mountzouris et al., 2010). However, the presence of such elements in 
those particular probiotic strains has not been established. Tetracycline resistance genes (tet) are the 
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most frequent in Lactobacillus (Ammor et al., 2008c) while aminoglycoside resistance genes and β-
lactam resistance genes (blaZ) are least frequent (Aquilanti et al., 2007). 
Table S6: Lactobacillus species with antibiotic resistance genes capable of horizontal transfer 
Species Source Antibiotic 
resistance gene(s) 
Associated 
mobile 
elements  
References 
L. brevis  Dairy tet(M) Not known (Nawaz et al., 2011) 
L. fermentum  Dairy erm(B), msrC, 
erm(C), erm(T), 
tet(K), tet(L) 
Plasmid, 
transposon 
(Nawaz et al., 2011, Thumu and 
Halami, 2012, Gfeller et al., 2003) 
L. paracasei Dairy tet(M) Tn916  (Devirgiliis et al., 2009) 
L. 
plantarum 
Dairy, 
Vegetables 
tet(M), erm(B), 
tet(W), tet(L) 
Plasmid (Nawaz et al., 2011) (Feld et al., 
2009, Thumu and Halami, 2012) 
L. salivarius Fermented 
food, 
Vegetable 
erm(B), tet(W), 
tet(M), tet(O), tet(L) 
Not known (Nawaz et al., 2011, Thumu and 
Halami, 2012) 
L. reuteri Fermented 
food, 
Poultry 
erm(B), Cat-TC, 
tet(W) 
Plasmid (Lin et al., 1996, Thumu and Halami, 
2012) 
 
7.3.2 Antibiotic resistance in Bifidobacterium 
Some species of Bifidobacterium demonstrate phenotypic antibiotic resistance characters and have 
associated antibiotic resistance genes (Ammor et al., 2008b) but most are not associated with 
mobile elements and thus are non-transferable. These bacteria are therefore suitable for use in the 
food chain as probiotics in animal feed (Ammor et al., 2008a, Van Hoek et al., 2008, Kazimierczak 
et al., 2006, Flórez et al., 2006). However, several species and strains of Bifidobacterium including 
B. longum and B. animalis subsp. lactis harbours the antibiotic resistance gene tet(W), which is 
capable of intra-species transfer among Bifidobacterium (Gueimonde et al., 2013, Aarts and 
Margolles, 2015). 
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7.3.3 Antibiotic resistance in Bacillus 
Antibiotic resistance has frequently been reported in Bacillus. B. subtilis, a frequently used 
probiotic can harbour conjugative transposons (e.g. Tn5397), which can transfer resistance to 
tetracycline encoded by the tet(M) gene (Mullany et al., 1990, Roberts et al., 1999). Phelan et al. 
(2011) reported another transferable tetracycline resistance gene tet(L) in a Bacillus sp. encoded by 
a plasmid. B. subtilis can contain the macrolide-lincosamide-streptogramin B (MLS) resistance 
determinants on a plasmid (Monod et al., 1986). Macrolides are a very important class of antibiotics 
widely used to control human and animal infections. The MLS determinant is homologous to the 
erm(C) gene, one of 19 analogous erm resistance genes (Monod et al., 1986). The most prevalent 
antibiotic resistance gene is erm(D) which encodes the determinants for the resistance to MLS 
(Gryczan et al., 1984, European Food Safety Authority, 2007). However, transferability of the 
determinants encoded by this gene has not been confirmed (European Food Safety Authority, 
2007).  
Transfer of antibiotic resistance genes to potential pathogenic microorganisms is one of the serious 
risks associated with probiotics, as many bacterial species used as probiotics harbour transferable 
antibiotic resistance genes. Therefore, stringent quality assurance measures are recommended in 
this regard using microbes as probiotics only with proven absence of transferable antibiotic 
resistance genes. Lactobacillus, Bacillus and Enterococcus have greater risk as many species of 
these genera have transferable antibiotic resistance genes while Bifidobacteria carry less risk as 
most of the resistance genes in these bacteria are non-transferable. However, the status of 
antibiotic resistance genes in microbial strains used as probiotics has not been determined. 
Presence of antibiotic resistance genes may not be a serious issue if such genes are intrinsic in 
chromosomes and not transferable. Nevertheless, precautions should be taken to avoid microbes 
with acquired genes to use as probiotics. 
8 Labelling of probiotics used in animal feed 
Labels in the packaging of commercial probiotic products should provide information about 
content, positive effects of the products, date of expiry, dose rates, contraindications (if any) etc. 
However, commercial probiotics are often inadequately or incorrectly labelled. Weese (2003) 
suggested that an ideal probiotic label “should state the organisms that are present to the strain 
level, correctly spell and identify the contents, state the number of live organisms, and guarantee 
that the stated number would be present at the time of expiry”. Another piece of essential 
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information that should be present on the label is the dose rate to be used for different categories of 
animals. This was often neglected on the labels (Weese, 2003). 
Few studies have examined the quality and authenticity of probiotic labelling. Weese and Martin 
(2011) found that the labelling of commercial probiotics was very poor. The common errors in the 
labelling were failing to mention specific names of microorganisms in the product, failing to give 
number of viable microorganisms in the product, giving conflicting information, not mentioning 
expiry date, and misspelling the microbial name (Weese and Martin, 2011, Weese, 2003). 
On labels of commercial probiotics produced for humans and animals, and marketed through health 
food stores, pharmacies, grocery stores, companion pet stores and veterinary clinics, some 
manufacturers use vaguely descriptive terms like “dried lactobacillus,” “lactobacillus cultures”, 
“probiotic cultures”, “fermentation products” etc. instead of specific names of the microorganisms 
in the product (Weese, 2003). Although a significant proportion of the commercial products 
included the name of the microorganism(s) on the label, only eight out of twenty five (32%) 
products studied in Canada had a label with the correct  names of microorganisms and the number 
of viable organisms in the product (Weese and Martin, 2011). A significant number of producers 
misspelled the name of microbes, including using the obsolete name and even listing the names of 
microbes which did not exist (Weese, 2003). Very few of the products were reported to have labels 
with the name of microorganisms to the strain level (Weese, 2003). 
Similarly, not all products had information about the number of viable microorganisms and even if 
the information was present it was not clear whether the specified quantity was at the time of 
manufacture or at the time of expiry (Weese, 2003). More serious was the problem that only four 
out of 15 (27%) products which mentioned the quantity of viable microorganisms, actually met 
their claimed quantity. Ironically, there was even a product with no viable microorganisms at all, 
despite claiming to have 14 million cfu/capsule. Only a small proportion (8%) of the studied 
products had both a satisfactory label and the quantity of viable bacteria as claimed on the label 
(Weese and Martin, 2011). 
The most serious probiotic labelling  errors occurred from wrong information, such as labelling the 
product as yeast instead of Lactobacillus sp., or claiming to have bacteria present that were not 
detected in the product, or claiming to have more bacteria than were actually present in the products 
(Lata et al., 2006, Weese, 2002). Inclusion of microorganisms with no proven probiotic effects and 
inclusion of potentially pathogenic microorganisms in commercial products were other serious 
issues noted (Weese, 2002).  
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The objectives of probiotic labelling should be to provide the users with all necessary information 
to properly handle, store, transport and use the products with necessary precautions to minimize 
hazards associated with the product. The label should be in a language understandable to the 
intended users. Probiotics with labels only in the English language are commonly marketed in 
developing countries, where the users may not understand English. Therefore, labels should be 
tailored to the intended audiences. The label should also assist in making an informed choice by 
end users.  
9 Global regulatory status of probiotics in animal feed 
The advancement in the knowledge of the GIT microbial ecology and the mechanism(s) of 
probiotic action increases the possibility of the introduction of new probiotics. There is therefore, 
increasing interest in the regulation of these products to protect human health, animal health and the 
environment. It is also important that the claims made by the manufacturers of probiotics are correct 
and consumers are appropriately protected.  
Unlike other feed additives, probiotics have certain distinctive attributes. Probiotics are living 
organisms, can be inactivated in the GIT, and may interact with the genetics of the host animals. 
These factors require probiotics to be regulated more stringently than other feed additives 
(Hoffmann et al., 2013). Moreover, there is a fine line between whether a probiotic is treated as a 
feed additive or a therapeutic agent. This affects the way in which the probiotic is regulated.  
There are no studies on the release of probiotics into the environment either from animal manures 
or from other sources in their production and use.  
9.1 Codex Alimentarius Commission 
Codex Alimentarius Commission (CAC), originally established by FAO and WHO to develop food 
safety guidelines, has defined a feed additive in “code of practice on good animal feeding - 
CAC/RCP 54-2004” as “any intentionally added ingredient not normally consumed as feed by 
itself, whether or not it has nutritional value, which affects the characteristics of feed or animal 
products” (Codex Alimentarius Commission, 2004), which includes microorganisms, enzymes, 
acidity regulators, trace elements and vitamins. Therefore, “code of practice on good animal 
feeding” is the relevant code of CAC to follow as guidelines for the production, processing, storage, 
transport and distribution of probiotics by member states, in addition to their national legislation, to 
regulate probiotics.  
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9.2  United States Food and Drug Administration 
The Food and Drug Administration (FDA) is the primary authority within the US Department of 
Health and Human Services which has a mandate to regulate and oversee the use of foods, 
medicines (both prescription and over the counter drugs), vaccines, veterinary products, dietary 
supplements etc. All products under the jurisdiction of the FDA are regulated by one of its six 
centres based on the category of the products according to the intended use, generally as stated by 
the manufacturers. Hence, intended use is more important than the contents of the products in 
determining the nature of regulation of the products.  
All livestock feeds, pet foods, veterinary drugs and devices and veterinary biologicals are regulated 
by the Center for Veterinary Medicine (CVM) under the FDA. The CVM regulates the safety, 
effectiveness, labelling and distribution of the products under its jurisdiction. In case of any 
ambiguity or when there is confusion about which product should be regulated by which centre, the 
Office of Combination Products (OCP) under the FDA provides guidelines. Similarly the Federal 
Trade Commission regulates the advertising and marketing of the products and may have a role in 
certain aspects of probiotic regulation.  
The FDA uses the phrase Direct-fed Microbial (DFM) products for probiotics used in animal feed. 
The FDA guidance document (CPG Sec. 689.100) has defined DFM as “products that are purported 
to contain live (viable) microorganisms (bacteria and/or yeast)” (USFDA, 2015). This FDA 
guideline has approved the microorganisms listed in the official publication of the Association of 
American Feed Control Officials (AAFCO) that can be used in DFM (Table S4). Products marketed 
solely as silage additives are not regulated as DFM. For regulatory purposes, DFM are considered 
either as fermentation products or yeast products.  
The regulation of probiotics by FDA is chiefly determined by the intended use or claim of the 
product (Table S5). It could be either food/feed or drug or both and regulated accordingly. The 
probiotics with the following claims are categorized as “new animal drug” and regulated as a drug 
and need an approved new animal drug application (USFDA, 2015).  
o Cure, mitigation, treatment or prevention of diseases 
o Affect the structure or function of the body 
The approved microorganisms listed in the publication of the AAFCO when marketed as DFM 
without any therapeutic or structure/function claims are categorized as food and regulated 
accordingly. The products categorized as food are monitored by the respective State Government 
rather than FDA unless these products have any safety issue (USFDA, 2015). However, if the 
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marketed microorganisms are not listed by AAFCO and have no therapeutic or structure/function 
claims, the product is categorized as a food additive and regulated accordingly.  
Table S7: Microorganisms in the official list of AAFCO that are suitable for use in animal feed 
(Pendleton, 1998) 
Aspergillus niger  
Aspergillus oryzae  
Bacillus coagulans  
Bacillus lentus  
Bacillus licheniformis  
Bacillus pumilus  
Bacillus subtilis  
Bacteroides amylophilus  
Bacteroides capillosus  
Bacteroides ruminocola  
Bacteroides suis  
Bifidobacterium adolescentis  
Bifidobacterium animalis  
Bifidobacterium bifidum  
Bifidobacterium infantis  
Bifidobacterium longum  
Bifidobacterium thermophilum  
Lactobacillus acidophilus  
Lactobacillus brevis  
Lactobacillus buchneri (cattle only)  
Lactobacillus bulgaricus  
Lactobacillus casei  
Lactobacillus cellobiosus 
Lactobacillus curvatus  
Lactobacillus delbruekii  
Lactobacillus farciminis (swine only)  
Lactobacillus fermentum  
Lactobacillus helveticus  
Lactobacillus lactis  
Lactobacillus plantarum  
Lactobacillus reuterii  
Leuconostoc mesenteroides  
Pediococcus acidilacticii  
Pediococcus cerevisiae (damnosus)  
Pediococcus pentosaceus  
Propionibacterium acidpropionici (cattle only)  
Propionibacterium freudenreichii  
Propionibacterium shermanii  
Saccharomyces cerevisiae  
Enterococcus cremoris  
Enterococcus diacetylactis  
Enterococcus faecium  
Enterococcus intermedius  
Enterococcus lactis  
Enterococcus thermophilus  
Yeast 
Table S8: Regulation of Direct Fed Microorganisms (Probiotics) by FDA 
Product Intended use/Claim Legal status Regulated as Regulated by 
DFM 
Cure, mitigate, treatment or prevention of 
disease 
New animal 
drug 
Drug FDA 
Affect the structure and function of the 
body 
New animal 
drug 
Drug FDA 
Without any therapeutic or 
structure/function claim (microorganisms 
listed in AAFCO official publication) 
Food Food State 
government 
Without any therapeutic or 
structure/function claim (microorganisms 
not listed in AAFCO official publication) 
Food 
additives 
Food additives FDA 
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9.2.1 Generally regarded as safe (GRAS) 
The US Food and Drug Administration’s Center for Veterinary Medicine (CVM) has a Generally 
Recognized as Safe (GRAS) notification programme for ingredients in animal feed. According to 
this programme “any substance that is intentionally added to food” is exempt from regulation as a 
food additive, if the substance is GRAS. A food additive could get GRAS status either through 
scientific justification or based on a long history of safe use of the product in animal feed (before 
1958).  
9.3  European Food Safety Authority (EFSA) 
The EU follows a very strict regulation for the assessment of probiotics for which manufacturers of 
the probiotics should provide evidence of the identity, safety and efficacy of the product which is 
assessed by a scientific committee of experts (Europen Commission, 2003). Probiotic products can 
only be marketed following assessment and approval from the scientific committee and 
authorization under EU regulation (EC) No. 1831/2003, additives for use in animal nutrition. The 
manufacturers should follow use and labelling conditions to market the product as authorized by the 
European Commission.  
Regulation (EC) No. 1831/2003 of the European Parliament and the Council of 22 September 2003 
on additives for use in animal nutrition has classified feed additives into 5 categories: (a) 
technological additives (b) sensory additives (c) nutritional additives (d) zootechnical additives and 
(e) coccidiostats and histomonastats (Europen Commission, 2003). Although the word ‘probiotics’ 
is not used in the regulation, “microorganisms or other chemically defined substances, which when 
fed to animals, have a positive effect on the gut flora” are categorized as “gut-flora stabilizers”, a 
functional group under zootechnical additives. Therefore, probiotics in animal feed are regulated as 
zootechnical additives in the EU. The regulation 1831/2003, legislates the authorization, use, 
monitoring, labelling and packaging of feed additives.  
In April 2008, the EU published commission (EC) No. 429/2008, gave detailed rules for the 
implementation of Regulation (EC) No. 1831/2003, which details procedures for authorization of 
new probiotics entering the EU (Europen Commission, 2008) as outlined in Figure 3. Authorization 
granted according to this legislation is valid for 10 years and should be renewed thereafter.  
 243 
 
Figure S3: Pathway for the authorization of new probiotics in the European Union as per Regulations 
(EC) No. 1831/2003 and 429/2008.  
9.4  Regulation of probiotic labelling 
In the EU, Regulation (EC) No 1831/2003 on additives for use in animal nutrition covers labelling 
of probiotics. According to this legislation, it is illegal to sell feed additives (including probiotics) 
without clearly labelling the products with (a) specific name and functional group of the additives 
(b) name and address of the business responsible for the product (c) net weight or net volume (in 
case of liquid) (d) approval number to establish and operate the establishment or the intermediary 
pursuant (where appropriate) (e) instructions for use including the species and categories of animal 
(f) date of manufacture with batch number (Europen Commission, 2003). In addition to these 
general requirements for feed additives, probiotics should have the following specific information 
on their label: “the expiry date of the guarantee or the storage life from the date of manufacture, the 
directions for use, the strain identification number, and the number of colony-forming units per 
gram” (Europen Commission, 2003).  
1 
Preparation of dossier by the manufacturer/marketer of the probiotics including identification of the probiotics, a proposal for its classification, specifications, purity criteria, method of production, intended use, method of analysis, details of the studies to demonstrate the safety of the products in animal, human and the environment, details of the studies to demonstrate the efficacy of the product etc. with the summary of all the information. 
 
2 
A) Submission of the application to authorize the probiotics to the commission (EC).  
B) Submission of dossier as prepared in step 1 directly to the EFSA.  C) Submission of 3 samples of probiotics to the community reference laboratory with material safety data sheet and certificate of identification and analysis with required fee. 
 
3 
A) The commission shall inform the member state about the application and forward the application to the EFSA.  B) EFSA shall send the information supplied by the applicant to the commission and to the member states. C) EFSA shall make the summary of the dossier submitted by the applicant and make available to the public. 
 
4 
A) EFSA shall verify the documents submitted by the applicant and report of the community reference laboratory.  B) EFSA shall request the applicant to submit the supplementary documents (where appropriate). A) EFSA shall give an opinion and assessment report within 6 months of a valid application and forward it to the commission, the member states and the applicant.  B) EFSA shall make its opinion public (excluding any information subject to be confidential) . 
 
5 
 The commission shall grant authorization or deny authorization within 3 months of the receipt of opinion from EFSA. 
 
 
6 
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In 1987, a joint exercise by FDA, Association of American Feed Control Officials (AAFCO) and 
National Feed Ingredients Association (later merged with the American Feed Industry Association) 
consensually agreed to include the phrase “contains a source of live (viable), naturally occurring 
microorganisms” followed by the name of the microorganisms in the product with the content 
guarantee, as colony-forming units per gram on the label of commercial probiotic products (DFM) 
to be used in animal feed (Pendleton, 1998). Before this decision, probiotics had been labelled and 
regulated as commercial feed in accordance with the AAFCO regulations and the label had to 
contain guarantees for protein, fat and fibre, which was obviously not relevant to the product 
(Pendleton, 1998).  
The classification and marketing of probiotics as feed additives in most countries, may result in the 
regulation and quality control of probiotics not being as stringent as that of veterinary drugs 
(Weese, 2003). This may result in probiotic labelling errors being overlooked.  
Confusion and ambiguity prevails with regard to the regulation of probiotics in most countries. 
Approaches of risk assessment and level of stringency to authorize novel probiotics varies among 
nations. A global approach and guidelines to classify and regulate probiotics and assess risk could 
be effective in harmonizing regulations and protect public health. 
10 Conclusion 
Increasing intensification of animal agriculture with consequent imprudent use of antibiotic growth 
promoters poses risks to human and animal health in terms of increasing antibiotic resistance in 
pathogenic microorganisms. Live microorganisms have been studied and used as probiotics for a 
long time, and as an alternative to antibiotic growth promoters in animal production. Several 
probiotics have been found effective in improving animal performance and preventing disease and 
the spread of the enteric pathogens in both monogastric and ruminant livestock industries.  
With the advancement in knowledge in gastrointestinal microbial ecology and mode of action of 
probiotics, the number of probiotic products available for use in animal nutrition is increasing. 
However, the microorganisms used as probiotics and their efficacy are highly variable. There are 
many promising effects of probiotics on animal performance and health. However, the major 
limitation for the widespread and sustainable use of probiotics is the uncertainty in the 
reproducibility of effect, with a wide range of probiotic species, livestock species and husbandry 
practice highlighting the complexity of the interactions in animal production systems. Study about 
the effects of a particular microbial strain on variety of animal species, age groups, growth 
condition, diet types may help to identify the condition in which the probiotics could work. 
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Although the use of probiotics could be a potentially viable solution to address the issue of 
increasing antibiotic resistance, it requires much further study on the effect, mechanism of action 
and safety of probiotics, to obtain consistent effects and a similar economic benefit to AGPs.  
The claims made by commercial probiotic producers are often difficult to substantiate due to 
variation in animal species and husbandry practices and lack of scientific publications regarding the 
product. It is not possible to generalize the mechanism of action of probiotics. As the effects of 
probiotics in host is the outcome of interaction between the host and the probiotic microorganism, 
further studies should be focussed on host-probiotic interactions to elucidate the mode of action. 
Although generally considered safe, there is little evidence that probiotics are absolutely safe and it 
has been agreed that “zero risk does not exist” (Marteau, 2001). Therefore, uncertainty would 
always exist about the efficacy and safety of probiotics. Studies about the minimum required dose 
of particular probiotic to achieve intended benefits and maximum dose rate which could be used 
without any adverse effects on host help to assure the benefits and minimize the risk. 
Further studies are also required to determine whether the probiotics used in animal nutrition enter 
the human food chain and how they affect human health. Information about specific precautions 
about handling by particularly vulnerable populations like immunocompromised people or use in 
such host may further help to reduce the risk.  
The stringencies of the regulations on the use of probiotics in animal agriculture vary even in 
developed countries. Regulation of probiotics in the EU based on the assessment by a scientific 
committee of experts reviewing identity, safety and efficacy of the probiotic microorganisms is 
exemplary.  
The issue of maintaining safety and efficacy of probiotics could be more serious in developing 
countries where institutions that can do research on the efficacy of such probiotics and regulate the 
proper use of probiotics, are often in need of strengthening and capacity building. Therefore, 
focussing on relevant research for identification of risk associated with probiotics together with 
capacity building of competent regulation authority are important aspects to protect public health 
and animal health.  
Bacterial genera commonly used as probiotics have been found to harbour antibiotic resistance 
genes on mobile genetic elements capable of transferring to potential enteric pathogens. Using 
microbial strain as probiotics only with proven absence of transferable antibiotic resistance genes 
could minimize this serious safety risk. Similar precautions should be carried out while using 
microbes with acquired resistance genes.   
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Therefore, international guidelines for the production, marketing and use of probiotics in animal 
nutrition are essential, especially with increasing globalisation. Such guidelines would help prevent 
the use of inappropriate microorganisms as probiotics and maintain the efficacy of probiotics in 
achieving the targeted benefits. Such guidelines would assist institutions involved in the production, 
marketing and regulation of probiotics and protect public health. Such guidelines should also give 
detailed instructions for the analysis of the risk associated with probiotics intended for use in animal 
production.  
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Appendix 2. Supplementary material for chapter 4  
Table S9: Sequencing run statistics of experiment no. 1 
Sample 
ID 
Sample Treatment Total 
Read 
Count R1 
Total 
Read 
Count R2 
Reads 
Passing 
QC R1 
Reads 
Passing 
QC R2 
QIIME 
pre-
filtered 
reads R1 
QIIME 
unclustered 
singletons R1 
Reads in 
complete 
OTU table 
R1 
Reads in filtered 
OTU table 
(>0.05% 
abundance) R1 
S1764 Ileum H57 65966 65966 42180 7156 92 698 41390 25891 
S1771 Ileum H57 96588 96588 59656 17040 388 144 59124 52794 
S1784 Ileum H57 113755 113755 83704 28025 78 203 83423 75773 
S1765 Ileum H57 182870 182870 112721 31412 1766 2319 108636 51165 
S1785 Ileum H57 81966 81966 59232 14349 1551 148 57533 50240 
S1795 Ileum H57 115362 115362 77258 23049 412 1487 75359 40234 
S1792 Caecum H57 84274 84274 57929 20316 517 98 57314 52835 
S1788 Caecum H57 121120 121120 86942 31500 11 332 86599 68976 
S1770 Caecum H57 100191 100191 72984 17866 219 53 72712 70357 
S1781 Caecum H57 98296 98296 66184 23757 21 163 66000 58470 
S1793 Caecum H57 138393 138393 90063 26941 577 1652 87834 47106 
S1761 Caecum H57 129071 129071 85945 17827 522 1030 84393 48317 
S1751 Caecum H57 115231 115231 86627 26181 116 90 86421 81685 
S1798 Caecum H57 81035 81035 54295 17919 637 478 53180 34184 
S1780 Caecum H57 172318 172318 107380 29135 2213 1746 103421 54502 
S1759 Caecum H57 135814 135814 86075 20782 1136 1338 83601 45902 
S1758 Caecum H57 115493 115493 75438 17122 450 1016 73972 45136 
S1757 Caecum H57 88403 88403 56997 10696 210 902 55885 36527 
S1794 Ileum H57 140505 140505 94779 26490 299 1757 92723 47674 
S1774 Ileum H57 81890 81890 56259 22055 16 122 56121 51414 
S1782 Ileum H57 140216 140216 95855 35985 21 438 95396 79700 
S1768 Ileum H57 128271 128271 83956 16667 286 1468 82202 47034 
S1791 Ileum H57 75298 75298 52836 18208 3753 123 48960 43748 
S1783 Ileum H57 104783 104783 75359 26353 51 245 75063 62401 
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S1753 Caecum Control 97139 97139 69043 20260 1143 178 67722 61454 
S1796 Caecum Control 104729 104729 71488 15401 7080 1166 63242 34442 
S1786 Caecum Control 83491 83491 60640 21431 2206 82 58352 54777 
S1772 Caecum Control 105891 105891 71298 24378 67 168 71063 61686 
S1752 Caecum Control 104227 104227 72700 19941 96 568 72036 56100 
S1773 Caecum Control 96034 96034 67921 13703 108 84 67729 63710 
S1763 Ileum Control 102443 102443 69716 7870 159 1478 68079 41360 
S1766 Ileum Control 130945 130945 85077 18049 547 1333 83197 47202 
S1769 Ileum Control 117869 117869 87131 20663 72 115 86944 80776 
S1776 Ileum Control 132003 132003 78061 18570 757 1415 75889 38931 
S1760 Ileum Control 146685 146685 98824 19408 380 2147 96297 49197 
S1789 Ileum Control 101975 101975 74215 30544 46 111 74058 68498 
S1778 Ileum Control 142096 142096 90255 21571 478 1827 87950 41495 
S1754 Ileum Control 110737 110737 80898 23002 128 120 80650 74719 
S1779 Ileum Control 168482 168482 103108 29630 629 2369 100110 51776 
S1787 Ileum Control 104218 104218 72477 25187 32 168 72277 62973 
S1762 Ileum Control 41466 41466 15817 126 31 371 15415 9090 
S1755 Ileum Control 70323 70323 49070 18027 30 60 48980 46127 
S1777 Caecum Control 126590 126590 78472 24000 872 1505 76095 37021 
S1790 Caecum Control 97265 97265 71295 28067 5 124 71166 62160 
S1756 Caecum Control 103780 103780 75248 20232 685 98 74465 69172 
S1797 Caecum Control 133700 133700 91181 18695 621 1278 89282 47274 
S1775 Caecum Control 186324 186324 105430 33716 4719 1510 99201 55362 
S1767 Caecum Control 115024 115024 73199 17002 575 1380 71244 40093 
Average   113136 113136 75692 21173 767 786 74140 52655 
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Table S10: Sequencing run statistics of experiment no. 2 
Sample Sample Treatment Location Total 
Read 
Count 
R1 
Total 
Read 
Count 
R2 
Reads 
Passing 
QC R1 
Reads 
Passing 
QC R2 
QIIME 
pre-
filtered 
reads R1 
QIIME 
unclustered 
singletons R1 
Reads in 
complete 
OTU table 
R1 
Reads in filtered 
OTU table 
(>0.05% 
abundance) R1 
SA1539 Ileum Control Pen 10636 10636 9221 5540 1 65 9155 6346 
SA1540 Ileum Control Pen 11433 11433 10142 5610 13 10 10119 9747 
SA1541 Ileum Control Pen 14098 14098 12407 6451 5 65 12337 9917 
SA1542 Ileum Control Pen 11085 11085 9715 5115 1 11 9703 9009 
SA1543 Ileum Control Pen 13012 13012 11451 5911 1 8 11442 10924 
SA1544 Ileum Control Pen 15048 15048 12006 6406 5 33 11968 11365 
SA1545 Ileum Control Cage 11572 11572 10112 5749 2 7 10103 9541 
SA1546 Ileum Control Cage 12916 12916 10944 6120 20 56 10868 9679 
SA1547 Ileum Control Cage 10472 10472 9522 5211 0 9 9513 9324 
SA1548 Ileum Control Cage 12728 12728 11394 6540 0 2 11392 11198 
SA1549 Ileum Control Cage 10779 10779 9710 4722 21 2 9687 9440 
SA1550 Ileum Control Cage 20071 20071 18120 9147 2 11 18107 18031 
SA1551 Ileum H57 Pen 10254 10254 8872 4887 0 40 8832 5682 
SA1552 Ileum H57 Pen 18850 18850 16611 9417 4 11 16596 16322 
SA1553 Ileum H57 Pen 12140 12140 10861 5946 0 23 10838 10054 
SA1554 Ileum H57 Pen 14601 14601 12622 7112 77 107 12438 7750 
SA1555 Ileum H57 Pen 15619 15619 13856 7493 0 15 13841 12978 
SA1556 Ileum H57 Pen 8227 8227 7052 4266 1 35 7016 4910 
SA1557 Ileum H57 Cage 10514 10514 9430 4580 4 18 9408 9114 
SA1558 Ileum H57 Cage 25504 25504 22672 10353 0 8 22664 21403 
SA1559 Ileum H57 Cage 8788 8788 7826 3944 2 9 7815 7323 
SA1560 Ileum H57 Cage 15015 15015 12870 6557 9 47 12814 10494 
SA1561 Ileum H57 Cage 12402 12402 11078 5549 2 10 11066 10495 
SA1562 Ileum H57 Cage 10954 10954 9646 4568 2 20 9624 8657 
SA1563 Caeca Control Pen 9118 9118 7848 4795 7 129 7712 4435 
SA1564 Caeca Control Pen 10079 10079 8618 5313 12 206 8400 3525 
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SA1565 Caeca Control Pen 11560 11560 8442 2460 8 157 8277 3846 
SA1566 Caeca Control Pen 11688 11688 10112 5641 2 131 9979 5841 
SA1567 Caeca Control Pen 8023 8023 3835 111 2 143 3690 1810 
SA1568 Caeca Control Pen 14782 14782 12187 7323 3 364 11820 4237 
SA1569 Caeca Control Cage 48928 48928 41212 25833 44 291 40877 24512 
SA1570 Caeca Control Cage 10777 10777 8883 5369 23 161 8699 4418 
SA1571 Caeca Control Cage 7382 7382 6422 3659 6 72 6344 3127 
SA1572 Caeca Control Cage 9284 9284 7859 4930 5 65 7789 4710 
SA1573 Caeca Control Cage 11093 11093 9333 4546 7 183 9143 4771 
SA1574 Caeca Control Cage 14440 14440 12384 7313 8 108 12268 6599 
SA1575 Caeca H57 Pen 11598 11598 9848 4230 16 201 9631 4324 
SA1576 Caeca H57 Pen 13966 13966 11989 7288 6 255 11728 6546 
SA1577 Caeca H57 Pen 23002 23002 18826 11155 6 354 18466 9883 
SA1578 Caeca H57 Pen 13268 13268 10890 5259 4 219 10667 5803 
SA1579 Caeca H57 Pen 9876 9876 8274 4676 5 107 8162 5259 
SA1580 Caeca H57 Pen 8607 8607 7240 4210 5 161 7074 3811 
SA1581 Caeca H57 Cage 8678 8678 7447 3974 7 81 7359 3892 
SA1582 Caeca H57 Cage 464 464 377 184 2 6 369 174 
SA1583 Caeca H57 Cage 12125 12125 10165 5296 10 122 10033 5299 
SA1584 Caeca H57 Cage 10575 10575 8336 4482 12 235 8089 2972 
SA1585 Caeca H57 Cage 12890 12890 10865 5838 5 169 10691 6329 
SA1586 Caeca H57 Cage 11308 11308 9472 4923 3 194 9275 5500 
Average    12921 12921 11021 5958 8 99 10914 7944 
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Table S11: Sequencing run statistics of experiment no. 3 
Sample ID Age Diet Sample Treatment Total 
Read 
Count 
R1 
Total 
Read 
Count 
R2 
Reads 
Passing 
QC R1 
Reads 
Passing 
QC R2 
QIIME 
pre-
filtered 
reads R1 
QIIME 
unclustered 
singletons 
R1 
Reads in 
complete 
OTU table 
R1 
Reads in 
filtered OTU 
table (>0.05% 
abundance) R1 
SA1587 4 Sorghum Ileum Control 21389 21389 19096 13029 3 14 19079 18809 
SA1588 4 Sorghum Ileum Control 19357 19357 16996 11653 0 17 16979 15314 
SA1589 4 Sorghum Ileum Control 12731 12731 11306 6593 7 7 11292 10680 
SA1590 4 Sorghum Ileum Control 8240 8240 7302 4628 8 11 7283 6646 
SA1591 4 Sorghum Ileum Control 12304 12304 10692 6956 0 23 10669 9458 
SA1592 4 Sorghum Ileum Control 13870 13870 11837 7890 4 23 11810 11184 
SA1593 4 Sorghum Ileum H57 14012 14012 12385 7998 0 25 12360 11450 
SA1594 4 Sorghum Ileum H57 11295 11295 9906 6525 9 9 9888 9491 
SA1595 4 Sorghum Ileum H57 11293 11293 9741 6802 30 13 9698 9408 
SA1596 4 Sorghum Ileum H57 8903 8903 7916 4807 4 1 7911 7638 
SA1597 4 Sorghum Ileum H57 11663 11663 10500 6135 3 8 10489 10025 
SA1598 4 Sorghum Ileum H57 22399 22399 19961 12519 6 9 19946 19326 
SA1599 4 Sorghum Caeca Control 19124 19124 16427 8636 9 95 16323 10310 
SA1600 4 Sorghum Caeca Control 13779 13779 11160 5905 13 109 11038 6209 
SA1601 4 Sorghum Caeca Control 9479 9479 8106 4310 35 71 8000 4068 
SA1602 4 Sorghum Caeca Control 8705 8705 7174 3732 8 102 7064 3728 
SA1603 4 Sorghum Caeca Control 9533 9533 7749 4563 3 84 7662 3352 
SA1604 4 Sorghum Caeca Control 13091 13091 10776 5248 36 79 10661 5901 
SA1605 4 Sorghum Caeca H57 21093 21093 17998 9694 34 149 17815 11039 
SA1606 4 Sorghum Caeca H57 12634 12634 10763 5914 4 43 10716 7879 
SA1607 4 Sorghum Caeca H57 9536 9536 8027 4414 9 53 7965 5287 
SA1608 4 Sorghum Caeca H57 13034 13034 10608 5882 3 126 10479 6158 
SA1609 4 Sorghum Caeca H57 9112 9112 7640 4251 8 35 7597 5308 
SA1610 4 Sorghum Caeca H57 11225 11225 9135 4997 29 50 9056 5810 
SA1611 4 Wheat Ileum Control 13979 13979 12254 7181 0 11 12243 11708 
SA1612 4 Wheat Ileum Control 13537 13537 11328 5966 1 13 11314 10956 
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SA1613 4 Wheat Ileum Control 12898 12898 11532 6843 4 13 11515 11017 
SA1614 4 Wheat Ileum Control 18009 18009 15471 9105 62 26 15383 13742 
SA1615 4 Wheat Ileum Control 13645 13645 12140 7291 1 28 12111 11890 
SA1616 4 Wheat Ileum Control 15098 15098 12816 8019 192 9 12615 11880 
SA1617 4 Wheat Ileum H57 12447 12447 10697 6722 1 11 10685 10306 
SA1618 4 Wheat Ileum H57 8914 8914 6296 3374 9 17 6270 5841 
SA1619 4 Wheat Ileum H57 11745 11745 10578 6985 7 11 10560 10359 
SA1620 4 Wheat Ileum H57 12649 12649 11105 7714 7 4 11094 10584 
SA1621 4 Wheat Ileum H57 7977 7977 7148 4388 14 15 7119 6734 
SA1622 4 Wheat Ileum H57 9621 9621 8425 5039 7 6 8412 8161 
SA1623 4 Wheat Caeca Control 9820 9820 8399 4265 14 95 8290 4563 
SA1624 4 Wheat Caeca Control 8689 8689 6953 4204 1 36 6916 4941 
SA1625 4 Wheat Caeca Control 20483 20483 16703 9936 7 85 16611 10908 
SA1626 4 Wheat Caeca Control 11589 11589 9493 5251 22 49 9422 5719 
SA1627 4 Wheat Caeca Control 13748 13748 11967 6931 38 33 11896 8925 
SA1628 4 Wheat Caeca Control 11573 11573 9902 5860 11 34 9857 6933 
SA1629 4 Wheat Caeca H57 13592 13592 11803 6565 12 41 11750 8520 
SA1630 4 Wheat Caeca H57 11721 11721 10142 5407 5 57 10080 7130 
SA1631 4 Wheat Caeca H57 12449 12449 10685 5917 20 49 10616 7738 
SA1632 4 Wheat Caeca H57 32295 32295 26277 15984 16 107 26154 18015 
SA1633 4 Wheat Caeca H57 15382 15382 13204 7387 20 55 13129 8732 
SA1634 4 Wheat Caeca H57 12927 12927 10946 5921 4 86 10856 5767 
SA1635 4 Blend Ileum Control 25441 25441 22785 13574 8 5 22772 22281 
SA1636 4 Blend Ileum Control 14232 14232 12656 8491 7 8 12641 12237 
SA1637 4 Blend Ileum Control 8363 8363 7460 4837 5 10 7445 7142 
SA1638 4 Blend Ileum Control 16818 16818 14876 8941 2 13 14861 14029 
SA1639 4 Blend Ileum Control 10300 10300 9131 5845 21 4 9106 8633 
SA1640 4 Blend Ileum Control 28331 28331 24792 16222 12 23 24757 22644 
SA1641 4 Blend Ileum H57 18390 18390 16402 10526 2 7 16393 15587 
SA1642 4 Blend Ileum H57 14663 14663 12718 7889 11 14 12693 11765 
SA1643 4 Blend Ileum H57 11968 11968 10738 6763 10 6 10722 10295 
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SA1644 4 Blend Ileum H57 39460 39460 34508 20682 113 19 34376 33414 
SA1645 4 Blend Ileum H57 16343 16343 14663 8333 10 18 14635 14106 
SA1646 4 Blend Ileum H57 15166 15166 13472 7787 9 10 13453 13047 
SA1647 4 Blend Caeca Control 21028 21028 18465 9561 24 89 18352 11414 
SA1648 4 Blend Caeca Control 20065 20065 16814 9241 9 86 16719 11530 
SA1649 4 Blend Caeca Control 30220 30220 23527 12045 19 151 23357 11987 
SA1650 4 Blend Caeca Control 11115 11115 6785 1148 4 52 6729 4443 
SA1651 4 Blend Caeca Control 19709 19709 16633 8995 22 66 16545 11342 
SA1652 4 Blend Caeca Control 14201 14201 11688 7100 40 119 11529 6922 
SA1653 4 Blend Caeca H57 11059 11059 9714 4988 20 58 9636 5977 
SA1654 4 Blend Caeca H57 15496 15496 12682 6869 13 105 12564 6750 
SA1655 4 Blend Caeca H57 16040 16040 13935 6906 63 53 13819 9835 
SA1656 4 Blend Caeca H57 14460 14460 11628 6535 33 69 11526 6676 
SA1657 4 Blend Caeca H57 24784 24784 20065 8990 5 140 19920 10856 
SA1658 4 Blend Caeca H57 9845 9845 8143 4643 15 44 8084 5248 
SA1659 13 Sorghum Ileum Control 36330 36330 31973 20293 166 35 31772 29220 
SA1660 13 Sorghum Ileum Control 9055 9055 7928 4887 50 4 7874 7656 
SA1661 13 Sorghum Ileum Control 37613 37613 33640 19109 67 34 33539 31994 
SA1662 13 Sorghum Ileum Control 14272 14272 12628 7236 97 10 12521 12150 
SA1663 13 Sorghum Ileum Control 14426 14426 12867 7386 2 4 12861 12604 
SA1664 13 Sorghum Ileum Control 24346 24346 20841 14113 18 17 20806 20258 
SA1665 13 Sorghum Ileum H57 14196 14196 12639 7389 10 14 12615 12386 
SA1666 13 Sorghum Ileum H57 23997 23997 18786 11696 77 36 18673 17235 
SA1667 13 Sorghum Ileum H57 14535 14535 13003 7986 11 13 12979 12347 
SA1668 13 Sorghum Ileum H57 27383 27383 23663 15569 1432 13 22218 21197 
SA1669 13 Sorghum Ileum H57 14456 14456 12856 6917 8 8 12840 12356 
SA1670 13 Sorghum Ileum H57 26570 26570 23041 13645 355 35 22651 20937 
SA1671 13 Sorghum Caeca Control 12564 12564 10581 5108 30 30 10521 8000 
SA1672 13 Sorghum Caeca Control 13016 13016 9989 5219 17 141 9831 5219 
SA1673 13 Sorghum Caeca Control 11402 11402 9564 6051 11 53 9500 6046 
SA1674 13 Sorghum Caeca Control 11629 11629 9502 5492 10 28 9464 6568 
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SA1675 13 Sorghum Caeca Control 13765 13765 11358 5965 20 87 11251 7764 
SA1676 13 Sorghum Caeca Control 11326 11326 9434 4757 6 69 9359 5395 
SA1677 13 Sorghum Caeca H57 11449 11449 9864 4669 10 46 9808 6299 
SA1678 13 Sorghum Caeca H57 18148 18148 14932 7399 19 54 14859 9998 
SA1679 13 Sorghum Caeca H57 12757 12757 10745 5549 9 15 10721 6585 
SA1680 13 Sorghum Caeca H57 32361 32361 26572 16581 21 118 26433 17987 
SA1681 13 Sorghum Caeca H57 11514 11514 9678 5534 24 99 9555 5304 
SA1682 13 Sorghum Caeca H57 22339 22339 18408 10455 13 52 18343 13574 
SA1683 13 Wheat Ileum Control 17142 17142 15217 9618 10 12 15195 14094 
SA1684 13 Wheat Ileum Control 26171 26171 23314 15174 22 24 23268 22899 
SA1685 13 Wheat Ileum Control 24217 24217 21617 12594 15 14 21588 20921 
SA1686 13 Wheat Ileum Control 10427 10427 9218 5376 32 6 9180 8939 
SA1687 13 Wheat Ileum Control 15790 15790 13896 8467 85 14 13797 12615 
SA1688 13 Wheat Ileum Control 18043 18043 15427 10357 75 22 15330 14142 
SA1689 13 Wheat Ileum H57 19467 19467 17184 10638 9 16 17159 16275 
SA1690 13 Wheat Ileum H57 19917 19917 17324 10279 77 24 17223 15900 
SA1691 13 Wheat Ileum H57 14498 14498 13037 8194 60 4 12973 12459 
SA1692 13 Wheat Ileum H57 8366 8366 7495 4771 10 9 7476 7038 
SA1693 13 Wheat Ileum H57 25604 25604 22956 13323 80 32 22844 21122 
SA1694 13 Wheat Ileum H57 22961 22961 20356 12241 181 15 20160 18652 
SA1695 13 Wheat Caeca Control 17582 17582 15116 7214 31 25 15060 11029 
SA1696 13 Wheat Caeca Control 15913 15913 13229 7033 8 48 13173 10151 
SA1697 13 Wheat Caeca Control 14459 14459 12397 6988 9 35 12353 8730 
SA1698 13 Wheat Caeca Control 17416 17416 14684 8476 19 41 14624 10904 
SA1699 13 Wheat Caeca Control 20737 20737 17471 10331 16 60 17395 10761 
SA1700 13 Wheat Caeca Control 16319 16319 13709 7438 48 109 13552 7524 
SA1701 13 Wheat Caeca H57 19812 19812 16850 8347 74 39 16737 13639 
SA1702 13 Wheat Caeca H57 13464 13464 11265 5886 15 48 11202 7719 
SA1703 13 Wheat Caeca H57 16686 16686 13919 6389 13 35 13871 10821 
SA1704 13 Wheat Caeca H57 11450 11450 9193 5709 12 37 9144 6364 
SA1705 13 Wheat Caeca H57 9927 9927 8434 4622 15 89 8330 5383 
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SA1706 13 Wheat Caeca H57 15552 15552 12924 6853 10 105 12809 8157 
SA1707 13 Blend Ileum Control 16641 16641 14480 9738 39 12 14429 13541 
SA1708 13 Blend Ileum Control 8049 8049 6918 4474 50 12 6856 6719 
SA1709 13 Blend Ileum Control 22781 22781 20171 11692 18 10 20143 19645 
SA1710 13 Blend Ileum Control 9624 9624 8414 5209 18 8 8388 7806 
SA1711 13 Blend Ileum Control 25701 25701 22767 13080 3 13 22751 21625 
SA1712 13 Blend Ileum Control 17694 17694 14644 9584 27 15 14602 13644 
SA1713 13 Blend Ileum H57 9753 9753 8636 5294 12 3 8621 8143 
SA1714 13 Blend Ileum H57 17742 17742 15316 9392 20 6 15290 14717 
SA1715 13 Blend Ileum H57 19165 19165 16964 10837 12 13 16939 15452 
SA1716 13 Blend Ileum H57 17584 17584 15546 10102 10 20 15516 14510 
SA1717 13 Blend Ileum H57 18581 18581 16581 9904 43 13 16525 15738 
SA1718 13 Blend Ileum H57 21932 21932 16367 9911 18 15 16334 15465 
SA1719 13 Blend Caeca Control 20593 20593 17501 9873 42 66 17393 12070 
SA1720 13 Blend Caeca Control 28630 28630 23372 13752 29 64 23279 16929 
SA1721 13 Blend Caeca Control 13747 13747 11818 7162 5 68 11745 8099 
SA1722 13 Blend Caeca Control 24487 24487 20540 11905 9 136 20395 12245 
SA1723 13 Blend Caeca Control 23087 23087 19870 11878 17 157 19696 11481 
SA1724 13 Blend Caeca Control 34783 34783 29585 18569 21 143 29421 21059 
SA1725 13 Blend Caeca H57 33653 33653 28985 12724 37 113 28835 19564 
SA1726 13 Blend Caeca H57 15007 15007 12933 7873 2 19 12912 10357 
SA1727 13 Blend Caeca H57 20495 20495 17042 7227 3 89 16950 9786 
SA1728 13 Blend Caeca H57 25934 25934 21803 12838 13 129 21661 11547 
SA1729 13 Blend Caeca H57 14133 14133 12023 6882 9 94 11920 7170 
SA1730 13 Blend Caeca H57 15557 15557 13108 7443 49 159 12900 7093 
SA1731 21 Sorghum Ileum Control 71719 71719 61148 26812 171 99 60878 51945 
SA1732 21 Sorghum Ileum Control 66077 66077 56906 34567 332 45 56529 54729 
SA1733 21 Sorghum Ileum Control 75039 75039 64608 38415 1260 56 63292 60430 
SA1734 21 Sorghum Ileum Control 57216 57216 49798 26338 10 53 49735 48326 
SA1735 21 Sorghum Ileum Control 55527 55527 48022 27566 2904 40 45078 42384 
SA1736 21 Sorghum Ileum Control 68555 68555 59457 34548 873 249 58335 54198 
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SA1737 21 Sorghum Ileum H57 67051 67051 55003 26740 70 77 54856 49099 
SA1738 21 Sorghum Ileum H57 69075 69075 60175 35161 399 73 59703 54227 
SA1739 21 Sorghum Ileum H57 69980 69980 61465 38344 51 113 61301 53709 
SA1740 21 Sorghum Ileum H57 33748 33748 29941 18855 157 23 29761 29002 
SA1741 21 Sorghum Ileum H57 52926 52926 47374 27658 32 22 47320 46415 
SA1742 21 Sorghum Ileum H57 109446 109446 97860 53342 119 62 97679 93375 
SA1743 21 Sorghum Caeca Control 79067 79067 67905 36048 66 1015 66824 39099 
SA1744 21 Sorghum Caeca Control 84883 84883 70857 32492 85 761 70011 42811 
SA1745 21 Sorghum Caeca Control 83935 83935 69658 30525 248 623 68787 44628 
SA1746 21 Sorghum Caeca Control 73293 73293 61357 31549 172 671 60514 36281 
SA1747 21 Sorghum Caeca Control 73716 73716 61659 29538 363 679 60617 34217 
SA1748 21 Sorghum Caeca Control 124517 124517 102181 42761 423 1668 100090 56012 
SA1749 21 Sorghum Caeca H57 42045 42045 35566 16625 89 728 34749 19213 
SA1750 21 Sorghum Caeca H57 48926 48926 41146 19073 74 433 40639 22134 
SA1751 21 Sorghum Caeca H57 65247 65247 56110 28481 199 299 55612 41233 
SA1752 21 Sorghum Caeca H57 75177 75177 63004 27823 54 837 62113 37366 
SA1753 21 Sorghum Caeca H57 48666 48666 38945 16690 27 766 38152 21806 
SA1754 21 Sorghum Caeca H57 71234 71234 59905 30196 93 852 58960 33367 
SA1755 21 Wheat Ileum Control 61530 61530 54041 33098 159 37 53845 52276 
SA1756 21 Wheat Ileum Control 64733 64733 57319 34901 89 63 57167 54179 
SA1757 21 Wheat Ileum Control 78782 78782 65172 41006 28 43 65101 63388 
SA1758 21 Wheat Ileum Control 48967 48967 42626 24513 110 60 42456 39771 
SA1759 21 Wheat Ileum Control 40745 40745 36440 22916 244 49 36147 33288 
SA1760 21 Wheat Ileum Control 72208 72208 63879 37877 1753 142 61984 56165 
SA1761 21 Wheat Ileum H57 73056 73056 63971 40345 48 56 63867 59535 
SA1762 21 Wheat Ileum H57 61830 61830 54838 33113 15 48 54775 52810 
SA1763 21 Wheat Ileum H57 53771 53771 48226 28960 98 17 48111 46741 
SA1764 21 Wheat Ileum H57 77433 77433 68844 43582 525 121 68198 59660 
SA1765 21 Wheat Ileum H57 60729 60729 54711 28875 574 31 54106 51988 
SA1766 21 Wheat Ileum H57 82778 82778 73684 43492 10 65 73609 68845 
SA1767 21 Wheat Caeca Control 67825 67825 57438 29279 46 1779 55613 26886 
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SA1768 21 Wheat Caeca Control 42526 42526 35623 17076 39 438 35146 21617 
SA1769 21 Wheat Caeca Control 59084 59084 48228 28264 25 517 47686 29188 
SA1770 21 Wheat Caeca Control 71122 71122 60254 34217 38 483 59733 36101 
SA1771 21 Wheat Caeca Control 61075 61075 48598 15895 43 575 47980 31117 
SA1772 21 Wheat Caeca Control 66968 66968 52176 23990 58 1205 50913 23809 
SA1773 21 Wheat Caeca H57 49050 49050 40107 18696 22 643 39442 22329 
SA1774 21 Wheat Caeca H57 40901 40901 33729 14644 32 466 33231 20048 
SA1775 21 Wheat Caeca H57 63295 63295 53343 24414 32 1048 52263 29644 
SA1776 21 Wheat Caeca H57 75176 75176 62916 32487 99 516 62301 41097 
SA1777 21 Wheat Caeca H57 68086 68086 55958 26080 72 478 55408 35824 
SA1778 21 Wheat Caeca H57 69435 69435 58081 31154 37 595 57449 36535 
SA1779 21 Blend Ileum Control 125120 125120 110080 67561 246 101 109733 103301 
SA1780 21 Blend Ileum Control 65276 65276 57494 35300 150 52 57292 54993 
SA1781 21 Blend Ileum Control 65755 65755 56810 35318 114 28 56668 55693 
SA1782 21 Blend Ileum Control 62633 62633 54607 31612 734 68 53805 50549 
SA1783 21 Blend Ileum Control 67759 67759 60758 38800 479 60 60219 57955 
SA1784 21 Blend Ileum Control 66901 66901 59259 36354 95 39 59125 56643 
SA1785 21 Blend Ileum H57 60142 60142 52673 31931 44 54 52575 50967 
SA1786 21 Blend Ileum H57 44499 44499 39297 23662 51 39 39207 37699 
SA1787 21 Blend Ileum H57 54442 54442 48748 26251 33 26 48689 45908 
SA1788 21 Blend Ileum H57 62627 62627 55461 32213 204 68 55189 51651 
SA1789 21 Blend Ileum H57 165809 165809 147189 80205 330 52 146807 139080 
SA1790 21 Blend Ileum H57 112227 112227 99073 53918 4599 69 94405 91054 
SA1791 21 Blend Caeca Control 210896 210896 177591 82517 225 2338 175028 103327 
SA1792 21 Blend Caeca Control 60023 60023 49703 23712 47 842 48814 27601 
SA1793 21 Blend Caeca Control 81683 81683 66966 26232 23 1025 65918 38402 
SA1794 21 Blend Caeca Control 60834 60834 50986 25138 70 549 50367 31113 
SA1795 21 Blend Caeca Control 95710 95710 77876 39622 91 1354 76431 35215 
SA1796 21 Blend Caeca Control 55078 55078 43626 23477 46 519 43061 28993 
SA1797 21 Blend Caeca H57 45999 45999 38073 18730 110 443 37520 22073 
SA1798 21 Blend Caeca H57 84125 84125 67283 29953 77 1091 66115 28234 
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SA1799 21 Blend Caeca H57 64672 64672 54716 27439 71 940 53705 32880 
SA1800 21 Blend Caeca H57 47686 47686 39866 21702 32 763 39071 22493 
SA1801 21 Blend Caeca H57 78730 78730 65052 30680 41 2397 62614 30796 
SA1802 21 Blend Caeca H57 61558 61558 50789 24881 26 1361 49402 26419 
SA1803 13 Sorghum Faeces Control 65697 65697 57649 33647 325 38 57286 56230 
SA1804 13 Sorghum Faeces Control 78298 78298 67978 41095 56 57 67865 65952 
SA1805 13 Sorghum Faeces Control 70666 70666 60412 33592 70 1061 59281 33140 
SA1806 13 Sorghum Faeces Control 40063 40063 35050 18283 74 127 34849 28573 
SA1807 13 Sorghum Faeces Control 84117 84117 75392 43397 17 47 75328 73093 
SA1808 13 Sorghum Faeces Control 85619 85619 75932 42389 51 56 75825 72887 
SA1809 13 Sorghum Faeces H57 45205 45205 39699 23399 76 47 39576 37622 
SA1810 13 Sorghum Faeces H57 50582 50582 44551 24754 48 48 44455 42121 
SA1811 13 Sorghum Faeces H57 46311 46311 40250 24187 69 13 40168 39141 
SA1812 13 Sorghum Faeces H57 37366 37366 31741 20510 21 16 31704 31170 
SA1813 13 Sorghum Faeces H57 80490 80490 71855 40362 81 47 71727 69334 
SA1814 13 Sorghum Faeces H57 112704 112704 95560 54498 54 67 95439 92366 
SA1815 13 Wheat Faeces Control 59243 59243 53148 31645 9 35 53104 51880 
SA1816 13 Wheat Faeces Control 74966 74966 63130 34729 23 517 62590 43452 
SA1817 13 Wheat Faeces Control 50287 50287 40706 26348 9 32 40665 39972 
SA1818 13 Wheat Faeces Control 59555 59555 49853 29023 12 49 49792 48036 
SA1819 13 Wheat Faeces Control 47574 47574 41391 23909 1 63 41327 39539 
SA1820 13 Wheat Faeces Control 64130 64130 55364 34157 10 215 55139 44014 
SA1821 13 Wheat Faeces H57 32230 32230 28587 14622 18 16 28553 28053 
SA1822 13 Wheat Faeces H57 29510 29510 25525 13281 6 51 25468 22504 
SA1823 13 Wheat Faeces H57 12885 12885 11578 6794 1 4 11573 11481 
SA1824 13 Wheat Faeces H57 32863 32863 29114 16331 1 16 29097 28134 
SA1825 13 Wheat Faeces H57 56926 56926 50137 27761 23 50 50064 46754 
SA1826 13 Wheat Faeces H57 44359 44359 37841 21080 689 57 37095 35167 
SA1827 13 Blend Faeces Control 291699 291699 256263 159362 80 255 255928 241947 
SA1828 13 Blend Faeces Control 275125 275125 239858 150741 750 355 238753 220996 
SA1829 13 Blend Faeces Control 280254 280254 247844 150021 195 327 247322 227979 
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SA1830 13 Blend Faeces Control 199029 199029 169325 94792 743 322 168260 148755 
SA1831 13 Blend Faeces Control 336112 336112 290732 178675 290 3651 286791 147651 
SA1832 13 Blend Faeces Control 342343 342343 302473 185949 321 136 302016 297591 
SA1833 13 Blend Faeces H57 359038 359038 306232 189355 1863 521 303848 266898 
SA1834 13 Blend Faeces H57 318909 318909 277696 171870 174 240 277282 265906 
SA1835 13 Blend Faeces H57 163465 163465 143539 85426 89 101 143349 139246 
SA1836 13 Blend Faeces H57 133513 133513 116225 51566 62 87 116076 108145 
SA1837 13 Blend Faeces H57 196575 196575 173133 97611 224 151 172758 165599 
SA1838 13 Blend Faeces H57 160035 160035 141453 74552 164 124 141165 135913 
Average  47194 47194 40600 22900 128 196 40276 33224 
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Table S12: Average relative abundance of functional genes at different level of KEGG Orthology (KO) classification in the caecum of chickens fed sorghum 
based and wheat based diet at the age of day 13 
KO Classification  Average relative abundance 
Level 1 Level 2 Level 3 Sorghum 
Control 
Sorghum 
H57 
Wheat 
Control 
Wheat 
H57 
Cellular Processes Cell communication 04530 Tight junction [PATH:ko04530] 0 0 0.000809 0 
Cellular Processes Cell growth and death 04110 Cell cycle [PATH:ko04110] 0 0.000142 0 0 
Cellular Processes Cell growth and death 04112 Cell cycle - Caulobacter [PATH:ko04112] 2.287779 2.321593 2.479505 1.877131 
Cellular Processes Cell growth and death 04113 Meiosis - yeast [PATH:ko04113] 0.000091 0 0.000200 0 
Cellular Processes Cell growth and death 04210 Apoptosis [PATH:ko04210] 0 0.003278 0.002357 0.012053 
Cellular Processes Cell motility 02030 Bacterial chemotaxis [PATH:ko02030] 0.280768 0.289414 0.360128 0.328790 
Cellular Processes Cell motility 02040 Flagellar assembly [PATH:ko02040] 0.032425 0.083631 0.015961 0.061261 
Cellular Processes Transport and catabolism 04142 Lysosome [PATH:ko04142] 0.384032 0.046664 0.036814 0.098756 
Cellular Processes Transport and catabolism 04144 Endocytosis [PATH:ko04144] 0.000878 0 0.000191 0.000087 
Cellular Processes Transport and catabolism 04145 Phagosome [PATH:ko04145] 0 0.000354 0.000809 0 
Cellular Processes Transport and catabolism 04146 Peroxisome [PATH:ko04146] 0.498239 0.243095 0.382283 0.295365 
Environmental 
Information Processing 
Membrane transport 02010 ABC transporters [PATH:ko02010] 6.261668 8.537975 8.998237 8.800924 
Environmental 
Information Processing 
Membrane transport 02060 Phosphotransferase system (PTS) [PATH:ko02060] 0.782979 1.511406 1.015719 1.441844 
Environmental 
Information Processing 
Membrane transport 03070 Bacterial secretion system [PATH:ko03070] 2.052348 2.201130 2.053015 2.152386 
Environmental 
Information Processing 
Signal transduction 02020 Two-component system [PATH:ko02020] 1.713799 1.560137 1.967743 1.736254 
Environmental 
Information Processing 
Signal transduction 04011 MAPK signaling pathway - yeast [PATH:ko04011] 0.021631 0.004340 0.003493 0.016080 
Environmental 
Information Processing 
Signal transduction 04020 Calcium signaling pathway [PATH:ko04020] 0.000102 0.000147 0 0 
Environmental 
Information Processing 
Signal transduction 04066 HIF-1 signaling pathway [PATH:ko04066] 0.566587 0.477539 0.421366 0.538426 
Environmental 
Information Processing 
Signal transduction 04070 Phosphatidylinositol signaling system 
[PATH:ko04070] 
0.067782 0.018341 0.080829 0.066764 
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Environmental 
Information Processing 
Signal transduction 04151 PI3K-Akt signaling pathway [PATH:ko04151] 0.194971 0.216140 0.121106 0.121625 
Environmental 
Information Processing 
Signal transduction 04310 Wnt signaling pathway [PATH:ko04310] 0 0.000337 0 0 
Environmental 
Information Processing 
Signaling molecules and interaction 04080 Neuroactive ligand-receptor interaction 
[PATH:ko04080] 
0 0.000049 0 0 
Environmental 
Information Processing 
Signaling molecules and interaction 04512 ECM-receptor interaction [PATH:ko04512] 0 0 0 0.000089 
Environmental 
Information Processing 
Signaling molecules and interaction 04514 Cell adhesion molecules (CAMs) [PATH:ko04514] 0 0 0 0.000331 
Genetic Information 
Processing 
Folding, sorting and degradation 03018 RNA degradation [PATH:ko03018] 3.271246 3.051442 2.945860 3.156704 
Genetic Information 
Processing 
Folding, sorting and degradation 03050 Proteasome [PATH:ko03050] 0.000681 0 0.098736 0.048840 
Genetic Information 
Processing 
Folding, sorting and degradation 03060 Protein export [PATH:ko03060] 0.147704 0.012507 0.038075 0.041043 
Genetic Information 
Processing 
Folding, sorting and degradation 04120 Ubiquitin mediated proteolysis [PATH:ko04120] 0 0.000098 0 0 
Genetic Information 
Processing 
Folding, sorting and degradation 04122 Sulfur relay system [PATH:ko04122] 0.274571 0.379589 0.311536 0.390393 
Genetic Information 
Processing 
Folding, sorting and degradation 04141 Protein processing in endoplasmic reticulum 
[PATH:ko04141] 
0.023779 0.001921 0.007145 0.008098 
Genetic Information 
Processing 
Replication and repair 03030 DNA replication [PATH:ko03030] 1.890663 2.103299 1.882236 1.777900 
Genetic Information 
Processing 
Replication and repair 03410 Base excision repair [PATH:ko03410] 0.521935 0.474688 0.438833 0.433062 
Genetic Information 
Processing 
Replication and repair 03420 Nucleotide excision repair [PATH:ko03420] 1.975357 2.093031 2.022562 2.047384 
Genetic Information 
Processing 
Replication and repair 03430 Mismatch repair [PATH:ko03430] 0.490717 0.484418 0.303812 0.328866 
Genetic Information 
Processing 
Replication and repair 03440 Homologous recombination [PATH:ko03440] 1.535587 1.482270 1.586034 1.372346 
Genetic Information 
Processing 
Transcription 03020 RNA polymerase [PATH:ko03020] 4.169055 4.450112 4.214214 3.994087 
Genetic Information 
Processing 
Transcription 03040 Spliceosome [PATH:ko03040] 0.000774 0 0.005034 0.007945 
Genetic Information 
Processing 
Translation 00970 Aminoacyl-tRNA biosynthesis [PATH:ko00970] 6.770924 7.342966 6.227955 7.415765 
Genetic Information 
Processing 
Translation 03010 Ribosome [PATH:ko03010] 4.032363 4.175597 4.288662 3.666576 
Genetic Information Translation 03013 RNA transport [PATH:ko03013] 0.127781 0.060408 0.067084 0.118098 
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Processing 
Human Diseases Cancers 05200 Pathways in cancer [PATH:ko05200] 0.005259 0.016465 0.006181 0.038963 
Human Diseases Cancers 05203 Viral carcinogenesis [PATH:ko05203] 0.301854 0.360568 0.234889 0.257388 
Human Diseases Cancers 05204 Chemical carcinogenesis [PATH:ko05204] 0.000583 0.002111 0.002041 0.002072 
Human Diseases Cancers 05215 Prostate cancer [PATH:ko05215] 0.001916 0 0 0 
Human Diseases Cancers 05219 Bladder cancer [PATH:ko05219] 0.004964 0.014036 0.003869 0.007620 
Human Diseases Endocrine and metabolic diseases 04940 Type I diabetes mellitus [PATH:ko04940] 0.032342 0.001048 0.000382 0.008703 
Human Diseases Immune diseases 05340 Primary immunodeficiency [PATH:ko05340] 0.000518 0.006056 0.003818 0.025685 
Human Diseases Infectious diseases 05100 Bacterial invasion of epithelial cells 
[PATH:ko05100] 
0.000790 0.021876 0.026654 0.030734 
Human Diseases Infectious diseases 05111 Vibrio cholerae pathogenic cycle [PATH:ko05111] 0.045902 0.011509 0.048147 0.048477 
Human Diseases Infectious diseases 05120 Epithelial cell signaling in Helicobacter pylori 
infection [PATH:ko05120] 
0.313873 0.196639 0.172268 0.231696 
Human Diseases Infectious diseases 05132 Salmonella infection [PATH:ko05132] 0.017519 0 0 0.001906 
Human Diseases Infectious diseases 05134 Legionellosis [PATH:ko05134] 0.252367 0.075781 0.162755 0.210492 
Human Diseases Infectious diseases 05142 Chagas disease (American trypanosomiasis) 
[PATH:ko05142] 
0 0.000108 0.086515 0.139472 
Human Diseases Infectious diseases 05143 African trypanosomiasis [PATH:ko05143] 0.001019 0.003393 0 0.003761 
Human Diseases Infectious diseases 05144 Malaria [PATH:ko05144] 0 0.000098 0 0 
Human Diseases Infectious diseases 05146 Amoebiasis [PATH:ko05146] 0.013313 0.000501 0.002028 0.000662 
Human Diseases Infectious diseases 05150 Staphylococcus aureus infection [PATH:ko05150] 0.030502 0.021524 0.010512 0.174058 
Human Diseases Neurodegenerative diseases 05010 Alzheimer's disease [PATH:ko05010] 0.000880 0.000132 0 0.000786 
Human Diseases Neurodegenerative diseases 05012 Parkinson's disease [PATH:ko05012] 0 0 0 0.000357 
Human Diseases Substance dependence 05030 Cocaine addiction [PATH:ko05030] 0.000119 0.000084 0 0 
Metabolism Amino acid metabolism 00250 Alanine, aspartate and glutamate metabolism 
[PATH:ko00250] 
5.524145 5.492114 5.272254 5.289959 
Metabolism Amino acid metabolism 00260 Glycine, serine and threonine metabolism 
[PATH:ko00260] 
3.244323 2.912098 2.994151 3.031144 
Metabolism Amino acid metabolism 00270 Cysteine and methionine metabolism 
[PATH:ko00270] 
2.104482 2.600167 2.500262 2.083621 
Metabolism Amino acid metabolism 00280 Valine, leucine and isoleucine degradation 
[PATH:ko00280] 
0.707426 0.565010 0.528968 0.485956 
Metabolism Amino acid metabolism 00290 Valine, leucine and isoleucine biosynthesis 
[PATH:ko00290] 
1.828326 2.063256 2.386016 1.846560 
Metabolism Amino acid metabolism 00300 Lysine biosynthesis [PATH:ko00300] 1.811626 2.070017 1.857568 1.935998 
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Metabolism Amino acid metabolism 00310 Lysine degradation [PATH:ko00310] 0.045568 0.057816 0.089381 0.039451 
Metabolism Amino acid metabolism 00330 Arginine and proline metabolism [PATH:ko00330] 2.070231 2.110306 2.166754 1.707950 
Metabolism Amino acid metabolism 00340 Histidine metabolism [PATH:ko00340] 1.106824 1.194488 1.203264 0.912890 
Metabolism Amino acid metabolism 00350 Tyrosine metabolism [PATH:ko00350] 0.336808 0.393100 0.507080 0.680020 
Metabolism Amino acid metabolism 00360 Phenylalanine metabolism [PATH:ko00360] 0.388464 0.310979 0.338793 0.254572 
Metabolism Amino acid metabolism 00380 Tryptophan metabolism [PATH:ko00380] 0.036145 0.004032 0.000792 0.051820 
Metabolism Amino acid metabolism 00400 Phenylalanine, tyrosine and tryptophan biosynthesis 
[PATH:ko00400] 
0.972707 0.747697 0.827996 0.835164 
Metabolism Biosynthesis of other secondary 
metabolites 
00311 Penicillin and cephalosporin biosynthesis 
[PATH:ko00311] 
0 0.000049 0 0 
Metabolism Biosynthesis of other secondary 
metabolites 
00312 beta-Lactam resistance [PATH:ko00312] 0.006798 0.002397 0.005494 0.006826 
Metabolism Biosynthesis of other secondary 
metabolites 
00521 Streptomycin biosynthesis [PATH:ko00521] 0.952181 0.706120 1.070862 1.073504 
Metabolism Biosynthesis of other secondary 
metabolites 
00940 Phenylpropanoid biosynthesis [PATH:ko00940] 1.013448 0.594014 0.645047 1.039915 
Metabolism Biosynthesis of Other Secondary 
Metabolites 
00941 Flavonoid biosynthesis [PATH:ko00941] 0.000098 0 0 0 
Metabolism Biosynthesis of other secondary 
metabolites 
00945 Stilbenoid, diarylheptanoid and gingerol 
biosynthesis [PATH:ko00945] 
0 0.000330 0 0.008702 
Metabolism Biosynthesis of other secondary 
metabolites 
00960 Tropane, piperidine and pyridine alkaloid 
biosynthesis [PATH:ko00960] 
0.000119 0.013373 0.004395 0.000689 
Metabolism Carbohydrate metabolism 00010 Glycolysis / Gluconeogenesis [PATH:ko00010] 2.852132 3.309255 2.638758 2.348353 
Metabolism Carbohydrate metabolism 00020 Citrate cycle (TCA cycle) [PATH:ko00020] 1.082470 0.511898 0.590755 0.841216 
Metabolism Carbohydrate metabolism 00030 Pentose phosphate pathway [PATH:ko00030] 1.247451 1.480809 1.361495 1.832354 
Metabolism Carbohydrate metabolism 00040 Pentose and glucuronate interconversions 
[PATH:ko00040] 
1.525952 1.462787 1.476369 1.461933 
Metabolism Carbohydrate metabolism 00051 Fructose and mannose metabolism 
[PATH:ko00051] 
1.198825 0.555040 0.695164 1.098311 
Metabolism Carbohydrate metabolism 00052 Galactose metabolism [PATH:ko00052] 2.207629 2.268026 2.050028 1.954769 
Metabolism Carbohydrate metabolism 00053 Ascorbate and aldarate metabolism 
[PATH:ko00053] 
0.030795 0.021303 0.027339 0.020507 
Metabolism Carbohydrate metabolism 00500 Starch and sucrose metabolism [PATH:ko00500] 1.924107 2.288293 2.391785 2.312768 
Metabolism Carbohydrate metabolism 00520 Amino sugar and nucleotide sugar metabolism 
[PATH:ko00520] 
1.690948 1.733578 1.788720 1.639225 
Metabolism Carbohydrate metabolism 00562 Inositol phosphate metabolism [PATH:ko00562] 0.033163 0.102913 0.125676 0.097285 
Metabolism Carbohydrate metabolism 00620 Pyruvate metabolism [PATH:ko00620] 2.273406 2.849409 2.508084 2.718437 
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Metabolism Carbohydrate metabolism 00630 Glyoxylate and dicarboxylate metabolism 
[PATH:ko00630] 
0.173743 0.226558 0.227961 0.255772 
Metabolism Carbohydrate metabolism 00640 Propanoate metabolism [PATH:ko00640] 0.043013 0.040584 0.055955 0.011718 
Metabolism Carbohydrate metabolism 00650 Butanoate metabolism [PATH:ko00650] 0.248851 0.321416 0.154792 0.151530 
Metabolism Carbohydrate metabolism 00660 C5-Branched dibasic acid metabolism 
[PATH:ko00660] 
0.009524 0.081466 0.032062 0.033815 
Metabolism Energy metabolism 00190 Oxidative phosphorylation [PATH:ko00190] 2.495418 1.915229 2.381371 2.329239 
Metabolism Energy metabolism 00680 Methane metabolism [PATH:ko00680] 0.394826 0.720278 0.621958 0.689541 
Metabolism Energy metabolism 00710 Carbon fixation in photosynthetic organisms 
[PATH:ko00710] 
0.019974 0.010729 0.072322 0.117446 
Metabolism Energy metabolism 00720 Carbon fixation pathways in prokaryotes 
[PATH:ko00720] 
0.374747 0.431598 0.536224 0.482650 
Metabolism Energy metabolism 00910 Nitrogen metabolism [PATH:ko00910] 0.032092 0.025711 0.054164 0.021254 
Metabolism Energy metabolism 00920 Sulfur metabolism [PATH:ko00920] 0.136941 0.009220 0.009333 0.014865 
Metabolism Glycan biosynthesis and 
metabolism 
00510 N-Glycan biosynthesis [PATH:ko00510] 0.026256 0.000698 0.003936 0.011822 
Metabolism Glycan biosynthesis and 
metabolism 
00511 Other glycan degradation [PATH:ko00511] 0.360034 0.153645 0.084772 0.069591 
Metabolism Glycan biosynthesis and 
metabolism 
00512 Mucin type O-glycan biosynthesis 
[PATH:ko00512] 
0 0.000049 0 0 
Metabolism Glycan biosynthesis and 
metabolism 
00531 Glycosaminoglycan degradation [PATH:ko00531] 0.044563 0.000225 0.020320 0.001726 
Metabolism Glycan biosynthesis and 
metabolism 
00532 Glycosaminoglycan biosynthesis - chondroitin 
sulfate / dermatan sulfate [PATH:ko00532] 
0 0.000142 0 0 
Metabolism Glycan biosynthesis and 
metabolism 
00533 Glycosaminoglycan biosynthesis - keratan sulfate 
[PATH:ko00533] 
0 0.000142 0 0 
Metabolism Glycan biosynthesis and 
metabolism 
00540 Lipopolysaccharide biosynthesis [PATH:ko00540] 0.350973 0.026929 0.067753 0.043795 
Metabolism Glycan biosynthesis and 
metabolism 
00550 Peptidoglycan biosynthesis [PATH:ko00550] 1.203687 0.835101 1.037116 1.146043 
Metabolism Lipid metabolism 00061 Fatty acid biosynthesis [PATH:ko00061] 1.108761 0.825275 0.974762 1.245448 
Metabolism Lipid metabolism 00071 Fatty acid metabolism [PATH:ko00071] 0.000189 0.004896 0 0.002230 
Metabolism Lipid metabolism 00120 Primary bile acid biosynthesis [PATH:ko00120] 0.044686 0.019083 0.025081 0.054500 
Metabolism Lipid metabolism 00140 Steroid hormone biosynthesis [PATH:ko00140] 0.014420 0 0.002245 0.001382 
Metabolism Lipid metabolism 00561 Glycerolipid metabolism [PATH:ko00561] 0.388770 0.669935 0.546262 0.729009 
Metabolism Lipid metabolism 00564 Glycerophospholipid metabolism [PATH:ko00564] 0.477019 0.550714 0.486880 0.551189 
Metabolism Lipid metabolism 00590 Arachidonic acid metabolism [PATH:ko00590] 0.003353 0.006091 0.003949 0.010961 
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Metabolism Lipid metabolism 01040 Biosynthesis of unsaturated fatty acids 
[PATH:ko01040] 
0.000639 0.003742 0.054474 0.037598 
Metabolism Metabolism of cofactors and 
vitamins 
00130 Ubiquinone and other terpenoid-quinone 
biosynthesis [PATH:ko00130] 
0.306733 0.056191 0.145714 0.185938 
Metabolism Metabolism of cofactors and 
vitamins 
00670 One carbon pool by folate [PATH:ko00670] 0.431615 0.430236 0.402261 0.364897 
Metabolism Metabolism of cofactors and 
vitamins 
00730 Thiamine metabolism [PATH:ko00730] 0.680639 0.357630 0.601086 0.448361 
Metabolism Metabolism of cofactors and 
vitamins 
00740 Riboflavin metabolism [PATH:ko00740] 0.250492 0.087781 0.090529 0.212203 
Metabolism Metabolism of cofactors and 
vitamins 
00750 Vitamin B6 metabolism [PATH:ko00750] 0.246018 0.029086 0.059575 0.116727 
Metabolism Metabolism of cofactors and 
vitamins 
00760 Nicotinate and nicotinamide metabolism 
[PATH:ko00760] 
0.813018 0.574383 0.823517 0.717025 
Metabolism Metabolism of cofactors and 
vitamins 
00770 Pantothenate and CoA biosynthesis 
[PATH:ko00770] 
0.428412 0.274855 0.373278 0.341389 
Metabolism Metabolism of cofactors and 
vitamins 
00780 Biotin metabolism [PATH:ko00780] 0.234450 0.044921 0.076317 0.130424 
Metabolism Metabolism of cofactors and 
vitamins 
00785 Lipoic acid metabolism [PATH:ko00785] 0.038581 0.007648 0.027309 0.049699 
Metabolism Metabolism of cofactors and 
vitamins 
00790 Folate biosynthesis [PATH:ko00790] 0.269459 0.164167 0.176740 0.132451 
Metabolism Metabolism of cofactors and 
vitamins 
00860 Porphyrin and chlorophyll metabolism 
[PATH:ko00860] 
0.668177 0.726352 0.510521 0.625926 
Metabolism Metabolism of other amino acids 00430 Taurine and hypotaurine metabolism 
[PATH:ko00430] 
0 0 0 0.001260 
Metabolism Metabolism of other amino acids 00440 Phosphonate and phosphinate metabolism 
[PATH:ko00440] 
0.115392 0.089151 0.085840 0.167832 
Metabolism Metabolism of other amino acids 00450 Selenocompound metabolism [PATH:ko00450] 0.079972 0.110047 0.188971 0.180503 
Metabolism Metabolism of other amino acids 00480 Glutathione metabolism [PATH:ko00480] 0.218961 0.069748 0.252620 0.365016 
Metabolism Metabolism of terpenoids and 
polyketides 
00281 Geraniol degradation [PATH:ko00281] 0.160166 0.003786 0.016464 0.010862 
Metabolism Metabolism of terpenoids and 
polyketides 
00900 Terpenoid backbone biosynthesis [PATH:ko00900] 0.832114 0.711969 0.968719 0.603458 
Metabolism Metabolism of terpenoids and 
polyketides 
00906 Carotenoid biosynthesis [PATH:ko00906] 0 0 0 0.000345 
Metabolism Metabolism of terpenoids and 
polyketides 
00908 Zeatin biosynthesis [PATH:ko00908] 0.118197 0.058172 0.113136 0.066590 
Metabolism Metabolism of terpenoids and 
polyketides 
01053 Biosynthesis of siderophore group nonribosomal 
peptides [PATH:ko01053] 
0.002604 0.010330 0.025601 0.008675 
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Metabolism Nucleotide metabolism 00230 Purine metabolism [PATH:ko00230] 3.829498 4.011497 4.095640 3.850074 
Metabolism Nucleotide metabolism 00240 Pyrimidine metabolism [PATH:ko00240] 1.797507 1.945831 1.854745 1.770959 
Metabolism Xenobiotics biodegradation and 
metabolism 
00361 Chlorocyclohexane and chlorobenzene degradation 
[PATH:ko00361] 
0.000274 0.003926 0.003930 0.004264 
Metabolism Xenobiotics biodegradation and 
metabolism 
00362 Benzoate degradation [PATH:ko00362] 0.034285 0.001111 0.000409 0.005844 
Metabolism Xenobiotics biodegradation and 
metabolism 
00622 Xylene degradation [PATH:ko00622] 0 0.000318 0 0 
Metabolism Xenobiotics Biodegradation and 
Metabolism 
00624 Polycyclic aromatic hydrocarbon degradation 
[PATH:ko00624] 
0 0.000071 0 0 
Metabolism Xenobiotics biodegradation and 
metabolism 
00625 Chloroalkane and chloroalkene degradation 
[PATH:ko00625] 
0 0.000587 0.000200 0 
Metabolism Xenobiotics biodegradation and 
metabolism 
00627 Aminobenzoate degradation [PATH:ko00627] 0.001145 0.003898 0.001649 0.016919 
Metabolism Xenobiotics biodegradation and 
metabolism 
00633 Nitrotoluene degradation [PATH:ko00633] 0.018802 0.005946 0.004589 0.033606 
Metabolism Xenobiotics biodegradation and 
metabolism 
00643 Styrene degradation [PATH:ko00643] 0.000584 0.000049 0 0.000228 
Metabolism Xenobiotics biodegradation and 
metabolism 
00791 Atrazine degradation [PATH:ko00791] 0.002139 0.015443 0.004546 0.011467 
Metabolism Xenobiotics biodegradation and 
metabolism 
00930 Caprolactam degradation [PATH:ko00930] 0 0.000049 0 0 
Metabolism Xenobiotics biodegradation and 
metabolism 
00983 Drug metabolism - other enzymes [PATH:ko00983] 0.041978 0.032385 0.025162 0.006019 
Organismal Systems Circulatory system 04260 Cardiac muscle contraction [PATH:ko04260] 0 0 0 0.000087 
Organismal Systems Development 04360 Axon guidance [PATH:ko04360] 0 0 0.000405 0 
Organismal Systems Digestive system 04974 Protein digestion and absorption [PATH:ko04974] 0.241116 0 0.047391 0.053256 
Organismal Systems Endocrine system 04910 Insulin signaling pathway [PATH:ko04910] 0.015526 0.004160 0.009230 0.000877 
Organismal Systems Environmental adaptation 04626 Plant-pathogen interaction [PATH:ko04626] 0.550139 0.508011 0.368556 0.355691 
Organismal Systems Excretory system 04962 Vasopressin-regulated water reabsorption 
[PATH:ko04962] 
0 0.000147 0 0 
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Table S13: Average relative abundance of functional genes, with significantly different relative abundance between control and H57 fed chickens, at level 3 
SEED subsystem classification in the caecum of chickens fed sorghum based and wheat based diet at the age of day 13  
 
Functional genes (SEED Subsystem Level 3 Classification) 
Average Relative Abundance 
Sorghum 
Control 
sorghum 
H57 
P-value* Wheat 
Control 
Wheat 
H57 
P-value* 
At5g63420 0.160712 0.254225 0.015 0.219713 0.372993 0.002 
Dihydroxyacetone_kinases 0.017816 0.050920 0.002 0.002339 0.055145 0.022 
Macromolecular_synthesis_operon 0.385415 0.683395 0.008 0.707608 0.411347 0.042 
Mannose_Metabolism 0.634260 0.132016 0.028 0.067116 0.256118 0.019 
Translation_termination_factors_bacterial 0.255279 0.340528 0.034 0.252377 0.359311 0.029 
tRNA_aminoacylation,_Ile 0.089506 0.204248 0.018 0.139186 0.291252 0.041 
16S_rRNA_modification_within_P_site_of_ribosome 0.084276 0.120724 0.048 0.089017 0.182569 0.076 
ABC_transporter_oligopeptide_(TC_3.A.1.5.1) 0.253477 0.562275 0.031 0.484378 0.752073 0.127 
Aerotolerance_operon_in_Bacteroides_and_potentially_orthologous_operons_in_
other_organisms 
0.186869 0.000000 0.028 0.027017 0.023013 0.898 
Bacterial_Cytoskeleton 0.762569 1.072622 0.019 0.798786 1.088408 0.177 
CBSS-176280.1.peg.1561 0.213466 0.048551 0.023 0.133435 0.068360 0.302 
CBSS-176299.4.peg.1292 0.185379 0.050513 0.006 0.102200 0.062707 0.135 
CBSS-194948.1.peg.143 0.040786 0.013504 0.022 0.007168 0.016421 0.130 
CBSS-288000.5.peg.1793 0.009607 0.107125 0.019 0.039475 0.065211 0.523 
CBSS-323850.3.peg.3284 0.056356 0.000000 0.042 0.000000 0.000302 0.347 
CBSS-354.1.peg.2917 0.073085 0.006676 0.047 0.047666 0.047300 0.989 
CBSS-56780.10.peg.1536 0.149081 0.091014 0.010 0.073100 0.092464 0.553 
CBSS-84588.1.peg.1247 0.024861 0.047254 0.048 0.047217 0.036972 0.691 
COG1836 0.182863 0.102837 0.037 0.138256 0.100169 0.371 
COG4319 0.041987 0.000540 0.036 0.010410 0.004138 0.306 
Cluster_with_phosphopentomutase_paralog 0.013086 0.062627 0.006 0.011907 0.036557 0.302 
Colanic_acid_biosynthesis 0.131809 0.004608 0.015 0.041376 0.005768 0.303 
Cysteine_Biosynthesis 0.347691 0.178312 0.026 0.178091 0.150620 0.753 
D-Sorbitol(D-Glucitol)_and_L-Sorbose_Utilization 0.005202 0.014528 0.034 0.025652 0.052077 0.162 
DNA_gyrase_subunits 0.229997 0.445423 0.007 0.378770 0.307906 0.398 
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DNA_processing_cluster 0.244496 0.461746 0.032 0.310657 0.237166 0.578 
Dipeptidases_(EC_3.4.13.-) 0.071775 0.018199 0.019 0.026321 0.022120 0.794 
Dipicolinate_Synthesis 0.032358 0.073382 0.006 0.071149 0.022880 0.073 
EC49-61 0.087293 0.014622 0.013 0.032776 0.029589 0.858 
Extracellular_Polysaccharide_Biosynthesis_of_Streptococci 0.001897 0.010004 0.033 0.009191 0.005693 0.585 
Fatty_Acid_Biosynthesis_FASII 0.635238 0.736901 0.021 0.661999 0.724958 0.565 
Fatty_acid_metabolism_cluster 0.081068 0.002885 0.036 0.061147 0.066833 0.882 
Glutamate_dehydrogenases 0.084460 0.240150 0.022 0.207457 0.264670 0.636 
Glutathione:_Non-redox_reactions 0.020414 0.000623 0.037 0.000222 0.002643 0.073 
Glycine_and_Serine_Utilization 0.321013 0.171071 0.031 0.243909 0.315215 0.439 
Heat_shock_dnaK_gene_cluster_extended 0.419260 0.642104 0.014 0.413703 0.529957 0.079 
Heme,_hemin_uptake_and_utilization_systems_in_GramNegatives 0.038658 0.002058 0.019 0.008741 0.006995 0.841 
Iron_acquisition_in_Vibrio 0.509186 0.021723 0.016 0.236633 0.046111 0.407 
Lactose_and_Galactose_Uptake_and_Utilization 0.820842 0.555635 0.015 0.674726 0.632842 0.620 
Lipopolysaccharide_assembly 0.152870 0.012780 0.033 0.008895 0.022403 0.080 
Listeria_phi-A118-like_prophages 0.002511 0.031147 0.020 0.025452 0.008546 0.284 
Mebrane_bound_hydrogenases 0.011544 0.067829 0.028 0.101739 0.009192 0.062 
Multidrug_Resistance_Efflux_Pumps 0.592731 0.182356 0.013 0.071999 0.132943 0.186 
Na(+)-translocating_NADH-quinone_oxidoreductase_and_rnf-
like_group_of_electron_transport_complexes 
0.384430 0.191682 0.025 0.145238 0.127350 0.618 
Neotrehalosadiamine_(NTD)_Biosynthesis_Operon 0.000000 0.000284 0.049 0.000202 0.000000 0.347 
P_uptake_(cyanobacteria) 0.205530 0.090542 0.038 0.134285 0.117538 0.703 
Peptidyl-prolyl_cis-trans_isomerase 0.058016 0.002726 0.037 0.020962 0.004579 0.406 
Periplasmic_disulfide_interchange 0.059301 0.000000 0.006 0.014955 0.002806 0.429 
Perosamine_Synthesis_Vibrio 0.055748 0.001688 0.048 0.025321 0.015860 0.532 
Photorespiration_(oxidative_C2_cycle) 0.122651 0.032328 0.003 0.062594 0.094831 0.054 
Potassium_homeostasis 0.355791 0.121590 0.034 0.342436 0.292794 0.659 
Protein_degradation 0.392461 0.093878 0.046 0.123670 0.212990 0.076 
Protocatechuate_branch_of_beta-ketoadipate_pathway 0.013126 0.076594 0.029 0.023240 0.048976 0.424 
Pterin_metabolism_3 0.040383 0.003303 0.040 0.012976 0.012081 0.917 
Pyridoxin_(Vitamin_B6)_Biosynthesis 0.320265 0.240357 0.007 0.187451 0.254887 0.249 
Respiratory_Complex_I 0.381903 0.008948 0.027 0.039978 0.015003 0.505 
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Serine-glyoxylate_cycle 1.045412 0.498338 0.013 0.569767 0.561567 0.886 
Sporulation-related_Hypotheticals 0.096656 0.212102 0.026 0.173643 0.241839 0.239 
Sporulation_Cluster 0.059317 0.163338 0.044 0.074200 0.076846 0.954 
Streptococcal_Mga_Regulon 0.076353 0.016151 0.029 0.007241 0.019610 0.284 
The_fimbrial_Stf_cluster 0.000105 0.000595 0.042 0.000000 0.003318 0.072 
The_mdtABCD_multidrug_resistance_cluster 0.198830 0.014779 0.040 0.021320 0.006180 0.489 
Threonine_and_Homoserine_Biosynthesis 0.351356 0.193797 0.028 0.240641 0.348940 0.248 
Ton_and_Tol_transport_systems 0.534177 0.003841 0.019 0.218429 0.042522 0.415 
Transport_of_Zinc 0.074171 0.010992 0.034 0.038398 0.048150 0.727 
Trehalose_Uptake_and_Utilization 0.271206 0.769278 0.009 0.571990 0.459153 0.627 
polyprenyl_synthesis 0.072882 0.129949 0.027 0.156188 0.082952 0.147 
r1t-like_streptococcal_phages 0.462801 0.811922 0.026 0.588664 0.512730 0.770 
rRNAs 0.056121 0.111901 0.000 0.067386 0.081141 0.673 
tRNA_aminoacylation,_Arg 0.145788 0.052261 0.002 0.079855 0.192663 0.204 
tRNA_aminoacylation,_Tyr 0.134038 0.037786 0.013 0.071090 0.112977 0.403 
Alkylphosphonate_utilization 0.015762 0.018564 0.866 0.002890 0.017093 0.035 
Biogenesis_of_c-type_cytochromes 0.027314 0.004958 0.344 0.002220 0.008717 0.043 
CBSS-176279.3.peg.868 0.027273 0.031411 0.764 0.041222 0.093297 0.043 
CBSS-323850.3.peg.3269 0.062387 0.112535 0.066 0.170043 0.045682 0.022 
Conjugative_transfer_related_cluster 0.064287 0.125281 0.126 0.173445 0.046459 0.045 
DNA-binding_regulatory_proteins,_strays 0.004312 0.010490 0.320 0.003094 0.021756 0.041 
Fermentations:_Lactate 0.120414 0.213535 0.312 0.238872 0.484384 0.028 
Fermentations:_Mixed_acid 0.252937 0.411548 0.107 0.538207 0.867814 0.004 
Formate_hydrogenase 0.030912 0.059308 0.338 0.008054 0.068106 0.034 
Galactose-inducible_PTS 0.012950 0.015466 0.823 0.011640 0.054189 0.048 
Glutamate_and_Aspartate_uptake_in_Bacteria 0.008906 0.011084 0.768 0.006962 0.044260 0.022 
Mannitol_Utilization 0.040250 0.039273 0.966 0.058238 0.143277 0.007 
Molybdopterin_cytosine_dinucleotide 0.000482 0.003315 0.378 0.000000 0.001438 0.012 
Multiple_Antibiotic_Resistance_MAR_locus 0.000000 0.000054 0.347 0.000000 0.001094 0.040 
Murein_Hydrolases 0.054492 0.038688 0.672 0.027947 0.068396 0.029 
Pentose_phosphate_pathway 0.245411 0.335315 0.178 0.269508 0.531579 0.038 
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Periplasmic_Stress_Response 0.003793 0.002698 0.742 0.000417 0.010278 0.012 
Phage_regulation_of_gene_expression 0.039503 0.023652 0.442 0.015377 0.050165 0.042 
Purine_Utilization 0.113932 0.212878 0.162 0.141607 0.321402 0.050 
RNA_pseudouridine_syntheses 0.042751 0.050298 0.594 0.037288 0.100224 0.020 
Respiratory_dehydrogenases_1 0.064623 0.024315 0.221 0.008686 0.069792 0.017 
Toxin-antitoxin_systems_(other_than_RelBE_and_MazEF) 0.028845 0.046654 0.249 0.055145 0.013832 0.039 
Transcription_factors_bacterial 0.270726 0.207807 0.438 0.177510 0.312108 0.027 
Type_1_pili_(mannose-sensitive_fimbriae,_gamma-fimbriae) 0.000791 0.000818 0.976 0.000596 0.004062 0.006 
Wyeosine-MimG_Biosynthesis 0.028776 0.012880 0.128 0.009121 0.072601 0.002 
YggW 0.024045 0.022968 0.924 0.016868 0.037697 0.035 
tRNAmodification_position_34 0.066658 0.104169 0.187 0.076767 0.124333 0.044 
trimethylamine_N-oxide_(TMAO)_reductase 0.000162 0.007294 0.189 0.000202 0.005394 0.041 
*Highlighted cells indicate statistically significant 
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Table S14: Average relative abundance of genes encoding KEGG Orthology (KO) level 1 functions in 
the caecum of chickens fed sorghum based and wheat based diet at the age of day 13 
 
KO Level 1 
Average Relative Abundance 
Sorghum Wheat 
Control H57 Control H57 
Cellular Processes 3.48 2.99 3.28 2.67 
Environmental Information Processing 11.66 14.53 14.66 14.87 
Genetic Information Processing 25.23 26.11 24.44 24.81 
Metabolism 57.79 55.13 56.44 56.05 
Human Diseases 1.02 0.73 0.76 1.18 
Organismal Systems 0.81 0.51 0.43 0.41 
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Table S15: Average relative abundance of genes encoding SEED subsystem level 1 functions in the 
caecum of chickens fed sorghum based and wheat based diet at the age of day 13 
 
Subsystem level 1 Average Relative Abundance 
Sorghum Wheat 
Control H57 Control H57 
Carbohydrates 17.56 18.73 17.39 17.65 
Clustering-based subsystems 12.34 13.15 13.42 12.70 
Protein Metabolism 9.98 10.04 9.76 10.61 
Amino Acids and Derivatives 8.88 8.75 9.68 9.61 
DNA Metabolism 6.93 7.81 7.05 6.43 
RNA Metabolism 5.14 5.18 5.10 5.54 
Miscellaneous 4.66 4.41 5.05 5.15 
Phages, Prophages, Transposable elements, Plasmids 4.54 3.20 3.11 3.06 
Cell Wall and Capsule 4.07 2.67 3.54 3.33 
Cofactors, Vitamins, Prosthetic Groups, Pigments 3.78 2.98 3.32 3.27 
Nucleosides and Nucleotides 3.50 3.80 3.99 4.20 
Virulence, Disease and Defense 3.04 2.36 1.94 1.77 
Membrane Transport 2.86 3.30 3.29 3.53 
Respiration 2.86 2.97 2.84 3.29 
Fatty Acids, Lipids, and Isoprenoids 1.47 1.48 1.76 1.94 
Cell Division and Cell Cycle 1.39 2.14 1.85 1.83 
Stress Response 1.22 1.62 1.18 1.25 
Phosphorus Metabolism 1.22 1.03 1.39 1.09 
Iron acquisition and metabolism 1.12 0.80 0.86 0.50 
Regulation and Cell signaling 0.80 0.61 0.64 0.78 
Nitrogen Metabolism 0.71 0.78 0.69 0.61 
Sulfur Metabolism 0.62 0.57 0.68 0.38 
Dormancy and Sporulation 0.40 0.79 0.53 0.44 
Potassium metabolism 0.39 0.14 0.40 0.34 
Metabolism of Aromatic Compounds 0.31 0.44 0.32 0.44 
Motility and Chemotaxis 0.15 0.14 0.10 0.14 
Photosynthesis 0.03 0.00 0.00 0.01 
Secondary Metabolism 0.03 0.09 0.09 0.10 
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Appendix 4. Animal Ethics Approval Certificate 
 
